{"title_page": "Stade Brestois 29", "text_new": "{{See also|Stade Brestois New York (formerly Stade breton)}}\n{{EngvarB|date=April 2020}}\n{{Use dmy dates|date=April 2020}}\n{{Infobox football club\n|  clubname = Brest\n|  image    = [[File:Stade Brestois 29 logo.svg|center|200px]]\n|  fullname = Stade Brestois 29\n|  nickname = ''Les Ty' Zefs'' (Our Winds)<br>''La Team Pirate'' (The Pirate Team)<br>''SB29''\n|  motto    =  \n|  founded  = {{Start date and age|df=yes|1950}}\n|  ground   = [[Stade Francis-Le Bl\u00e9]],<br/>[[Brest, France|Brest]]\n|  capacity = 15,931\n|  chairman = Denis Le Saint\n|  manager  = [[Olivier Dall'Oglio]]\n|  league   = [[Ligue 1]]\n|  season   = [[2018\u201319 Ligue 2|2018\u201319]]\n|  position = [[Ligue 2]], 2nd (promoted)\n|  current = 2019\u201320 Stade Brestois 29 season\n|  website = http://www.sb29.bzh\n|pattern_la1 =_nikevapor1920r\n|pattern_b1  =_nikevapor1920r\n|pattern_ra1 =_nikevapor1920r\n|pattern_sh1 =\n|pattern_so1 =\n|leftarm1    =FF0000\n|body1       =FF0000\n|rightarm1   =FF0000\n|shorts1     =FFFFFF\n|socks1      =FF0000\n|pattern_la2 =_nikevapor1920bb\n|pattern_b2  =_nikevapor1920bb\n|pattern_ra2 =_nikevapor1920bb\n|pattern_sh2 =\n|pattern_so2 =\n|leftarm2    =000000\n|body2       =000000\n|rightarm2   =000000\n|shorts2     =000000\n|socks2      =000000\n|pattern_la3 =_nikevapor1920w\n|pattern_b3  =_nikevapor1920w\n|pattern_ra3 =_nikevapor1920w\n|pattern_sh3 =\n|pattern_so3 =\n|leftarm3=FFFFFF\n|body3=FFFFFF\n|rightarm3=FFFFFF\n|shorts3=FFFFFF\n|socks3=FFFFFF\n}}\n'''Stade Brestois 29''' ({{IPA-fr|st\u0251d b\u0281\u025bstw\u0251\u02d0}}; {{IPA-fr|st\u0252d brestw\u0252|local}}; commonly referred to as '''Stade Brest''' or simply '''Brest''') is a [[French football]] club based in [[Brest, France|Brest]]. The club was founded in 1950. Brest currently plays in [[Ligue 1]], the first division in [[French football]].\nThe club plays its home matches at the [[Stade Francis le Bl\u00e9]], a stadium with a capacity of 15,097.\n\n== League participations (from 1950) ==\n\n'''Ligue 1:''' 1979\u201380, 1981\u201388, 1989\u201391, 2010\u201313, 2019\u2014''present''\n\n'''Ligue 2:''' 1970\u201379, 1980\u201381, 1988\u201389, 2004\u201310, 2013\u20132019\n\n'''National (Before 1970 CFA, Division 3 between 1970\u201393):''' 1958\u201363, 1966\u201370, 1991\u201397, 2000\u201304\n\n'''CFA (Before 1970 Division Honour):''' 1953\u201358, 1963\u201366, 1997\u201300\n\n'''CFA2 (Before 1970 Division Honour Regional):''' 1952\u201353\n\n'''Division Honour (Before 1970 Promotion Honour):''' 1951\u201352\n\n'''Promotion Ligue (Before 1970 District):''' 1950\u201351\n\n== Sponsors ==\n\n*[[:fr:Qu\u00e9guiner Mat\u00e9riaux|Qu\u00e9guiner]]\n*[[Groupe Casino]]\n*[[Guyot]]\n*[[Breizh Cola]]\n*[[Sill (food manufacturer)|Sill]]\n\n== Players ==\n\n=== Current squad ===\n{{updated|14 January 2020.|<ref>{{cite web|url=http://www.sb29.bzh/effectif.php |title= Effectif Ligue 1 Conforama / 2019\u20132020 |accessdate=2 August 2019}}</ref><ref>{{cite web|url=https://www.sb29.bzh/mercato-2019.php |title= MERCATO ESTIVAL 2019 |publisher=Stade Brestois Official Site |accessdate=16 July 2019}}</ref>}}\n\n{{Fs start}}\n{{Fs player|no= 1|nat=FRA|name=[[Gautier Larsonneur]]|pos=GK}}\n{{Fs player|no= 2|nat=FRA|name=[[Jean-K\u00e9vin Duverne]]|pos=DF}}\n{{Fs player|no= 5|nat=FRA|name=[[Brendan Chardonnet]]|pos=DF}}\n{{Fs player|no= 6|nat=FRA|name=[[Ibrahima Diallo (footballer, born 1999)|Ibrahima Diallo]]|pos=MF}}\n{{Fs player|no= 7|nat=ALG|name=[[Haris Belkebla]]|pos=MF}}\n{{Fs player|no= 8|nat=FRA|name=[[Yoann Court]]|pos=MF}}\n{{Fs player|no= 9|nat=FRA|name=[[K\u00e9vin Mayi]]|pos=FW}}\n{{Fs player|no=10|nat=FRA|name=[[Ga\u00ebtan Charbonnier]]|pos=FW}}\n{{Fs player|no=11|nat=ITA|name=[[Christian Battocchio]]|pos=MF}}\n{{Fs player|no=12|nat=BEN|name=[[David Kiki]]|pos=DF}}\n{{Fs player|no=13|nat=FRA|name=[[Paul Lasne]]|pos=MF}}\n{{Fs Player|no=14|nat=FRA|name=[[Irvin Cardona]]|pos=FW}}\n{{Fs player|no=15|nat=FRA|name=[[Alexandre Mendy (footballer, born 1994)|Alexandre Mendy]]|pos=FW|other=on loan from [[FC Girondins de Bordeaux|Bordeaux]]}}\n{{fs mid}}\n{{Fs player|no=16|nat=GYF|natvar=local|name=[[Donovan L\u00e9on]]|pos=GK}}\n{{Fs player|no=17|nat=FRA|name=[[D\u00e9nys Bain]]|pos=DF}}\n{{Fs player|no=18|nat=FRA|name=[[Romain Perraud]]|pos=DF}}\n{{Fs player|no=19|nat=FRA|name=[[Ferris N'Goma]]|pos=MF}}\n{{Fs player|no=20|nat=FRA|name=[[Ga\u00ebtan Belaud]]|pos=DF|other=[[Captain (association football)|captain]]}}\n{{Fs player|no=21|nat=CMR|name=[[Jean-Charles Castelletto]]|pos=DF}}\n{{Fs player|no=22|nat=FRA|name=[[Julien Faussurier]]|pos=MF}}\n{{Fs player|no=23|nat=FRA|name=[[Mathias Autret]]|pos=MF|other=[[Captain (association football)|vice-captain]]}}\n{{Fs player|no=24|nat=GYF|natvar=local|name=[[Ludovic Baal]]|pos=DF}}\n{{Fs player|no=25|nat=FRA|name=[[Samuel Grandsir]]|pos=FW|other=on loan from [[AS Monaco FC|Monaco]]}}\n{{Fs player|no=27|nat=FRA|name=[[Hugo Magnetti]]|pos=MF}}\n{{Fs player|no=28|nat=FRA|name=[[Hiang'a Mbock]]|pos=MF}}\n{{Fs player|no=30|nat=FRA|name=[[S\u00e9bastien Cibois]]|pos=GK}}\n{{Fs end}}\n\n===Out on loan===\n{{Fs start}}\n{{Fs player|no= \u2014|nat=FRA|name=Guillaume Buon|pos=DF|other=on loan to [[US Avranches|Avranches]]}}\n{{Fs player|no= \u2014|nat=FRA|name=[[Derick Osei]]|pos=MF|other=on loan to [[AS B\u00e9ziers|B\u00e9ziers]]}}\n{{Fs end}}\n\n=== Notable players ===\nBelow are the notable former and current players who have represented Stade Brestois in [[Ligue 1|league]] and international competition since the club's foundation in 1903. To appear in the section below, a player must have either played in at least 80 official matches for the club or represented their country's national team either while playing for Brest or after departing the club.\n''For a complete list of Stade Brestois players, see [[:Category:Stade Brestois 29 players]].''\n{{col-start}}\n{{col-3}}\n*{{Flagicon|Argentina}} [[Jos\u00e9 Luis Brown]]\n*{{Flagicon|Argentina}} [[Jorge Higua\u00edn]]\n*{{Flagicon|Brazil}} [[J\u00falio C\u00e9sar da Silva|J\u00falio C\u00e9sar]]\n*{{Flagicon|France}} [[G\u00e9rard Buscher]]\n*{{Flagicon|France}} [[Patrick Colleter]]\n*{{Flagicon|France}} [[David Ginola]]\n*{{Flagicon|France}} [[Vincent Gu\u00e9rin]]\n*{{Flagicon|France}} [[St\u00e9phane Guivarc'h]]\n*{{Flagicon|France}} [[Bernard Lama]]\n*{{Flagicon|France}} [[Paul Le Guen]]\n{{col-3}}\n*{{Flagicon|France}} [[Yvon Le Roux]]\n*{{Flagicon|France}} [[Corentin Martins]]\n*{{Flagicon|France}} [[Bernard Pardo]]\n*{{Flagicon|France}} [[Pascal Pierre]]\n*{{Flagicon|France}} [[Franck Rib\u00e9ry]]\n*{{Flagicon|France}} [[Nolan Roux]]\n*{{Flagicon|Paraguay}} [[Roberto Caba\u00f1as]]\n*{{Flagicon|Yugoslavia}} [[Drago Vabec]]\n{{col-3}}\n\n{{col-end}}\n\n==Coaches==\n{{columns-list|colwidth=22em|\n*Francis Chopin (1950\u201362)\n*Albert Toris (1962\u201363)\n*Sarkis Garabedian (1963\u201376)\n*Armand Fouillen  ''(1)'' (1963\u201376)\n*Ernest Rannou  (1964\u201366)\n*[[Alain de Martigny]] ''(1)'' (1976\u201382)\n*[[Du\u0161an Nenkovi\u0107]] (1982\u201384)\n*[[Robert Dewilder]] (1984\u201386)\n*[[Raymond K\u00e9ruzor\u00e9]] (1986\u201387)\n*Bernard Maligorne (1987\u201389)\n*[[Slavoljub Muslin]] (1989\u201391)\n*Armand Fouillen ''(2)'' (1991\u201393)\n*[[Yvon Le Roux]] (1991\u201393)\n*[[Yves Todorov]] (1993\u201394)\n*[[Pierre Garcia]] (1994\u201395)\n*Denis Goavec (1995\u201397)\n*[[Pascal Robert]] (1997\u201399)\n*[[Alain de Martigny]] ''(2)'' (1999\u201302)\n*Sylvain Matrisciano (2002\u201303)\n*[[Albert Rust (footballer)|Albert Rust]] (July 2003 \u2013 Mar 2006)\n*[[Thierry Goudet]] (March 2006 \u2013 Dec 2006)\n*[[Pascal Janin]] (Jan 2007 \u2013 Oct 2008)\n*[[G\u00e9rald Baticle]] (Nov 2008 \u2013 May 2009)\n*[[Alex Dupont]] ''(1)'' (May 2009 \u2013 Apr 2012)\n*[[Landry Chauvin]] (May 2012 \u2013 Apr 2013)\n*[[Corentin Martins]] ''(interim)'' (April 2013 \u2013 May 2013)\n*[[Alex Dupont]] ''(2)'' (June 2013 \u2013 May 2016)\n*[[Jean-Marc Furlan]] (May 2016 \u2013 May 2019)\n*[[Olivier Dall'Oglio]] (May 2019\u2013''present'')\n}}\n\n==Club honours==\n\n*[[Ligue 2]]\n**''Champions'': [[1980\u201381 French Division 2|1980\u201381]]\n*[[Coupe de France]]\n**''Quarter-finalist'': (2) [[1982\u201383 Coupe de France|1982\u201383]], [[2014\u201315 Coupe de France|2014\u201315]]\n*[[Coupe Gambardella]]\n**''Winner'': 1990\n*'''Division d'Honneur (Bretagne)'''\n**''Champions'': (4) 1966, 1972, 1977, 2005\n*'''Cup of Brittany'''\n**''Winner'': 1969\n*'''Championnat de France des patronages (catholic football league)'''\n**''Winner'': 1923\n\n==History of last 22 years==\n{| bgcolor=\"#f7f8ff\" cellpadding=\"3\" cellspacing=\"0\" border=\"1\" style=\"font-size: 95%; border: grey solid 1px; border-collapse: collapse;\"\n|- bgcolor=\"#CCCCCC\"\n| align=\"center\"|'''Season'''\n| align=\"center\"|'''Level'''\n| align=\"center\"|'''Div.'''\n| align=\"center\"|'''Pos.'''\n| align=\"center\"|'''GP'''\n| align=\"center\"|'''W'''\n| align=\"center\"|'''D'''\n| align=\"center\"|'''L'''\n| align=\"center\"|'''GF'''\n| align=\"center\"|'''GA'''\n| align=\"center\"|'''Points'''\n| align=\"center\"|'''Eur.Cup Entrance'''\n| align=\"center\"|'''French Cup'''\n| align=\"center\"|'''French League Cup'''\n| align=\"center\"|'''Av.Attendance'''<ref>Average attendances since 2004 from ''lfp.fr'': [http://www.lfp.fr/ligue1/affluences/club ''Ligue 1 \u2013 Affluences par journ\u00e9e, par club, taux de remplissage''] (Ligue1 seasons), [http://www.lfp.fr/ligue2/affluences/club ''Ligue 2 \u2013 Affluences par journ\u00e9e, par club, taux de remplissage''] (Ligue2 seasons)</ref>\n|- bgcolor=\"#DDDDDD\"\n| colspan=\"15\" | ''Stade Brestois 29''\n|-bgcolor=\"#EFEFEF\" align=\"center\"\n| 1997\u201398 || 4 || [[Championnat de France Amateurs|''CFA-D'']]  || '''9.''' || 34 || 12 || 10 || 12 || 45 || 40 || '''46''' || --- ||qual.stage || \u2013 ||   530\n|-align=\"center\"\n| 1998\u201399 || 4 || [[Championnat de France Amateurs|''CFA-D'']]  || '''9.''' || 34 || 12 || 12 || 10 || 44 || 38 || '''48''' || --- || qual.stage || \u2013 || \u2013\n|- style=\"background:gold;\" align=\"center\"\n| 1999\u201300 || 4 || [[Championnat de France Amateurs|''CFA-D'']]  || '''1.''' || 34 || 20 || 9 || 5 || 50 || 31 || '''69''' || --- || R. 1/32 || \u2013 || \u2013\n|-align=\"center\"\n| 2000\u201301 || 3 || [[Championnat National]]   || '''6.''' || 38 || 19 || 6 || 13 || 64 || 48 || '''63''' || --- || qual.stage || \u2013 || \u2013\n|-bgcolor=\"#EFEFEF\" align=\"center\"\n| 2001\u201302 || 3 || Championnat National || '''13.''' || 38 || 11 || 11 || 16 || 40 || 43 || '''44''' || --- || qual.stage || \u2013 || \u2013\n|-align=\"center\"\n| 2002\u201303 || 3 || Championnat National || '''10.''' || 38 || 13 || 11 || 14 || 49 || 44 || '''50''' || --- || qual.stage || \u2013 || \u2013\n|- style=\"background:silver;\" align=\"center\"\n| 2003\u201304 || 3 || Championnat National || '''2.''' || 38 || 20 || 8 || 10 || 45 || 30 || '''68''' || --- || R.1/8 || \u2013 || \u2013\n|-align=\"center\"\n| 2004\u201305 || 2 || ''[[Ligue 2]]'' || '''9.''' || 38 || 13 || 16 || 9 || 38 || 34 || '''55''' || --- || R.1/32 || R.1/16 || ''7,340'\n|-bgcolor=\"#EFEFEF\" align=\"center\"\n| 2005\u201306 || 2 || ''[[Ligue 2]]''  || '''17.''' || 38 || 9 || 15 || 14 || 34 || 48 || '''42''' || --- || R.1/8 || qual.stage || ''6,167''\n|-align=\"center\"\n| 2006\u201307 || 2 || ''[[Ligue 2]]''  || '''14.''' || 38 || 10 || 15 || 13 || 40 || 40 || '''45''' || --- || R.1/32 || qual.stage || ''5,932''\n|-align=\"center\"\n| 2007\u201308 || 2 || ''[[Ligue 2]]''  || '''7.''' || 38 || 15 || 12 || 11 || 38 || 38 || '''57''' || --- || R.1/16 || R.1/32  || ''5,739''\n|-align=\"center\"\n| 2008\u201309 || 2 || ''[[Ligue 2]]''  || '''14.''' || 38 || 13 || 6 || 19 || 45 || 50 || '''45''' || --- || R.1/16 || qual.stage || ''6,334''\n|- style=\"background:silver;\" align=\"center\"\n| 2009\u201310 || 2 || ''[[Ligue 2]]''  || '''2.''' || 38 || 20 || 7 || 11 || 53 || 34 || '''67''' || --- || R.1/8 || first round || ''7,702''\n|-align=\"center\"\n| 2010\u201311 || 1 || ''[[Ligue 1]]''  || '''16.''' || 38 || 11 || 13 || 14 || 36 || 43 || '''46''' || --- || R.1/32 || third round || ''13,549''\n|-align=\"center\"\n| 2011\u201312 || 1 || ''[[Ligue 1]]''  || '''15.''' || 38 || 8 || 17 || 13 || 31 || 38 || '''41''' || --- || R.1/64 || third round || ''13,597''\n|-align=\"center\"\n| 2012\u201313 || 1 || ''[[Ligue 1]]''  || '''20.''' || 38 || 8 || 5 || 25 || 32 || 62 || '''29''' || --- || R.1/16 || third round || ''11,796''\n|-align=\"center\"\n| 2013\u201314 || 2 || ''[[Ligue 2]]''  || '''7.''' || 38 || 15 || 11 || 12 || 38 || 32 || '''56''' || --- || R.1/32 || third round || ''7,609''\n|-align=\"center\"\n| 2014\u201315 || 2 || ''[[Ligue 2]]''  || '''6.''' || 38 || 14 || 15 || 9 || 41 || 27 || '''57''' || --- || R.1/4 || first round || ''7,557''\n|-align=\"center\"\n| 2015\u201316 || 2 || ''[[Ligue 2]]''  || '''10.''' || 38 || 12 || 11 || 15 || 34 || 41 || '''47''' || --- || qual. stage || first round || ''6,887''\n|-align=\"center\"\n| 2016\u201317 || 2 || ''[[Ligue 2]]''  || '''5.''' || 38 || 19 || 8 || 11 || 58 || 44 || '''65''' || --- || R.1/64 || second round || ''8,042''\n|-align=\"center\"\n| 2017\u201318 || 2 || ''[[Ligue 2]]''  || '''5.''' || 38 || 18 || 11 || 9 || 58 || 43 || '''65''' || --- || qual. stage || first round || ''7,458''\n|-align=\"center\"\n|- style=\"background:silver;\" align=\"center\"\n| 2018\u201319 || 2 || ''[[Ligue 2]]''  || '''2.''' || 38 || 21 || 11 || 6 || 64 || 35 || '''74''' || --- || R.1/64 || second round || ''9,216''\n|-align=\"center\"\n|}\n\n==Partnership==\nSince September 2011, Stade Brestois 29 sponsors its amateur American counterpart in New York, [[Stade Brestois New York]].\n<ref>{{cite web|title=Stade Brestois provide Bretons in NY with soccer equipment|publisher=Le Telegramme|date=26 September 2011|url=http://www.letelegramme.com/local/finistere-nord/brest/ville/brest-le-stade-brestois-habillera-les-bretons-de-new-york-26-09-2011-1443824.php}}</ref>{{,}}<ref>{{cite web|title=Stade Brestois is represented in NY|publisher=Ouest France|date=27 September 2011|url=http://www.ouest-france.fr/actu/actuLocale_-Le-Stade-brestois-sera-represente-a-New-York-_29019-avd-20110927-61349153_actuLocale.Htm}}</ref>\n\n==References==\n{{Reflist}}\n\n==External links==\n{{commons category|Stade Brestois 29}}\n*[http://www.sb29.bzh/ Official website]\n\n{{Ligue 1 teamlist}}\n{{Championnat National 3 Group Brittany}}\n\n{{DEFAULTSORT:Brestois 29}}\n[[Category:Stade Brestois 29| ]]\n[[Category:Association football clubs established in 1950]]\n[[Category:Sports clubs established in 1950]]\n[[Category:Sport in Brest, France]]\n[[Category:1950 establishments in France]]\n", "text_old": "{{See also|Stade Brestois New York (formerly Stade breton)}}\n{{Use dmy dates|date=May 2014}}\n{{Infobox football club\n|  clubname = Brest\n|  image    = [[File:Stade Brestois 29 logo.svg|center|200px]]\n|  fullname = Stade Brestois 29\n|  nickname = ''Les Ty' Zefs'' (Our Winds)<br>''La Team Pirate'' (The Pirate Team)<br>''SB29''\n|  motto    =  \n|  founded  = {{Start date and age|df=yes|1950}}\n|  ground   = [[Stade Francis-Le Bl\u00e9]],<br/>[[Brest, France|Brest]]\n|  capacity = 15,931\n|  chairman = Denis Le Saint\n|  manager  = [[Olivier Dall'Oglio]]\n|  league   = [[Ligue 1]]\n|  season   = [[2018\u201319 Ligue 2|2018\u201319]]\n|  position = [[Ligue 2]], 2nd (promoted)\n|  current = 2019\u201320 Stade Brestois 29 season\n|  website = http://www.sb29.bzh\n|pattern_la1 =_nikevapor1920r\n|pattern_b1  =_nikevapor1920r\n|pattern_ra1 =_nikevapor1920r\n|pattern_sh1 =\n|pattern_so1 =\n|leftarm1    =FF0000\n|body1       =FF0000\n|rightarm1   =FF0000\n|shorts1     =FFFFFF\n|socks1      =FF0000\n|pattern_la2 =_nikevapor1920bb\n|pattern_b2  =_nikevapor1920bb\n|pattern_ra2 =_nikevapor1920bb\n|pattern_sh2 =\n|pattern_so2 =\n|leftarm2    =000000\n|body2       =000000\n|rightarm2   =000000\n|shorts2     =000000\n|socks2      =000000\n|pattern_la3 =_nikevapor1920w\n|pattern_b3  =_nikevapor1920w\n|pattern_ra3 =_nikevapor1920w\n|pattern_sh3 =\n|pattern_so3 =\n|leftarm3=FFFFFF\n|body3=FFFFFF\n|rightarm3=FFFFFF\n|shorts3=FFFFFF\n|socks3=FFFFFF\n}}\n'''Stade Brestois 29''' ({{IPA-fr|st\u0251d b\u0281\u025bstw\u0251\u02d0}}; {{IPA-fr|st\u0252d brestw\u0252|local}}; commonly referred to as '''Stade Brest''' or simply '''Brest''') is a [[French football]] club based in [[Brest, France|Brest]]. The club was founded in 1950. Brest currently plays in [[Ligue 1]], the first division in [[French football]].\nThe club plays its home matches at the [[Stade Francis le Bl\u00e9]], a stadium with a capacity of 15,097.\n\n== League participations (from 1950) ==\n\n'''Ligue 1:''' 1979\u201380, 1981\u201388, 1989\u201391, 2010\u201313, 2019\u2014''present''\n\n'''Ligue 2:''' 1970\u201379, 1980\u201381, 1988\u201389, 2004\u201310, 2013\u20132019\n\n'''National (Before 1970 CFA, Division 3 between 1970\u201393):''' 1958\u201363, 1966\u201370, 1991\u201397, 2000\u201304\n\n'''CFA (Before 1970 Division Honour):''' 1953\u201358, 1963\u201366, 1997\u201300\n\n'''CFA2 (Before 1970 Division Honour Regional):''' 1952\u201353\n\n'''Division Honour (Before 1970 Promotion Honour):''' 1951\u201352\n\n'''Promotion Ligue (Before 1970 District):''' 1950\u201351\n\n== Sponsors ==\n\n*[[:fr:Qu\u00e9guiner Mat\u00e9riaux|Qu\u00e9guiner]]\n*[[Groupe Casino]]\n*[[Guyot]]\n*[[Breizh Cola]]\n*[[Sill (food manufacturer)|Sill]]\n\n== Players ==\n\n=== Current squad ===\n{{updated|14 January 2020.|<ref>{{cite web|url=http://www.sb29.bzh/effectif.php |title= Effectif Ligue 1 Conforama / 2019-2020 |accessdate=2 August 2019}}</ref><ref>{{cite web|url=https://www.sb29.bzh/mercato-2019.php |title= MERCATO ESTIVAL 2019 |publisher=Stade Brestois Official Site |accessdate=16 July 2019}}</ref>}}\n\n{{Fs start}}\n{{Fs player|no= 1|nat=FRA|name=[[Gautier Larsonneur]]|pos=GK}}\n{{Fs player|no= 2|nat=FRA|name=[[Jean-K\u00e9vin Duverne]]|pos=DF}}\n{{Fs player|no= 5|nat=FRA|name=[[Brendan Chardonnet]]|pos=DF}}\n{{Fs player|no= 6|nat=FRA|name=[[Ibrahima Diallo (footballer, born 1999)|Ibrahima Diallo]]|pos=MF}}\n{{Fs player|no= 7|nat=ALG|name=[[Haris Belkebla]]|pos=MF}}\n{{Fs player|no= 8|nat=FRA|name=[[Yoann Court]]|pos=MF}}\n{{Fs player|no= 9|nat=FRA|name=[[K\u00e9vin Mayi]]|pos=FW}}\n{{Fs player|no=10|nat=FRA|name=[[Ga\u00ebtan Charbonnier]]|pos=FW}}\n{{Fs player|no=11|nat=ITA|name=[[Christian Battocchio]]|pos=MF}}\n{{Fs player|no=12|nat=BEN|name=[[David Kiki]]|pos=DF}}\n{{Fs player|no=13|nat=FRA|name=[[Paul Lasne]]|pos=MF}}\n{{Fs Player|no=14|nat=FRA|name=[[Irvin Cardona]]|pos=FW}}\n{{Fs player|no=15|nat=FRA|name=[[Alexandre Mendy (footballer, born 1994)|Alexandre Mendy]]|pos=FW|other=on loan from [[FC Girondins de Bordeaux|Bordeaux]]}}\n{{fs mid}}\n{{Fs player|no=16|nat=GYF|natvar=local|name=[[Donovan L\u00e9on]]|pos=GK}}\n{{Fs player|no=17|nat=FRA|name=[[D\u00e9nys Bain]]|pos=DF}}\n{{Fs player|no=18|nat=FRA|name=[[Romain Perraud]]|pos=DF}}\n{{Fs player|no=19|nat=FRA|name=[[Ferris N'Goma]]|pos=MF}}\n{{Fs player|no=20|nat=FRA|name=[[Ga\u00ebtan Belaud]]|pos=DF|other=[[Captain (association football)|captain]]}}\n{{Fs player|no=21|nat=CMR|name=[[Jean-Charles Castelletto]]|pos=DF}}\n{{Fs player|no=22|nat=FRA|name=[[Julien Faussurier]]|pos=MF}}\n{{Fs player|no=23|nat=FRA|name=[[Mathias Autret]]|pos=MF|other=[[Captain (association football)|vice-captain]]}}\n{{Fs player|no=24|nat=GYF|natvar=local|name=[[Ludovic Baal]]|pos=DF}}\n{{Fs player|no=25|nat=FRA|name=[[Samuel Grandsir]]|pos=FW|other=on loan from [[AS Monaco FC|Monaco]]}}\n{{Fs player|no=27|nat=FRA|name=[[Hugo Magnetti]]|pos=MF}}\n{{Fs player|no=28|nat=FRA|name=[[Hiang'a Mbock]]|pos=MF}}\n{{Fs player|no=30|nat=FRA|name=[[S\u00e9bastien Cibois]]|pos=GK}}\n{{Fs end}}\n\n===Out on loan===\n{{Fs start}}\n{{Fs player|no= \u2014|nat=FRA|name=Guillaume Buon|pos=DF|other=on loan to [[US Avranches|Avranches]]}}\n{{Fs player|no= \u2014|nat=FRA|name=[[Derick Osei]]|pos=MF|other=on loan to [[AS B\u00e9ziers|B\u00e9ziers]]}}\n{{Fs end}}\n\n=== Notable players ===\nBelow are the notable former and current players who have represented Stade Brestois in [[Ligue 1|league]] and international competition since the club's foundation in 1903. To appear in the section below, a player must have either played in at least 80 official matches for the club or represented their country's national team either while playing for Brest or after departing the club.\n''For a complete list of Stade Brestois players, see [[:Category:Stade Brestois 29 players]].''\n{{col-start}}\n{{col-3}}\n*{{Flagicon|Argentina}} [[Jos\u00e9 Luis Brown]]\n*{{Flagicon|Argentina}} [[Jorge Higua\u00edn]]\n*{{Flagicon|Brazil}} [[J\u00falio C\u00e9sar da Silva|J\u00falio C\u00e9sar]]\n*{{Flagicon|France}} [[G\u00e9rard Buscher]]\n*{{Flagicon|France}} [[Patrick Colleter]]\n*{{Flagicon|France}} [[David Ginola]]\n*{{Flagicon|France}} [[Vincent Gu\u00e9rin]]\n*{{Flagicon|France}} [[St\u00e9phane Guivarc'h]]\n*{{Flagicon|France}} [[Bernard Lama]]\n*{{Flagicon|France}} [[Paul Le Guen]]\n{{col-3}}\n*{{Flagicon|France}} [[Yvon Le Roux]]\n*{{Flagicon|France}} [[Corentin Martins]]\n*{{Flagicon|France}} [[Bernard Pardo]]\n*{{Flagicon|France}} [[Pascal Pierre]]\n*{{Flagicon|France}} [[Franck Rib\u00e9ry]]\n*{{Flagicon|France}} [[Nolan Roux]]\n*{{Flagicon|Paraguay}} [[Roberto Caba\u00f1as]]\n*{{Flagicon|Yugoslavia}} [[Drago Vabec]]\n{{col-3}}\n\n{{col-end}}\n\n{{EngvarB|date=May 2014}}\n{{Use dmy dates|date=May 2014}}\n\n==Coaches==\n{{columns-list|colwidth=22em|\n*Francis Chopin (1950\u201362)\n*Albert Toris (1962\u201363)\n*Sarkis Garabedian (1963\u201376)\n*Armand Fouillen  ''(1)'' (1963\u201376)\n*Ernest Rannou  (1964\u201366)\n*[[Alain de Martigny]] ''(1)'' (1976\u201382)\n*[[Du\u0161an Nenkovi\u0107]] (1982\u201384)\n*[[Robert Dewilder]] (1984\u201386)\n*[[Raymond K\u00e9ruzor\u00e9]] (1986\u201387)\n*Bernard Maligorne (1987\u201389)\n*[[Slavoljub Muslin]] (1989\u201391)\n*Armand Fouillen ''(2)'' (1991\u201393)\n*[[Yvon Le Roux]] (1991\u201393)\n*[[Yves Todorov]] (1993\u201394)\n*[[Pierre Garcia]] (1994\u201395)\n*Denis Goavec (1995\u201397)\n*[[Pascal Robert]] (1997\u201399)\n*[[Alain de Martigny]] ''(2)'' (1999\u201302)\n*Sylvain Matrisciano (2002\u201303)\n*[[Albert Rust (footballer)|Albert Rust]] (July 2003\u2013Mar 2006)\n*[[Thierry Goudet]] (March 2006\u2013Dec 2006)\n*[[Pascal Janin]] (Jan 2007\u2013Oct 2008)\n*[[G\u00e9rald Baticle]] (Nov 2008\u2013May 2009)\n*[[Alex Dupont]] ''(1)'' (May 2009\u2013Apr 2012)\n*[[Landry Chauvin]] (May 2012\u2013Apr 2013)\n*[[Corentin Martins]] ''(interim)'' (April 2013\u2013May 2013)\n*[[Alex Dupont]] ''(2)'' (June 2013\u2013May 2016)\n*[[Jean-Marc Furlan]] (May 2016\u2013May 2019)\n*[[Olivier Dall'Oglio]] (May 2019-''present'')\n}}\n\n==Club honours==\n\n*[[Ligue 2]]\n**''Champions'': [[1980\u201381 French Division 2|1980\u201381]]\n*[[Coupe de France]]\n**''Quarter-finalist'': (2) [[1982\u201383 Coupe de France|1982\u201383]], [[2014\u201315 Coupe de France|2014\u201315]]\n*[[Coupe Gambardella]]\n**''Winner'': 1990\n*'''Division d'Honneur (Bretagne)'''\n**''Champions'': (4) 1966, 1972, 1977, 2005\n*'''Cup of Brittany'''\n**''Winner'': 1969\n*'''Championnat de France des patronages (catholic football league)'''\n**''Winner'': 1923\n\n==History of last 22 years==\n{| bgcolor=\"#f7f8ff\" cellpadding=\"3\" cellspacing=\"0\" border=\"1\" style=\"font-size: 95%; border: grey solid 1px; border-collapse: collapse;\"\n|- bgcolor=\"#CCCCCC\"\n| align=\"center\"|'''Season'''\n| align=\"center\"|'''Level'''\n| align=\"center\"|'''Div.'''\n| align=\"center\"|'''Pos.'''\n| align=\"center\"|'''GP'''\n| align=\"center\"|'''W'''\n| align=\"center\"|'''D'''\n| align=\"center\"|'''L'''\n| align=\"center\"|'''GF'''\n| align=\"center\"|'''GA'''\n| align=\"center\"|'''Points'''\n| align=\"center\"|'''Eur.Cup Entrance'''\n| align=\"center\"|'''French Cup'''\n| align=\"center\"|'''French League Cup'''\n| align=\"center\"|'''Av.Attendance'''<ref>Average attendances since 2004 from ''lfp.fr'': [http://www.lfp.fr/ligue1/affluences/club ''Ligue 1 \u2013 Affluences par journ\u00e9e, par club, taux de remplissage''] (Ligue1 seasons), [http://www.lfp.fr/ligue2/affluences/club ''Ligue 2 \u2013 Affluences par journ\u00e9e, par club, taux de remplissage''] (Ligue2 seasons)</ref>\n|- bgcolor=\"#DDDDDD\"\n| colspan=\"15\" | ''Stade Brestois 29''\n|-bgcolor=\"#EFEFEF\" align=\"center\"\n| 1997\u201398 || 4 || [[Championnat de France Amateurs|''CFA-D'']]  || '''9.''' || 34 || 12 || 10 || 12 || 45 || 40 || '''46''' || --- ||qual.stage || \u2013 ||   530\n|-align=\"center\"\n| 1998\u201399 || 4 || [[Championnat de France Amateurs|''CFA-D'']]  || '''9.''' || 34 || 12 || 12 || 10 || 44 || 38 || '''48''' || --- || qual.stage || \u2013 || \u2013\n|- style=\"background:gold;\" align=\"center\"\n| 1999\u201300 || 4 || [[Championnat de France Amateurs|''CFA-D'']]  || '''1.''' || 34 || 20 || 9 || 5 || 50 || 31 || '''69''' || --- || R. 1/32 || \u2013 || \u2013\n|-align=\"center\"\n| 2000\u201301 || 3 || [[Championnat National]]   || '''6.''' || 38 || 19 || 6 || 13 || 64 || 48 || '''63''' || --- || qual.stage || \u2013 || \u2013\n|-bgcolor=\"#EFEFEF\" align=\"center\"\n| 2001\u201302 || 3 || Championnat National || '''13.''' || 38 || 11 || 11 || 16 || 40 || 43 || '''44''' || --- || qual.stage || \u2013 || \u2013\n|-align=\"center\"\n| 2002\u201303 || 3 || Championnat National || '''10.''' || 38 || 13 || 11 || 14 || 49 || 44 || '''50''' || --- || qual.stage || \u2013 || \u2013\n|- style=\"background:silver;\" align=\"center\"\n| 2003\u201304 || 3 || Championnat National || '''2.''' || 38 || 20 || 8 || 10 || 45 || 30 || '''68''' || --- || R.1/8 || \u2013 || \u2013\n|-align=\"center\"\n| 2004\u201305 || 2 || ''[[Ligue 2]]'' || '''9.''' || 38 || 13 || 16 || 9 || 38 || 34 || '''55''' || --- || R.1/32 || R.1/16 || ''7,340'\n|-bgcolor=\"#EFEFEF\" align=\"center\"\n| 2005\u201306 || 2 || ''[[Ligue 2]]''  || '''17.''' || 38 || 9 || 15 || 14 || 34 || 48 || '''42''' || --- || R.1/8 || qual.stage || ''6,167''\n|-align=\"center\"\n| 2006\u201307 || 2 || ''[[Ligue 2]]''  || '''14.''' || 38 || 10 || 15 || 13 || 40 || 40 || '''45''' || --- || R.1/32 || qual.stage || ''5,932''\n|-align=\"center\"\n| 2007\u201308 || 2 || ''[[Ligue 2]]''  || '''7.''' || 38 || 15 || 12 || 11 || 38 || 38 || '''57''' || --- || R.1/16 || R.1/32  || ''5,739''\n|-align=\"center\"\n| 2008\u201309 || 2 || ''[[Ligue 2]]''  || '''14.''' || 38 || 13 || 6 || 19 || 45 || 50 || '''45''' || --- || R.1/16 || qual.stage || ''6,334''\n|- style=\"background:silver;\" align=\"center\"\n| 2009\u201310 || 2 || ''[[Ligue 2]]''  || '''2.''' || 38 || 20 || 7 || 11 || 53 || 34 || '''67''' || --- || R.1/8 || first round || ''7,702''\n|-align=\"center\"\n| 2010\u201311 || 1 || ''[[Ligue 1]]''  || '''16.''' || 38 || 11 || 13 || 14 || 36 || 43 || '''46''' || --- || R.1/32 || third round || ''13,549''\n|-align=\"center\"\n| 2011\u201312 || 1 || ''[[Ligue 1]]''  || '''15.''' || 38 || 8 || 17 || 13 || 31 || 38 || '''41''' || --- || R.1/64 || third round || ''13,597''\n|-align=\"center\"\n| 2012\u201313 || 1 || ''[[Ligue 1]]''  || '''20.''' || 38 || 8 || 5 || 25 || 32 || 62 || '''29''' || --- || R.1/16 || third round || ''11,796''\n|-align=\"center\"\n| 2013\u201314 || 2 || ''[[Ligue 2]]''  || '''7.''' || 38 || 15 || 11 || 12 || 38 || 32 || '''56''' || --- || R.1/32 || third round || ''7,609''\n|-align=\"center\"\n| 2014\u201315 || 2 || ''[[Ligue 2]]''  || '''6.''' || 38 || 14 || 15 || 9 || 41 || 27 || '''57''' || --- || R.1/4 || first round || ''7,557''\n|-align=\"center\"\n| 2015\u201316 || 2 || ''[[Ligue 2]]''  || '''10.''' || 38 || 12 || 11 || 15 || 34 || 41 || '''47''' || --- || qual. stage || first round || ''6,887''\n|-align=\"center\"\n| 2016\u201317 || 2 || ''[[Ligue 2]]''  || '''5.''' || 38 || 19 || 8 || 11 || 58 || 44 || '''65''' || --- || R.1/64 || second round || ''8,042''\n|-align=\"center\"\n| 2017\u201318 || 2 || ''[[Ligue 2]]''  || '''5.''' || 38 || 18 || 11 || 9 || 58 || 43 || '''65''' || --- || qual. stage || first round || ''7,458''\n|-align=\"center\"\n|- style=\"background:silver;\" align=\"center\"\n| 2018\u201319 || 2 || ''[[Ligue 2]]''  || '''2.''' || 38 || 21 || 11 || 6 || 64 || 35 || '''74''' || --- || R.1/64 || second round || ''9,216''\n|-align=\"center\"\n|}\n\n==Partnership==\nSince September 2011, Stade Brestois 29 sponsors its amateur American counterpart in New York, [[Stade Brestois New York]].\n<ref>{{cite web|title=Stade Brestois provide Bretons in NY with soccer equipment|publisher=Le Telegramme|date=26 September 2011|url=http://www.letelegramme.com/local/finistere-nord/brest/ville/brest-le-stade-brestois-habillera-les-bretons-de-new-york-26-09-2011-1443824.php}}</ref>{{,}}<ref>{{cite web|title=Stade Brestois is represented in NY|publisher=Ouest France|date=27 September 2011|url=http://www.ouest-france.fr/actu/actuLocale_-Le-Stade-brestois-sera-represente-a-New-York-_29019-avd-20110927-61349153_actuLocale.Htm}}</ref>\n\n==References==\n{{Reflist}}\n\n==External links==\n{{commons category|Stade Brestois 29}}\n*[http://www.sb29.bzh/ Official website]\n\n{{Ligue 1 teamlist}}\n{{Championnat National 3 Group Brittany}}\n\n{{DEFAULTSORT:Brestois 29}}\n[[Category:Stade Brestois 29| ]]\n[[Category:Association football clubs established in 1950]]\n[[Category:Sports clubs established in 1950]]\n[[Category:Sport in Brest, France]]\n[[Category:1950 establishments in France]]\n", "name_user": "Dawnseeker2000", "label": "safe", "comment": "fixeddashesusing ascript, date formats perMOS:DATEFORMATbyscript, EngvarB", "url_page": "//en.wikipedia.org/wiki/Stade_Brestois_29"}
{"title_page": "Parimal Nathwani", "text_new": "{{Use dmy dates|date=May 2018}}\n{{Use Indian English|date=May 2018}}\n{{multiple issues|\n{{COI|date=March 2016}}\n{{peacock|date=March 2016}}\n{{BLP sources|date=October 2015}}\n}}\n\n{{Infobox officeholder\n| name =Parimal Dhirajlal Nathwani\n| image =Shri Parimal Nathwaniji.jpg\n| imagesize = \n| caption = \n| birth_date = {{birth date and age|1956|02|01|df=y}}\n| birth_place = [[Mumbai|Bombay]], [[Bombay State]], [[India]]\n| residence = [[Delhi]]<ref>{{cite web|url=http://www.archive.india.gov.in/govt/rajyasabhampbiodata.php?mpcode=2081|title=Detailed Profile - Shri Parimal Nathwani - Members of Parliament (Rajya Sabha) - Who's Who - Government: National Portal of India|work=india.gov.in|accessdate=5 August 2015}}</ref>\n| office1 = [[Member of Parliament|MP]] of [[Rajya Sabha]] from [[Andhra Pradesh]]\n| term_start1 = Apirl 2020\n| constituency1 = [[Andhra Pradesh]]\n| term_end1=\n| office2 = [[Member of Parliament|MP]] of [[Rajya Sabha]]\n| constituency2 =  [[Jharkhand]]\n| term_start2 = March 2014\n| term_end2= March  2020\n| predecessor2 =\n| successor2 =\n| office3 =[[MP of Rajya Sabha]]\n| term_start3 = March 2008\n| constituency3 = [[Jharkhand]]\n| term_end3 = March 2014\n| party = [[YSR Congress Party]]\n| nationality = [[India]]n \n| religion = Hindu\n| children = Dhanraj Nathwani (son) <br/> Karan Nathwani (son)\n| parents = Dhirajlal Nathwani (Father)<br>Pushpaben Nathwani(Mother)\n| spouse = Varsha Nathwani\n| occupation = Trader and Industrialist\n| publication = [[Jharkhand]] : Meri Karmabhoomi (A book in Hindi)\n| website = {{url|http://www.parimalnathwani.com/}}\n}}\n\n'''Parimal Dhirajlal Nathwani''' (born 1 February 1956) is an Indian politician and industrialist who has been elected as Member of Parliament ([[Rajya Sabha]]) from Jharkhand(2 times) and Andhra Pradesh (1time). He was first elected to [[Rajya Sabha]] in March 2008. Currently he has re-elected from Andhra Pradesh in March 2020.\n\nHe was an entrepreneur and a trader until the mid-1990s. He joined [[Reliance Group]] in 1997.<ref>{{cite web|url=https://www.bloomberg.com/Research/stocks/people/person.asp?personId=106680388&privcapId=878373|title=Sharing sorrow|work=Bloomberg|accessdate=11 April 2016}}</ref> As of 2016, he was the Group President of Corporate Affairs at Reliance Industries Ltd., a part of the headed by [[Mukesh Ambani]].<ref>{{cite web|url=https://www.bloomberg.com/Research/stocks/people/person.asp?personId=106680388&privcapId=878373|title=Bloomberg|accessdate=11 April 2016}}</ref> Nathwani closely worked with [[Dhirubhai Ambani]] and now has been working with RIL CMD [[Mukesh Ambani]].He is a key member in the core leadership at RIL.<ref>{{cite web|url=http://articles.economictimes.indiatimes.com/2013-01-24/news/36527036_1_jamnagar-refinery-reliance-foundation-nita-ambani/2|title=Meet the people who run Reliance Industries|work=economictimes-indiatimes|accessdate=11 April 2016}}</ref> Nathwani helped Dhirubhai Ambani in realizing his dream.{{clarify|reason=What dream? This is vague.|date=December 2018}} He played a pivotal role in land acquisition and setting up the biggest grassroots crude oil refinery on the western coast near [[Jamnagar]] in [[Gujarat]].<ref>{{cite web|url=http://www.vselindia.com/management.html|title=Vadodara Stock Exchange Management|work=Vadodara Stock Exchange|accessdate=11 April 2016}}</ref>\n\nNathwani became the face of Reliance Industries Limited (RIL) in [[Gujarat]] and other parts of the country. He spearheaded several of the group's projects including land acquisition for the [[Jamnagar]] refinery and building infrastructure to roll out 4-G broadband in 22 [[Administrative divisions of India#Sub-district|circles]] of the country.<ref>{{cite web|url=http://doodlevoodle.com/introduction-to-parimal-nathwani-member-of-parliament/|work=Doodlevoodle|title= Introduction to Parimal Nathwani Member of Parliament|accessdate=11 April 2016}}</ref>. {{clarify|reason=Source is vague.|date=February 2020}}\n\n==Biography==\nParimal D. Nathwani serves as Group President of Corporate Affairs at Reliance Industries Ltd.<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=106680388&privcapId=878373|title=Board Members-Reliance Industries Ltd (RIL:Natl India)|work=Bloomberg.com|accessdate=11 April 2015}}</ref> Nathwani is also the Vice President of the [[Gujarat Cricket Association]]. He serves as Director of [[Gujarat]] Petcoke and Petroproducts P. Ltd.<ref>{{cite web|url=http://companydata.in/gujarat-petcoke-and-petroproducts-supply-private-limited/825854.py|title=GUJARAT PETCOKE AND PETROPRODUCTS SUPPLY PRIVATE LIMITED|work=Companydata.in|accessdate=11 April 2016}}\n</ref> and Shri Dwarkadheesh Salt Works Pvt. Ltd.<ref>{{cite web|url=https://www.zaubacorp.com/company/SHREE-DWARKADHEESH-SALT-WORKS-PRIVATE-LIMITED/U27209GJ1995PTC027751|title=SHREE DWARKADHEESH SALT WORKS PRIVATE LIMITED|work=zaubacorp.com|accessdate=4 April 2016}}</ref><ref>{{cite web|url=http://www.indidata.in/1440827-shree-dwarkadheesh-salt-works-private-limited/|title=SHREE DWARKADHEESH SALT WORKS PRIVATE LIMITED|work=indidata.com|accessdate=4 April 2016}}</ref> He served as the Chairman of the Board of Vadodara Stock Exchange Limited from 30 September 2011 to 15 September 2012 and its Director from February 2008 to 15 September 2012.<ref>{{cite web|url=http://www.vselindia.com/management.html|title=Vadodara Stock Exchange Management|work=Vadodara Stock Exchange|accessdate=11 April 2016}}</ref> He steered his life as a business man and an entrepreneur till mid nineties. He joined Reliance group in 1997. He spearheaded several prestigious projects of the group from grass-root level since then. Nathwani holds key positions in various prestigious institutions viz. Reliance Rural Development Trust (RRDT)-Chairman, Dwarkadheesh Devasthan Samiti (DOS)- Vice-Chairman (appointed by Govt. of [[Gujarat]]), Nathdwara Temple Board- Member (appointed by Govt. of Rajasthan), National Safety Council, [[Gujarat]] Chapter- Ex-Chairman, and Organization of Business, Commerce and Industries (OBCI)- President.<ref>{{cite web|url=http://www.vselindia.com/management.html|title=Vadodara Stock Exchange Management|work=Vadodara Stock Exchange|accessdate=11 April 2016}}</ref> He also remained Director, Pavitra Yatradham Vikas Board formed to improve and enhance facilities at all important Temples of [[Gujarat]]. He is also an Executive Member of Lions Club<ref>{{cite web|url=http://www.business-standard.com/article/pti-stories/nathwani-seeks-measures-to-protect-gir-lions-frm-train-mishaps-115031800593_1.html|title=Nathwani seeks measures to protect Gir lions from train mishaps|author=Press Trust of India|date=18 March 2015|work=business-standard.com|accessdate=5 August 2015}}</ref> of [[Jamnagar]]; Member of Rotary Club of [[Jamnagar]], [[Jamnagar]] Chamber of Commerce and Industries and Executive Committee of [[Gujarat]] Chamber of Commerce and Industries. Nathwani accolades include a coveted Award for Social Service from the then Governor of Gujarat Shri R.K. Trivedi. Nathwani's elected to [[Rajya Sabha]] as an independent candidate from the state of [[Jharkhand]]. He holds Professional Doctorate in Management from National Institute of Management, Mumbai. He pursued his graduation from Mumbai.<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=106680388&ticker=878373|title=Board Members-Reliance Industries Ltd (RIL:Natl India)|work=Bloomberg.com|accessdate=5 August 2015}}</ref>\n\n==Journey With Reliance==\nA meeting with [[Dhirubhai Ambani]] and [[Mukesh Ambani]] in 1995 changed his life. The father of India's capital markets took Nathwani under his wings at a time when Reliance was planning the world's the largest single location greenfield refinery at Moti Khavdi near [[Jamnagar]].\nNathwani helped in realizing Dhirubhai's dream, literally. He played a pivotal role in removing hurdles in land acquisition and facilitated setting up of the refinery. That was the turning point of his life. \nThe task was herculean. But, Nathwani worked round the clock in rural areas of [[Jamnagar]], dealing with farmers, developing personal rapport with each of them to help Reliance acquire 10,000 acres land. The most important thing was that the land was acquired with consent of all the farmers. Having tested his potential in [[Jamnagar]], Reliance bosses relocated Nathwani at Ahmedabad and entrusted bigger responsibilities and assignment to operate on a bigger canvas in 1997. And, he did not let the company down.\nIn no time, Nathwani became the face of Reliance Industries Limited (RIL) in [[Gujarat]] and elsewhere. He spearheaded several prestigious projects of the group.<ref>{{cite web|url=https://economictimes.indiatimes.com/slideshows/corporate-industry/meet-the-people-who-run-reliance-industries/slideshow/18162820.cms|title=Meet the people who run Reliance Industries|date=24 January 2013|work=Economic Times|accessdate=13 May 2018}}</ref> Be it land acquisition for the [[Jamnagar]] refinery, setting up of petroleum retail outlets and even establishing [[Jamnagar]] Special Economic Zone, Nathwani was always at the centre of all important business activities of the company. He also contributed to cross country gas transportation pipeline network, played a key role in executing telecom network for erstwhile Reliance Infocomm in a record time and helped setting up of consumer retail chain for the group. Now since the RIL is poised to roll out 4-G broadband network in 22 circles of the country, he is once again on the steering wheel to lead the project on the fast track. \nAll this while he remained in charge of the company's Corporate Affairs and industrial relations of the Group's establishments in [[Gujarat]], [[Delhi]] and Madhya Pradesh. He is a key member of RIL's top management.<ref>{{cite web|url=http://doodlevoodle.com/journey-of-parimal-nathwani-with-relaince-industries-limited/|work=Doodlevoodle|title= Journey of Parimal Nathwani with Reliance Industries Limited|accessdate=11 April 2016}}</ref>\n\n==Political career==\nIn March 2008, Nathwani entered into the RajyaSabha as an independent candidate from [[Jharkhand]].<ref>{{cite web|url=http://nocorruption.in/mps/parimal-nathwani/|title=Parimal Nathwani|work=nocorruption.in|accessdate=5 August 2015}}</ref> He got re-elected as [[Rajya Sabha]] member from the tribal state in March 2014.Again he is going to be elected as Member of Rajya Sabha from the state of [[Andhra Pradesh]] in April 2020 for that he joined [[ YSR Congress Party]] on 11 March 2020 in the presence of [[Y. S. Jagan Mohan Reddy]] [[Chief Minister of Andhra Pradesh]] and President of [[YSR Congress Party]].\n\n==Role as Gujarat Cricket Association Vice-President==\nNathwani has been the Vice President of Gujarat Cricket Association (GCA) since early 2010. GCA is rebuilding the Motera stadium at Ahmedabad and plans to make it a Melbourne type world class stadium.<ref>{{cite web|url=http://indiatoday.intoday.in/story/sardar-patel-stadium-to-get-a-mcg-like-makeover/1/471875.html|work=indiatoday|title=Sardar Patel Stadium in Motera to get a MCG-like makeover|accessdate=13 April 2016}}</ref><ref>{{cite web|url=http://www.dnaindia.com/sport/report-motera-likely-to-be-world-s-biggest-cricket-stadium-amit-shah-2021728|work=dnaindia|title=Motera likely to be world's biggest cricket stadium: Amit Shah|accessdate=13 April 2016}}</ref> The previously built Motera stadium is demolished and erased.<ref>{{cite web|url=http://www.espncricinfo.com/india/content/story/919559.html|work=espncricinfo|title=Sardar Patel Stadium in Motera to be demolished|accessdate=13 April 2016}}</ref> Nathwani also provided umbrella to cricketers of Gujarat like [[Parthiv Patel]], [[Yusuf Pathan]], [[Irfan Pathan]], [[Ravindra Jadeja]] etc. and motivated them so that they focused on their game.<ref>{{cite web|url=http://timesofindia.indiatimes.com/cricket/Let-me-learn-bowling-first-Irfan/articleshow/632550.cms|work=timesofindia|title=Let me learn bowling first: Irfan|accessdate=13 April 2016}}</ref><ref>{{cite web|url=http://www.sify.com/entertainment/movies/tamil/boxoffice/fullstory.php?id=13507751|work=sify|title=Parthiv gets a Reliance job|accessdate=13 April 2016}}</ref> Nathwani has helped sportsmen of Jharkhand by providing them incentives during 34th National Games at Ranchi,<ref>{{cite web|url=http://deshgujarat.com/2011/02/27/jharkhand-gujarat-national-games-and-nathwani-check-this/|work=deshgujarat|title=Jharkhand, Gujarat, National Games and Nathwani, check this!|accessdate=13 April 2016}}</ref> providing cricket equipment to local sports club, constructing stadiums in villages etc.\n\n==Role as Dwarkadheesh Devasthan Samiti Ex-Vice Chairman==\nA setback in stock market in early 90s drew Nathwani to [[Lord Krishna]] or Dwarkadheesh. Previously, He has served as Vice Chairman of Dwarkadheesh Devasthan Samiti.<ref>{{cite web|url=http://www.dwarkadhish.org/devasthan-samiti/members-of-the-committee/|work=dwarkadhish.org|title=Members of the Committee|accessdate=13 April 2016}}</ref> He is also a member in [[Nathdwara]] Temple Board.<ref>{{cite web|url=http://www.nathdwaratemple.org/Management/BoardMemberInfo.aspx|work=nathdwaratemple.org|title=Management :: Board Members|accessdate=13 April 2016}}</ref> He has been instrumental in development of [[Dwarka]] as an important destination for pilgrimage tourism. Renovation of Gomatighat, Dhirubhai Ambani Marg, Dwarka Parisar development, Kokila Dhiraj Dham, traffic circle and a road, floral decoration and illumination of Dwarkadheesh temple during festivals like Janmashtami etc. have much of the credit to Nathwani and Reliance Industries. [[Sudama Setu]], a cable-staid bridge to cross Gomati river is the latest addition in Dwarka.<ref>{{cite web|url=http://economictimes.indiatimes.com/news/economy/infrastructure/construction-of-sudama-setu-completed-in-gujarat/articleshow/51209137.cms|work=dwarkadhish.org|title=Construction of 'Sudama Setu' completed in Gujarat|accessdate=13 April 2016}}</ref> Development of Dwarka of late has much to do with joint efforts of Government of Gujarat and Reliance Industries.<ref>{{cite web|url=http://economictimes.indiatimes.com/news/economy/infrastructure/construction-of-sudama-setu-completed-in-gujarat/articleshow/51209137.cms|work=dwarkadhish.org|title=Construction of 'Sudama Setu' completed in Gujarat|accessdate=13 April 2016}}</ref>\n\n==Positions held==\n* Member of Parliament ([[Rajya Sabha]]) from [[Jharkhand]]\n* Group President (Corporate Affairs and Projects), Reliance Industries Limited (RIL)\n* Chairman, Reliance Rural Development Trust (RRDT) view more \u00bb\n* Member - Standing Committee on Personnel, Public Grievances, Law & Justice\n* Member - Standing Committee on Railways<ref>{{cite web|url=http://www.thehindubusinessline.com/industry-and-economy/logistics/plea-to-set-up-railway-tariff-regulatory-commission/article7003835.ece|title=Plea to set up railway tariff regulatory commission|author=Our Bureau|work=The Hindu Business Line|accessdate=5 August 2015}}</ref>\n* Member - Consultative Committee, Ministry of Civil Aviation\n* Member - Select Committee on Payment & Settlement (Amendment) Bill\n* Permanent Special Invitee - Consultative Committee, Ministry of External Affairs\n* Member, Multi-sectoral Development Program Committee (MsDP), [[Jharkhand]]\n* Member - Hindi Salahkar Samiti, Economic Affairs Division and Financial Services Division, Ministry of Finance\n* Trustee in the Board of Governor's Social Welfare Fund ([[Gujarat]])\n* Vice President, [[Gujarat Cricket Association]]\n* Ex-Vice Chairman, Dwarka Devasthan Samiti<ref>{{cite web|url=http://www.dwarkadhish.org/devasthan-samiti/members-of-the-committee/|work=dwarkadhish.org|title=Members of the Committee|accessdate=13 April 2016}}</ref>\n* Member, [[Nathdwara]] Temple Board\n* Chancellor, Shree Bruhad Gujarat Sanskrut Parishad\n* Member, [[Gujarat Ayurved University]] Development Board\n* Director, Gujarat Petcoke and Petro-products Supply Pvt. Ltd.\n* President, Gujarat Industries Navratri Festival Society (GINFS)\n* Ex-chairman, [[Vadodara Stock Exchange]] <ref>http://www.parimalnathwani.com/life.html</ref>\n\n== References ==\n{{Reflist}}\n\n== External links ==\n* [http://india.gov.in/my-government/indian-parliament/parimal-nathwani Parliamentary profile] at India.gov.in\n*[https://www.facebook.com/pages/Parimal-Nathwani/393768164105774 Official Facebook]\n*[https://twitter.com/mpparimal Official Twitter]\n*[https://in.linkedin.com/pub/parimal-nathwani/b6/35a/774 Official linkedin]\n*[http://www.parimalnathwani.com/ OfficiaL Website]\n\n{{DEFAULTSORT:Nathwani, Parimal}}\n[[Category:Living people]]\n[[Category:1956 births]]\n[[Category:Politicians from Mumbai]]\n[[Category:Rajya Sabha members from Jharkhand]]\n[[Category:Indian industrialists]]\n[[Category:Independent politicians in India]]\n[[Category:YSR Congress politicians]]\n", "text_old": "{{Use dmy dates|date=May 2018}}\n{{Use Indian English|date=May 2018}}\n{{multiple issues|\n{{COI|date=March 2016}}\n{{peacock|date=March 2016}}\n{{BLP sources|date=October 2015}}\n}}\n\n{{Infobox officeholder\n| name =Parimal Dhirajlal Nathwani\n| image =Shri Parimal Nathwaniji.jpg\n| imagesize = \n| caption = \n| birth_date = {{birth date and age|1956|02|01|df=y}}\n| birth_place = [[Mumbai|Bombay]], [[Bombay State]], [[India]]\n| residence = [[Delhi]]<ref>{{cite web|url=http://www.archive.india.gov.in/govt/rajyasabhampbiodata.php?mpcode=2081|title=Detailed Profile - Shri Parimal Nathwani - Members of Parliament (Rajya Sabha) - Who's Who - Government: National Portal of India|work=india.gov.in|accessdate=5 August 2015}}</ref>\n| office1 = [[Member of Parliament|MP]] of [[Rajya Sabha]] from [[Andhra Pradesh]]\n| term_start1 = Apirl 2020\n| constituency1 = [[Andhra Pradesh]]\n| term_end1=\n| office2 = [[Member of Parliament|MP]] of [[Rajya Sabha]]\n| constituency2 =  [[Jharkhand]]\n| term_start2 = March 2014\n| term_end2= March  2020\n| predecessor2 =\n| successor2 =\n| office3 =[[MP of Rajya Sabha]]\n| term_start3 = March 2008\n| constituency3 = [[Jharkhand]]\n| term_end3 = March 2014\n| party = [[YSR Congress Party]]\n| nationality = [[India]]n \n| religion = Hindu\n| children = [[Dhanraj Nathwani]] (son) <br/> Karan Nathwani (son)\n| parents = Dhirajlal Nathwani (Father)<br>Pushpaben Nathwani(Mother)\n| spouse = Varsha Nathwani\n| occupation = Trader and Industrialist\n| publication = [[Jharkhand]] : Meri Karmabhoomi (A book in Hindi)\n| website = {{url|http://www.parimalnathwani.com/}}\n}}\n\n'''Parimal Dhirajlal Nathwani''' (born 1 February 1956) is an Indian politician and industrialist who has been elected as Member of Parliament ([[Rajya Sabha]]) from Jharkhand(2 times) and Andhra Pradesh (1time). He was first elected to [[Rajya Sabha]] in March 2008. Currently he has re-elected from Andhra Pradesh in March 2020.\n\nHe was an entrepreneur and a trader until the mid-1990s. He joined [[Reliance Group]] in 1997.<ref>{{cite web|url=https://www.bloomberg.com/Research/stocks/people/person.asp?personId=106680388&privcapId=878373|title=Sharing sorrow|work=Bloomberg|accessdate=11 April 2016}}</ref> As of 2016, he was the Group President of Corporate Affairs at Reliance Industries Ltd., a part of the headed by [[Mukesh Ambani]].<ref>{{cite web|url=https://www.bloomberg.com/Research/stocks/people/person.asp?personId=106680388&privcapId=878373|title=Bloomberg|accessdate=11 April 2016}}</ref> Nathwani closely worked with [[Dhirubhai Ambani]] and now has been working with RIL CMD [[Mukesh Ambani]].He is a key member in the core leadership at RIL.<ref>{{cite web|url=http://articles.economictimes.indiatimes.com/2013-01-24/news/36527036_1_jamnagar-refinery-reliance-foundation-nita-ambani/2|title=Meet the people who run Reliance Industries|work=economictimes-indiatimes|accessdate=11 April 2016}}</ref> Nathwani helped Dhirubhai Ambani in realizing his dream.{{clarify|reason=What dream? This is vague.|date=December 2018}} He played a pivotal role in land acquisition and setting up the biggest grassroots crude oil refinery on the western coast near [[Jamnagar]] in [[Gujarat]].<ref>{{cite web|url=http://www.vselindia.com/management.html|title=Vadodara Stock Exchange Management|work=Vadodara Stock Exchange|accessdate=11 April 2016}}</ref>\n\nNathwani became the face of Reliance Industries Limited (RIL) in [[Gujarat]] and other parts of the country. He spearheaded several of the group's projects including land acquisition for the [[Jamnagar]] refinery and building infrastructure to roll out 4-G broadband in 22 [[Administrative divisions of India#Sub-district|circles]] of the country.<ref>{{cite web|url=http://doodlevoodle.com/introduction-to-parimal-nathwani-member-of-parliament/|work=Doodlevoodle|title= Introduction to Parimal Nathwani Member of Parliament|accessdate=11 April 2016}}</ref>. {{clarify|reason=Source is vague.|date=February 2020}}\n\n==Biography==\nParimal D. Nathwani serves as Group President of Corporate Affairs at Reliance Industries Ltd.<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=106680388&privcapId=878373|title=Board Members-Reliance Industries Ltd (RIL:Natl India)|work=Bloomberg.com|accessdate=11 April 2015}}</ref> Nathwani is also the Vice President of the [[Gujarat Cricket Association]]. He serves as Director of [[Gujarat]] Petcoke and Petroproducts P. Ltd.<ref>{{cite web|url=http://companydata.in/gujarat-petcoke-and-petroproducts-supply-private-limited/825854.py|title=GUJARAT PETCOKE AND PETROPRODUCTS SUPPLY PRIVATE LIMITED|work=Companydata.in|accessdate=11 April 2016}}\n</ref> and Shri Dwarkadheesh Salt Works Pvt. Ltd.<ref>{{cite web|url=https://www.zaubacorp.com/company/SHREE-DWARKADHEESH-SALT-WORKS-PRIVATE-LIMITED/U27209GJ1995PTC027751|title=SHREE DWARKADHEESH SALT WORKS PRIVATE LIMITED|work=zaubacorp.com|accessdate=4 April 2016}}</ref><ref>{{cite web|url=http://www.indidata.in/1440827-shree-dwarkadheesh-salt-works-private-limited/|title=SHREE DWARKADHEESH SALT WORKS PRIVATE LIMITED|work=indidata.com|accessdate=4 April 2016}}</ref> He served as the Chairman of the Board of Vadodara Stock Exchange Limited from 30 September 2011 to 15 September 2012 and its Director from February 2008 to 15 September 2012.<ref>{{cite web|url=http://www.vselindia.com/management.html|title=Vadodara Stock Exchange Management|work=Vadodara Stock Exchange|accessdate=11 April 2016}}</ref> He steered his life as a business man and an entrepreneur till mid nineties. He joined Reliance group in 1997. He spearheaded several prestigious projects of the group from grass-root level since then. Nathwani holds key positions in various prestigious institutions viz. Reliance Rural Development Trust (RRDT)-Chairman, Dwarkadheesh Devasthan Samiti (DOS)- Vice-Chairman (appointed by Govt. of [[Gujarat]]), Nathdwara Temple Board- Member (appointed by Govt. of Rajasthan), National Safety Council, [[Gujarat]] Chapter- Ex-Chairman, and Organization of Business, Commerce and Industries (OBCI)- President.<ref>{{cite web|url=http://www.vselindia.com/management.html|title=Vadodara Stock Exchange Management|work=Vadodara Stock Exchange|accessdate=11 April 2016}}</ref> He also remained Director, Pavitra Yatradham Vikas Board formed to improve and enhance facilities at all important Temples of [[Gujarat]]. He is also an Executive Member of Lions Club<ref>{{cite web|url=http://www.business-standard.com/article/pti-stories/nathwani-seeks-measures-to-protect-gir-lions-frm-train-mishaps-115031800593_1.html|title=Nathwani seeks measures to protect Gir lions from train mishaps|author=Press Trust of India|date=18 March 2015|work=business-standard.com|accessdate=5 August 2015}}</ref> of [[Jamnagar]]; Member of Rotary Club of [[Jamnagar]], [[Jamnagar]] Chamber of Commerce and Industries and Executive Committee of [[Gujarat]] Chamber of Commerce and Industries. Nathwani accolades include a coveted Award for Social Service from the then Governor of Gujarat Shri R.K. Trivedi. Nathwani's elected to [[Rajya Sabha]] as an independent candidate from the state of [[Jharkhand]]. He holds Professional Doctorate in Management from National Institute of Management, Mumbai. He pursued his graduation from Mumbai.<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=106680388&ticker=878373|title=Board Members-Reliance Industries Ltd (RIL:Natl India)|work=Bloomberg.com|accessdate=5 August 2015}}</ref>\n\n==Journey With Reliance==\nA meeting with [[Dhirubhai Ambani]] and [[Mukesh Ambani]] in 1995 changed his life. The father of India's capital markets took Nathwani under his wings at a time when Reliance was planning the world's the largest single location greenfield refinery at Moti Khavdi near [[Jamnagar]].\nNathwani helped in realizing Dhirubhai's dream, literally. He played a pivotal role in removing hurdles in land acquisition and facilitated setting up of the refinery. That was the turning point of his life. \nThe task was herculean. But, Nathwani worked round the clock in rural areas of [[Jamnagar]], dealing with farmers, developing personal rapport with each of them to help Reliance acquire 10,000 acres land. The most important thing was that the land was acquired with consent of all the farmers. Having tested his potential in [[Jamnagar]], Reliance bosses relocated Nathwani at Ahmedabad and entrusted bigger responsibilities and assignment to operate on a bigger canvas in 1997. And, he did not let the company down.\nIn no time, Nathwani became the face of Reliance Industries Limited (RIL) in [[Gujarat]] and elsewhere. He spearheaded several prestigious projects of the group.<ref>{{cite web|url=https://economictimes.indiatimes.com/slideshows/corporate-industry/meet-the-people-who-run-reliance-industries/slideshow/18162820.cms|title=Meet the people who run Reliance Industries|date=24 January 2013|work=Economic Times|accessdate=13 May 2018}}</ref> Be it land acquisition for the [[Jamnagar]] refinery, setting up of petroleum retail outlets and even establishing [[Jamnagar]] Special Economic Zone, Nathwani was always at the centre of all important business activities of the company. He also contributed to cross country gas transportation pipeline network, played a key role in executing telecom network for erstwhile Reliance Infocomm in a record time and helped setting up of consumer retail chain for the group. Now since the RIL is poised to roll out 4-G broadband network in 22 circles of the country, he is once again on the steering wheel to lead the project on the fast track. \nAll this while he remained in charge of the company's Corporate Affairs and industrial relations of the Group's establishments in [[Gujarat]], [[Delhi]] and Madhya Pradesh. He is a key member of RIL's top management.<ref>{{cite web|url=http://doodlevoodle.com/journey-of-parimal-nathwani-with-relaince-industries-limited/|work=Doodlevoodle|title= Journey of Parimal Nathwani with Reliance Industries Limited|accessdate=11 April 2016}}</ref>\n\n==Political career==\nIn March 2008, Nathwani entered into the RajyaSabha as an independent candidate from [[Jharkhand]].<ref>{{cite web|url=http://nocorruption.in/mps/parimal-nathwani/|title=Parimal Nathwani|work=nocorruption.in|accessdate=5 August 2015}}</ref> He got re-elected as [[Rajya Sabha]] member from the tribal state in March 2014.Again he is going to be elected as Member of Rajya Sabha from the state of [[Andhra Pradesh]] in April 2020 for that he joined [[ YSR Congress Party]] on 11 March 2020 in the presence of [[Y. S. Jagan Mohan Reddy]] [[Chief Minister of Andhra Pradesh]] and President of [[YSR Congress Party]].\n\n==Role as Gujarat Cricket Association Vice-President==\nNathwani has been the Vice President of Gujarat Cricket Association (GCA) since early 2010. GCA is rebuilding the Motera stadium at Ahmedabad and plans to make it a Melbourne type world class stadium.<ref>{{cite web|url=http://indiatoday.intoday.in/story/sardar-patel-stadium-to-get-a-mcg-like-makeover/1/471875.html|work=indiatoday|title=Sardar Patel Stadium in Motera to get a MCG-like makeover|accessdate=13 April 2016}}</ref><ref>{{cite web|url=http://www.dnaindia.com/sport/report-motera-likely-to-be-world-s-biggest-cricket-stadium-amit-shah-2021728|work=dnaindia|title=Motera likely to be world's biggest cricket stadium: Amit Shah|accessdate=13 April 2016}}</ref> The previously built Motera stadium is demolished and erased.<ref>{{cite web|url=http://www.espncricinfo.com/india/content/story/919559.html|work=espncricinfo|title=Sardar Patel Stadium in Motera to be demolished|accessdate=13 April 2016}}</ref> Nathwani also provided umbrella to cricketers of Gujarat like [[Parthiv Patel]], [[Yusuf Pathan]], [[Irfan Pathan]], [[Ravindra Jadeja]] etc. and motivated them so that they focused on their game.<ref>{{cite web|url=http://timesofindia.indiatimes.com/cricket/Let-me-learn-bowling-first-Irfan/articleshow/632550.cms|work=timesofindia|title=Let me learn bowling first: Irfan|accessdate=13 April 2016}}</ref><ref>{{cite web|url=http://www.sify.com/entertainment/movies/tamil/boxoffice/fullstory.php?id=13507751|work=sify|title=Parthiv gets a Reliance job|accessdate=13 April 2016}}</ref> Nathwani has helped sportsmen of Jharkhand by providing them incentives during 34th National Games at Ranchi,<ref>{{cite web|url=http://deshgujarat.com/2011/02/27/jharkhand-gujarat-national-games-and-nathwani-check-this/|work=deshgujarat|title=Jharkhand, Gujarat, National Games and Nathwani, check this!|accessdate=13 April 2016}}</ref> providing cricket equipment to local sports club, constructing stadiums in villages etc.\n\n==Role as Dwarkadheesh Devasthan Samiti Ex-Vice Chairman==\nA setback in stock market in early 90s drew Nathwani to [[Lord Krishna]] or Dwarkadheesh. Previously, He has served as Vice Chairman of Dwarkadheesh Devasthan Samiti.<ref>{{cite web|url=http://www.dwarkadhish.org/devasthan-samiti/members-of-the-committee/|work=dwarkadhish.org|title=Members of the Committee|accessdate=13 April 2016}}</ref> He is also a member in [[Nathdwara]] Temple Board.<ref>{{cite web|url=http://www.nathdwaratemple.org/Management/BoardMemberInfo.aspx|work=nathdwaratemple.org|title=Management :: Board Members|accessdate=13 April 2016}}</ref> He has been instrumental in development of [[Dwarka]] as an important destination for pilgrimage tourism. Renovation of Gomatighat, Dhirubhai Ambani Marg, Dwarka Parisar development, Kokila Dhiraj Dham, traffic circle and a road, floral decoration and illumination of Dwarkadheesh temple during festivals like Janmashtami etc. have much of the credit to Nathwani and Reliance Industries. [[Sudama Setu]], a cable-staid bridge to cross Gomati river is the latest addition in Dwarka.<ref>{{cite web|url=http://economictimes.indiatimes.com/news/economy/infrastructure/construction-of-sudama-setu-completed-in-gujarat/articleshow/51209137.cms|work=dwarkadhish.org|title=Construction of 'Sudama Setu' completed in Gujarat|accessdate=13 April 2016}}</ref> Development of Dwarka of late has much to do with joint efforts of Government of Gujarat and Reliance Industries.<ref>{{cite web|url=http://economictimes.indiatimes.com/news/economy/infrastructure/construction-of-sudama-setu-completed-in-gujarat/articleshow/51209137.cms|work=dwarkadhish.org|title=Construction of 'Sudama Setu' completed in Gujarat|accessdate=13 April 2016}}</ref>\n\n==Positions held==\n* Member of Parliament ([[Rajya Sabha]]) from [[Jharkhand]]\n* Group President (Corporate Affairs and Projects), Reliance Industries Limited (RIL)\n* Chairman, Reliance Rural Development Trust (RRDT) view more \u00bb\n* Member - Standing Committee on Personnel, Public Grievances, Law & Justice\n* Member - Standing Committee on Railways<ref>{{cite web|url=http://www.thehindubusinessline.com/industry-and-economy/logistics/plea-to-set-up-railway-tariff-regulatory-commission/article7003835.ece|title=Plea to set up railway tariff regulatory commission|author=Our Bureau|work=The Hindu Business Line|accessdate=5 August 2015}}</ref>\n* Member - Consultative Committee, Ministry of Civil Aviation\n* Member - Select Committee on Payment & Settlement (Amendment) Bill\n* Permanent Special Invitee - Consultative Committee, Ministry of External Affairs\n* Member, Multi-sectoral Development Program Committee (MsDP), [[Jharkhand]]\n* Member - Hindi Salahkar Samiti, Economic Affairs Division and Financial Services Division, Ministry of Finance\n* Trustee in the Board of Governor's Social Welfare Fund ([[Gujarat]])\n* Vice President, [[Gujarat Cricket Association]]\n* Ex-Vice Chairman, Dwarka Devasthan Samiti<ref>{{cite web|url=http://www.dwarkadhish.org/devasthan-samiti/members-of-the-committee/|work=dwarkadhish.org|title=Members of the Committee|accessdate=13 April 2016}}</ref>\n* Member, [[Nathdwara]] Temple Board\n* Chancellor, Shree Bruhad Gujarat Sanskrut Parishad\n* Member, [[Gujarat Ayurved University]] Development Board\n* Director, Gujarat Petcoke and Petro-products Supply Pvt. Ltd.\n* President, Gujarat Industries Navratri Festival Society (GINFS)\n* Ex-chairman, [[Vadodara Stock Exchange]] <ref>http://www.parimalnathwani.com/life.html</ref>\n\n== References ==\n{{Reflist}}\n\n== External links ==\n* [http://india.gov.in/my-government/indian-parliament/parimal-nathwani Parliamentary profile] at India.gov.in\n*[https://www.facebook.com/pages/Parimal-Nathwani/393768164105774 Official Facebook]\n*[https://twitter.com/mpparimal Official Twitter]\n*[https://in.linkedin.com/pub/parimal-nathwani/b6/35a/774 Official linkedin]\n*[http://www.parimalnathwani.com/ OfficiaL Website]\n\n{{DEFAULTSORT:Nathwani, Parimal}}\n[[Category:Living people]]\n[[Category:1956 births]]\n[[Category:Politicians from Mumbai]]\n[[Category:Rajya Sabha members from Jharkhand]]\n[[Category:Indian industrialists]]\n[[Category:Independent politicians in India]]\n[[Category:YSR Congress politicians]]\n", "name_user": "Premeditated Chaos", "label": "safe", "comment": "Removing link(s):Wikipedia:Articles for deletion/Dhanraj Nathwaniclosed as delete (XFDcloser)", "url_page": "//en.wikipedia.org/wiki/Parimal_Nathwani"}
{"title_page": "List of cocaine analogues", "text_new": "[[File:Cocaine positions numbered.PNG|thumb|Cocaine with its numerical substitution position [[locant]]s.<br>'''2\u2032''' ('''6\u2032''') = ''ortho'', '''3\u2032''' ('''5\u2032''') = ''meta'' & '''4\u2032''' = ''para'']]\nThis is a list of [[cocaine]] [[Derivative (chemistry)|analogues]]. A '''cocaine analogue''' is a (usually) artificial construct of a novel [[chemical compound]] from (often the starting point of natural) cocaine's molecular structure, with the result product sufficiently similar to cocaine to display similarity in, but alteration to, its chemical function. Within the scope of analogous compounds created from the structure of cocaine, so named \"cocaine analogues\" retain 3''\u03b2''-benzoyloxy or similar functionality (the term specifically used usually distinguishes from [[phenyltropane]]s, but in the broad sense generally, as a category, includes them) on a tropane skeleton, as compared to other stimulants of the kind. Many of the semi-synthetic cocaine analogues ''proper'' which have been made & studied have consisted of among the nine following classes of compounds:{{efn|<ref name=\"Singh2\">{{cite journal | last1 = Singh | first1 = Satendra |display-authors=etal  | year = 2000 | title = Chemistry, Design, and Structure-Activity Relationship of Cocaine Antagonists | url = https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf | journal = Chem. Rev. | volume = 100 | issue = 3| pages = 925\u20131024 | doi=10.1021/cr9700538 | pmid=11749256}}</ref> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#45 Page #969 (45th page of article)] \u00a7III. \u00b61. Final line. Last sentence.}}\n* stereoisomers of cocaine\n* 3''\u03b2''-phenyl ring substituted analogues\n* 2''\u03b2''-substituted analogues\n* ''N''-modified analogues of cocaine\n* 3''\u03b2''-carbamoyl analogues\n* 3''\u03b2''-alkyl-3-benzyl tropanes\n* 6/7-substituted cocaines\n* 6-alkyl-3-benzyl tropanes\n* piperidine homologues of cocaine\n {{multiple image\n | direction = vertical\n | footer = Above: Cocaine in the chair conformation of the tropane-ring, with only its tropane locants given.<br><br>Below: Alternate two-dimensional molecular diagram of cocaine; shown specifically as a [[Protonation|protonated]], NH+, [[hydrochloride]], and disregarding 3D stereochemistry\n | image1 = Cocaine positions tropane-ring only.png\n | width1 = 250\n | image2 = CocaineHCl.svg\n | width2 = 250\n }}\nHowever strict analogues of cocaine would also include such other potential combinations as phenacyltropanes & other carbon branched replacements not listed above. The term may also be loosely used to refer to drugs manufactured from cocaine or having their basis as a [[total synthesis]] of cocaine, but modified to alter their effect & [[Quantitative structure\u2013activity relationship|QSAR]]. These include both intracellular sodium channel blocker anaesthetics and stimulant [[dopamine reuptake inhibitor]] [[ligand]]s (such as certain, namely tropane-bridged-excised, [[piperidine]]s). Additionally, researchers have supported combinatorial approaches for taking the most promising analogues currently elucidated and mixing them to the end of discovering novel & efficacious compounds to optimize their utilization for differing distinct specified purposes.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#94 Page #1,018 (94th page of article) 2nd column, 2nd paragraph.]}}\n[[File:Schematic of cocaine ligand structure.png|thumb|x240px|Two dimensional schematic drawing of cocaine's structural dynamic interaction points with dopamine transporter binding sites.<br><br><small>Although the carbmethoxy is denoted in its function as a hydrogen bond in this depiction, it has been found that it is primarily electrostatic factors which dominate binding within this space of the molecular surface area over the operative principle of hydrogen bonding.</small>{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#16 Page #940 (16th page of article) underneath Table 8., above \u00a74]}}]]\n[[File:Cocaine reverse esters.png|thumb|x400px|Two out of three potential \"reverse esters\" of cocaine (the third one being a single \"''di-substituted''\" structure with both the 'methyl ester' & 'benzoate' reversed in tandem)]]\n\n==[[Structural analog#Chemistry|Analogs ''sensu stricto'']]==\n\n===Cocaine Stereoisomers===\n[[File:Cocaine Stereoisomers.svg|thumb|x500px|There are eight [[Stereoisomerism|stereoisomers]] of cocaine (with the internal portion of the tropane ring unchanged).{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#46 Page #970 (46th page of article)] Table 27. Figure 29.}} <small>Not counting [[Resonance (chemistry)|mesomers]] but including the one & five to eight position bond bridge of the tropane system having ''R-'' & ''S-'' configurations potentially, containing four asymmetric carbons, cocaine can be counted as having as many as sixteen stereoisomers. However geometric constraints imparted by the bridgehead amine allow only eight to be created.</small>]]\n{| class=\"wikitable\" style = \"float: center; margin-left:15px; text-align:center\"\n! Stereoisomer\n! S. Singh's<br>alphanumeric<br>assignation\n! [[IC50|IC<sub>50</sub>]] ([[Mole (unit)#Related units|nM]])<br>[[tritium|[<sup>3</sup>H]]]WIN 3542 inhibition to <br>rat [[Striatum|striatal]] membranes<br><small>Mean error standard \u22645% in all cases</small>\n! [[Chemical nomenclature|IUPAC<br>nomenclature]]\n|-\n| [[Cocaine|''R''-cocaine]]<br>(Erythroxyline)\n| \u2014\n| 102\n| methyl(1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[R-pseudococaine|''R''-pseudococaine]]<br>(Delcaine, Depsococaine, Dextrocaine, Isococaine, Psicaine.<ref>{{cite journal | pmid = 20771843 | pmc=2196615 | volume=1 |issue = 3340| year=1925 | journal=Br Med J | pages=11 | last1 = Watson-Williams | first1 = E | title=Psicaine: An Artificial Cocaine | doi=10.1136/bmj.1.3340.11}}</ref>)\n| 172\n| 15800\n| methyl(1R,'''2S''',3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[R-allococaine|''R''-allococaine]]\n| 173\n| 6160\n| methyl(1R,2R,'''3R''',5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[R-allopseudococaine|''R''-allopseudococaine]]\n| 174\n| 28500\n| methyl(1R,'''2S''','''3R''',5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[S-cocaine|''S''-cocaine]]\n| 175\n| 15800\n| methyl(1S,3R,4R,5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n| [[S-pseudococaine|''S''-pseudococaine]]\n| 176\n| 22500\n| methyl(1S,3R,'''4S''',5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n| [[S-allococaine|''S''-allococaine]]\n| 177\n| 9820\n| methyl(1S,'''3S''',4R,5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n| [[S-allopseudococaine|''S''-allopseudococaine]]\n| 178\n| 67700\n| methyl(1S,'''3S''','''4S''',5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n|}\n\nWhere the 2D diagrams given for the structural analogs below do not indicate stereochemistry, it should be assumed they share the conformation of ''R''-cocaine, unless noted otherwise.\n\nThe natural isomerism of cocaine is unstable in several ways besides having a high degree of [[lability]]; for instance: the C2 carbomethoxy in its biosynthesis end-product maintains the ''axial'' position, which can undergo [[epimer]]ization via [[saponification]] to obtain the former in an ''equatorial'' position.\n\nThe creation of the following analogues of cocaine have traditionally required a step which has utilized [[2-Carbomethoxytropinone|2-CMT]] as an intermediate molecular product.\n\n===Benzoyl branch cleavage substitutions (excluding the exhaustive phenyl group)===\n{| class=\"wikitable\"\n | [[Salicylmethylecgonine]]<ref name=Salicyl>{{cite journal | last1 = Singh | first1 = S | last2 = Basmadjian | first2 = GP | last3 = Avor | first3 = K | last4 = Pouw | first4 = B | last5 = Seale | first5 = TW | year = 1997 | title = A convenient synthesis of 2?- or 4?-hydroxycocaine | url = https://www.scribd.com/doc/39496623/salicylmethylecgonine | journal = Synthetic Communications | volume = 27 | issue = 22| pages = 4003\u20134012 | doi = 10.1080/00397919708005923 }}<br>et. {{cite journal | last1 = el-Moselhy | first1 = TF | last2 = Avor | first2 = KS | last3 = Basmadjian | first3 = GP | date = Sep 2001 | title = 2?-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies | url = | journal = Archiv der Pharmazie (Weinheim) | volume = 334 | issue = 8\u20139| pages = 275\u20138 | pmid = 11688137 | doi = 10.1002/1521-4184(200109)334:8/9<275::aid-ardp275>3.0.co;2-b }}<br> et. {{cite journal | last1 = Seale | first1 = TW | last2 = Avor | first2 = K | last3 = Singh | first3 = S | last4 = Hall | first4 = N | last5 = Chan | first5 = HM | last6 = Basmadjian | first6 = GP | year = 1997 | title = 2?-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding | url = | journal = NeuroReport | volume = 8 | issue = 16| pages = 3571\u20135 | pmid = 9427328 | doi = 10.1097/00001756-199711100-00030 }}</ref>||[[Methylvanillylecgonine]]<ref name=Vanillyl>{{cite journal | year = 1984 | title = Hydroxymethoxybenzoylmethylecgonines: New metabolites of cocaine from human urine | pmid = 6708474 | journal = Journal of Analytical Toxicology | volume = 8 | issue = 1| pages = 29\u201334  | last1 = Smith | first1 = RM | last2 = Poquette | first2 = MA | last3 = Smith | first3 = PJ | doi=10.1093/jat/8.1.29}}</ref>\n |-\n | [[File:Salicylecgonine.png|x220px]] || [[File:Hydroxymethoxycocaine.svg|x150px]]\n |-\n|}\n[[Nota bene|N.B.]] [[Fries rearrangement]] product of aspirin used to make [[salbutamol]]. It is relevant to the precursor here though because the migrated acetyl group can be the subject of a [[haloform reaction]]. A more direct route to [[vanillic acid]] though is just oxidation of the [[vanillin]] to a functionalized [[benzoic acid]].\n\n===[[Aromatic hydrocarbon|Arene benzene-ring]] 2\u2032, 3\u2032, 4\u2032 (5\u2032 & 6\u2032) position ([[aryl]]) substitutions===\n\n====''para''-substituted benzoylmethylecgonines====\n[[File:4-fluorococaine.png|x170px]]\n[[File:P-ISOCOC.svg|x140px]]\n[[File:Cocaine analog 183a.svg|x150px]]<br>\n[[File:Cocaine analog 183b.svg|x150px]]\n[[File:Cocaine analog 183c.svg|x150px]]\n[[File:Cocaine analog 183d.svg|x150px]]\n{| class=\"wikitable sortable\"\n|+Carbon 4\u2032-hydrogen Substitutions ([[benzene]]-4\u2032 \"''para''\" substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30. & Page #973 (49th page of article) Table 28.}}<br><sup>Data-set congruent to, and aggregate with, following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 4\u2032=[[Side chain|R]]\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n| ||(cocaine)||[[hydrogen|H]]||249 \u00b1 37||615 \u00b1 120||2500 \u00b1 70||2.5||10.0\n|-\n|''non-benzoyloxy analogue<br>comparative ligands''<br>{{smallsub|''non-tropane analogue<br>comparative ligands''}}||11b (WIN 35428)<small><br><sub>(nisoxetine)</sub><br><sup>(fluoxetine)</sup></small>||[[fluorine|F]]<small><br><sub>\u2014</sub><br><sup>\u2014</sup></small>||24 \u00b1 4<small><br><sub>775 \u00b1 20</sub><br><sup>5200 \u00b1 1270</sup></small>||690 \u00b1 14<small><br><sub>762 \u00b1 90</sub><br><sup>15 \u00b1 3</sup></small>||258 \u00b1 40<small><br><sub>135 \u00b1 21</sub><br><sup>963 \u00b1 158</sup></small>||28.7<small><br><sub>1.0</sub><br><sup>0.003</sup></small>||10.7<small><br><sub>0.2</sub><br><sup>0.2</sup></small>\n|-\n|rowspan=7|[[File:183a-d.svg|200px|Satendra Singh Rev]]\n|-\n| 183a || [[Iodine|I]] ||2522 \u00b1 4||1052 \u00b1 23||18458 \u00b1 1073||0.4||7.3\n|-\n| 183b || [[Phenyl group|Ph]] ||486 \u00b1 63|| - || - || - || -\n|-\n| 183c || [[Acetoxy group|OAc]] ||144 \u00b1 2|| - || - || - || -\n|-\n| 183d || [[Hydroxyl|OH]] ||158 \u00b1 8||3104 \u00b1 148||601 \u00b1 11||19.6||3.8\n|-\n| ([[4\u2032-Fluorococaine]])<ref name=\"pmid8113802\">{{cite journal |vauthors=Gatley SJ, Yu DW, Fowler JS, MacGregor RR, Schlyer DJ, Dewey SL, Wolf AP, Martin T, Shea CE, Volkow ND |title=Studies with differentially labeled [11C]cocaine, [11C]norcocaine, [11C]benzoylecgonine, and [11C]- and 4\u2032-[18F]fluorococaine to probe the extent to which [11C]cocaine metabolites contribute to PET images of the baboon brain |journal=Journal of Neurochemistry |volume=62 |issue=3 |pages=1154\u201362 |date=March 1994 |pmid=8113802 |doi= 10.1046/j.1471-4159.1994.62031154.x|url=}}</ref> || [[Fluorine|F]] || - || - || - || - || -\n|-\n| ([[(R)-p-Isothiocyanatobenzoylecgonine methyl ester|''para''-Isothiocyanatobenzoylecgonine<br>methyl ester]])<ref>{{cite journal |title= Cocaine Receptor: Biochemical Characterization and Structure-Activity Relationships of Cocaine Analogues at Dopamine Transporter |author1=Carroll, F. I. |author2=Lewin, A. H. |author3=Boja, J. W. |author4=Kuhar, M. J. |journal= Journal of Medicinal Chemistry |volume= 35 |issue= 6 |year= 1992 |pages= 969\u2013981 |doi= 10.1021/jm00084a001 |pmid=1552510}}</ref><br>([[Arene substitution pattern#Ortho, meta, and para substitution|''p'']]-Isococ) || [[Isothiocyanate|NCS]] || - || - || - || - || -\n|}\nThe [[Monoamine transporter|MAT]] [[Active site#Binding site|binding pocket]] analogous to the lipophilic place on cocaine-like compounds, inclusive of the benzene ring, is approximate to 9 [[Angstrom|\u00c5]] in length. Which is only slightly larger than a phenyl ring by itself.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)]}}\n\n====''meta''-substituted benzoylmethylecgonines====\n[[File:Cocaine analog 184a.svg|x150px]]\n[[File:Cocaine analog 184b.svg|x150px]]\n[[File:M-Isococ.svg|x160px]]\n[[File:C3benzyloxycocaine.svg|x170px]]\n\n{| class=\"wikitable sortable\"\n|+Carbon 3\u2032-hydrogen Substitutions (benzene-3\u2032 \"''meta''\" substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 3\u2032=R\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n|rowspan=5|[[File:184a-b.svg|200px|Satendra Singh Rev]]\n|-\n| 184a || I ||325<sup>'''\u0251'''</sup>|| - || - || - || -\n|-\n| 184b || OH ||1183 \u00b1 115||793 \u00b1 33||3760 \u00b1 589||0.7||3.2\n|-\n| 191 || O[[Benzyl|Bn]] || - || - || - || - || -\n|-\n| ([[Arene substitution pattern#Ortho, meta, and para substitution|''m'']]-Isococ) || [[Isothiocyanate|NCS]] || - || - || - || - || -\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> value for displacement of [<sup>3</sup>H]cocaine</small>\n\n====''ortho''-substituted benzoylmethylecgonines====\n[[File:Cocaine analog 185a.svg|x150px]]\n[[File:Cocaine analog 185b.svg|x150px]]\n[[File:Cocaine analog 185c.svg|x190px]]\n[[File:Cocaine analog 185d.svg|x150px]]\n\nThe hydroxylated 2\u2032-OH analogue exhibited a tenfold increase in potency over cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#48 Page #972 (48th page of article)] \u00b62, Line 10.}}\n\n{| class=\"wikitable sortable\"\n|+Carbon 2\u2032-hydrogen Substitutions (benzene-2\u2032 \"''ortho''\" substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 2\u2032=R\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n|rowspan=5|[[File:185a-d.svg|200px|Satendra Singh Rev]]\n|-\n| 185a || I ||350<sup>'''\u0251'''</sup>|| - || - || - || -\n|-\n| 185b || F ||604 \u00b1 67||1770 \u00b1 309||1392 \u00b1 173||2.9||2.3\n|-\n| 185c<br>([[2\u2032-Acetoxycocaine]])<ref>{{cite journal | pmid = 9427328 | year = 1997 | last1 = Seale | first1 = TW | last2 = Avor | first2 = K | last3 = Singh | first3 = S | last4 = Hall | first4 = N | last5 = Chan | first5 = HM | last6 = Basmadjian | first6 = GP | title = 2\u2032-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding | volume = 8 | issue = 16 | pages = 3571\u20135 | journal = NeuroReport | doi=10.1097/00001756-199711100-00030}}</ref> || OAc ||70 \u00b1 1||219 \u00b1 20||72 \u00b1 9||3.1||1.0\n|-\n| 185d<br>([[Salicylmethylecgonine|2\u2032-Hydroxycocaine]])<ref name=Salicyl /> || OH ||25 \u00b1 4||143 \u00b1 21||48 \u00b1 2||5.7||1.9\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> value for displacement of [<sup>3</sup>H]cocaine</small>\n\n====manifold benzoyloxy phenyl-substitutions====\n[[File:Hydroxymethoxycocaine.svg|x150px]]\n[[File:Cocaine analog 186.svg|x150px]]\n\nMulti-substitutions (substitutions of substitutions; e.g. [[Arene substitution pattern#Ortho, meta, and para substitution|''meta''- & ''para''-]]) or manifold (\"many-fold\") substituted analogues are analogues where more than one modification from the parent molecule takes place (having numerous intermediary constituents). These are created with often surprising structure\u2013activity relationship results extrapolated therefrom. It is even a common case where two separate substitutions can each yield a weaker, lower affinity or even wholly non-efficacious compound respectively; but due to findings that oftentimes, when used together, such two mutually inferior changes being added in tandem to one analogue has the potential to make the resultant derivative display much greater efficacy, affinity, selectivity &/or strength than even the parent compound; which otherwise was compromised by either of those two alternations when made alone.\n\n<small>For an exposition & allusion to this mechanism observe that the opioid oxycodone, derived from codeine, is 1.5\u00d7\u20141.7\u00d7 the analgesic potency of morphine (an opioid to which codeine is by comparison only 8%\u201412% as potent relatively, or 0.17th its strength in rats); yet oxycodone's intermediates in its synthesis from codeine are: \u2153 the potency of codeine (''i.e.'' codeinone); 0.13 that of morphine (''i.e.'' 14-hydroxycodeine) in rats and less in mice (to illustrate: the former even being less than the 0.17 of morphine that codeine is); with the final possible stand alone intermediate compound between codeine & oxycodone (''i.e.'' 7,8-dihydrocodeine) being at most 150% to 200% that of codeine.</small><ref>{{cite journal | year = 1964 | title = The analgesic properties of some 14-substituted derivatives of codeine and codeinone | url = | journal = J. Pharm. Pharmacol | volume = 16 | issue = | pages = 174\u2013182 | doi = 10.1111/j.2042-7158.1964.tb07440.x  | last1 = Buckett | first1 = W. R. | last2 = Farquharson | first2 = Muriel E. | last3 = Haining | first3 = C. G.}}</ref>\n\n{| class=\"wikitable sortable\"\n|+Manifold Compositions of Terminating Phenyl Ring Substitutions (Multiple benzene-2\u2032,3\u2032 & 4\u2032 combined substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set (excepting instanced references inside table) congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''ortho''-2\u2032=''R''\n! ''meta''-3\u2032=''R''\n! ''para''-4\u2032=''R''\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n| [[File:2hydroxy4iodococaine.png|x120px]] || 186 || HO || H || I ||215 \u00b1 19||195 \u00b1 10||1021 \u00b1 75||0.9||4.7\n|-\n| [[File:Hydroxymethoxycocaine.svg|x70px]] || ([[Methylvanillylecgonine|Vanillylmethylecgonine]])<ref name=Vanillyl /> || H || [[Methoxy|OCH<sub>3</sub>]] || OH || - || - || - || - || -\n|}\n\n====benzoyl phenyl-alterations====\n[[File:Cocaine analog 187.svg|x150px]]\n[[File:Cocaine analog 188.svg|x150px]]\n\nThe naphthalene analogs allow for further numeric substitutions, including eight position ''[[Arene substitution pattern#Ipso, meso, and peri substitution|peri]]'' substituted patterns. Many more alterations creating [[Simple aromatic ring|differing aromatic rings]] are possible.\n\n{| class=\"wikitable sortable\"\n|+Terminating Phenyl Carbon Ring Fusions & Alterations{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set congruent to, and aggregate with, preceding table<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! C=''R''\n! DAT\n[<sup>3</sup>H]Cocaine (IC<sub>50</sub>)\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n| [[File:Cocaine analog 187 alt.png|x110px]] || 187 || 1-naphthalene ||742 \u00b1 48|| - || - || - || -\n|-\n| [[File:Cocaine analog 188 alt.png|x120px]] || 188 || 2-naphthalene ||327 \u00b1 63|| - || - || - || -\n|}\n\n===Benzoyl branch modifications===\n {{multiple image\n | direction = vertical\n | image1 = Spirocyclic cocaine analog.svg\n | width1 = 220\n | caption1 = Spirocyclic benzoyl branch modification [[List of phenyltropanes#C3 to 1\u2032 + 2\u2032 (ortho) tropane locant dual arene bridged|that fits criteria]] as a cocaine analog and a phenyltropane both (tropane 2nd locant ester rendered in given depiction shows, as has been attested, to only having been successfully alpha configured)<ref>{{cite journal | last1 = Sakamuri | first1 = Sukumar |display-authors=etal  | year = 2000 | title = Synthesis of novel spirocyclic cocaine analogs using the Suzuki coupling | url = | journal = Tetrahedron Letters | volume = 41 | issue = 13| pages = 2055\u20132058 | doi = 10.1016/S0040-4039(00)00113-1 }}</ref>\n | image2 = Spirocyclic_cocaine_analog_12.svg\n | width2 = 220\n }}\n* [[Benzoylthiomethylecgonine]]<ref>{{cite journal | last1 = Isomura | first1 = Shigeki | last2 = Hoffman | first2 = Timothy Z. | last3 = Wirsching | first3 = Peter | last4 = Janda | first4 = Kim D. | year = 2002 | title = Benzoylthio-. cocaine, analogue substitution. Synthesis, Properties, and Reactivity of Cocaine Benzoylthio Ester Possessing the Cocaine Absolute Configuration | url = | journal = J. Am. Chem. Soc. | volume = 124 | issue = 14| pages = 3661\u20133668 | doi = 10.1021/ja012376y | pmid=11929256}}</ref>\n\n[[File:Benzoylthiomethylecgonine.svg|x150px]]<br>\nA sulfur in place of the oxygen at the benzoyl ester single bond results in a lower electronegativity than that of cocaine.\n\n===C1-tropane-ring hydrogen\u2014substitutions===\n[[File:C1-tropane cocaine analogues.png|350px]]<br>\n''cf.'' [[List of cocaine analogues#See also|hydroxytropacocaine]] for a natural alkaloid (lacking however, the 2-position carbmethoxy) that is a C1 substituent with a [[hydroxy group]].\n{| class=\"wikitable sortable\"\n|+C1 substitutions<ref name=\"DavisGaddiraju2012\">{{cite journal|last1=Davis|first1=Franklin A.|last2=Gaddiraju|first2=Narendra V.|last3=Theddu|first3=Naresh|last4=Hummel|first4=Joshua R.|last5=Kondaveeti|first5=Sandeep K.|last6=Zdilla|first6=Michael J.|title=Enantioselective Synthesis of Cocaine C-1 Analogues using Sulfinimines (N-Sulfinyl Imines)|journal=The Journal of Organic Chemistry|volume=77|issue=5|year=2012|pages=2345\u20132359|issn=0022-3263|doi=10.1021/jo202652f|pmid=22300308|url=https://figshare.com/articles/Enantioselective_Synthesis_of_Cocaine_C_1_Analogues_using_Sulfinimines_i_N_i_Sulfinyl_Imines_/2544925}}</ref><br>HEK-293 heterologously expressed human monoamine transporter cells for ''K''<sub>i</sub> values of compounds inhibiting neurotransmitter uptake.<ref name=\"ReithAli2012\">{{cite journal|last1=Reith|first1=M. E. A.|last2=Ali|first2=S.|last3=Hashim|first3=A.|last4=Sheikh|first4=I. S.|last5=Theddu|first5=N.|last6=Gaddiraju|first6=N. V.|last7=Mehrotra|first7=S.|last8=Schmitt|first8=K. C.|last9=Murray|first9=T. F.|last10=Sershen|first10=H.|last11=Unterwald|first11=E. M.|last12=Davis|first12=F. A.|title=Novel C-1 Substituted Cocaine Analogs Unlike Cocaine or Benztropine|journal=Journal of Pharmacology and Experimental Therapeutics|volume=343|issue=2|year=2012|pages=413\u2013425|issn=1521-0103|doi=10.1124/jpet.112.193771|pmid=22895898|pmc=3477221}} [http://jpet.aspetjournals.org/content/343/2/413.full.pdf#page=1&view=FitH Full article]</ref>\n! Structure\n! Trivial name\n! ''R''<br>(C1 moiety)\n! ''K''<sub>i</sub> (''nM'') @ DAT\n! ''K''<sub>i</sub> (''nM'') @ SERT\n! ''K''<sub>i</sub> (''nM'') @ NET\n! \u03c3<sub>1</sub> affinity<br>''K''<sub>i</sub>\n! \u03c3<sub>2</sub> affinity<br>''K''<sub>i</sub>\n! IC<sub>50</sub> (\u03bcM) Na+ inhibition<br>(Vertridine-Stimulated<br>influx of sodium channels<br>in Neocortical neurons)<sup>'''c'''</sup>\n! LogP<br>(XLogP3 algorithm, Cheng et al., 2007)\n|-\n| || (\u2014)-Cocaine || H ||326 \u00b1 106||513 \u00b1 143||358 \u00b1 69||6.7 \u00b1 0.3 \u03bcM'''<sup>d</sup>'''<ref>{{cite journal | pmid = 2840298 | volume=149 | issue=1\u20132 | title=Cocaine binding at sigma receptors | journal=Eur J Pharmacol | pages=171\u20134 | last1 = Sharkey | first1 = J | last2 = Glen | first2 = KA | last3 = Wolfe | first3 = S | last4 = Kuhar | first4 = MJ | doi = 10.1016/0014-2999(88)90058-1 | year=1988 }}</ref>||\"significant\"<ref name=\"NuwayhidWerling2006\">{{cite journal|last1=Nuwayhid|first1=Samer J.|last2=Werling|first2=Linda L.|title=Sigma2 (\u03c32) receptors as a target for cocaine action in the rat striatum|journal=European Journal of Pharmacology|volume=535|issue=1\u20133|year=2006|pages=98\u2013103|issn=0014-2999|doi=10.1016/j.ejphar.2005.12.077|pmid=16480713}}</ref>||6.99 \u00b1 2.43||2.30\n|-\n|[[File:1-methylcocaine.svg|x120px]] || (\u2014)-1-methyl-cocaine|| Me ||163 \u00b1 23||435 \u00b1 77||488 \u00b1 101||\"unappreciable\"||1.13 \u03bcM||16.01 \u00b1 1.90||2.67\n|-\n|[[File:1-ethylcocaine.svg|x120px]] || (\u2014)-1-ethyl-cocaine|| Et ||95.1 \u00b1 17.0<sup>'''\u0251'''</sup>||1,106 \u00b1 112||598 \u00b1 179||\u2014||\u2014||\u2014||3.20\n|-\n|[[File:1-propylcocaine.svg|x150px]] || (\u2014)-1-n-propyl-cocaine||''n''-Pr ||871 \u00b1 205<sup>'''\u0251'''</sup>||2,949 \u00b1 462<sup>'''b'''</sup>||796 \u00b1 195||\u2014||\u2014||\u2014||3.56\n|-\n|[[File:1-pentylcocaine.svg|x160px]] || (\u2014)-1-n-pentyl-cocaine||''n''-C<sub>5</sub>H<sub>11</sub> ||1,272 \u00b1 199<sup>'''b'''</sup>||1,866 \u00b1 400<sup>'''\u0251'''</sup>||1,596 \u00b1 21<sup>'''b'''</sup>||\u2014||\u2014||\u2014||4.64\n|-\n|[[File:1-phenylcocaine.svg|x150px]] || (\u2014)-1-phenyl-cocaine|| Ph ||32.3 \u00b1 5.7<sup>'''b'''</sup>||974 \u00b1 308||1,980 \u00b1 99<sup>'''b'''</sup>||524 ''nM''||198 ''nM''||0.29 \u00b1 0.07||3.77\n|}\n*<small><sup>'''\u0251'''</sup>, ''P'' < 0.05 compared with (\u2014)-cocaine (one-way ANOVA followed by Dunnett's multiple comparisons test)</small>\n*<small><sup>'''b'''</sup>, ''P'' < 0.01 compared with (\u2014)-cocaine (one-way ANOVA followed by Dunnett's multiple comparisons test)</small>\n*<small><sup>'''c'''</sup>Lidocaine was found to have a value of 39.6 \u00b1 2.4, the weakest of all tested.</small>\n*<small><sup>'''d'''</sup>Same reference gives 25.9 \u00b1 2.4 \u03bcM for (+)-cocaine and 13.6 \u00b1 1.3 \u03bcM for norcocaine. Comparably it gives 12.7 \u00b1 1.5 \u03bcM for the sigmaergic affinity of (+)-amphetamine. Another reference gives 1.7-6.7 \u03bcM for (\u2014)-cocaine. All values ''K''<sub>i</sub>.</small><ref>[http://www.nature.com/npp/journal/v26/n4/full/1395834a.html Involvement of the Sigma<sub>1</sub> Receptor in Cocaine-induced Conditioned Place Preference: Possible Dependence on Dopamine Uptake Blockade] Pascal Romieu et al. Neuropsychopharmacology (2002) 26 444-455.10.1038/S0893-133X(01)00391-8</ref>\n*<small>'''Using same data-set as above table, the following compounds were found to compare as:'''</small>\n**<small>CFT @ DAT = 39.2 \u00b1 7.1 (n = 5)</small>\n**<small>fluoxetine @ SERT = 27.3 \u00b1 9.2 (n = 3)</small>\n**<small>desipramine @ NET = 2.74 \u00b1 0.59 (n = 3)</small>\nCocaine analogs substituting the C1-tropane ring position, requiring sulfinimine (''N''-sulfinyl-imine) chemistry (before the innovation of which were untenable) which bind unlike the typical configuration at DAT (open to out) as cocaine (with its terminal D79-Y156 distance of 6.03 \u00c5), or in the atypical (closed to out) conformation of the benztropines (3.29 \u00c5). Though closer to the open to out: (\u2014)-1-methyl-cocaine = 4.40 \u00c5 & (\u2014)-1-phenyl-cocaine = 4.89 \u00c5, and exhibiting preferential interaction with outward facing DAT conformation, they appear to have the lack of behavioral stimulation as-like the closed to out type. Despite having non-stimulant behavior profiles, they still seem to have anti-depressant behavioral profiles.<ref name=\"ReithAli2012\"/>\n\nThe C1 phenyl analog is ten times stronger than cocaine as a dopamine reuptake pump ligand, and twenty four times stronger as a local anesthetic (voltage-dependent Na+ channel blocker), whereas the C1 methyl analog is 2.3 times less potent as a local anesthetic.<ref name=\"ReithAli2012\"/>\n\n===2''\u03b2''-substitutions (including transesterification metabolite substitution cocaethylene)===\n[[File:Cocaine analog (former 196c error).svg|190px|thumb|Extra methylene length to the 196c cocaine analogue, as given in error previously; \"2-methylpropyl\", ''i.e.'' isobutanol.]]\n[[File:Cocaine analog 196a.svg|x165px]]\n[[File:Cocaine analog 196b.svg|x195px]]\n[[File:Cocaine analog 196c.svg|x185px]]\n[[File:Cocaine analog 196d.svg|x225px]]\n[[File:Cocaine analog 197a.svg|x175px]]<br>\nThe consideration that large, bulky C2 substituents would alter the tropane by distorting the piperidine ring part of its skeleton sufficiently enough to impair its functionality, or that in said event such would hamper binding, in particular at the 8-aza end to ease steric strain going toward its place from the 2-position,{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50st page of article)] First (left) column, third \u00b6}} appear to in many cases be unfounded.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #937 (13th page of article)] Second (right) column, first \u00b6. Above/before \u00a72}} (examples shown in table of images below)\n\n{| class=\"wikitable\"\n|+ Compounds with greater SERT affinity than cocaine parent (slightly less @ DAT, significantly less, except for #196g, @ NET)\n |-\n |[[File:Cocaine analog 196e.svg|x220px]] || [[File:Cocaine analog 196f.svg|x220px]] || [[File:Cocaine analog 196g.svg|x210px]] || [[File:Cocaine analog 196h.svg|x210px]]\n|}\n[[File:Cocaine analog 196i.svg|x280px]]\n[[File:Cocaine analog 196j.svg|x260px]]\n[[File:Cocaine analog 196l.svg|x250px]]\n[[File:Cocaine analog 196m.svg|x270px]]\n{| class=\"wikitable\"\n|+ Compounds with greater DAT affinity than cocaine parent (SERT & NET affinity untested; note however their similarity to more potent SERT ligands above) ||(greater)>@ DAT, (lesser)<@ SERT, (much less)<<@ NET\n |-\n |[[File:Cocaine analog 196k.svg|x260px]] || [[File:Cocaine analog 196n.svg|x270px]] || [[File:Cocaine analog 196o.svg|x260px]] || [[File:Cocaine analog 197c.svg|x170px]]\n|}\n[[File:Hydroxypropyl_benzoylecgonine.svg|190px|thumb|hydroxypropylbenzoylecgonine (HPBE), which imparts the topical analgesic effect in the preparation [[Esterom]].<ref>{{cite journal | title = A-854: Comparative Potency for Impulse-Blockade and for Cutaneous Analgesia of Traditional and Novel Local Anesthetics | author = Yoshihiro Hamaya, Hesham Abdelrazek, Gary R. Strichartz | date = 2002 | url = http://w.asaabstracts.com/strands/asaabstracts/abstract.htm?year=2002&index=10&absnum=1331 | quote = ...hydroxypropylbenzoylecgonine (HPBE) is the only effective analgesic compound in [Esterom]. | journal = Abstracts of American Society of Anesthesiologists Annual Meeting }}{{Dead link|date=March 2020 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>]]\n[[File:Cocaine analog 197b.svg|x170px]]\n[[File:Cocaine analog 197d.svg|x170px]]\n[[File:Cocaine analog 197e.svg|x170px]]\n[[File:Cocaine analog 197f.svg|x160px]]\n[[File:Cocaine analog 197g.svg|x160px]]\n\nCompound '''197b''' displayed a 1,131-fold increased selectivity in affinity over the serotonin transporter, with only slight reductions in potency for the dopamine & norepinephrine transporters.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Final \u00b6 (5th), Second line.}} Whereas '''197c''' had a 469\u00d7 increase at [[serotonin transporter|SERT]], with greater affinity for [[dopamine transporter|DAT]] than cocaine & was approximately equipotent to [[norepinephrine transporter|NET]].{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#51 Page #975 (51st page of article)] First \u00b6, first line.}} '''197b''' was 137\u00d7, and '''196c''' 27\u00d7 less potent at binding to the serotonin transporter, but both had a NET / DAT ratio that made for a better [[dopaminergic]] than cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#51 Page #975 (51st page of article)] First \u00b6, 4th line.}}\n[[File:196a-o.svg|thumb|325px]] [[File:197a-d.svg|thumb|325px]] [[File:197f.svg|thumb|325px]]\n{| class=\"wikitable sortable\"\n|+Direct 2''\u03b2'' Substitutions{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973 (49th page of article)] \u00a7C. & Page #974 (50th page of article) Figure 31 & Page #976 (52nd page of article) Table 29.}}<br><sup>(IC<sub>50</sub> nM values)</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n|rowspan=17|[[File:Cocaine analog 196a-o.svg|200px|Satendra Singh Rev]]\n|-\n| (Cocaine) || [[Methyl group|Me]] ||89 \u00b1 4.8||1045 \u00b1 89||3298 \u00b1 293||11.7||37.0\n|-\n| 196a<br>([[Cocaethylene]]) || [[Ethyl group|Et]] ||195 \u00b1 45||5801 \u00b1 493||10000 \u00b1 751||29.7||51.3\n|-\n| 196b || ''n''-Pr ||196 \u00b1 46||4517 \u00b1 430||6124 \u00b1 262||23.3||31.2\n|-\n| 196c || ''i''-Pr ||219 \u00b1 48||25224 \u00b1 1498||30384 \u00b1 1685||115||139\n|-\n| 196d || Ph ||112 \u00b1 31||33666 \u00b1 3330||31024 \u00b1 1909||300||277\n|-\n| 196e || Bn||257 \u00b1 14||302 \u00b1 23||20794 \u00b1 950||1.2||80.9\n|-\n| 196f || \u03b2-phenethyl ||181 \u00b1 10||615 \u00b1 52||19944 \u00b1 1026||3.4||110\n|-\n| 196g || \u03b3-phenylpropyl ||147 \u00b1 19||374 \u00b1 15||4893 \u00b1 344||2.5||33.3\n|-\n| 196h || [[cinnamyl]] ||371 \u00b1 15||368 \u00b1 6.3||68931 \u00b1 3476||1.0||186\n|-\n| 196i || ''p''-NO<sub>2</sub>-\u03b2-phenethyl ||601 \u00b1 28|| - || - || - || -\n|-\n| 196j || ''p''-Cl-\u03b2-phenethyl ||271 \u00b1 12|| - || - || - || -\n|-\n| 196k || ''p''-NH<sub>2</sub>-\u03b2-phenethyl ||72 \u00b1 7|| - || - || - || -\n|-\n| 196l || ''p''-[[isothiocyanato|NCS]]-\u03b2-phenethyl||196 \u00b1 14|| - || - || - || -\n|-\n| 196m || ''p''-[[azido]]-\u03b2-phenethyl ||227 \u00b1 19|| - || - || - || -\n|-\n| 196n || (''p''-NHCOCH<sub>2</sub>Br)\u03b2-phenethyl ||61 \u00b1 6|| - || - || - || -\n|-\n| 196o || (''p''-NHCO(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>Et)\u03b2-phenethyl ||86 \u00b1 4|| - || - || - || -\n|-\n|rowspan=5|[[File:Cocaine analog 197a-d.svg|200px|Satendra Singh Rev]]|| 197a || NH<sub>2</sub> ||753 \u00b1 41.3||13725 \u00b1 1256||3981 \u00b1 229||18.2||5.3\n|-\n| 197b || -NMe<sub>2</sub> ||127 \u00b1 6.36||143713 \u00b1 8854||7329 \u00b1 158||1131||57.7\n|-\n| 197c || -N(OMe)Me ||60 \u00b1 6.4||28162 \u00b1 2565||3935 \u00b1 266||469||65.6\n|-\n| 197d || -NHMe ||2424 \u00b1 118||44798 \u00b1 2105||4213 \u00b1 206||18.5||1.7\n|-\n| 197e<br>([[Benzoylecgonine]]) || -OH || 195000 || - || - || - || -\n|-\n|rowspan=2|[[File:Cocaine analog 196-197.svg|200px|Satendra Singh Rev]]|| 197f || HOCH<sub>2</sub>- ||561 \u00b1 149|| - || - || - || -\n|-\n| 197g<br>([[Tropacocaine]]) || H ||5180 \u00b1 1160|| - || - || - || -\n|}\n\n====[[Bioisostere]] 2-position carbmethoxy-ester functional replacements====\n[[File:Cocaine analog 203.svg|thumb|200px|Intermediate compound #'''203''']]\n[[File:Cocaine analog 198a.svg|x180px]]\n[[File:Cocaine analog 198b.svg|x220px]]\n[[File:Cocaine analog 198c.svg|x220px]]\n[[File:Cocaine analog 198d.svg|x220px]]\n[[File:Cocaine analog 198e.svg|x250px]]<br>\nBenzoylecgonine, ''i.e.'' compound '''197e''', (differing from its cocaine parent only by de-methylation of the C2 carbmethoxy to that of a carboxy) has an extreme loss in potency (its approximate affinity being 195,000 nM) as displayed by ''in vitro'' methodologies for determining binding efficacy (wherein [[Blood\u2013brain barrier|BBB]] penetration does not factor-in on the matter in the manner as ''in vivo'' studies) and is posited to be due possibly to [[zwitterion]] [[Ion#Formation|formation]].{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50st page of article)] First (left) column, fourth \u00b6}}\n[[File:198a-e.svg|thumb|400px]]\n{| class=\"wikitable sortable\"\n|+2''\u03b2''-isoxazole and isoxazoline ring containing analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, following tables<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! [<sup>3</sup>H][[Mazindol]]\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n| || (Cocaine) || (H) ||580 \u00b1 70||570 \u00b1 180||1.0\n|-\n|rowspan=7|[[File:Cocaine analog 198.svg|200px|Satendra Singh Rev]]\n|-\n| 198a || H ||520 \u00b1 40||260 \u00b1 70||0.5\n|-\n| 198b || CO<sub>2</sub>Et (5\u2032-carboethoxy-)||120 \u00b1 10||290 \u00b1 40||2.4\n|-\n| 198c || [[tert-Butyloxycarbonyl protecting group|BOC]] ||2230 \u00b1 220||1820 \u00b1 810||0.8\n|-\n| 198d || Ph ||2000 \u00b1 640||2920 \u00b1 1620||1.5\n|-\n| 198e || CH=CHCO<sub>2</sub>Me ||3600 \u00b1 400||3590 \u00b1 1180||1.0\n|}\n[[File:2-((2-methoxy-2-oxoethoxy)methyl)_cocaine_analogue.png|thumb|right|x180px|2-<nowiki>[</nowiki>(2-methoxy-2-oxoethoxy)methyl<nowiki>]</nowiki> cocaine analogue.<ref name=\"Carroll\"/>]]\n[[File:Cocaine analog 199a.svg|x220px]]\n[[File:Cocaine analog 199b.svg|x220px]]\n[[File:D3-methyl cocaine.svg|thumb|<nowiki>[</nowiki>''<sup>2</sup>H<sub>3</sub>-N-methyl''<nowiki>]</nowiki>-cocaine: [[reagent]] analogue used in [[Radioactive tracer|radio-labeling]] ligand binding sites.]]\n{| class=\"wikitable sortable\"\n|+nonplanar 2''\u03b2''-isoxazoline ring containing analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n|rowspan=3|\n|-\n| 199a || \u03b2(or ''R'')CO<sub>2</sub>Et ||710 \u00b1 150||1060 \u00b1 340||1.5\n|-\n| 199b || \u03b1(or ''S'')CO<sub>2</sub>Et ||5830 \u00b1 630||8460 \u00b1 620||1.4\n|}\n[[File:Cocaine analogue C2-EthOSO2CF2.png|thumb|C2-ethyl-OSO<sub>2</sub>CF<sub>2</sub> cocaine analogue.<ref name=\"Carroll\"/>]]\n[[File:Cocaine analog 200.svg|x260px]]\n\n{| class=\"wikitable sortable\"\n|+2''\u03b2''-isoxazoline atomically N/O reversed analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n| || 200 || ||880 \u00b1 350||400 \u00b1 140||0.4\n|}\n\n====Vinylogous 2''\u03b2''-position carbmethoxy-ester functional replacements====\n[[File:Cocaine analog 201a.svg|x150px]]\n[[File:Cocaine analog 201b.svg|x180px]]\n[[File:Cocaine analog 201c.svg|x220px]]\n[[File:Cocaine analog 201d.svg|x260px]]\n[[File:Cocaine analog 201e.svg|x260px]]\n\n'''201b''' & '''201c''' show significant increased potency over cocaine; whereas '''201a''', '''201d''' & '''201e''' are considerably less so. This infers the hydrogen bond acceptor at the 2''\u03b2'' position to not necessarily be of exclusive import in creation of higher binding analogues of cocaine.\n[[File:D5-phenyl cocaine.svg|thumb|<nowiki>[</nowiki>''<sup>2</sup>H<sub>5</sub>-phenyl''<nowiki>]</nowiki>-cocaine: reagent analogue, as above thumbnail of similar compound: rendered from its cocaine parent by replacing a cluster of several adjacent hydrogens (from among the hydrogens that comprise the entire circumference common to every basic molecular perimeter) with [[deuterium]], in an equivalent but localized spread or cluster.]]\n{| class=\"wikitable sortable\"\n|+vinylogous 2''\u03b2'' analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, preceding table<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n|rowspan=6|[[File:Cocaine analog 201.svg|220px]]\n|-\n| 201a || H ||1730 \u00b1 550||1120 \u00b1 390||0.6\n|-\n| 201b || Cl ||222 \u00b1 49||368 \u00b1 190||1.6\n|-\n| 201c || CO<sub>2</sub>Et ||50 \u00b1 10||130 \u00b1 10||2.6\n|-\n| 201d || CH=CHCO<sub>2</sub>Et ||1220 \u00b1 100||870 \u00b1 50||0.7\n|-\n| 201e || PO(OEt)<sub>2</sub> ||4850 \u00b1 470||5500 \u00b1 70||1.1\n|}\n\n===''N''-modifications===\n[[File:Cocaine analog 218 (norcocaine).svg|x170px]]\n[[File:Cocaine analog 219a.svg|x170px]]\n[[File:Cocaine analog 219b.svg|x170px]]\n[[File:219a-b.svg|thumb|325px]]\n[[File:Cocaine analog 219c.svg|x160px]]\n[[File:Cocaine analog 219d.svg|x160px]]\n[[File:Cocaine analog 219e.svg|x160px]]\n\n{| class=\"wikitable\"\n|+ Additional ''N''-modified cocaine analogue molecular structures\n|-\n[[File:Norcocaine.png|x180px]]\n[[File:Cocaine analog 220a.svg|x170px]]\n[[File:Cocaine analog 220b.svg|x170px]]\n[[File:Cocaine analog 220c.svg|x170px]]<br>\n[[File:Cocaine analog 220d.svg|x170px]]\n[[File:Cocaine analog 220e.svg|x190px]]\n[[File:Cocaine analog 220f.svg|x170px]]\n|}\n[[File:Cocaine analog 221a.svg|x160px]]\n[[File:Cocaine analog 221b.svg|x160px]]\n[[File:Cocaine analog 221c.svg|x160px]]\n[[File:Cocaine analog 221d.svg|x160px]]\n[[File:8-oxa cocaine.svg|thumb|200px|right|'''''8-oxa'' cocaine''' analogs:<ref>{{Cite journal | doi = 10.1016/S0960-894X(99)00273-5| pmid = 10406650| title = Synthesis of 8-oxa analogues of norcocaine endowed with interesting cocaine-like activity| journal = Bioorganic & Medicinal Chemistry Letters| volume = 9| issue = 13| pages = 1831\u20131836| year = 1999| last1 = Kozikowski | first1 = A. P. | last2 = Simoni | first2 = D. | last3 = Roberti | first3 = M. | last4 = Rondanin | first4 = R. | last5 = Wang | first5 = S. | last6 = Du | first6 = P. | last7 = Johnson | first7 = K. M. }}</ref> (cf Meltzer with [[List of phenyltropanes|PTs]])]]\n {{multiple image\n | direction = vertical\n | footer = Eight position carba ''N''6 & ''N''7 analogues.<ref name=\"Carroll\"/>\n | image1 = (1R,3S,5S)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl_benzoate.svg\n | width1 = 250\n | image2 = (1S,3R,5R)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl_benzoate.svg\n | width2 = 290\n }}\n[[File:(1S,3R,5R)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl 2-phenylbenzoate.svg|thumb|right|x200px|''ortho''-phenyl of the moved nitrogen.<ref name=\"Carroll\"/>]]\n{| class=\"wikitable sortable\"\n|+Nitrogen Substitutions<br>Mazindol comparison table<br>(<sup>'''\u0251'''</sup>''\u03b2''-CFT comparison notation){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#54 Page #978 (54th page of article)] \u00a7D & Page #980 (56th page of article) Figure 33 & Page #981 (57th page of article) Table 32.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''N''8-''R''\n! [<sup>3</sup>H]Mazindol<br>binding\n! [<sup>3</sup>H]DA<br>uptake\n! Selectivity\nUptake/Binding\n|-\n| [[File:Cocaine methiodide.svg|240px]] ||217<br>(Cocaine methiodide)||-||10700 \u00b1 1530<sup>'''\u0251'''</sup>|| - || -\n|-\n|rowspan=17|[[File:Cocaine analog 219.svg|210px|Satendra Singh Rev]]|| (Cocaine) || CH<sub>3</sub> ||280 \u00b1 60<br>102<sup>'''\u0251'''</sup>||320 \u00b1 10||1.1\n|-\n| 218<br>([[Norcocaine]]) || H ||303 \u00b1 59<sup>'''\u0251'''</sup>|| - || -\n|-\n| 219a || [[benzyl|Bn]] ||668 \u00b1 67<sup>'''\u0251'''</sup>|| - || -\n|-\n| 219b || [[acetyl|Ac]] ||3370 \u00b1 1080<sup>'''\u0251'''</sup>|| - || -\n|-\n| 219c || CH<sub>2</sub>CH<sub>2</sub>OH ||700 \u00b1 100||1600 \u00b1 200||2.3\n|-\n| 219d || CH<sub>2</sub>CO<sub>2</sub>CH<sub>3</sub> ||480 \u00b1 40||1600 \u00b1 100||3.3\n|-\n| 219e || CH<sub>2</sub>CO<sub>2</sub>H ||380 \u00b1 20||2100 \u00b1 400||5.5\n|-\n| 220a || SO<sub>2</sub>CH<sub>3</sub> ([[mesyl|Ms]]) ||1290 \u00b1 80||1970 \u00b1 70||1.5\n|-\n| 220b || SO<sub>2</sub>CF<sub>3</sub> ([[Triflyl|Tf]]) ||330 \u00b1 30||760 \u00b1 20||2.3\n|-\n| 220c || SO<sub>2</sub>NCO ||120 \u00b1 10||160 \u00b1 10||1.3\n|-\n| 220d || SO<sub>2</sub>Ph ||20800 \u00b1 3500|| 61000 ||2.9\n|-\n| 220e || SO<sub>2</sub>C<sub>6</sub>H<sub>4</sub>-4-NO<sub>2</sub> ([[nosyl]]) ||5720 \u00b1 1140||18800 \u00b1 90||3.3\n|-\n| 220f || SO<sub>2</sub>C<sub>6</sub>H<sub>4</sub>-4-OCH<sub>3</sub> ||6820 \u00b1 580||16400 \u00b1 1400||2.4\n|-\n| 221a || NO ||99500 \u00b1 12300||231700 \u00b1 39500||2.3\n|-\n| 221b || NO<sub>2</sub> ||7500 \u00b1 900||21200 \u00b1 600||2.8\n|-\n| 221c || NHCOCH<sub>3</sub> || >1000000 || >1000000 || -\n|-\n| 221d || NH<sub>2</sub> || - || - || -\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> (nM) for displacement of [<sup>3</sup>H]WIN 35428</small>\n\n===Bridged (''N''-constrained/tethered) tropane-fused cocaine analogues===\n====8 to 2 position tropane bridge====\n[[File:Bridged Cocaine Analogs.svg|right|thumb|x350px|A selection of \"front bridged\" & \"back bridged\" cocaine analogs.<br>''See'' [[List of phenyltropanes#Bridged N-constrained phenyltropanes (fused/tethered)|''N''-front & back bridged phenyltropanes]].]]\n{| class=\"wikitable sortable\"\n|+Derivations upon fusions of the tropane's nitrogen bridge{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#56 Page #980 (56th page of article)] Scheme 52.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n| [[File:Cocaine analog 222.svg|200px]] || 222 || ||44900 \u00b1 6200||115000 \u00b1 15700||2.6\n|}\nBack-bridged cocaine analogues are considered more akin to untethered cocaine analogs & phenyltropane derivatives (where the nitrogen [[Orbital hybridisation|lone pair is not fixed or constrained]]) and better mimics their affinities. This is due to when the eighth carbon tropane position is freely rotatable and unbound it preferably occupies the ''axial'' position as defining its least energy & most unhindered state. In front-bridged analogs the nitrogen lone pairings rigid fixity makes it reside in an ''equatorial'' placing for the piperidine ring-part of the tropane nucleus, pointing to the two-carbon & three methylene unit bridgehead; giving the attested front-bridged cocaine analogues preference for SERT over DAT.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#39 Page #963 (39th page of article)] 2nd (right side) column, 2nd paragraph.}}\n\n=== Tricyclic cocaine analogues ===\nTethering the nitrogen 8 tropane position one position further (beyond 2''\u03b2'' and crossed-over it / leaving it open as hydrogen and thus possible of having additional unconstrained substitutions there) and linking all the way across to the 3''\u03b2'' aryl, replacing it; yields an expansive front-bridged structure to create a structurally [[tricyclic]] series of cocaine analogues.\n\n==== 8 to 3 position ====\n[[File:Constrained tropane.png|thumb|right|400px|Constrained thiophene tropane<ref>{{cite journal | doi = 10.1021/jm0001121 | pmid= 10821718 | title= Novel Conformationally Constrained Tropane Analogues by 6- e ndo-trig Radical Cyclization and Stille Coupling \u2212 Switch of Activity toward the Serotonin and/or Norepinephrine Transporter | journal=Journal of Medicinal Chemistry | date=2000 | volume=43 | issue=10 | pages=2064\u20132071 | first=Alexander | last=Hoepping}}</ref><ref>{{cite journal | doi = 10.1016/S0960-894X(02)00103-8 | pmid=11909701 | title=Thiophene derivatives: a new series of potent norepinephrine and serotonin reuptake inhibitors | journal=Bioorganic | date=2002 | volume=12 | issue=7 | pages=993\u2013995 | first=Ao | last=Zhang}}</ref> Note the [[Green\u2013Davies\u2013Mingos rules|''pi'' symmetry]] of the partially hydrogen-unsaturated cyclopentane substitutes the benzene place with the other tricyclic tropanes to the left.]]\n[[File:Tricyclic tropanes.png|thumb|left|800px|Tricyclic tropanes, values in ''K<sub>i</sub>'' (nM)<ref>{{cite journal | doi = 10.1021/jm0105373 | pmid= 11960503 | title= Further Studies on Conformationally Constrained Tricyclic Tropane Analogues and Their Uptake Inhibition at Monoamine Transporter Sites: Synthesis of ( Z )-9-(Substituted arylmethylene)-7-azatricyclo[4.3.1.0 3,7 ]decanes as a Novel Class of Serotonin Transporter Inhibitors | journal=Journal of Medicinal Chemistry | date=2002 | volume=45 | issue=9 | pages=1930\u20131941 | first=Ao | last=Zhang}}</ref><br>1st structure (di-''chloro'' benzene, 2''\u03b2''-CH<sub>2</sub>OCOMe) SERT = 1.6, DAT = 1870, NET = 638<br>2nd structure (''para''-bromo, ''meta''-chloro, 2''\u03b2''-CO<sub>2</sub>Me) SERT = 2.3, DAT = 5420, NET = 459<br>3rd structure (''para''-iodo, ''meta''-chloro, 2''\u03b2''-CH<sub>2</sub>OCOPh) SERT = 0.06, DAT/NET both = >10K]]\n\n{| class=\"wikitable\" colwidth=\"500px\" align=\"center\"\n|Compound||X||Y||R||SERT ''K<sub>i</sub>'' (nM)||DAT ''K<sub>i</sub>'' (nM)||NET ''K<sub>i</sub>'' (nM)\n|-\n|1||Cl||Cl||CH<sub>2</sub>OCOMe||1.6||1870||638\n|-\n|2||Br||Cl||CO<sub>2</sub>Me||2.3||5420||459\n|-\n|3||I||Cl||CH<sub>2</sub>OCOPh||0.06||>10K||>10K\n|}\n{{clear}}\n\n===Azabornane tropane ring contraction===\nAlterations shortening the tropane ring system while including the benzoyloxy length at the C3 have been made, contrasting the [[List of phenyltropanes#Azabornane (outer ring contracted)|azabornane phenyltropanes]];<ref name=\"Carroll\">{{US patent|6479509}}</ref> likely remedying the shallow penetration (for good efficacy) of the latter.<br>\n5-benzoatic (left, below) & 6-benzoatic (right, below)<br>\n[[File:(5S)-2-methyl-2-azabicyclo(2.2.1)heptan-5-yl benzoate.svg|275px]]\n[[File:(6R)-2-methyl-2-azabicyclo(2.2.1)heptan-6-yl benzoate.svg|275px]]<br>\n[[File:NorbornaneBMEanalog.png]]<br>\nComparison of tropane ring versus the norbornane in overlay, with contrast of benzoyl branch in its configuration of how it lays extended out from body of either main ring type (shown twice in different colors, for visibility, above)\n\n===6/7 tropane position methoxycocaine & methoxypseudococaine analogues===\n[[File:Cocaine analog 225a.svg|270px]]\n[[File:Cocaine analog 225b.svg|270px]]\n[[File:Cocaine analog 225c.svg|270px]]\n[[File:Cocaine analog 225d.svg|270px]]\n[[File:Cocaine analog 225e.svg|270px]]\n[[File:Methyl (1R,4R,5S)-4-chloro-8-methyl-3-(phenylsulfanyl)-8-azabicyclo(3.2.1)oct-2-ene-2-carboxylate.svg|thumb|right|Phenylsulfanyl, C2-C3 unsaturated nonisomeric (C2 inclusive) C4 chloro analog.<ref name=\"Carroll\"/>]]\n{| class=\"wikitable sortable\"\n|+Substitutions upon the 6 & 7 positions of the tropane{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)] \u00a7G & Page #983 (59th page of article) Figure 36 & Page #984 (60th page of article) Table 35.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''X''\n! K<sub>i</sub> (nM)<br>[<sup>3</sup>H]Mazindol binding\n! K<sub>i</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! Selectivity\nUptake/Binding\n|-\n| || (Cocaine) || ||280 \u00b1 60||320 \u00b1 10||1.1\n|-\n| || (Pseudococaine) || ||10400 \u00b1 300||13800 \u00b1 1500||1.3\n|-\n|rowspan=6|\n|-\n| 225a || 2\u03b2, 6\u03b2-OCH<sub>3</sub> ||98000 \u00b1 12000||68000 \u00b1 5000||0.7\n|-\n| 225b || 2\u03b1, 6\u03b2-OCH<sub>3</sub> ||190000 \u00b1 11000||510000 \u00b1 110000||2.7\n|-\n| 225c || 2\u03b2, 7\u03b2-OCH<sub>3</sub> ||4200 \u00b1 100||6100 \u00b1 200||1.4\n|-\n| 225d || 2\u03b1, 7\u03b2-OCH<sub>3</sub> ||45000 \u00b1 5000||110000 \u00b1 4000||2.4\n|-\n| 225e || 2\u03b1, 7\u03b1-OCH<sub>3</sub> ||54000 \u00b1 3000||200000 \u00b1 70000||3.7\n|}\n\n===3''\u03b2''-position 2\u2032\u2014(6\u2032) & 2''\u03b2''-substitution combination analogues===\n[[File:Cocaine analog 211a.svg|260px]]\n[[File:Cocaine analog 211b.svg|260px]]\n[[File:Cocaine analog 211c.svg|260px]]\n[[File:Cocaine analog 211d.svg|260px]]\n[[File:Cocaine analog 211e.svg|260px]]<br>\n[[File:Cocaine analog 211f.svg|260px]]\n[[File:Cocaine analog 211g.svg|260px]]\n[[File:Cocaine analog 211h.svg|260px]]\n[[File:Cocaine analog 211i.svg|260px]]\n[[File:Cocaine analog 211j.svg|260px]]\n{| class=\"wikitable sortable\"\n|+4\u2032-Iodococaine-2''\u03b2''-substituted analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#55 Page #979 (55th page of article)] Table 31.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation\n! 2''\u03b2''-''R''\n! C2\u2032-''R''\n! IC<sub>50</sub> (nM)<br>(displacement of [<sup>3</sup>H]WIN 35428)\n|-\n|rowspan=8|[[File:Cocaine_analog_211.svg|220px]]\n|-\n| 211a || CO<sub>2</sub>OH || H ||6214 \u00b1 1269\n|-\n| 211b || CH<sub>2</sub>OCOCH<sub>3</sub> || H ||2995 \u00b1 223\n|-\n| 211c || CONHCH<sub>3</sub> || H || >100000\n|-\n| 211d || CO<sub>2</sub>Et || H ||2031 \u00b1 190\n|-\n| 211e || CO<sub>2</sub>-''i''-Pr || H ||1377 \u00b1 10\n|-\n| 211f || CO<sub>2</sub>Ph || H ||2019 \u00b1 253\n|-\n| 211g || CO<sub>2</sub>CH<sub>2</sub>Ph || H ||4602 \u00b1 325\n|-\n| || 211h || 3-phenyl-1,2,4-oxadiazole || H ||3459 \u00b1 60\n|-\n|rowspan=3|\n|-\n| 211i || CH=CH<sub>2</sub> || H ||2165 \u00b1 253\n|-\n| 211j || CH<sub>2</sub>CH<sub>3</sub> || H ||2692 \u00b1 486\n|-\n| [[File:Cocaine analog 212.svg|200px]] || 212 || CO<sub>2</sub>-''i''-Pr || HO ||663 \u00b1 70<br>4507 \u00b1 13<sup>'''\u0251'''</sup><br>34838 \u00b1 796<sup>'''b'''</sup>\n|}\n*<sup>'''\u0251'''</sup><small>For displacement of [<sup>3</sup>H]paroxetine (5-HTT & NET)</small>\n*<sup>'''b'''</sup><small>For displacement of [<sup>3</sup>H]nisoxetine (5-HTT & NET)</small>\n\n===3''\u03b2''-Carbamoyl analogues===\n[[File:Cocaine analog 223a.svg|x170px]]<br>\n[[File:Cocaine analog 223b.svg|x200px]]\n[[File:Cocaine analog 223c.svg|x170px]]\n[[File:Cocaine analog 223d.svg|x170px]]\n[[File:Cocaine analog 223e.svg|x170px]]<br>\n[[File:Cocaine analog 223f.svg|x170px]]\n[[File:Cocaine analog 223g.svg|x170px]]\n[[File:Cocaine analog 223h.svg|x170px]]\n[[File:Cocaine analog 223i.svg|x170px]]\n{| class=\"wikitable sortable\"\n|+3-position carbamoyl linkage substituting benzoyloxy analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#57 Page #981 (57th page of article)] \u00a7E & Page #982 (58th page of article) Table 33.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''X''\n! IC<sub>50</sub> (nM)<br>inhibition of [<sup>3</sup>H]Cocaine binding<br>(Rat Striatal Tissue)\n! IC<sub>50</sub> (nM)<br>inhibition of [<sup>3</sup>H]DA uptake<br>(Rat Striatal Tissue)\n! Selectivity<br>uptake/binding\n|-\n| || (Cocaine) || (H) ||70 \u00b1 10||210 \u00b1 70||3.0\n|-\n|rowspan=6|[[File:Cocaine analog 223a-e.svg|x120px]]\n|-\n| 223a || H ||5600 \u00b1 700||52600 \u00b1 3000||9.4\n|-\n| 223b || 4-NO<sub>2</sub> ||1090 \u00b1 250||5700 \u00b1 1200||5.2\n|-\n| 223c || 4-NH<sub>2</sub> ||63300 \u00b1 12200|| >100000 || -\n|-\n| 223d || 4-N<sub>3</sub> ||1000 \u00b1 240||1180 \u00b1 360||1.2\n|-\n| 223e || 4-NCS ||260 \u00b1 60||490 \u00b1 80||1.9\n|-\n|rowspan=5|[[File:Cocaine analog 223f-i.svg|x120px]]\n|-\n| 223f || 3-NO<sub>2</sub> ||37 \u00b1 10||178 \u00b1 23||4.8\n|-\n| 223g || 3-NH<sub>2</sub> ||2070 \u00b1 340||23100 \u00b1 900||11.1\n|-\n| 223h || 3-N<sub>3</sub> ||630 \u00b1 150||3900 \u00b1 1590||6.2\n|-\n| 223i || 3-NCS ||960 \u00b1 210||4900 \u00b1 420||5.1\n|}\n\n===Phenyl 3-position linkage substitutions===\n<div style=\"background-color: #CFCFCF; border:10px solid #666666\">\n[[File:Phenyltropane.gif|thumb|A 3-Dimensional ([[Ball-and-stick model|stick-&-ball]]) rendering of [[Troparil]]: A structural analogue of cocaine with omitted -COO- linkage \u2013 a parent compound of many MAT ligands; those of the [[phenyltropane]] class. (Here it is depicted in an unfavourable conformation of the O-Me; The methyl has to be at the other oxygen and ''[[Cis\u2013trans isomerism|trans]]'' to optimize its functional stimulation.)]]\n{{multiple image\n | align = left\n | direction = vertical\n | footer = The top image above is a 2-Dimensional emulation of the orientation for the animated 3D image to the far right, with a methoxy that is distal from the phenyl group and ''cis''. While the alternate image below that to its bottom shown above is one with the carboxyl methyl group proximal to the phenyl, in its optimum conformation, with a likewise optimum ''trans'' configuration.\n | image1 = Troparil w ph distal cis OMe.png\n | width1 = 190\n | image2 = Troparil w ph proximal trans OMe.png\n | width2 = 200\n }}\n\nSee: [[List of phenyltropanes]] (Many phenyltropanes are derived from cocaine metabolites, such as [[methylecgonidine]], as [[Precursor (chemistry)|precursors]]. Whereas fully synthetic methods have been devised from the starting material of vinylcarbenoids & pyrroles.)<ref>{{cite journal | pmid = 8420793 | volume=244 | issue=1 | title=Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum | year=1993 | journal=Eur. J. Pharmacol. | pages=93\u20137 | last1 = Davies | first1 = HM | last2 = Saikali | first2 = E | last3 = Sexton | first3 = T | last4 = Childers | first4 = SR | doi=10.1016/0922-4106(93)90063-f}}</ref>\n\nThe difference in the length of the benzoyloxy and the phenyl linkage contrasted between cocaine and phenyltropanes makes for a shorter distance between the [[centroid]] of the aromatic benzene and the bridge nitrogen of the tropane in the latter PTs. This distance being on a scale of 5.6 [[Angstrom|\u00c5]] for phenyltropanes and 7.7 [[Angstrom|\u00c5]] for cocaine or analogs with the benzoyloxy intact.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#46 Page #970 (46th page of article)] \u00a7B, 10th line}} This may account for PTs increased behavioral stimulation profile over cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] 1st \u00b6, 10th line}} Differences in binding potency have also been explained considering solvation effects; cocaine containing 2''\u03b2'',3''\u03b2''-ester groups being calculated as more solvated than the WIN-type compounds (i.e. troparil). Higher p''K''<sub>\u0251</sub>s of the tropane nitrogen (8.65 for cocaine, 9.55 for troparil & 11.95 for vinyl analogue '''43a'''), decreased aqueous solvation & decreased conformational flexibility added to increased binding affinity.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#25 Page #949 (25th page of article)] 3rd \u00b6, 20th line}}\n\n[[File:WIN 35,065-2.svg|x150px]]\n[[File:WF-31.svg|x170px]]\n[[File:RTI-11W.svg|x150px]]\n[[File:WF-23.svg|x160px]]\n\nDespite the observation of increased stimulation, phenyltropanes lack the local anesthetic sodium channel blocking effect that the benzoyloxy imparts to cocaine. Beside topical affect, this gives cocaine an affinity for binding to sites on the dopamine and serotonin sodium dependent transport areas that are distinct & specific to MAT in contrast to the general sodium channels; creating a separate mechanism of relational affinity to the transporters in addition to its inhibition of the reuptake for those transporters; this is unique to the local anesthetic value in cocaine & analogues with a similar substitute for the benzoyloxy that leaves the sodium channel blockage ability intact. Rendering such compounds as different functionally in their relation to MAT contrasted to phenyltropane analogues which have the local anesthetic bridge removed.<ref>{{cite web|url=http://www.drugbank.ca/drugs/DB00907 |title=Drugbank website \"drug card\", \"(DB00907)\" for Cocaine: Giving ten targets of the molecule in vivo, including dopamine/serotonin sodium channel affinity & K-opioid affinity |publisher=Drugbank.ca |accessdate=9 March 2010}}</ref> (Requiring some of the sodium ions to be pumped from the axon via [[Na+/K+-ATPase]]). In addition, it even has been postulated that a crucial role regarding the electron energy imparted via voltage sensitization (and thus [[action potential]] blockage with a molecule capable of intersecting its specific channel, in the case of cocaine a [[sodium channel]], that potentially serves in [[Elementary charge#Quantization|re-quantifying]] its charge) upon a receptor binding site may attenuate the mediating influence of the inhibitory regulation that autoreceptors play by their slowing neurotransmitter release when an [[efflux (microbiology)|efflux]] is created through an instance of agonism by a compound; allowing said efflux to be continued without the body's attempt to maintain [[homeostasis]] enacting in as readily responsive a manner to its conformational change.<ref>{{cite journal | last1 = Sahlholm | first1 = Kristoffer | last2 = Nilsson | first2 = Johanna | last3 = Marcellino | first3 = Daniel | last4 = Fuxe | first4 = Kjell | last5 = \u00c5rhem | first5 = Peter | year = 2012 | title = Voltage sensitivities and deactivation kinetics of histamine H<sub>3</sub> and H<sub>4</sub> receptors | url = | journal = Biochimica et Biophysica Acta (BBA) - Biomembranes | volume = 1818 | issue = 12| pages = 3081\u20133089 | doi = 10.1016/j.bbamem.2012.07.027 }} ''...Agonist potency at some neurotransmitter receptors has been shown to be regulated by voltage, a mechanism which has been suggested to play a crucial role in the regulation of neurotransmitter release by inhibitory autoreceptors...''</ref>\n\n{| class=\"wikitable\"\n|+ Various phenyltropane examples\n|-\n<div style=\"background-color: #FFFFFF; border:10px solid #E9E9E9\">\n[[File:RTI-353 structure.png|x180px]]\n[[File:RTI-150.png|x200px]]\n[[File:RTI-171 structure.png|x195px]]\n[[File:RTI-336.png|x185px]]\n<br>\n[[File:Altropane.svg|x170px]]\n[[File:Ioflupane.png|x190px]]\n[[File:Brasofensine.svg|x200px]]\n[[File:Tesofensine chemical structure.png|x140px]]\n</div>\n|}\n{{clear}}\n</div>\n\n===3''\u03b2''-Alkylphenyltropane & 3''\u03b2''-Alkenyl analogues===\n\nThe compound '''224e''', the 3''\u03b2''-styrene analogue, had the highest potency in its group. While '''224b''' & '''224c''' showed the most selectivity, with '''224b''' having a ten-fold greater potency for the dopamine transporter than cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)] 3rd \u00b6, lines 2, 5 & 6.}}\n\n[[File:Cocaine analog 224a.svg|x190px]]\n[[File:Cocaine analog 224b.svg|x140px]]\n[[File:Cocaine analog 224c.svg|x200px]]<br>\n[[File:Cocaine analog 224d.svg|x190px]]\n[[File:Cocaine analog 224e.svg|x140px]]\n[[File:Cocaine analog 224e alt.svg|thumb|3''\u03b2''-styrene alkylphenyl cocaine analog image showing stereochemistry.<br>(''i.e.'' compound \"'''224e'''\")]]\n{| class=\"wikitable sortable\"\n|+3-position alkylphenyl linkage substituting benzoyloxy analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)] \u00a7F, Table 34 & Figure 35.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''n''\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]Cocaine binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! Selectivity<br>uptake/binding\n|-\n| || (Cocaine) || ||101 \u00b1 26||209 \u00b1 20||2.1\n|-\n|rowspan=4|[[File:Cocaine_analog_224.svg|x140px]]\n|-\n| 224a || <sub>1</sub> ||885 \u00b1 18||1020 \u00b1 52||1.1\n|-\n| 224b || <sub>2</sub> ||9.9 \u00b1 0.33||70.5 \u00b1 1.0||7.1\n|-\n| 224c || <sub>3</sub> ||344 \u00b1 12||2680 \u00b1 190||7.8\n|-\n| || 224d ||  ||71.6 \u00b1 0.7||138 \u00b1 9||1.9\n|-\n| || 224e ||  ||2.10 \u00b1 0.04||5.88 \u00b1 0.09||2.8\n|}\n\n===6-Alkyl-3-benzyltropane analogues===\n[[File:Cocaine analog 229a.svg|x200px]]\n[[File:Cocaine analog 230a.svg|x180px]]\n[[File:Cocaine analog 231b.svg|x200px]]\n[[File:Cocaine analog 232b.svg|x180px]]\n\n{| class=\"wikitable\"\n|+ Cocaine 229b\u2014f series analogues\n|-\n[[File:Cocaine analog 229b.svg|x200px]]\n[[File:Cocaine analog 229c.svg|x200px]]\n<br>\n[[File:Cocaine analog 229d.svg|x240px]]\n[[File:Cocaine analog 229e.svg|x250px]]\n[[File:Cocaine analog 229f.svg|x250px]]\n|}\n\n{| class=\"wikitable\"\n|+ Cocaine 230b\u2014f series analogues\n|-\n[[File:Cocaine analog 230b.svg|x180px]]\n[[File:Cocaine analog 230c.svg|x180px]]\n<br>\n[[File:Cocaine analog 230d.svg|x220px]]\n[[File:Cocaine analog 230e.svg|x220px]]\n[[File:Cocaine analog 230f.svg|x220px]]\n|}\n\n{| class=\"wikitable\"\n|+ Cocaine 231c\u2014f series analogues\n|-\n[[File:Cocaine analog 231c.svg|x200px]]\n[[File:Cocaine analog 231d.svg|x200px]]\n<br>\n[[File:Cocaine analog 231e.svg|x200px]]\n[[File:Cocaine analog 231f.svg|x200px]]\n|}\n\n{| class=\"wikitable\"\n|+ Cocaine 232c, d & f series analogues\n|-\n[[File:Cocaine analog 232c.svg|x200px]]\n[[File:Cocaine analog 232d.svg|x200px]]\n[[File:Cocaine analog 232f.svg|x200px]]\n|}\n\n{| class=\"wikitable sortable\"\n|+6-Alkyl-3-benzyl-2[(methoxycarbonyl)methyl]tropane analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#60 Page #984 (60th page of article)] \u00a7H, Figure 37 & Page #985 (61st page of article) Table 36.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name/[[Sterling Drug|WIN]] number)\n! ''R''\n! K<sub>i</sub> (nM)<br>[<sup>3</sup>H]WIN 35428 binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! Selectivity\nuptake/binding\n|-\n| || (Cocaine) || ||32 \u00b1 5<br>338 \u00b1 221||405 \u00b1 91<br>405 \u00b1 91||12.6<br>1.2\n|-\n| || 11a<br>(WIN 35065-2) || ||33 \u00b1 17<br>314 \u00b1 222||373 \u00b1 10||11.3\n|-\n|rowspan=8|\n|-\n| (\u2212)-229a || H ||33 \u00b1 5||161 \u00b1 100||4.9\n|-\n| 229a || H ||91 \u00b1 10||94 \u00b1 26||1.0\n|-\n| 229b || Me ||211 \u00b1 23|| - || -\n|-\n| 229c || Et ||307 \u00b1 28|| - || -\n|-\n| 229d || ''n''-Pr ||4180 \u00b1 418|| - || -\n|-\n| 229e || ''n''-Bu ||8580 \u00b1 249|| - || -\n|-\n| 229f || Bn ||3080 \u00b1 277|| - || -\n|-\n|rowspan=8|\n|-\n| (+)-230a || H ||60 \u00b1 6||208 \u00b1 63||3.5\n|-\n| 230a || H ||108 \u00b1 14||457 \u00b1 104||4.2\n|-\n| 230b || Me ||561 \u00b1 64|| - || -\n|-\n| 230c || Et ||1150 \u00b1 135|| - || -\n|-\n| 230d || ''n''-Pr ||7240 \u00b1 376|| - || -\n|-\n| 230e || ''n''-Bu ||19700 \u00b1 350|| - || -\n|-\n| 230f || Bn ||7590 \u00b1 53|| - || -\n|-\n|rowspan=5|\n|-\n| 231b || Me ||57 \u00b1 5||107 \u00b1 36||1.9\n|-\n| 231c || Et ||3110 \u00b1 187|| - || -\n|-\n| 231d || ''n''-Pr ||5850 \u00b1 702|| - || -\n|-\n| 231f || Bn ||1560 \u00b1 63|| - || -\n|-\n|rowspan=5|\n|-\n| 232b || Me ||294 \u00b1 29||532 \u00b1 136||1.8\n|-\n| 232c || Et ||6210 \u00b1 435|| - || -\n|-\n| 232d || ''n''-Pr ||57300 \u00b1 3440|| - || -\n|-\n| 232f || Bn ||3080 \u00b1 277|| - || -\n|-\n| || 241 || Bn ||4830 \u00b1 434|| - || -\n|}\n\n{| class=\"wikitable sortable\"\n|+Benzylidene derivatives of 6-alkyl-3-benzyltropanes{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#60 Page #984 (60th page of article)] Scheme 56.}}\n! Sub-category<br>(''S. Singh compound #'')\n! a<br>''R''=H\n! b<br>''R''=Me\n! c<br>''R''=Et\n! d<br>''R''=''n''-Pr\n! e<br>''R''=''n''-Bu\n! f<br>''R''=Bn\n|-\n|rowspan=2|6\u03b1-isomers:<br>''237a\u2014f''\n|-\n|[[File:Cocaine analog 237a.svg|x95px]]||[[File:Cocaine analog 237b.svg|x105px]]||[[File:Cocaine analog 237c.svg|x110px]]||[[File:Cocaine analog 237d.svg|x125px]]||[[File:Cocaine analog 237e.svg|x135px]]||[[File:Cocaine analog 237f.svg|x135px]]\n|-\n|rowspan=2|6\u03b2-isomers (exo):<br>''238a\u2014f''\n|-\n|[[File:Cocaine analog 238a.svg|x87px]]||[[File:Cocaine analog 238b.svg|x95px]]||[[File:Cocaine analog 238c.svg|x95px]]||[[File:Cocaine analog 238d.svg|x95px]]||[[File:Cocaine analog 238e.svg|x95px]]||\n[[File:Cocaine analog 238f.svg|x115px]]\n|-\n|rowspan=2|3\u03b2-benzyl derivatives:<br>''239a\u2014f''\n|-\n|[[File:Cocaine analog 239a.svg|x115px]]||[[File:Cocaine analog 239b.svg|x110px]]||[[File:Cocaine analog 239c.svg|x110px]]||[[File:Cocaine analog 239d.svg|x130px]]||[[File:Cocaine analog 239e.svg|x135px]]||[[File:Cocaine analog 239f.svg|x135px]]\n|-\n|rowspan=2|intermediate<br>alkylidene esters:<br>''240a\u2014f''\n|-\n|[[File:Cocaine analog 240a.svg|x115px]]||[[File:Cocaine analog 240b.svg|x115px]]||[[File:Cocaine analog 240c.svg|x115px]]||[[File:Cocaine analog 240d.svg|x130px]]||[[File:Cocaine analog 240e.svg|x135px]]||[[File:Cocaine analog 240f.svg|x135px]]\n|-\n|}\n''[[Nota bene|N.B.]]'' that ''237a'' and ''238a'' are the same compound as both are the parent for either series with a hydrogen saturated in their respective substitution place.\n\n===Direct 2,3-pyrimidino fused===\n {{multiple image\n | direction = vertical\n | image1 = Strobamine.svg\n | width1 = 280\n | caption1 = ''above:'' [[Strobamine]], a DARI functional cocaine analog with structural semblance.<ref>[http://www.arkat-usa.org/get-file/36494/ Enantioselective synthesis of strobamine and its analogues] Xing Zhang et al. Center for Organic and Medicinal Chemistry, Research Triangle Institute. Issue in Honor of Prof. James M.Cook ARKIVOC 2010 (iv)96-103</ref> Compare the phenyltropane length [[List of phenyltropanes#C2 + C3 (side-chain) fused (carboxylate & benzene conjoined)|tropane C2 & C3 functional group fusion]] variant.<ref>[https://books.google.com/books?id=rjtEwOFM5owC&pg=PA17&lpg=PA17&dq=Strobamine&source=bl&ots=OsrGUb9wma&sig=S8zt2WGOrdxlQqJ4g0r_njNrATo&hl=en&sa=X&ved=0ahUKEwjax8mlqNTTAhUD6mMKHcIECJUQ6AEIRzAJ#v=onepage&q&f=false The Alkaloids; Vol. 44, Geoffrey Cordell]</ref><br><br>''below:'' [[Chalcostrobamine]]\n | image2 = Chalcostrobamine.png\n | width2 = 190\n }}\n''cf.'' strobamine (at right) for a more efficacious compound as like the below.\n{| class=\"wikitable sortable\"\n|+2,3-direct fused \"di-hetero-benzene\" rigidified cocaine analogs.<ref name=\"AppellDunn2002\">{{cite journal|last1=Appell|first1=Michael|last2=Dunn|first2=William J.|last3=Reith|first3=Maarten E.A.|last4=Miller|first4=Larry|last5=Flippen-Anderson|first5=Judith L.|title=An Analysis of the Binding of Cocaine Analogues to the Monoamine Transporters Using Tensor Decomposition 3-D QSAR|journal=Bioorganic & Medicinal Chemistry|volume=10|issue=5|year=2002|pages=1197\u20131206|issn=0968-0896|doi=10.1016/S0968-0896(01)00389-3|pmid=11886784}}</ref><br>(Binding values @ biogenic amine transporters (BATs) for rigid and semi-rigid analogs)\n! Structure\n! alphanumeric<br>assignation\n! ''R<sub>1</sub>''\n! ''R<sub>2</sub>''\n! hDAT<br>IC<sub>50</sub> (nM)\n! hSERT<br>IC<sub>50</sub> (nM)\n! hNET<br>IC<sub>50</sub> (nM)\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3a.png|230px]]\n|-\n| (\u2014)-3a || H || C<sub>6</sub>H<sub>5</sub> || 58,300 (20,200) || 6140 (3350) || NA\n|-\n| (+)-3a || H || C<sub>6</sub>H<sub>5</sub>  || 48,700 (20,100) || 6030 (3400) || NA\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3b.png|190px]]\n|-\n| (\u2014)-3b || H || NH<sub>2</sub> || NA || NA || NA\n|-\n| (+)-3b || H || NH<sub>2</sub> || NA || NA || NA\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3c.png|190px]]\n|-\n| (\u2014)-3c || H || CH<sub>3</sub> ||NA||NA||NA\n|-\n| (+)-3c || H || CH<sub>3</sub> ||NA||NA||NA\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3d.png|150px]]\n|-\n| (\u2014)-3d || H || H ||NA||NA||NA\n|-\n| (+)-3d || H || H ||NA||NA||NA\n|-\n| [[File:Rigid 2,3-fused pyrimidino cocaine analog 3e.png|240px]] ||(+/\u2014)-3e || C<sub>6</sub>H<sub>5</sub> || C<sub>6</sub>H<sub>5</sub> || 30,000 (11,200) || 3650 (1700) || NA\n|}\n*<small>\"'''NA'''\" = \"no affinity\", ''e.g.'' unquantifiable.</small>\n\nDirect di-hetero-benzene (pyrimidino) 2,3-fused and thus rigidified cocaine analogs.<ref name=\"AppellDunn2002\"/>\n\n===Piperidine cocaine-homologues===\n[[File:Methyl (1R,2R,3S,5S)-8-methyl-3-(tricyclo(9.4.0.0\u00b3,\u2078)pentadeca-1(11),3,5,7,12,14-hexaene-2-carbonyloxy)-8-azabicyclo(3.2.1)octane-2-carboxylate.svg|thumb|right|x200px|Tricyclo benzoyloxy dibenzene cocaine analogue. ''cf.'' benztropine compound #'''277''', tropatepine, ''etc''.<ref name=\"Carroll\"/>]]\n''cf.'' [[List of phenyltropanes#Piperidine homologues (inner two-carbon bridge excised)|phenyltropane piperidine-homologues]] for compounds with a more optimized conformation that yield higher affinities when binding to MAT.<br>\n[[File:Cocaine analog 242.svg|x140px]]\n[[File:Cocaine analog 243.svg|x180px]]\n{| class=\"wikitable sortable\"\n|+binding potency of piperidine homologues for displacement of [<sup>3</sup>H]WIN 35428{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#62 Page #986 (62nd page of article)] \u00a7I, Table 37 & Scheme 58}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 2''\u03b2''-R\n! IC<sub>50</sub> (nM)\n|-\n| || (Cocaine) ||CO<sub>2</sub>CH<sub>3</sub><br>(''i.e.'' CO<sub>2</sub>Me)||249 \u00b1 37\n|-\n| || 183a ||CO<sub>2</sub>CH<sub>3</sub>||2522 \u00b1 4\n|-\n|rowspan=3|\n|-\n| 242 || H ||11589 \u00b1 4\n|-\n| 243 || CO<sub>2</sub>CH<sub>3</sub> ||8064 \u00b1 4\n|}\n\n===Cocaine [[hapten]] analogues===\n[[File:Cocaine analog GNC.svg|right|thumb|x200px|\"'''GNC'''\", a cocaine analog designed to minimize the formation of noncocaine-like structures through its chemical coupling to the Ad proteins; all while maintaining the element of its antigenic determinant from the moiety of cocaine.<ref>{{cite journal | pmc = 3048190 | pmid=21206484 | doi=10.1038/mt.2010.280 | volume=19 | issue=3 | title=Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs | journal=Mol Ther | pages=612\u20139 | last1 = Hicks | first1 = MJ | last2 = De | first2 = BP | last3 = Rosenberg | first3 = JB | last4 = Davidson | first4 = JT | last5 = Moreno | first5 = AY | last6 = Janda | first6 = KD | last7 = Wee | first7 = S | last8 = Koob | first8 = GF | last9 = Hackett | first9 = NR | last10 = Kaminsky | first10 = SM | last11 = Worgall | first11 = S | last12 = Toth | first12 = M | last13 = Mezey | first13 = JG | last14 = Crystal | first14 = RG | year=2011}}</ref>]]\n{| class=\"wikitable sortable\"\n|+Cocaine analogs which elicit noncatalytic antibodies{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#90 Page #1,014 (90th page of article)] \u00a7VIII, A. Figure 59.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 2''\u03b2''-R\n|-\n| [[File:CocaineNoncatalyticHapten394.svg|200px]] ||394<br>(GNC)<sup>'''\u0251'''</sup>||CO<sub>2</sub>(CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|-\n| [[File:CocaineNoncatalyticHapten395.svg|240px]] ||395<br>(Succinyl Norcocaine)<ref>{{cite journal | pmc = 3142961 | pmid=21796226 | doi=10.1358/dof.2010.035.04.1474292 | volume=35 | issue=4 | title=Active immunotherapy for the Treatment of Cocaine Dependence | journal=Drugs of the Future | pages=301\u2013306 | last1 = Kinsey | first1 = BM | last2 = Kosten | first2 = TR | last3 = Orson | first3 = FM | year=2010}}</ref>||CO<sub>2</sub>CH<sub>3</sub>\n|-\n| [[File:Cocaine hapten GNE.svg|210px]] ||GNE<sup>'''b'''</sup><ref>{{cite journal | pmc = 3306868 | pmid=21918504 | doi=10.1038/npp.2011.200 | volume=37 | issue=5 | title=Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects | journal=Neuropsychopharmacology | pages=1083\u201391 | last1 = Wee | first1 = S | last2 = Hicks | first2 = MJ | last3 = De | first3 = BP | last4 = Rosenberg | first4 = JB | last5 = Moreno | first5 = AY | last6 = Kaminsky | first6 = SM | last7 = Janda | first7 = KD | last8 = Crystal | first8 = RG | last9 = Koob | first9 = GF | year=2011}}</ref><br><small>including carrier proteins:<br>GNE-FLiC<br>GNE-KLH<br>GNE-BSA</small>||\n|-\n| [[File:CocaineNoncatalyticHapten396.svg|200px]]||396||CONH(CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|}\n*<sup>'''\u0251'''</sup><small>6-(2R,3S)-3-(benzoyloxy)-8-methyl-8-azabicyclo <nowiki>[3.2.1]</nowiki> octane-2-carbonyloxy-hexanoic acid</small>\n*<sup>'''b'''</sup><small>6-(2R,3S)-3-(benzoyloxy)-8-methyl-8-azabicyclo <nowiki>[3.2.1]</nowiki> octane-2-carboxamido-hexanoic acid</small>\n[[File:Cocaine analog 400 intermediate.svg|right|thumb|x150px|Tetrahedral-intermediate cocaine-hapten compound #'''400''']]\n{| class=\"wikitable sortable\"\n|+Cocaine transition state analogues (TSAs) which generate catalytic antibodies{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#92 Page #1,016 (92nd page of article)] Figure 60.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n|-\n|rowspan=8|[[File:Cocaine analog 401.svg|200px]]\n|-\n| 401a || CH<sub>3</sub>\n|-\n| 401b || (CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|-\n| 401c || CH<sub>2</sub>CO<sub>2</sub>H\n|-\n| 401d || COCH<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H\n|-\n| 401e || H\n|-\n| 401f || CH<sub>2</sub>CH<sub>2</sub>Br\n|-\n| 385g || (CH<sub>2</sub>)<sub>2</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CONH<sub>2</sub>\n|-\n|rowspan=6|[[File:Cocaine analog 402.svg|200px]]\n|-\n| 402a || O(CH<sub>2</sub>)<sub>4</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>...2,3-dihydro-1H-isoindole-1,3-dione\n|-\n| 402b || OH\n|-\n| 402c || O(CH<sub>2</sub>)<sub>2</sub>...1,4-xylene...NH<sub>2</sub>\n|-\n| 402d || NH(CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|-\n| 402e || O(CH<sub>2</sub>)<sub>4</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CONH<sub>2</sub>\n|-\n|rowspan=5|[[File:Cocaine analog 403.svg|220px]]\n|-\n| 403a || NH<sub>2</sub>\n|-\n| 403b || NHCOCH<sub>2</sub>Br\n|-\n| 403c || NHCO(CH<sub>2</sub>)<sub>3</sub>CO<sub>2</sub>H\n|-\n| 403d || (CH<sub>2</sub>)<sub>3</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CONH<sub>2</sub>\n|}\nCocaine haptens that create catalytic anti-bodies require transitional states as affected ''in vivo''.<ref>[https://www.google.com/patents/US6566084 Catalytic antibodies against cocaine and methods of using and producing same] Google patents US 6566084 B1</ref><ref name=\"DengBharat2004\">{{cite journal|last1=Deng|first1=Shixian|last2=Bharat|first2=Narine|last3=de Prada|first3=Paloma|last4=Landry|first4=Donald W.|title=Substrate-assisted antibody catalysis|journal=Organic & Biomolecular Chemistry|volume=2|issue=3|year=2004|pages=288\u201390|issn=1477-0520|doi=10.1039/b314264g|pmid=14747854}}</ref>\n{| class=\"wikitable sortable\"\n|+Anti-idiotypic & butyl-cholinesterase mediated immunopharmacotherapy cocaine analogs<ref>{{cite journal | pmc = 3295240 | pmid=12878327 | volume=1638 | issue=3 | title=Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties | journal=Biochim Biophys Acta | pages=257\u201366 | last1 = Ho | first1 = M | last2 = Segre | first2 = M | doi=10.1016/s0925-4439(03)00091-7 | year=2003}}</ref>\n! Compound\n! Name\n|-\n|rowspan=2|[[File:K1-KLH-BSA.svg|x260px]]\n|-\n| K1-KLH/BSA<ref>{{cite journal | pmc = 2326984 | pmid=10809958 | volume=100 | issue=1 | title=Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies | journal=Immunology | pages=48\u201356 | last1 = Schabacker | first1 = DS | last2 = Kirschbaum | first2 = KS | last3 = Segre | first3 = M | doi=10.1046/j.1365-2567.2000.00004.x | year=2000}}</ref>\n|-\n|rowspan=2|[[File:K2-KLH-BSA.svg|x170px]]\n|-\n| K2-KLH/BSA\n|}\n\n==Structural/Functional intermediate analogues==\n\n===Tropane (non-ecgonine) analogues===\nThe first compound of those categorized as an \"intermediate analog\" in the series presented immediately below (''para''-fluoro-benzoyl-tropane), although several modifications distant from its cocaine parent structure, fits every technical criteria of a strict analog type to cocaine. It is given here, however, as the nearest relational structure along the instanced spectrum trajectory of substituent permutations of those following from it (in this first section), and set it as the beginning ingress point for the range of those comparable but sufficiently divergent from those in full homogeneity of structure and function to distinguish a more median class that is not in as much a rigid stereotyped placement to both (and not yet approaching the fringe or outermost terms allowing inclusion)\n {{multiple image\n | direction = vertical\n | footer = [[Tematropium]], an anticholinergic that diverges from the MAT relational criteria for being a functional analog to cocaine.<ref>{{cite journal| doi=10.1016/S0968-0896(00)82119-7 | pmid=8081850 | volume=1 | issue=3 | title=Soft drugs\u2014XIV. Synthesis and anticholinergic activity of soft phenylsuccinic analogs of methatropine | year=1993 | journal=Bioorganic & Medicinal Chemistry | pages=183\u2013187 | last1 = Hammer | first1 = R.H. | last2 = Gunes | first2 = E. | last3 = Kumar | first3 = G.N. | last4 = Wu | first4 = W.M. | last5 = Srinivasan | first5 = V. | last6 = Bodor | first6 = N.S.}}</ref> (''cf.'' [[tropatepine]])\n | image1 = Tematropium.png\n | width1 = 240\n | image2 = Tematropium.svg\n | width2 = 280\n }}\n''p''FBT: [[File:3-(p-Fluorobenzoyloxy)tropane.png|x150px]]\nZatosetron: [[File:Zatosetron.svg|x200px]]\nTropanserin: [[File:Tropanserin.svg|x180px]]\nBemesetronum: [[File:Bemesetron.svg|x170px]]\n\n* [[3-(p-Fluorobenzoyloxy)tropane|3-(''p''-Fluorobenzoyloxy)tropane]] (30% stimulant potency of cocaine & equipotent as an anaesthetic)\n* [[Zatosetron]] (anxiolytic & antinauseant 5HT<sub>3</sub> receptor antagonist)\n* [[Tropanserin]] (migraine medication, potent & selective 5HT<sub>3</sub> antagonist)\n* [[Bemesetron]]um (antiemetic, mechanisms related to oxytocin function, serotonin D-receptors, cholinoreceptors of the muscarinic or nicotinic kind and histamine H<sub>1</sub>-receptors<ref>[http://chem.sis.nlm.nih.gov/chemidplus/rn/40796-97-2 Bemesetron @ U.S. National Library of Medicine's TOXNET: Toxicology Data Network]</ref>)\n:''cf.'' [[Tropisetron]]\nConvolamine: [[File:Convolamine.svg|x200px]]\nPhyllalbine: [[File:Phyllalbine.svg|x200px]]\nMeteloidine: [[File:((6R,7S)-6,7-dihydroxy-8-methyl-8-azabicyclo(3.2.1)octan-3-yl) (E)-2-methylbut-2-enoate.png|x200px]]<br>\nSimilarly, many natural tropane alkaloids found in plants of various families have benzoyl tropane structures. Including; [[catuabine]], [[convolamine]] of the ''convolvulaceae'' & [[phyllalbine]] of ''euphorbiaceae'' (''Phyllanthus disco\u00efdes'') families. The latter is a central and peripheral sympathomimetic drug.<ref>[https://www.researchgate.net/publication/17341322_An_alkaloid_of_Phyllanthus_discoides_%28Euphorbiaceae%29_phyllalbine_a_central_and_peripheral_sympathomimetic An alkaloid of Phyllanthus discoides (Euphorbiaceae) phyllalbine, a central and peripheral sympathomimetic] (Impact Factor: 0.4). 01/1965; 20(4):1033-41</ref> Phyllalbine is also to [[methylvanillylecgonine]] what [[tropacocaine]], as a metabolite, is to cocaine. Likewise [[vanillin]] would be a [[Hydrolysis|hydrolytic]] degradation product of phyllalbine just as [[methyl benzoate]] is for cocaine. The alkaloid Meteloidine, found in Datura & Brugmansia, is tentatively also extant in the Australian Erythroxylum species.\n\n[[Hyoscine butylbromide|Butylscopolamine]]: [[File:Butylscopolamine_skeletal.svg|x210px]]\n[[Methylscopolamine bromide|Methylscopolamine]]: [[File:Methscopolamine.png|x220px]]\n[[Fentonium]]: [[File:Fentonium bromide.svg|x180px]]\n\nOther tropanyl compounds (naturally found or otherwise) begin to fall outside the spectrum of functional analogues to cocaine altogether; having negligible affinity of any kind for the monoamine system. Compare for example [[Ipratropium bromide|ipratropium]], [[mirisetron]], [[technepine]], [[levomepate]] or [[Hyoscine|scopolamine]] & [[atropine]]. Many of the natural varieties being [[deliriant]]s.\n\nNK-1145: [[File:NK1145.png|x200px]]\nEGIS-3886: [[File:Deramciclane.svg|x200px]]\n[[Chemical compound|cpd]] #278{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#66 Page #990 (66th page of article)] Figure 44}} (mono-phenyl benztropine):[[File:Benztropine 278.svg|x160px]]<br>\nThe benzoyloxy can even be replaced with other branch formations (terminating in a benzene ring) and the bridge between will still serve to create a parasympatholytic drug compound that causes behavioral stimulation, as the above: [[NK-1145]] \"tropine-3''\u03b2''-phenyl ether.\"<ref>ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1-1951-Volume(issue)/page/year: 18,517,1968</ref> [[Deramciclane]] (EGIS-3886) is a [[camphor]] derived [[serotonergic]]. Similar to several other kinds of [[aroma compound|aromatics]] in structure and being an [[inverse agonist]] at the [[5-HT2C receptor|5-HT<sub>2C</sub> receptor]] as well as an antagonist at the [[5-HT2A receptor|5-HT<sub>2A</sub>]].\n\nAzaprocin: [[File:Azaprocin.png|x200px]]\nPseudotropinearylether: [[File:US4861889.png|x200px]]\n* [[Azaprocin]] (a fast onset, short duration opioid analgesic with tropane emulating every constituent element shared by cocaine; somewhat similar to how fentanyl overlays methylphenidate, save for in that case there's an additional constituent of a phenylethyl tail).\n* Also of note: arene-fluorinated pseudotropinearylethers with respect to {{US patent|4861889}}\n\n===Piperidine Analogues===\n<div style=\"background-color: #E9E9E9; border:10px solid #CFCFCF\">\n {{multiple image\n | direction = vertical\n | footer = 3-dimensional ([[Space-filling model|space-filling]]) rendering of piperidine structure-based, MAT re-uptake inhibiting functional stimulant: \"methylphenidate\" (MPH)\n | image1 = DextroMPH-overlays-betaCPT.png\n | width1 = 300\n | image2 = Methylphenidate3Dan.gif\n | width2 = 300\n }}\nSee: [[List of methylphenidate analogues]]\n\nMany of the piperidine analogues of cocaine serve as the 'missing link' between the cocaine structure and that of the [[methylphenidate]] class of drugs. For example, [[N,O-Dimethyl-4-(2-naphthyl)piperidine-3-carboxylate|DMNPC]] preserves an orientation similar to the phenyltropanes, but is a structural isomer of [[HDMP-28|methylnaphthidate]].\n\n[[File:HDMP28andCFT-3D-overlay.png|x200px]]\n\nThe above depicts the 3D structure of the above-mentioned methylnaphthidate shown with the same modeling for the cocaine derivative [[WIN 35428]], a simple phenyltropane with a short addition to its ''para'' position. This overlay shows the closeness of where the two hold their respective oxygen and nitrogens in their structure (also their benzene & cycloalkane ring formations) and is meant to convey a sense of their similarity for binding to MAT. Correspondingly most other monoamine reuptake inhibitors bind to the dopamine transporter ''substrate recognition site'' at [[Tm ligands|Tm]] loci 1, 7 & 10\u201412; whereas cocaine & methylphenidate similarly share the 1 & 7 places, but diverge from the usual ligand site of the latter and instead cohabit the 9\u201411 loci.{{efn|<ref>Dopamine reuptake transporter (DAT) ``inverse agonism\u00b4\u00b4 - A novel hypothesis to explain the enigmatic pharmacology of cocaine 2014-12-24 17:08:48  2014-12-25 00:28:27</ref> \u2190Page #31, \u00a73.2. \u00b63, 15th & 16th lines, final sentence.}} Site-directed mutagenesis techniques have elucidated that the hydrophobic putative transmembrane regions at one & seven contain aspartate and serine residues, and that the carboxyl-group interacts with the former aspartic acid residue ''79'' which engages with cocaine & methylphenidate's protonated nitrogen at the transporter.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#3 Page #927 (3rd page of article)] second \u00b6. Lines seven \u2014 fifteen.}} Previous theories of an allosteric site for cocaine and related compounds which do not overlap with the binding site of dopamine itself are less prevalent in light of more recent observations since [[Bacterial Leucine Transporter|LeuT]] became feasible as a modeling template.<ref>{{cite journal | pmc = 2692229 | pmid=18568020 | doi=10.1038/nn.2146 | volume=11 | issue=7 | title=The binding sites for cocaine and dopamine in the dopamine transporter overlap | date=July 2008 | journal=Nat. Neurosci. | pages=780\u20139 | last1 = Beuming | first1 = T | last2 = Kniazeff | first2 = J | last3 = Bergmann | first3 = ML |display-authors=etal }}</ref>\n\nOne rationale to denote the subjective preference for cocaine over methylphenidate in animal habituation & human addiction models has to do with the respective difference in their entropy of binding: cocaine being \u20145.6 kcal/mol & methylphenidate being \u201425.5 kcal/mol ([[Derivative|\u0394]][[Entropy|''s'']]\u00b0, measured using <nowiki>[</nowiki>\u00b3H<nowiki>]</nowiki>GBR 1278 @ 25&nbsp;\u00b0C){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#82 Page #1,006 (82nd page of article)] 2nd row, 1st \u00b6 (orig. ref.: Bonnet, J.-J.; Benmansour, S.; Costenin, J.; Parker, E. M. ;Cubeddu, L. X. ''J. Pharmacol. Exp. Ther.'' '''1990''', ''253'', 1206)}}\n</div>\n* [[JZ-IV-10]] (a \"[[Modafinil]] hybrid\" with nocaine.<ref name=\"ZhouHe2004\">{{cite journal|last1=Zhou|first1=Jia|last2=He|first2=Rong|last3=Johnson|first3=Kenneth M.|last4=Ye|first4=Yanping|last5=Kozikowski|first5=Alan P.|title=Piperidine-Based Nocaine/Modafinil Hybrid Ligands as Highly Potent Monoamine Transporter Inhibitors: Efficient Drug Discovery by Rational Lead Hybridization|journal=Journal of Medicinal Chemistry|volume=47|issue=24|year=2004|pages=5821\u20135824|issn=0022-2623|doi=10.1021/jm040117o|pmid=15537337|pmc=1395211}}</ref> ''cf.'' [[Modafinil#Modafinil analogs|List of modafinil analogues]])\n[[File:16e chemical structure.png|x150px]]\n* [[(+)-CPCA|Nocaine]]\n[[File:(+)-CPCA.svg|x100px]]\n\nA somewhat recent occurrence among tentative modern folklore which has traversed the circling of rumors mostly confined to the likes of universities and popular culture trivia has been that cocaine is one element, or molecule increment of weight or charge etc., away from the molecular structure of sugar.<ref>[http://skeptics.stackexchange.com/questions/20216/is-sugar-one-element-away-from-cocaine-or-any-other-drug Skeptics Stack Exchange: Is sugar one element away from cocaine (or any other drug?)]</ref> Though such a statement is false as a general pretense, there is a dextrose based super-structure that has a vaguely similar overlay with cocaine which is \"benzoyl-''beta''-<small>D</small>-glucoside.\"\n*[[Benzoyl-beta-D-glucoside|'''Benzoyl-''beta''-<small>D</small>-glucoside''']]\n[[File:Benzoyl-beta-D-glucoside.svg|x110px]]\n\n===Benztropine (3\u03b1-Diphenylmethoxy Tropane) Analogs===\n[[File:Benzatropina.gif|right|300px]]\n* [[Benzatropine]] (BZT)<ref name=\"Vel\u00e1zquez-S\u00e1nchezGarc\u00eda-Verdugo2013\">{{cite journal|last1=Vel\u00e1zquez-S\u00e1nchez|first1=Clara|last2=Garc\u00eda-Verdugo|first2=Jos\u00e9 M.|last3=Murga|first3=Juan|last4=Canales|first4=Juan J.|title=The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens|journal=Progress in Neuro-Psychopharmacology and Biological Psychiatry|volume=44|year=2013|pages=73\u201380|issn=0278-5846|doi=10.1016/j.pnpbp.2013.01.016|pmid=23385166}}</ref>\n* [[Difluoropine]] (O-620), More selective as a DARI than cocaine. Also an anticholinergic & antihistamine.\n* [[AHN 1-055]] Same structure as for benztropine but 4\u2032,4\u2032-bisfluorinated.\n* [[GA 103]] N-phenylpropyl bis-4-fluorobenztropine.\n* [[JHW 007]]<ref>{{cite journal | last1 = Tanda | first1 = G | last2 = Newman | first2 = A | last3 = Ebbs | first3 = AL | last4 = Tronci | first4 = V | last5 = Green | first5 = J | last6 = Tallarida | first6 = RJ | last7 = Katz | first7 = JL | year = 2009 | title = Combinations of Cocaine with other Dopamine Uptake Inhibitors: Assessment of Additivity | url = | journal = J Pharmacol Exp Ther | volume = 330| issue = 3| pages = 802\u20139| doi = 10.1124/jpet.109.154302 | pmid = 19483071 | pmc=2729796}}</ref> N-(n-butyl)-3\u03b1-[bis(4\u2032-fluorophenyl)methoxy]-tropane.\n[[File:Benzatropine.svg|x150px]]\n[[File:Difluoropine.png|x200px]]\n[[File:MFZ-R.svg|x180px]]<br>\nUnlike cocaine & phenyltropanes, the benztropines & GBR compounds (and, as an exception to the cocaine pharmacophore itself, ''allotropacocaine'') among others are considered \"atypical\" DAT re-uptake pump ligands because they stabilize the dopamine transporter in an inward-facing or closed-to-out conformation, this contrasts what is considered \"cocaine-like\" affinity to DAT; which would instead keep DAT stable in an open-to-out conformation. This means the binding of many dopamine reuptake inhibitors is atypical of cocaine's method of binding to DAT and significantly diverges from it.<ref>{{cite journal | pmc = 3684841 | pmid=23568856 | doi=10.1124/jpet.111.191056 | volume=346 | issue=1 | title=Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates | year=2013 | journal=J. Pharmacol. Exp. Ther. | pages=2\u201310 | last1 = Schmitt | first1 = KC | last2 = Rothman | first2 = RB | last3 = Reith | first3 = ME}}</ref>\n\n\"Difluoropine\" is not a phenyltropane but actually belongs to the benzatropine family of DRIs. Not to be confused for the [[List of phenyltropanes#Diaryl|\"diaryl\"-phenyltropanes]].\n\nIn certain respects these are important because they share SAR overlap with [[Vanoxerine|GBR 12909]] and related analogs.\n\nSARs have shown that 4\u2032,4\u2032-difluorination is an excellent way to boost DAT activity of benztropine, and gives excellent selectivity over the SERT and the NET.<ref name=Rothman>Rothman RB, Baumann MH, Prisinzano TE, Newman AH. \"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.  Biochem Pharmacol. 2008 Jan 1;75(1):2-16.  {{DOI|10.1016/j.bcp.2007.08.007}} {{PMID|17897630}}</ref><ref name=Runyon>{{cite journal | last1 = Runyon | first1 = SP | last2 = Carroll | first2 = FI | year = 2006 | title = Dopamine transporter ligands: recent developments and therapeutic potential | url = | journal = Curr Top Med Chem | volume = 6 | issue = 17| pages = 1825\u201343 | doi = 10.2174/156802606778249775 | pmid = 17017960 }}</ref>\n\nFurthermore, replacing the N-Me with, e.g. n-phenylpropyl helps to bring [[muscarinic]] activity down to something that is the same as DRI affinity.<ref name=Rothman/>\n\nThis is remarkable considering unmodified (native) benztropine is 60 times more active as an anticholinergic than as a dopaminergic.<ref name=Rothman/>\n\nM1 receptor considerations aside, analogues of this benztropine class still won't substitute for cocaine, and have no propensity to elevate locomotor activity.\n[[File:Benztropine 276.svg|thumb|right|x230px|Compound '''276''']]\n[[File:Etybenzatropine.svg|thumb|x230px|[[Etybenzatropine]]]]\n[[File:3-CPMT.svg|thumb|x210px|3-CPMT]]\n[[File:PG01053.svg|thumb|x230px|PG01053]]\n[[File:MFZ 2-71.svg|thumb|x240px|MFZ 2-71]]\n[[File:MFZ 4-86.svg|thumb|x240px|MFZ 4-86]]\n{| class=\"wikitable sortable\"\n|+3\u03b1-Diphenylmethoxy tropanes<br>(Benztropine analog affinities binding to DAT & DA uptake){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#63 Page #987 (63rd page of article)] \u00a7IV, Figure 39 & Page #988 (64th page of article) Table 38.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R\u2032''\n! ''K<sub>i</sub>'' (nM)<br>[<sup>3</sup>H]WIN 35428 binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA\nuptake\n! Selectivity\nuptake/binding\n|-\n| || (Cocaine) || || ||388 \u00b1 47|| - || -\n|-\n| || (GBR 12909) || || ||11.6 \u00b1 31|| - || -\n|-\n|rowspan=29|[[File:Cocaine analog 249-251.svg|200px]]\n|-\n| (Benztropine) || H || H ||118 \u00b1 9||403 \u00b1 115||3.4\n|-\n| 249a || 4\u2032-F || H ||32.2 \u00b1 10|| 48 ||1.5\n|-\n| 249b<br>(AHN 1-055) || 4\u2032-F || 4\u2032-F ||11.8 \u00b1 1|| 71 ||6.0\n|-\n| 249c || 3\u2032,4\u2032-di-F || H ||27.9 \u00b1 11||181 \u00b1 45.7||6.5\n|-\n| 249d || 4\u2032-Cl || H ||30.0 \u00b1 12|| 115 ||3.8\n|-\n| 249e || 4\u2032-Cl || 4\u2032-Cl ||20.0 \u00b1 14|| 75 ||3.8\n|-\n| 249f || 3\u2032,4\u2032-di-Cl || H ||21.1 \u00b1 19|| 47 ||2.2\n|-\n| 249g || 3\u2032,4\u2032-di-Cl || F ||18.9 \u00b1 14|| 24 ||1.3\n|-\n| 249h || 4\u2032-Br || H ||37.9 \u00b1 7|| 29 ||0.8\n|-\n| 249i || 4\u2032-Br || 4\u2032-Br || 91.6 || 34 ||0.4\n|-\n| 249j || 4\u2032-NO<sub>2</sub> || H ||197 \u00b1 8|| 219 ||1.1\n|-\n| 249k || 4\u2032-CN || H ||196 \u00b1 9|| 222 ||1.1\n|-\n| 249l || 4\u2032-CF<sub>3</sub> || H ||635 \u00b1 10|| 2155 ||3.4\n|-\n| 249m || 4\u2032-OH || H ||297 \u00b1 13|| 677 ||2.3\n|-\n| 249n || 4\u2032-OMe || H ||78.4 \u00b1 8|| 468 ||6.0\n|-\n| 249o || 4\u2032-OMe || 4\u2032-OMe ||2000 \u00b1 7|| 2876 ||1.4\n|-\n| 249p || 4\u2032-Me || H ||187 \u00b1 5|| 512 ||2.7\n|-\n| 249q || 4\u2032-Me || 4\u2032-Me ||420 \u00b1 7|| 2536 ||6.0\n|-\n| 249r || 4\u2032-Et || H ||520 \u00b1 8|| 984 ||1.9\n|-\n| 249s || 4\u2032-''t''-Bu || H || 1918 || 4456 ||2.3\n|-\n| 250a || 3\u2032-F || H ||68.5 \u00b1 12||250 \u00b1 64.7||3.6\n|-\n| 250b || 3\u2032-F || 3\u2032-F ||47.4 \u00b1 1||407 \u00b1 63.9||8.6\n|-\n| 250c || 3\u2032-Cl || H ||21.6 \u00b1 7||228 \u00b1 77.1||10.5\n|-\n| 250d || 3\u2032-CF<sub>3</sub> || H ||187 \u00b1 5||457 \u00b1 72.0||2.4\n|-\n| 251a || 2\u2032-F || H ||50.0 \u00b1 12||140 \u00b1 17.2||2.8\n|-\n| 251b || 2\u2032-Cl || H ||228 \u00b1 9||997 \u00b1 109||4.4\n|-\n| 251c || 2\u2032-Me || H ||309 \u00b1 6||1200 \u00b1 1.64||3.9\n|-\n| 251d || 2\u2032-NH<sub>2</sub> || H ||840 \u00b1 8||373 \u00b1 117||0.4\n|}\n{| class=\"wikitable sortable\"\n|+3\u03b1-Diphenylmethoxy-2\u03b2-carbomethoxybenztropine<br>(Benztropine affinities to DAT & 5-HTT in [[Crab-eating macaque|cynomologous monkey]] [[Striatum|caudate-putamen]]){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#63 Page #987 (63rd page of article)] Figure 40, Page #988 (64th page of article) \u00a7B & Page #989 (65th page of article) Table 39.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R\u2032''\n! IC<sub>50</sub> (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Binding of [<sup>3</sup>H]Citalopram)\n! Selectivity<br>5-HTT/DAT\n|-\n| || (benztropine) || || ||312 \u00b1 1.1 || 24100 \u00b1 14800||77.2\n|-\n| || (WIN 35428) || || ||12.9 \u00b1 1.1||160 \u00b1 20||12.4\n|-\n| || ''R''-256 || || ||2040 \u00b1 283||1460 \u00b1 255||0.7\n|-\n|rowspan=13|[[File:Cocaine analog 257.svg|200px]]\n|-\n| ''S''-257a || H || H ||33.5 \u00b1 4.5||10100 \u00b1 1740||301\n|-\n| ''S''-257b || H || F ||13.2 \u00b1 1.9||4930 \u00b1 1200||373\n|-\n| ''S''-257c<br>(difluoropine) || F || F ||10.9 \u00b1 1.2||3530 \u00b1 1480||324\n|-\n| ''S''-257d || H || Cl ||15.8 \u00b1 0.95||5960 \u00b1 467||377\n|-\n| ''S''-257e || Cl || Cl ||91.4 \u00b1 0.85||3360 \u00b1 1480||36.8\n|-\n| ''S''-257f || H || Br ||24.0 \u00b1 4.6||5770 \u00b1 493||240\n|-\n| ''S''-257g || Br || Br ||72.0 \u00b1 3.65||2430 \u00b1 339||33.7\n|-\n| ''S''-257h || H || I ||55.9 \u00b1 10.3||9280 \u00b1 1640||166\n|-\n| ''S''-257i || Br || I ||389 \u00b1 29.4||4930 \u00b1 82||12.7\n|-\n| ''S''-257j || I || I ||909 \u00b1 79||8550 \u00b1 442||9.4\n|-\n| ''S''-257k || H || Me ||49.5 \u00b1 6.0|| 13200 ||266\n|-\n| ''S''-257l || Me || Me ||240 \u00b1 18.4||9800 \u00b1 2680||40.8\n|}\n[[File:Benztropine 277.svg|thumb|right|Compound '''277''']]\n{| class=\"wikitable sortable\"\n|+''N''-Modified 2-carbomethoxybenztropines<br>(Benztropine affinities to DAT & 5-HTT in cynomologous monkey caudate-putamen){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#63 Page #987 (63rd page of article)] Figure 41, Page #989 (65th page of article) \u00a7C & Page #990 (66th page of article) Table 40.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! n\n! IC<sub>50</sub> (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Binding of [<sup>3</sup>H]Citalopram)\n! Selectivity<br>5-HTT/DAT\n|-\n|rowspan=7|[[File:Cocaine analog 258.svg|300px]]\n|-\n| 258a || || ||20.3 \u00b1 3.5|| - || -\n|-\n| 258b || H || <sub>1</sub> ||223 \u00b1 53||4970 \u00b1 700||22.3\n|-\n| 258c || H || <sub>3</sub> ||22.0 \u00b1 11.9||19.7 \u00b1 3||0.9\n|-\n| 258d || Br || <sub>3</sub> ||80.2 \u00b1 8.8||234 \u00b1 0.5||2.9\n|-\n| 258e || I || <sub>3</sub> ||119 \u00b1 11||2200 \u00b1 1250||18.5\n|-\n| 258f || H || <sub>5</sub> ||99.0 \u00b1 28||550 \u00b1 63||5.5\n|-\n| || 259 ||  ||  ||616 \u00b1 88||55200 \u00b1 20000||89.3\n|}\n\n{| class=\"wikitable sortable\"\n|+''N''-substituted 3\u03b1[bis(4\u2032-fluorophenyl)methoxy]tropanes<br>(Benztropine affinities to DAT & 5-HTT){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#64 Page #988 (64th page of article)] Figure 42, Page #990 (66th page of article) \u00a72 & Page #992 (68th page of article) Table 41.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''K<sub>i</sub>'' (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Uptake of [<sup>3</sup>H]DA)\n! Selectivity<br>uptake/binding\n|-\n|rowspan=23|[[File:Cocaine analog 260-265.svg|200px]]\n|-\n| 260<br>(AHN 2-003) || H ||11.2 \u00b1 11|| 9.7 ||0.9\n|-\n| 261a || 3-phenylpropyl ||41.9 \u00b1 11|| 230 ||5.5\n|-\n| 261b || indole-3-ethyl ||44.6 \u00b1 11|| 1200 ||26.9\n|-\n| 261c || 4-phenylbutyl ||8.51 \u00b1 14|| 39 ||4.6\n|-\n| 261d || 4-(4\u2032-nitrophenyl)butyl ||20.2 \u00b1 11|| 650 ||32.2\n|-\n| 261e || 3-(4\u2032-fluorophenyl)propyl ||60.7 \u00b1 12|| - || -\n|-\n| 262a || ''n''-butyl ||24.6 \u00b1 8|| 370 ||15.0\n|-\n| 262b || cyclopropylmethyl ||32.4 \u00b1 9|| 180 ||5.5\n|-\n| 262c || allyl ||29.9 \u00b1 10|| 14 ||0.5\n|-\n| 262d || benzyl ||82.2 \u00b1 15|| 290 ||3.5\n|-\n| 262e || 4-fluorobenzyl ||95.6 \u00b1 10|| 200 ||2.1\n|-\n| 262f || cinnanyl ||86.4 \u00b1 12|| 180 ||2.1\n|-\n| 262g || [bis(4-fluorophenyl)methoxy]ethyl ||634 \u00b1 23|| - || -\n|-\n| 262h || [(4-nitrophenyl)phenylmethoxy]ethyl ||57.0 \u00b1 17|| - || -\n|-\n| 263 || acetyl || 2340 || 4600 ||2.0\n|-\n| 264 || formyl ||2020 \u00b1 13|| 5400 ||2.7\n|-\n| 265a || Ts || 0%<sup>'''\u0251'''</sup> || - || -\n|-\n| 265b || Ms || 18%<sup>'''\u0251'''</sup> || - || -\n|-\n| (AHN 2-005)<ref name=\"LolandDesai2007\">{{cite journal|last1=Loland|first1=C. J.|last2=Desai|first2=R. I.|last3=Zou|first3=M.-F.|last4=Cao|first4=J.|last5=Grundt|first5=P.|last6=Gerstbrein|first6=K.|last7=Sitte|first7=H. H.|last8=Newman|first8=A. H.|last9=Katz|first9=J. L.|last10=Gether|first10=U.|title=Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors|journal=Molecular Pharmacology|volume=73|issue=3|year=2007|pages=813\u2013823|issn=0026-895X|doi=10.1124/mol.107.039800|pmid=17978168|url=https://semanticscholar.org/paper/217b45ef75e8d9ba8fb73d9a130968daf77a9368}}</ref> || CH<sub>2</sub>CH=CH<sub>2</sub> || - || - || -\n|-\n| (JHW 007)<ref name=\"LolandDesai2007\"/> || CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> || - || - || -\n|-\n| (GA 2-99)<ref name=\"LolandDesai2007\"/> || CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub> || - || - || -\n|-\n| (GA 103)<ref name=\"LolandDesai2007\"/> || CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>Ph || - || - || -\n|-\n| [[File:Cocaine analog 266.svg|200px]] || 266 ||  ||108 \u00b1 12|| 130 ||1.2\n|-\n|}\n<sup>'''\u0251'''</sup><small>Inhibition at 10 \u03bcM</small>\n[[File:JHW 007-d9.png|thumb|350px|Deuterium labeled radio-ligand of benztropine analog [[JHW-007]]; a di-''para''-fluoro benztropine, and hybrid between benzatropine & difluoropine (with fluorine groups in the former to breach the difference or the latter being descarbmethoxy to approach identification with the former).]]\n{| class=\"wikitable sortable\"\n|+8-Oxa-2-carbomethoxy norbenztropines<br>(8-Oxanortropane benztropine analog affinities to DAT & 5-HTT){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#64 Page #988 (64th page of article)] Figure 43, Page #992 (68th page of article) \u00a73 & Table 42.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n!\n! IC<sub>50</sub> (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Binding of [<sup>3</sup>H]Citalopram)\n|-\n| [[File:Cocaine analog 268.svg|200px]] || ''R/S''-268 || 2\u03b2,3\u03b2 || >10000 || >1660\n|-\n| || ''R/S''-269 || 2\u03b1,3\u03b2 || 20300 || >1660\n|-\n| || ''R/S''-270 || 2\u03b1,3\u03b1 || 22300 || >1660\n|-\n| [[File:Cocaine analog 271.svg|200px]] || ''R/S''-271 || 2\u03b2,3\u03b1 || 520 || >1660\n|}\n\n===Tropanyl Isoxazoline Analogues===\n {{multiple image\n | header = Spirocyclic tropanyl-\u0394(2)-isoxazoline compound:\n | direction = vertical\n | footer = ''[[3\u2032-methoxy-8-methyl-spiro(8-azabicyclo(3.2.1)octane-3,5\u2032(4\u2032H)-isoxazole]]'' which allosterically enhances SERT binding of other reuptake ligands. Compound '''7a ''' (likewise compound '''11a''' with regard to DAT), construed as a potentiating allosteric effect (by unveiling occluded configured serotonin uptake-area ligand-site on surface of transporter that allows for binding by exogenous ligand, when SERT is otherwise conformed in a transitional manner where a SERT ligand cannot bind, this effect with compound in question occurs) at concentrations of 10\u03bcM\u201430\u03bcM (wherein it acts by interconverting the conformational state of unexposed SERTs to ones exposing the SSRI binding site via a shift to the equilibrium of the MAT) while exerting an inhibitory orthosteric effect when concentrations reach >30\u03bcM and above.<br><br>This is the only known compound to allosterically modulate SERT in such a way within ''in vitro'' conditions ([[tianeptine]] has been shown to do similar, but has only shown efficacy doing so in living ''in vivo'' tissue samples). Considering its noncompetitive inhibition of 5-HT transporters decreasing ''V''<sub>max</sub> with small change in the ''K''<small>m</small> for serotonin, putatively stabilizing the cytoplasm-facing conformation of SERT: in such respect it is considered to have the opposite effect profile of the anti-addiction drug [[ibogaine]] (save for the function by which its anti-addictive properties are thought to be mediated, ''i.e.'' \u03b1<sub>3</sub>\u03b2<sub>4</sub> nicotinic channel blockage. ''cf.'' [[18-Methoxycornaridine]] for such nicotinergic activity without the likewise SERT affinity).<ref name=\"DallanoceCanovi2012\">{{cite journal|last1=Dallanoce|first1=Clelia|last2=Canovi|first2=Mara|last3=Matera|first3=Carlo|last4=Mennini|first4=Tiziana|last5=De Amici|first5=Marco|last6=Gobbi|first6=Marco|last7=De Micheli|first7=Carlo|title=A novel spirocyclic tropanyl-\u03942-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake|journal=Bioorganic & Medicinal Chemistry|volume=20|issue=21|year=2012|pages=6344\u20136355|issn=0968-0896|doi=10.1016/j.bmc.2012.09.004|pmid=23022052}}</ref><br><br>Similarly, such peripheral DAT considerations (when, as often is, considered conformational rather than otherwise explained as being electrostatic) may constitute the difference in affinity, through allosertic occulsion, between [[List of phenyltropanes#\u03b76-3\u03b2-(transition metal complexed phenyl)tropanes|cyclopentyl-ruthenium]] phenyltropane in its difference from the tricarbonyl-chromium\n | image1 = 3\u2032-methoxy-8-methyl-spiro(8-azabicyclo(3.2.1)octane-3,5\u2032(4\u2032H)-isoxazole.svg\n | width1 = 260\n | image2 = 3\u2032-methoxy-8-methyl-spiro(8-azabicyclo(3.2.1)octane-3,5\u2032(4\u2032H)-isoxazole.png\n | width2 = 260\n }}\n\n{| class=\"wikitable sortable\"\n|+ Tropanyl-\u03942-isoxazoline derivatives<ref>C. Dallanoce et al. - Bioorg. Med. Chem. 20 (2012) 6344-6355</ref>\n|-\n! Compound\n! Name\n|-\n|rowspan=2| -||[[File:Dallanoce 4a.svg|x200px]]||[[File:Dallanoce 4c.svg|x210px]]||[[File:Dallanoce 5a.svg|x190px]]||[[File:Dallanoce 5c.svg|x210px]]\n|-\n| 4a||4c||5a||5c\n|-\n|rowspan=2| -||[[File:Dellancoe 6a.svg|x170px]]||[[File:Dallanoce 6b.svg|x170px]]||[[File:Dallanoce 6c.svg|x170px]]||[[File:Dallanoce 7a.svg|x170px]]\n|-\n| 6a||6b||6c||7a\n|-\n|rowspan=2| -||[[File:Dallanoce 7b.svg|x170px]]||[[File:Dallanoce 7c.svg|x190px]]||[[File:Dallanoce 8a.svg|x190px]]||[[File:Dallanoce 8b.svg|x170px]]\n|-\n| 7b||7c||8a||8b\n|-\n|rowspan=2| -||[[File:Dallanoce 8c.svg|x170px]]||[[File:Dallanoce 9a.svg|x170px]]||[[File:Dallanoce 9b.svg|x170px]]||[[File:Dallanoce 9c.svg|x190px]]\n|-\n| 8c||9a||9b||9c\n|-\n|rowspan=2| -||[[File:Dallanoce 10a.svg|x170px]]||[[File:Dallanoce 10b.svg|x170px]]||[[File:Dallanoce 10c.svg|x190px]]\n|-\n| 9c||10a||10b||10c\n|-\n|rowspan=2| -||[[File:Dallanoce 11a.svg|x180px]]||[[File:Dallanoce 11b.svg|x180px]]||[[File:Dallanoce 12a.svg|x180px]]||[[File:Dallanoce 12b.svg|x180px]]\n|-\n| 11a||11b||12a||12b\n|} <!-- End of the table -->\n\n===8-Aminopentacyclo (\u03c3 receptor ligand) [[Trishomocubane]] Analogs===\n<small>''cf.'' other trishomocubanes such as [[basketane]].</small>\n\nSigma receptor agonists with nanomolar affinity such as [[CM156]] have been shown to counteract the deleterious effects of cocaine when co-administered with it. Indicative that ''e.g.'' the local anesthetic effect at the sigma site mediating the toxicity or otherwise a cross over or tie in of cocaine's separate functionalities lowering threshold to its safety profile.<ref name=\"XuKaushal2010\">{{cite journal|last1=Xu|first1=Y. T.|last2=Kaushal|first2=N.|last3=Shaikh|first3=J.|last4=Wilson|first4=L. L.|last5=Mesangeau|first5=C.|last6=McCurdy|first6=C. R.|last7=Matsumoto|first7=R. R.|title=A Novel Substituted Piperazine, CM156, Attenuates the Stimulant and Toxic Effects of Cocaine in Mice|journal=Journal of Pharmacology and Experimental Therapeutics|volume=333|issue=2|year=2010|pages=491\u2013500|issn=0022-3565|doi=10.1124/jpet.109.161398|pmid=20100904|pmc=2872963}}</ref><br>\n[[File:Banister sigmaergic cocaine analog 1 & 2.png]][[File:Banister sigmaergic cocaine analog 3.png]][[File:Banister sigmaergic cocaine analog 4.png]][[File:Banister sigmaergic cocaine analog 5.png]][[File:Banister sigmaergic cocaine analog 6.png]]<br>Polycyclic cage molecules: ''N''-substituted 8-aminopentacyclo[5.4.0.0<sup>2,6</sup>.0<sup>3,10</sup>.0<sup>5,9</sup>]undecanes (AHDs) & related.<br>The 3-FPh, '''14b''', has  1.2 \u00b1 0.1 ''K<sub>i</sub>'' (nM \u00b1 SEM) @ DAT.<ref name=\"BanisterManoli2013\">{{cite journal|last1=Banister|first1=Samuel D.|last2=Manoli|first2=Miral|last3=Barron|first3=Melissa L.|last4=Werry|first4=Eryn L.|last5=Kassiou|first5=Michael|title=N-substituted 8-aminopentacyclo[5.4.0.02,6.03,10.05,9]undecanes as \u03c3 receptor ligands with potential neuroprotective effects|journal=Bioorganic & Medicinal Chemistry|volume=21|issue=19|year=2013|pages=6038\u20136052|issn=0968-0896|doi=10.1016/j.bmc.2013.07.045|pmid=23981939}}</ref><br>\n[[File:(1R,2S,3S,5S,6S,7R,8R,9S,10S)-N-((3-fluorophenyl)methyl)-N-methylpentacyclo(5.4.0.0<sup>2,6</sup>.0<sup>3,10</sup>.0<sup>5,9</sup>)undecan-8-amine.png]]\n\n===Bicyclic Amine Analogues===\n* [[EXP-561]]\n[[File:EXPfivesixone.png|x150px]]\n\n===Quinuclidine Analogues===\n* [[Butyltolylquinuclidine]]\n[[File:Butyltolylquinuclidine.png|x150px]]\n\n==Miscellaneous [[Functional analog (chemistry)|loosely analogous]] stimulants==\n{| class=\"wikitable\"  style=\"margin:auto 1em auto 1em; float:right;\"\n|-\n|<center>'''Chromen-2-one<br>(SNDRI compound)'''<br>[[File:Chromen-2-one (SNDRI).png|center|300px]]</center>\n{| class=\"wikitable\" style=\"text-align:center\"\n|+ {{Patent|US|2011136854}}\n|-\n!IUPAC name\n! 5-HT-uptake IC<sub>50</sub>(\u03bcM)\n! DA-uptake IC<sub>50</sub>(\u03bcM)\n! NE-uptake IC<sub>50</sub>(\u03bcM)\n|-\n|<small>7-(((1R,3r,5S)-9-Azabicyclo[3.3.1]nonan-3-yl)oxy)-2H-chromen-2-one</small>||0.0013||0.24||0.076\n|-\n|<small>7-(((1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-yl)oxy)-2H-chromen-2-one</small>||0.0029||0.15||0.27\n|}\n|}\n\n===Benzoates (Structures with both [[stimulant]] & [[local anesthetic]] effects)===\n* [[Dimethocaine|Dimethocaine/Larocaine (DMC)]] (An aniline)\n* [[Nitracaine]]\n[[File:Dimethocaine-structure.svg|x220px]]\n[[File:Nitracaine structure.png|x150px]]\n\nSee some of [http://pubs.acs.org/action/doSearch?text1=Robert+Clarke&field1=Contrib Robert Clarke's contributions]\n\n===Organochlorides===\n[[File:ORG 6582.png|thumb|[[Org 6582]]<br>A potent and long-lasting monoamine re-uptake inhibitor used in drug research.]]\n* [[Diclofensine]]\n* [[LR-5182]]\n[[File:Diclofensine.svg|x130px]]\n[[File:LR-5182.png|x100px]]\n\n====Quinolizidines====\n*[[List of methylphenidate analogues#Restricted rotational analogs of methylphenidate (quinolizidines)|Quinolizidine analogues of piperidine methylphenidate structure]]\n[[File:MPH RRA 11.png|80px]][[File:MPH RRA 12a\u2014c.png|95px]][[File:MPH RRA 16.png|100px]][[File:MPH RRA 18\u201419.png|100px]][[File:MPH RRA 23a 24ab 31ab.png|100px]][[File:MPH RRA 25ab.png|100px]][[File:MPH RRA 26ab 27a 33ab.png|90px]][[File:MPH RRA 29ab.png|110px]][[File:MPH RRA 30.png|120px]][[File:MPH RRA 36a\u201436e.png|100px]]\n\n===2,3-Benzodiazepines===\n* [[GYKI-52895]]\n[[File:GYKI 52895.svg|x175px]]\n\n===Phenethylamines===\n[[Methylenedioxypyrovalerone]]: [[File:MDPV.svg|x150px]] [[Prolintane]]: [[File:Prolintane.svg|x150px]] [[alpha-Pyrrolidinopropiophenone|\u03b1-Pyrrolidinopropiophenone]]: [[File:A-PPP.svg|x110px]]\n\nMany phenethylamines are dopamine releasers, however, certain drugs of the family inhibit dopamine reuptake & transport which may be loosely classed as cocaine analogs. Dependent upon their specific configurations. Like has been shown with cocaine, methylenedioxypyrovalerone (MDPV) has been shown to similarly be neuroprotective against the neural damage caused by amphetamine type drugs (''i.e.'' releasers)<ref>{{cite journal | pmc = 4759647 | pmid=25626880 | doi=10.1111/jnc.13048 | volume=133 | issue=2 | title=3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: \u03b2-ketoamphetamine modulation of neurotoxicity by the dopamine transporter | journal=J Neurochem | pages=211\u201322 | last1 = Anneken | first1 = JH | last2 = Angoa-P\u00e9rez | first2 = M | last3 = Kuhn | first3 = DM | year=2015}}</ref>\n\n===Adamantanes===\n* [[A-77636]]\n[[File:A-77636.svg|x150px]]\n* [[Bromantane]]\n[[File:Bromantan.svg|x100px]]\n\n===Pyridines===\n* [[Altinicline]]\n[[File:Altinicline_structure.png|x150px]]\n\nNicotinic agonist which stimulates the release of dopamine.\n\n===Naphthyridines===\n[[File:Desmethoxyyangonin.svg|thumb|right|x175px|[[Desmethoxyyangonin]] (''5,6-dehydrokawain''), reversible [[Monoamine oxidase B|MAO-B]] [[monoamine oxidase inhibitor|inhibitor]] believed to contribute to mediating dopamine release in [[nucleus accumbens]].]]\n* [[Amfonelic acid]]\n[[File:Amfonelic acid.png|x150px]]<br>\nBeing a carboxylic acid, amfonelic acid could potentially be used as a carboxylate for the protonation to the free base of another compound; even conceivably creating a 'cocaine amfonelate' or 'cocaine AFA' as opposed to cocaine [[Hydrogen chloride|HCl]], cocaine [[citrate]] or cocaine [[Hydrobromic acid|HBr]] ''et cetera'' wherein such a case it's conjugate used to form it as a salt would additionally be dopaminergic.\n\n===Quinazolinamines (Allosteric functional DAT reuptake inhibitors)===\n* [[SoRI-20041]]\n* [[SoRI-9804]]\n[[File:SoRI-20041.png|x200px]]\n[[File:SoRI-9804.svg|x200px]]\n''cf.'' the benztropine phenyltropanes:\n[[File:Benztropine phenyltropane.png|x200px]]\n\nSoRI-20041 is a functional, but not structural, cocaine analog which violates traditional structure analog categorization in its case that it has an entirely other binding site. It is however an analog to cocaine in the sense that it functions as a partial DARI on DAT, although doing so when said DAT is compromised by amphetamine-type mediated release of DA. Something unaugmented cocaine cannot do. It nevertheless performs the role of an analogous adjunct to cocaine's function for phosphorylated DAT. It is however worth noting that as for its structure, it displays a certain degree of shared conformation with the benztropine phenyltropanes.\n\n===Piperazines (Aryl-1,4-dialkyl piperazines)===\n[[File:Methylphenidate overlaid 1-(2-Phenylethyl)piperazine.png|thumb|Methylphenidate rendered in 3D (in blue) overlaid with 1-(2-Phenylethyl) piperazine skeleton (turquoise) showing the basic 3- point pharmacophore shared between them and other dopamine reuptake inhibitors such as [[1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine|3C-PEP]] (that itself is only a 3-chlorophenyl more than 1-(2-Phenylethyl) piperazine).]]\nGBR-13098: [[File:GBR 13098.svg|370px]]\n281 (decanoate 5): [[File:GBR compound 281 decanoate 5.svg|370px]]\n* [[GBR-13098]]\n* [[DBL-583]]\n\nGBR compounds were derived from the benztropines by replacing their tropane nucleus with a piperazine ring (and therefore constitute being [[Congener (chemistry)|congener]]s with cocaine).{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#69 Page #993 (69th page of article)] \u00a7V. \u00b62. Fourth line. First sentence.}} The name \"GBR\" is derived from its maker [[DSM (company)|'''G'''ist-'''Br'''ocades]] (now DSM), Netherlands.\n\n[[File:Vanoxerine.png|x170px]]\n[[File:GBR-12783.svg|x170px]]\n\n[[File:3C-PEP_structure.png|thumb|right|x150px|''cf.'' to the GBRs the non-diphenyl and still quite highly specific dopaminergic (selective) stimulant [[1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine|3C-PEP]]; shown to be roughly 10,000\u00d7 more potent than cocaine as a DAT reuptake inhibitor. There are other related stimulants structurally.<ref name=\"SchmittZhen2008\">{{cite journal|last1=Schmitt|first1=Kyle C.|last2=Zhen|first2=Juan|last3=Kharkar|first3=Prashant|last4=Mishra|first4=Manoj|last5=Chen|first5=Nianhang|last6=Dutta|first6=Aloke K.|last7=Reith|first7=Maarten E. A.|title=Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties|journal=Journal of Neurochemistry|year=2008|issn=0022-3042|doi=10.1111/j.1471-4159.2008.05667.x|pmid=18786172|pmc=2728472|volume=107|issue=4|pages=928\u201340}}</ref>]]\n[[File:UMB38.svg|thumb|right|x150px|UMB38]]\n[[File:UMB38 analogs.svg|thumb|right|x150px|UMB38 analogs:<ref name=\"MotelHealy2013\">{{cite journal|last1=Motel|first1=William C.|last2=Healy|first2=Jason R.|last3=Viard|first3=Eddy|last4=Pouw|first4=Buddy|last5=Martin|first5=Kelly E.|last6=Matsumoto|first6=Rae R.|last7=Coop|first7=Andrew|title=Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands|journal=Bioorganic & Medicinal Chemistry Letters|volume=23|issue=24|year=2013|pages=6920\u20136922|issn=0960-894X|doi=10.1016/j.bmcl.2013.09.038|pmid=24211020|pmc=3919026}}</ref><br>''R'' = 2-Cl, ''n'' = 1<br>''R'' = 3-Cl, ''n'' = 1<br>''R'' = 4-Cl, ''n'' = 1<br>''R'' = 2-Cl, ''n'' = 2<br>''R'' = 3-Cl, ''n'' = 2<br>''R'' = 4-Cl, ''n'' = 2]]\nGBR compounds are sometimes broadly classed as being, and referred to by the term, \"[[rimcazole]] analogs\"<ref name=\"KatzLibby2003\">{{cite journal|last1=Katz|first1=Jonathan L.|last2=Libby|first2=Therissa A.|last3=Kopajtic|first3=Theresa|last4=Husbands|first4=Stephen M.|last5=Newman|first5=Amy Hauck|title=Behavioral effects of rimcazole analogues alone and in combination with cocaine|journal=European Journal of Pharmacology|volume=468|issue=2|year=2003|pages=109\u2013119|issn=0014-2999|doi=10.1016/S0014-2999(03)01638-8|pmid=12742518}}</ref> - for example the compounds: [[JJC 2-006]], [[JJC 2-010]], and [[JJC 1-059]].<ref name=\"LolandDesai2007\"/>\n[[File:JJC 2-006.svg|x170px]]\n[[File:JJC 2-010.svg|x170px]]\n[[File:JJC 1-059.svg|x170px]]\n{| class=\"wikitable sortable\"\n|+GBR 12783 analogues inhibition of DAT binding & DA uptake{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#69 Page #993 (69th page of article)] \u00a7V, Figure 46 & Table 43.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''K<sub>i</sub>'' (nM)<br>[<sup>3</sup>H]WIN 35425\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA\n! Selectivity<br>DA/DAT<br>uptake/binding\n|-\n| || (Cocaine) || ||224 \u00b1 3.4||208 \u00b1 7.4||0.93\n|-\n| || (WIN 35428) || ||24 \u00b1 3.1||14 \u00b1 1.8||0.58\n|-\n| [[File:Dopamine2.svg|170px]] || (DA) || ||10000 \u00b1 2400||44 \u00b1 5.3||0.004\n|-\n| [[File:GBR 12909.svg|300px]] || 279<br>([[Vanoxerine|GBR 12909]]/Vanoxerine) ||  ||27 \u00b1 4.1<br>0.06 \u00b1 0.02<sup>'''b'''</sup><br>52.8 \u00b1 4.4<sup>'''c'''</sup><br> >20,000<sup>'''d'''</sup>||0.21 \u00b1 0.06||0.007<br>880<sup>'''e'''</sup><br> >333,333.3<sup>'''f'''</sup>\n|-\n| [[File:GBR 12783.svg|300px]] || 282<br>([[GBR-12783|GBR 12783]]) || H ||12 \u00b1 1.2<sup>'''\u0251'''</sup>|| - || -\n|-\n|rowspan=7|[[File:GBR compound 284.svg|300px]]\n|-\n| 284a || 3-NH<sub>2</sub> ||12 \u00b1 1.0||7 \u00b1 3.5||0.58\n|-\n| 284b || 3-NCS ||160 \u00b1 17||106 \u00b1 37||0.67\n|-\n| 284c || 4-NH<sub>2</sub> ||11 \u00b1 0.7||1.6 \u00b1 0.2||0.14\n|-\n| 284d || 4-NO<sub>2</sub> ||26 \u00b1 9.3||2.7 \u00b1 0.1||0.10\n|-\n| 284e || 4-NCS ||159 \u00b1 12||26 \u00b1 1.8||0.16\n|-\n| 284f || 4-[[maleimide]] ||2327 \u00b1 1000||476 \u00b1 61||0.20\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> for inhibiting [<sup>3</sup>H]methylphenidate</small>\n*<sup>'''b'''</sup><small>''K<sub>i</sub>'' (nM) for inhibiting [<sup>3</sup>H]GBR 12935</small>\n*<sup>'''c'''</sup><small>''K<sub>i</sub>'' (nM) for inhibiting [<sup>3</sup>H]Paroxetine @ 5-HTT</small>\n*<sup>'''d'''</sup><small>''K<sub>i</sub>'' (nM) for inhibiting [<sup>3</sup>H]Nisoxetine @ NET</small>\n*<sup>'''e'''</sup><small>Selectivity between 5-HTT/DAT</small>\n*<sup>'''f'''</sup><small>Selectivity between NET/DAT</small>\n{| class=\"wikitable sortable\"\n|+GBR analogue compounds with piperazine ring-alterations. Binding affinities and inhibition of uptake for DA & 5-HT.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#71 Page #995 (71st page of article)] Figure 47 & Page #997 (73rd page of article) Table 44.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''X-Y'' (289-290)<br> ''R<sub>1</sub>'' (298)\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]GBR 12935 binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]5-HT uptake\n! Selectivity<br>[<sup>3</sup>H]DA uptake/DAT binding\n! Selectivity<br>[<sup>3</sup>H]5-HT/[<sup>3</sup>H]DA uptake\n|-\n| || (Cocaine) ||  ||  ||660 \u00b1 30<br>(''K<sub>i</sub>'' value)||478 \u00b1 25||304 \u00b1 10|| 0.72 ||0.64\n|-\n| [[File:GBR 12935.svg|300px]] || ([[GBR-12935|GBR 12935]]) ||  ||  ||4.1 \u00b1 0.6||3.7 \u00b1 0.4||289 \u00b1 29|| 0.90 ||78.1\n|-\n| || 279<br>(GBR 12909) ||  ||  ||5.5 \u00b1 0.4||4.3 \u00b1 0.3||73 \u00b1 1.5|| 0.78 ||17.0\n|-\n|rowspan=7|[[File:GBR compound 289.svg|300px]]\n|-\n| 289a || H || C-C ||21 \u00b1 1.0||9.6 \u00b1 1.5||1720 \u00b1 70|| 0.46 ||179\n|-\n| 289b || F || C-C ||40 \u00b1 1||15 \u00b1 2||459 \u00b1 26|| 0.37 ||30.6\n|-\n| (-)289b (2''S'',5''R'') || F || C-C ||3.6 \u00b1 0.14||8.1 \u00b1 0.3|| - || 2.25 || -\n|-\n| (+)289b (2''R'',5''S'') || F || C-C ||125 \u00b1 7.0||87 \u00b1 4.1|| - || 0.70 || -\n|-\n| 289c || H || C=C ||103 \u00b1 13||20 \u00b1 4||2680 \u00b1 122|| 0.19 ||134\n|-\n| 289d || F || C=C ||23 \u00b1 3||28 \u00b1 5||1180 \u00b1 404|| 1.22 ||42.1\n|-\n|rowspan=5|[[File:GBR compound 290.svg|300px]]\n|-\n| 290a<br>(LR1111) || H || C-C ||7.9 \u00b1 1.7||7.2 \u00b1 0.5||34100 \u00b1 359|| 0.91 ||4736\n|-\n| 290b || F || C-C ||4.4 \u00b1 0.4||3.4 \u00b1 0.4||112 \u00b1 24|| 0.77 ||32.9\n|-\n| 290c || H || C=C ||8.6 \u00b1 1.1||0.6 \u00b1 0.1||503 \u00b1 103|| 0.07 ||838\n|-\n| 290d || F || C=C ||2.6 \u00b1 0.4||3.4 \u00b1 0.4||234 \u00b1 10|| 1.31 ||68.8\n|-\n| [[File:GBR compound 291.svg|300px]] || 291 ||  || ||286 \u00b1 8||87 \u00b1 5||3150 \u00b1 491|| 0.30 ||36.2\n|-\n| [[File:GBR compound 292.svg|300px]] || 292 ||  || ||864 \u00b1 91||93 \u00b1 6||1590 \u00b1 60|| 0.11 ||17.1\n|-\n| [[File:GBR compound 293.svg|310px]] || 293 ||  || ||27 \u00b1 4||18 \u00b1 1||2450 \u00b1 57|| 0.67 ||136\n|-\n| [[File:GBR compound 294.svg|330px]] || 294 ||  || ||169 \u00b1 5||83 \u00b1 7||1890 \u00b1 268|| 0.49 ||22.8\n|-\n| [[File:GBR compound 295.svg|330px]] || 295 ||  || ||80 \u00b1 6||35 \u00b1 2||376 \u00b1 19|| 0.44 ||10.7\n|-\n| [[File:GBR compound 296.svg|210px]] || 296 ||  || ||74 \u00b1 5||57 \u00b1 10||2860 \u00b1 45|| 0.77 ||50.2\n|-\n| [[File:GBR compound 297.svg|180px]] || 297 ||  || ||20 \u00b1 0.7||9.3 \u00b1 1.8||1480 \u00b1 69|| 0.46 ||159\n|-\n|rowspan=5|[[File:GBR compound 298.svg|350px]]\n|-\n| (-)298a || H || H ||5.1 \u00b1 0.4||0.7 \u00b1 0.05||986 \u00b1 34|| 0.14 ||1409\n|-\n| (+)298a || H || H ||747 \u00b1 163||127 \u00b1 10||3210 \u00b1 450|| 0.17 ||25.3\n|-\n| (-)298b || F || H ||104 \u00b1 8||29 \u00b1 2||20100 \u00b1 2400|| 0.28 ||693\n|-\n| (-)298c || H || OH ||222 \u00b1 13||31 \u00b1 0.1||857 \u00b1 17|| 0.14 ||27.6\n|}\n\n{| class=\"wikitable sortable\"\n|+Heteroaromatic and fused ring GBR analogue affinities reuptake inhibition for DA & 5-HT and [<sup>125</sup>I]RTI-55 labeled DAT & 5-HTT binding affinities.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#73 Page #997 (73rd page of article)] \u00a7C, Page #998 (74th page of article) Figure 48 & Page #1,000 Table 45.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R<sub>1</sub>''\n! IC<sub>50</sub> (nM)<br>[<sup>125</sup>I]RTI-55 binding<br>DAT\n! IC<sub>50</sub> (nM)<br>[<sup>125</sup>I]RTI-55 binding<br>5-HTT\n! IC<sub>50</sub> (nM)<br>reuptake<br>[<sup>3</sup>H]DA\n! IC<sub>50</sub> (nM)<br>reuptake<br>[<sup>3</sup>H]5-HT\n! Selectivity<br>binding<br>5-HTT/DAT\n! Selectivity<br>uptake<br>[<sup>3</sup>H]5-HT/[<sup>3</sup>H]DA\n|-\n| || (GBR 12935) || C<sub>6</sub>H<sub>5</sub> ||  ||3.7 \u00b1 0.3||623 \u00b1 13||3.7 \u00b1 0.4||298 \u00b1 29|| 168 ||80.5\n|-\n|rowspan=4|[[File:GBR compound 304.svg|300px]]\n|-\n| 304a || 2-thienyl ||  ||5.2 \u00b1 0.3||842 \u00b1 30||9.7 \u00b1 0.2||1990 \u00b1 58|| 162 ||205\n|-\n| 304b || 2-furyl ||  ||6.5 \u00b1 0.2||1520 \u00b1 47||8.5 \u00b1 0.5||2550 \u00b1 87|| 34 ||300\n|-\n| 304c || 2-pyridyl ||  ||78 \u00b1 4||2420 \u00b1 65||70 \u00b1 6||3700 \u00b1 148|| 31.0 ||52.8\n|-\n| [[File:GBR compounds 279-281.svg|300px]] || 279 (GBR 12909) || C<sub>6</sub>H<sub>5</sub> ||  ||3.7 \u00b1 0.4||126 \u00b1 5||7.3 \u00b1 0.2||73 \u00b1 2|| 34.0 ||10.0\n|-\n|rowspan=4|[[File:GBR compound 305.svg|300px]]\n|-\n| 305a || 2-thienyl ||  ||3.3 \u00b1 0.1||105 \u00b1 2||6.1 \u00b1 0.7||335 \u00b1 17|| 31.8 ||54.9\n|-\n| 305b || 2-furyl ||  ||5.9 \u00b1 0.3||204 \u00b1 7||7.9 \u00b1 0.5||412 \u00b1 9|| 34.6 ||52.1\n|-\n| 305c || 2-pyridyl ||  ||16 \u00b1 0.2||2800 \u00b1 139||20 \u00b1 0.8||6520 \u00b1 293|| 175 ||326\n|-\n| || 282 (GBR 12783) || C<sub>6</sub>H<sub>5</sub> ||  || - || - || - || - || - || -\n|-\n|rowspan=4|[[File:GBR compound 306.svg|300px]]\n|-\n| 306a || 2-thienyl ||  ||6.4 \u00b1 0.3||1170 \u00b1 31||10 \u00b1 0.7||2020 \u00b1 141|| 183 ||202\n|-\n| 306b || 2-furyl ||  ||5.0 \u00b1 0.3||1840 \u00b1 59||9.6 \u00b1 0.3||2700 \u00b1 136|| 368 ||281\n|-\n| 306c || 2-pyridyl ||  ||44 \u00b1 3||2670 \u00b1 66||64 \u00b1 2||3620 \u00b1 179|| 60.7 ||56.6\n|-\n| [[File:GBR 13069.svg|300px]] || 283 ([[GBR-13069|GBR 13069]]) || C<sub>6</sub>H<sub>5</sub> ||  ||0.9 \u00b1 0.1||135 \u00b1 7||11 \u00b1 0.6||576 \u00b1 32|| 150 ||52.4\n|-\n|rowspan=4|[[File:GBR compound 307.svg|300px]]\n|-\n| 307a || 2-thienyl ||  ||2.2 \u00b1 0.1||88 \u00b1 2||13 \u00b1 1.4||374 \u00b1 17|| 40.0 ||28.8\n|-\n| 307b || 2-furyl ||  ||1.8 \u00b1 0.3||109 \u00b1 4||7.2 \u00b1 0.4||442 \u00b1 23|| 60.5 ||61.4\n|-\n| 307c || 2-pyridyl ||  ||13.6 \u00b1 0.2||334 \u00b1 12||14.5 \u00b1 1.9||666 \u00b1 21|| 24.5 ||45.9\n|-\n|rowspan=3|[[File:GBR compound 308.svg|300px]]\n|-\n| 308a || H || (benzothiophen-2-yl)methyl ||18.1 \u00b1 1||2420 \u00b1 109||19 \u00b1 1||3520 \u00b1 289|| 134 ||185\n|-\n| 308b || F || (benzothiophen-2-yl)methyl ||4.1 \u00b1 1.1||495 \u00b1 18||34 \u00b1 2||1230 \u00b1 40|| 121 ||36.2\n|-\n|rowspan=3|[[File:GBR compound 309.svg|300px]]\n|-\n| 309a || H || (benzofuran-2-yl)methyl ||17 \u00b1 0.5||1890 \u00b1 48||22 \u00b1 0.7||3040 \u00b1 213|| 111 ||138\n|-\n| 309b || F || (benzofuran-2-yl)methyl ||6.4 \u00b1 0.2||286 \u00b1 10||18.6 \u00b1 0.6||767 \u00b1 27|| 44.7 ||41.2\n|-\n|rowspan=3|[[File:GBR compound 310.svg|300px]]\n|-\n| 310a || H || (indol-2-yl)methyl ||1.1 \u00b1 0.1||668 \u00b1 39||8.8 \u00b1 0.7||2120 \u00b1 166|| 607 ||241\n|-\n| 310b || F || (indol-2-yl)methyl ||0.7 \u00b1 0.1||119 \u00b1 5||13 \u00b1 0.2||506 \u00b1 23|| 170 ||38.9\n|-\n|rowspan=3|[[File:GBR compound 311.svg|300px]]\n|-\n| 311a || H || (benzimidazol-2-yl)methyl ||46 \u00b1 1||1884 \u00b1 72||37 \u00b1 2||4076 \u00b1 221|| 41.0 ||110\n|-\n| 311b || F || (benzimidazol-2-yl)methyl ||15 \u00b1 0.2||256 \u00b1 7||20 \u00b1 0.8||797 \u00b1 43|| 17.1 ||39.8\n|-\n|rowspan=3|[[File:GBR compound 312.svg|300px]]\n|-\n| 312a || H || (quinolin-2-yl)methyl ||199 \u00b1 5||1990 \u00b1 5||192 \u00b1 8||4120 \u00b1 212|| 10.0 ||21.5\n|-\n| 312b || F || (quinolin-2-yl)methyl ||56 \u00b1 1||51 \u00b1 16||106 \u00b1 12||339 \u00b1 31|| 0.9 ||3.2\n|-\n|rowspan=3|[[File:GBR compound 313.svg|300px]]\n|-\n| 313a || H || (quinolin-3-yl)methyl ||72 \u00b1 2||1160 \u00b1 27||111 \u00b1 3||3040 \u00b1 252|| 16.1 ||27.4\n|-\n| 313b || F || (quinolin-3-yl)methyl ||16 \u00b1 3||485 \u00b1 16||74 \u00b1 3||851 \u00b1 36|| 30.3 ||11.5\n|-\n|rowspan=3|[[File:GBR compound 314.svg|300px]]\n|-\n| 314a || H || (quinolin-6-yl)methyl ||190 \u00b1 6||845 \u00b1 15||140 \u00b1 4||1640 \u00b1 58|| 4.4 ||11.7\n|-\n| 314b || F || (quinolin-6-yl)methyl ||62 \u00b1 2||551 \u00b1 21||73 \u00b1 3||1040 \u00b1 46|| 8.9 ||14.2\n|-\n|rowspan=3|[[File:GBR compound 315.svg|300px]]\n|-\n| 315a || H || 3-(benzimidazol-2-yl)propyl ||23 \u00b1 0.5||309 \u00b1 9||17 \u00b1 0.7||627 \u00b1 12|| 13.4 ||36.9\n|-\n| 315b || F || 3-(benzimidazol-2-yl)propyl  ||2.5 \u00b1 0.1||28 \u00b1 2||8.1 \u00b1 0.3||74 \u00b1 4|| 11.2 ||9.1\n|-\n|rowspan=3|[[File:GBR compound 316.svg|300px]]\n|-\n| 316a || H || (naphthalen-2-yl)methyl ||43 \u00b1 2||903 \u00b1 47||32 \u00b1 0.6||926 \u00b1 33|| 21.0 ||28.9\n|-\n| 316b || F || (naphthalen-2-yl)methyl ||8.0 \u00b1 0.3||312 \u00b1 15||30 \u00b1 1||588 \u00b1 39|| 39.0 ||19.6\n|-\n|rowspan=3|[[File:GBR compound 317.svg|300px]]\n|-\n| 317a || H || (naphthalen-1-yl)methyl ||114 \u00b1 5||336 \u00b1 22||406 \u00b1 11||83 \u00b1 5|| 2.9 ||0.2\n|-\n| 317b || F || (naphthalen-1-yl)methyl ||31 \u00b1 1||243 \u00b1 6||312 \u00b1 19||257 \u00b1 12|| 7.8 ||0.8\n|-\n|rowspan=3|[[File:GBR compound 318.svg|300px]]\n|-\n| 318a || H || 2-(naphthalen-1-yl)ethyl ||92 \u00b1 13||462 \u00b1 17||42 \u00b1 0.9||578 \u00b1 17|| 5.0 ||13.8\n|-\n| 318b || F || 2-(naphthalen-1-yl)ethyl ||7.8 \u00b1 0.2||46 \u00b1 1||25 \u00b1 0.8||119 \u00b1 4|| 5.9 ||4.8\n|-\n|}\n\n{| class=\"wikitable sortable\"\n|+Piperidine analogues of piperazine GBR compounds & their affinity to bind at DAT & 5-HTT{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#76 Page #1,000 (76th page of article)] \u00a7D, Page #1,001 (77th page of article) Figure 49 & Page #1,005 (81st page of article) Table 46.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R\u2032''\n! ''R\u2033''\n! IC<sub>50</sub> (nM)<br>DAT<br>[<sup>3</sup>H]WIN 35428\n! IC<sub>50</sub> (nM)<br>5-HTT<br>[<sup>3</sup>H]citalopram\n! Selectivity<br>5-HTT/DAT\n|-\n| || 279 (GBR 12909) ||  || || ||14.0 \u00b1 0.6||82 \u00b1 4||5.8\n|-\n| [[File:GBR compound 320.svg|300px]] || 320 (O-549) ||  || || ||595 \u00b1 148||38 \u00b1 127||0.6\n|-\n|rowspan=6|[[File:GBR compound 321-322.svg|300px]]\n|-\n| 321 (O-526) || F || || ||24.9 \u00b1 3.23||248 \u00b1 72||9.9\n|-\n| 322a || H || || ||12.0 \u00b1 0.4||232 \u00b1 28||19.3\n|-\n| 322b || Cl || || ||65.0 \u00b1 12||224 \u00b1 10||3.4\n|-\n| 322c || Br || || ||159 \u00b1 56||835 \u00b1 142||5.2\n|-\n| 322d || OCH<sub>3</sub> || || ||255 \u00b1 32||340 \u00b1 24||1.3\n|-\n|rowspan=6|[[File:GBR compound 323.svg|300px]]\n|-\n| 323a || H || || ||10.6 \u00b1 0.85||102 \u00b1 5||9.6\n|-\n| 323b || F || || ||19.9 \u00b1 9.5||31.9 \u00b1 7.1||1.6\n|-\n| 323c || Cl || || ||115 \u00b1 22||414 \u00b1 32||3.6\n|-\n| 323d || Br || || ||382 \u00b1 167||638 \u00b1 71||1.7\n|-\n| 323e || CH<sub>3</sub> || || ||311 \u00b1 71||888 \u00b1 58||2.8\n|-\n|rowspan=3|[[File:GBR compound 324.svg|300px]]\n|-\n| 324a || H || || ||15.2 \u00b1 2.8||743 \u00b1 6||48.9\n|-\n| 324b || F || || ||9.7 \u00b1 0.4||198 \u00b1 7||20.4\n|-\n|rowspan=3|[[File:GBR compound 325.svg|300px]]\n|-\n| 325a || H || || ||14.5 \u00b1 1.9||58 \u00b1 7||3.7\n|-\n| 325b || F || || ||13.0 \u00b1 2.5||112 \u00b1 4||8.6\n|-\n|rowspan=3|[[File:GBR compound 326.svg|300px]]\n|-\n| 326a || H || || ||108 \u00b1 14||456 \u00b1 90||4.2\n|-\n| 326b || F || || ||13.5 \u00b1 2.6||237 \u00b1 53||17.5\n|-\n|rowspan=3|[[File:GBR compound 327.svg|300px]]\n|-\n| 327a || H || || ||702 \u00b1 34||544 \u00b1 91||0.8\n|-\n| 327b || F || || ||126 \u00b1 13||761 \u00b1 101||6.0\n|-\n|rowspan=12|[[File:GBR compound 328.svg|300px]]\n|-\n| 328a || H || H || F ||17.2 \u00b1 4.7||1920 \u00b1 233||111.6\n|-\n| 328b || H || H || Cl ||24.7 \u00b1 5.5||1610 \u00b1 119||65.2\n|-\n| 328c || H || H || Br ||31.1 \u00b1 2.9||1490 \u00b1 319||47.9\n|-\n| 328d || H || Cl || Cl ||85.7 \u00b1 4.7||2880 \u00b1 281||33.6\n|-\n| 328e || H || H || OCH<sub>3</sub> ||27.8 \u00b1 6.8||1240 \u00b1 342||44.6\n|-\n| 328f || Cl || H || F ||52.4 \u00b1 7.8||1810 \u00b1 107||34.5\n|-\n| 328g || F || H || F ||14.0 \u00b1 3.3||1260 \u00b1 72||90.0\n|-\n| 328h || H || H || CH<sub>3</sub> ||23.0 \u00b1 3.7||1390 \u00b1 240||60.4\n|-\n| 328i || H || Cl || F ||28.2 \u00b1 3.1||2530 \u00b1 50||89.7\n|-\n| 328j || H || H || NO<sub>2</sub> ||16.4 \u00b1 3.0||1770 \u00b1 305||107.9\n|-\n| 328k || H || H || NH<sub>2</sub> ||101 \u00b1 13||1570 \u00b1 201||15.5\n|-\n|rowspan=7|[[File:GBR compound 329.svg|240px]]\n|-\n| 329a || Ph || 3-pyridyl || ||48.6 \u00b1 8.4||680 \u00b1 12.0||14.0\n|-\n| 329b || Ph || 2-benzo[''b'']thiophenyl || ||172 \u00b1 16.4||1540 \u00b1 251||8.9\n|-\n| 329c || Ph || 2-thienyl || ||59.3 \u00b1 5.8||1250 \u00b1 87||21.1\n|-\n| 329d || 2-thienyl || Ph || ||27.2 \u00b1 0.1||741 \u00b1 108||27.2\n|-\n| 329e || 2-thienyl || 4-F-Ph || ||13.8 \u00b1 3.4||1390 \u00b1 243||101\n|-\n| 329f || 2-thienyl || 3-pyridyl || ||58.3 \u00b1 5.7||927 \u00b1 34||15.9\n|-\n|rowspan=6|[[File:GBR compound 330.svg|300px]]\n|-\n| 330a || F || 4-F-Ph || ||15.1 \u00b1 2.0||75.8 \u00b1 22.1||5.0\n|-\n| 330b || F || Ph || ||41.4 \u00b1 8.0||271 \u00b1 18.4||6.5\n|-\n| 330c || H || Ph || ||10.1 \u00b1 1.6||231 \u00b1 4.5||22.9\n|-\n| 330d || H || 4-F-Ph || ||10.8 \u00b1 3.2||205 \u00b1 13.3||19.0\n|-\n| 330e || H || 2-thienyl || ||9.8 \u00b1 2.4||290 \u00b1 63||29.6\n|-\n|rowspan=5|[[File:GBR compound 331.svg|300px]]\n|-\n| 331a || Ph || H || 4-F-Ph ||6.6 \u00b1 1.4||223 \u00b1 32.3||33.8\n|-\n| 331b || Ph || H || 3-pyridyl ||29.9 \u00b1 0.3||194 \u00b1 20.1||6.5\n|-\n| 331c || 2-thienyl || H || Ph ||6.0 \u00b1 0.5||180 \u00b1 21.6||30.0\n|-\n| 331d || 2-thienyl || F || Ph ||11.7 \u00b1 1.0||85.7 \u00b1 2.6||7.3\n|-\n|rowspan=3|[[File:GBR compound 332.svg|300px]]\n|-\n| 332a || H || F || ||9.4 \u00b1 2.6||585 \u00b1 101||62.2\n|-\n| 332b || F || H || || - || - || -\n|}\n\n===Dihydroimidazoles===\n[[File:Mazindol analogs 2.svg|thumb|right|200px|Possible substitutions of the [[Mazindol]] molecular structure.]]\nSee: [[Mazindol#Analogs|List of Mazindol analogues]]\n\nMazindol is usually considered a non-habituating (in humans, and some other mammals, but is habituating for ''e.g.'' [[Beagle]]s{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#87 Page #1,011 (87th page of article)] \u00a7VII (7) 1st \u00b6.}}) [[Tetracyclic antidepressant|tetracyclic]] dopamine reuptake inhibitor (of somewhat spurious classification in the former).\n\nIt is a loosely functional analog used in cocaine research; due in large part to [[N-Ethylmaleimide|''N''-Ethylmaleimide]] being able to inhibit approximately 95% of the specific binding of [<sup>3</sup>H]Mazindol to the residues of the MAT binding site(s), however said effect of 10 [[Molar concentration#millimolar|mM]] ''N''-Ethylmaleimide was prevented in its entirety by just 10 ''\u03bc''M cocaine. Whereas neither 300 ''\u03bc''M dopamine or <small>D</small>-amphetamine afforded sufficient protection to contrast the efficacy of cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#45 Page #969 (45th page of article)] 2nd (right-side) column 2nd [[Paragraph|\u00b6]].}}<br>\n[[File:Mazindol synthesis.svg|1000px]][[File:Mazindol3Dan.gif]]\n<br>The above steps in its synthesis show the similitude of its precursors to the MAT reuptake inhibitor [[pipradrol]] & related compounds.\n{{Clear}}\n\n==Local anesthetics (not usually CNS stimulants)==\n {{multiple image\n | direction = vertical\n | image1 = Amylocaine.png\n | width1 = 220\n | caption1 = [[Amylocaine]], or Stovaine (above), the first synthetically constructed local anesthetic. Compare structure to [[dimethylaminopivalophenone]] (below), an analgesic (opioid). Cocaine's classification as a narcotic under [[United States|U.S.]] legal code, as has been stretched to be medicinally rationalized such when defining terms very broadly (due to its topical numbing affect, hindering pain signals from CNS recognition via local anesthesia) usually considered an exaggeration of traditional medicine naming convention, in this instance between the first synthetic sodium channel blocker and one of the very simplest opioids there remains a measure of apparent structural similarity between the former anesthetic and latter analgesic \"narcotic\"; despite the highly differing methods of action for the respective 'pain-killing' properties of either.<ref>{{cite journal | last1 = Ruetsch | first1 = YA | last2 = B\u00f6ni | first2 = T | last3 = Borgeat | first3 = A | date = Aug 2001 | title = From cocaine to ropivacaine: the history of local anesthetic drugs | url = | journal = Curr Top Med Chem | volume = 1 | issue = 3| pages = 175\u201382 | pmid = 11895133 | doi=10.2174/1568026013395335}}</ref>\n | image2 = 3-(dimethylamino)-2,2-dimethyl-1-phenylpropan-1-one.png\n | width2 = 220\n }}\n[[File:Beta-Eucaine.png|thumb|right|\u03b2-Eucaine (Betacain)]]\nIn animal studies, certain of the local anesthetics have displayed residual [[dopamine reuptake inhibitor]] properties,<ref name=Wilcox>{{cite journal|last1=Wilcox |first1=K.M. |last2=Kimmel |first2=H.L. |last3=Lindsey |first3=K.P. |last4=Votaw |first4=J.R. |last5=Goodman |first5=M.M. |last6=Howell |first6=L.L. |year=2005 |title=In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys |url=http://research.yerkes.emory.edu/Howell/Synapse58.pdf |journal=Synapse |volume=58 |issue= 4|pages=220\u2013228 |doi=10.1002/syn.20199 |pmid=16206183 |url-status=dead |archiveurl=https://web.archive.org/web/20100611201857/http://research.yerkes.emory.edu/Howell/Synapse58.pdf |archivedate=2010-06-11 |citeseerx=10.1.1.327.1264 }}</ref> although not normally ones that are easily available. These are expected to be more cardiotoxic than phenyltropanes. For example, dimethocaine has behavioral stimulant effects (and therefore not here listed below) if a dose of it is taken that is 10 times the amount of cocaine. Dimethocaine is equipotent to cocaine in terms of its anesthetic equivalency.<ref name=Wilcox/> [[Local anesthetic#Treatment of overdose: \"Lipid rescue\"|Intralipid \"rescue\"]] has been shown to reverse the cardiotoxic effects of sodium channel blockers and presumably those effects when from cocaine administered intravenously as well.\n\n{| class=\"wikitable\"\n|+ [[List of local anesthetics]]\n|-\n! scope=\"col\" | Name\n! scope=\"col\" | Other common names\n|-\n| [[Amylocaine]] || Stovaine\n|-\n| [[Articaine]] || Astracaine, Septanest, Septocaine, Ultracaine, Zorcaine\n|-\n| [[Benzocaine]] ||\n|-\n| [[Bupivacaine]] || Marcaine, Sensorcaine, Vivacaine\n|-\n| [[Butacaine]] ||\n|-\n| [[Carticaine]] ||\n|-\n| [[Chloroprocaine]] || Nesacaine\n|-\n| [[Cinchocaine|Cinchocaine/Dibucaine]] || Cincain, Cinchocaine, Nupercainal, Nupercaine, Sovcaine\n|-\n| [[Cyclomethycaine]] || Surfacaine, Topocaine\n|-\n| [[Etidocaine]] ||\n|-\n| [[Eucaine]] || \u03b1-eucaine, \u03b2-eucaine\n|-\n| [[Fomocaine]]<ref name=\"SchoenbergerDamijonaitis2014\">{{cite journal|last1=Schoenberger|first1=Matthias|last2=Damijonaitis|first2=Arunas|last3=Zhang|first3=Zinan|last4=Nagel|first4=Daniel|last5=Trauner|first5=Dirk| authorlink5 = Dirk Trauner | title=Development of a New Photochromic Ion Channel Blocker via Azologization of Fomocaine|journal=ACS Chemical Neuroscience|volume=5|issue=7|year=2014|pages=514\u2013518|issn=1948-7193|doi=10.1021/cn500070w|pmid=24856540|pmc=4102962}} [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102962/ nih.gov article]</ref>||\n|-\n| [[Fotocaine]]<ref name=\"SchoenbergerDamijonaitis2014\"/>||\n|-\n| [[Hexylcaine]] || Cyclaine, Osmocaine\n|-\n| [[Levobupivacaine]] || Chirocaine\n|-\n| [[Lidocaine|Lidocaine/Lignocaine]] || Xylocaine, Betacain'''e'''\n|-\n| [[Mepivacaine]] || Carbocaine, Polocaine\n|-\n| [[Meprylcaine|Meprylcaine/Oracaine]] || Epirocain\n|-\n| [[Metabutoxycaine]] || Primacaine\n|-\n| [[Phenacaine|Phenacaine/Holocaine]] ||\n|-\n| [[Piperocaine]] || Metycaine\n|-\n| [[Pramocaine|Pramocaine/Pramoxine]] ||\n|-\n| [[Prilocaine]] || Citanest\n|-\n| [[Propoxycaine|Propoxycaine/Ravocaine]] ||\n|-\n| [[Procaine|Procaine/Novocaine]] || Borocaine (Procaine Borate), Ethocaine\n|-\n| [[Proparacaine|Proparacaine/Alcaine]] ||\n|-\n| [[Quinisocaine]] || Dimethisoquin\n|-\n| [[Risocaine]] ||\n|-\n| [[Ropivacaine]] || Naropin\n|-\n| [[Tetracaine|Tetracaine/Amethocaine]] || Pontocaine, Dicaine\n|-\n| [[Trimecaine]] || Mesdicain, Mesocain, Mesokain\n|}\n\n==Analogues for other purposes==\n\n===Tropanes (Non-ecgonine)===\n[[File:Homatropine.svg|x150px]]\n* [[Homatropine]]\n* [[Methylhomatropine]]\n[[File:Homatropine.svg|x150px]]\n[[File:Methylhomatropine bromide.svg|x150px]]\n\n===Benzamides===\n[[File:Mefexamide.svg|x150px|thumb|right|[[Mefexamide]] is not a benzamide, but it has structure that is related and is described as a central stimulant, and therefore more correctly a \"functional analog\". ''cf.'' the benzoate stimulants]]\n* [[Procainamide]] (also an aniline, like dimethocaine)\n[[File:Procainamide.svg|x180px]]\n\n===Toxins===\n[[File:Cocaine to Anatoxin-a.svg|thumb|right|700px|Cocaine to [[Anatoxin-a]]:<ref>{{cite journal|doi=10.1016/S0957-4166(00)00059-8|title=A new and efficient synthetic route to enantiopure (+)-anatoxin-a from (\u2212)-cocaine hydrochloride|journal=Tetrahedron: Asymmetry|volume=11|issue=6|pages=1405\u20131410|year=2000|last1=Wegge|first1=Thomas|last2=Schwarz|first2=Simone|last3=Seitz|first3=Gunther}}</ref>]]\n* [[Anatoxin-a]], also known as \"Very Fast Death Factor\" (VFDF), is an acutely toxic cyanotoxin with a method of action as an agonist of acetylcholine via those nicotinic class of receptors. Cocaine can be used as a precursor in its synthesis.\n{| class=\"wikitable\"\n|-\n| [[File:Anatoxin-a.png|x200px]]<br>VFDF<br><small>Note its eight, instead of seven, sides<br>(not counting the nitrogen-bridge inside ring)</small>||[[File:methylecgonidine.png|thumb|left|200px|''[[cf.]]'' [[methylecgonidine]], a [[pyrolysis]] product of cocaine freebase.]] ||[[File:Ferruginine.svg|200px|thumb|left|''[[cf.]]'' also: [[ferruginine]], a compound even more analogous to the former.<ref>[http://biol-chem.uwb.edu.pl/new/pdf/ferrugine_tet_aam_2012%20.pdf Approaches to the enantioselective synthesis of ferrugine and its analogues] Institute of Chemistry, University of Bialystok, ul. Hurtowa 1, 15-339 Bialystok, Poland</ref>]]\n|}\n[[File:UB-165_structure.png|thumb|right|[[UB-165]], a [[Nicotinic acetylcholine receptor|nAChR]] agonist of a subtype with a function leading to release of dopamine and noradrenaline in the brain.\n\n<small>(''n.b.'' UB-165 is similarly manufactured (in depicted \"''Cocaine-to-Anatonix\u2014a''\" schematic @ top current \u00a7) from numbered precursor intermediate '''7''', ''i.e.'' ''9-azabicyclo[4.2.1]nonan-2-one'')</small>]]\n[[File:Epibatidine structure.png|300px]]\n* [[Epibatidine]] <small>(''cf.'' [[nicotine]])</small>\n[[File:Pinnamine.png|250px]]\n* [[Pinnamine]] <small>(''vide supra''; locants shown)</small>\n[[File:3-quinuclidinyl_benzilate.svg]]\n* [[3-Quinuclidinyl benzilate]]<ref>{{cite journal | pmid = 7823767 | volume=56 | issue=3 | title=Antagonism of nicotine's action by cocaine analogs | journal=Life Sci | pages=PL67\u201370 | last1 = Lerner-Marmarosh | first1 = N | last2 = Carroll | first2 = FI | last3 = Abood | first3 = LG | doi=10.1016/0024-3205(94)00900-7 | year=1995}}</ref> <small>(synthetic deliriant used as [[incapacitating agent]])</small>\n[[File:EBOB.svg|160px]]\n* [[EBOB|1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo[2.2.2]octane]]<ref>{{cite journal|title=[3H]Ethynylbicycloorthobenzoate ([3H]EBOB) Binding in Recombinant GABAA Receptors|journal=Neurotoxicology|volume=24|issue=6|pages=817\u201324|doi=10.1016/s0161-813x(03)00051-2|pmid=14637376|year=2003|last1=Yagle|first1=M. A|last2=Martin|first2=M. W|last3=De Fiebre|first3=C. M|last4=De Fiebre|first4=N. C|last5=Drewe|first5=J. A|last6=Dillon|first6=G. H}}</ref><small> (GABA receptor antagonist neurotoxin)</small>\n{{Clear}}\n\n==See also==\n[[Cocaine-N-oxide|Cocaine-''N''-oxide]]: [[File:Cocaine N-oxide.svg|x180px]]\n[[Hydroxytropacocaine]]: [[File:Hydroxytropacocaine.svg|x150px]]\n[[m-Hydroxybenzoylecgonine|''m''-Hydroxybenzoylecgonine]]: [[File:M-Hydroxybenzoylecgonine.svg|x150px]]\n[[File:Cinnamoylcocaine.svg|thumb|[[Methylecgonine cinnamate]], an alkaloid widely considered inactive in its own right, but postulated to be active under pyrolysis. (''cf.'' alkylphenyltropane analogue \"[[List of cocaine analogues#3\u03b2-Alkylphenyltropane & 3\u03b2-Alkenyl analogues|224e]]\") It is, however, found in patents of active cocaine analogue structures.<ref>{{US patent|6479509}} Patent inventor Frank Ivy Carroll, Assignee: Research Triangle Institute</ref><ref>[https://patentimages.storage.googleapis.com/US6479509B1/US06479509-20021112-C00016.png U.S. patent US6479509 B1 structures given for submission, 5th compound down in image.]</ref>|right|x150px]]\n[[File:Methyl benzoate.svg|thumb|Cocaine HCl hydrolyzes in moist air and enucleates from on its tropane-skeleton arrangement to become the above compound; [[methyl benzoate]]|right|x150px]]\n* [[Coca alkaloid]]s, the ones relating to [[Biosynthesis of cocaine|cocaine biosynthesis]] include: benzoylecgonine, ecgonidine, ecgonine, hydroxytropacocaine, methylecgonine cinnamate, tropacocaine & truxilline\n* [[Cocaine#Pharmacology|Cocaine metabolites (Human)]], which include: benzoylecgonine (BE), ecgonine methyl ester (EME), ecgonine, norcocaine, ''p''-hydroxycocaine, ''m''-hydroxycocaine, ''p''-hydroxybenzoylecgonine (''p''OHBE) & ''m''-hydroxybenzoylecgonine\n* [[Dopaminergic]]s\n* [[Federal Analog Act]]\n* [[Pharmacophore]]\n* [[Pharmacopoeia]]\n* [[Pharmacokinetics]]\n* [[Pharmacodynamics]]\n\n'''Common analogues to prototypical [[Dopamine|D]]-[[Monoamine releasing agent|RAs]]:'''\n:*[[Substituted amphetamine]]s\n:*[[Substituted cathinone]]s\n:*[[Substituted phenethylamine]]s\n:*[[Substituted phenylmorpholine]]s\n:*[[Substituted methylenedioxyphenethylamine]]s\n\n==Notes (inclu. specific locations of citations from within references used)==\n{{Notelist|20em}}\n\n==References==\n{{Reflist}}\n\n==External links==\n{{commons category|Cocaine analogs}}\n* [http://www.wipo.int/pctdb/en/wo.jsp?wo=2003099783&IA=WO2003099783&DISPLAY=DESC U. S. Provisional Patent Application listing examples of compounds which are tropanes for prospective use in research]\n* [http://www.emory.edu/ACAD_EXCHANGE/2001/octnov/kuharqa.html Article on cocaine analogue research]\n* [http://chemicalland21.com/info/TROPANYL%20COMPOUNDS.htm List of tropanyl type molecules] and their [[CAS Registry Number]]s\n\n{{Phenyltropanes}}\n{{Stimulants}}\n{{Serotonergics}}\n{{Sigmaergics}}\n{{Anorectics}}\n{{Antidepressants}}\n{{Receptor agonists and antagonists}}\n\n{{DEFAULTSORT:Cocaine Analogues}}\n[[Category:Cocaine]]\n[[Category:Local anesthetics]]\n[[Category:Euphoriants]]\n[[Category:Carboxylate esters]]\n[[Category:Methyl esters]]\n[[Category:Tropanes]]\n[[Category:Chemical classes of psychoactive drugs]]\n", "text_old": "[[File:Cocaine positions numbered.PNG|thumb|Cocaine with its numerical substitution position [[locant]]s.<br>'''2\u2032''' ('''6\u2032''') = ''ortho'', '''3\u2032''' ('''5\u2032''') = ''meta'' & '''4\u2032''' = ''para'']]\nThis is a list of [[cocaine]] [[Derivative (chemistry)|analogues]]. A '''cocaine analogue''' is a (usually) artificial construct of a novel [[chemical compound]] from (often the starting point of natural) cocaine's molecular structure, with the result product sufficiently similar to cocaine to display similarity in, but alteration to, its chemical function. Within the scope of analogous compounds created from the structure of cocaine, so named \"cocaine analogues\" retain 3''\u03b2''-benzoyloxy or similar functionality (the term specifically used usually distinguishes from [[phenyltropane]]s, but in the broad sense generally, as a category, includes them) on a tropane skeleton, as compared to other stimulants of the kind. Many of the semi-synthetic cocaine analogues ''proper'' which have been made & studied have consisted of among the nine following classes of compounds:{{efn|<ref name=\"Singh2\">{{cite journal | last1 = Singh | first1 = Satendra |display-authors=etal  | year = 2000 | title = Chemistry, Design, and Structure-Activity Relationship of Cocaine Antagonists | url = https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf | journal = Chem. Rev. | volume = 100 | issue = 3| pages = 925\u20131024 | doi=10.1021/cr9700538 | pmid=11749256}}</ref> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#45 Page #969 (45th page of article)] \u00a7III. \u00b61. Final line. Last sentence.}}\n* stereoisomers of cocaine\n* 3''\u03b2''-phenyl ring substituted analogues\n* 2''\u03b2''-substituted analogues\n* ''N''-modified analogues of cocaine\n* 3''\u03b2''-carbamoyl analogues\n* 3''\u03b2''-alkyl-3-benzyl tropanes\n* 6/7-substituted cocaines\n* 6-alkyl-3-benzyl tropanes\n* piperidine homologues of cocaine\n {{multiple image\n | direction = vertical\n | footer = Above: Cocaine in the chair conformation of the tropane-ring, with only its tropane locants given.<br><br>Below: Alternate two-dimensional molecular diagram of cocaine; shown specifically as a [[Protonation|protonated]], NH+, [[hydrochloride]], and disregarding 3D stereochemistry\n | image1 = Cocaine positions tropane-ring only.png\n | width1 = 250\n | image2 = CocaineHCl.svg\n | width2 = 250\n }}\nHowever strict analogues of cocaine would also include such other potential combinations as phenacyltropanes & other carbon branched replacements not listed above. The term may also be loosely used to refer to drugs manufactured from cocaine or having their basis as a [[total synthesis]] of cocaine, but modified to alter their effect & [[Quantitative structure\u2013activity relationship|QSAR]]. These include both intracellular sodium channel blocker anaesthetics and stimulant [[dopamine reuptake inhibitor]] [[ligand]]s (such as certain, namely tropane-bridged-excised, [[piperidine]]s). Additionally, researchers have supported combinatorial approaches for taking the most promising analogues currently elucidated and mixing them to the end of discovering novel & efficacious compounds to optimize their utilization for differing distinct specified purposes.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#94 Page #1,018 (94th page of article) 2nd column, 2nd paragraph.]}}\n[[File:Schematic of cocaine ligand structure.png|thumb|x240px|Two dimensional schematic drawing of cocaine's structural dynamic interaction points with dopamine transporter binding sites.<br><br><small>Although the carbmethoxy is denoted in its function as a hydrogen bond in this depiction, it has been found that it is primarily electrostatic factors which dominate binding within this space of the molecular surface area over the operative principle of hydrogen bonding.</small>{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#16 Page #940 (16th page of article) underneath Table 8., above \u00a74]}}]]\n[[File:Cocaine reverse esters.png|thumb|x400px|Two out of three potential \"reverse esters\" of cocaine (the third one being a single \"''di-substituted''\" structure with both the 'methyl ester' & 'benzoate' reversed in tandem)]]\n\n==[[Structural analog#Chemistry|Analogs ''sensu stricto'']]==\n\n===Cocaine Stereoisomers===\n[[File:Cocaine Stereoisomers.svg|thumb|x500px|There are eight [[Stereoisomerism|stereoisomers]] of cocaine (with the internal portion of the tropane ring unchanged).{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#46 Page #970 (46th page of article)] Table 27. Figure 29.}} <small>Not counting [[Resonance (chemistry)|mesomers]] but including the one & five to eight position bond bridge of the tropane system having ''R-'' & ''S-'' configurations potentially, containing four asymmetric carbons, cocaine can be counted as having as many as sixteen stereoisomers. However geometric constraints imparted by the bridgehead amine allow only eight to be created.</small>]]\n{| class=\"wikitable\" style = \"float: center; margin-left:15px; text-align:center\"\n! Stereoisomer\n! S. Singh's<br>alphanumeric<br>assignation\n! [[IC50|IC<sub>50</sub>]] ([[Mole (unit)#Related units|nM]])<br>[[tritium|[<sup>3</sup>H]]]WIN 3542 inhibition to <br>rat [[Striatum|striatal]] membranes<br><small>Mean error standard \u22645% in all cases</small>\n! [[Chemical nomenclature|IUPAC<br>nomenclature]]\n|-\n| [[Cocaine|''R''-cocaine]]<br>(Erythroxyline)\n| \u2014\n| 102\n| methyl(1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[R-pseudococaine|''R''-pseudococaine]]<br>(Delcaine, Depsococaine, Dextrocaine, Isococaine, Psicaine.<ref>{{cite journal | pmid = 20771843 | pmc=2196615 | volume=1 |issue = 3340| year=1925 | journal=Br Med J | pages=11 | last1 = Watson-Williams | first1 = E | title=Psicaine: An Artificial Cocaine | doi=10.1136/bmj.1.3340.11}}</ref>)\n| 172\n| 15800\n| methyl(1R,'''2S''',3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[R-allococaine|''R''-allococaine]]\n| 173\n| 6160\n| methyl(1R,2R,'''3R''',5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[R-allopseudococaine|''R''-allopseudococaine]]\n| 174\n| 28500\n| methyl(1R,'''2S''','''3R''',5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate\n|-\n| [[S-cocaine|''S''-cocaine]]\n| 175\n| 15800\n| methyl(1S,3R,4R,5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n| [[S-pseudococaine|''S''-pseudococaine]]\n| 176\n| 22500\n| methyl(1S,3R,'''4S''',5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n| [[S-allococaine|''S''-allococaine]]\n| 177\n| 9820\n| methyl(1S,'''3S''',4R,5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n| [[S-allopseudococaine|''S''-allopseudococaine]]\n| 178\n| 67700\n| methyl(1S,'''3S''','''4S''',5R)-3-(benzoyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane-'''4'''-carboxylate\n|-\n|}\n\nWhere the 2D diagrams given for the structural analogs below do not indicate stereochemistry, it should be assumed they share the conformation of ''R''-cocaine, unless noted otherwise.\n\nThe natural isomerism of cocaine is unstable in several ways besides having a high degree of [[lability]]; for instance: the C2 carbomethoxy in its biosynthesis end-product maintains the ''axial'' position, which can undergo [[epimer]]ization via [[saponification]] to obtain the former in an ''equatorial'' position.\n\nThe creation of the following analogues of cocaine have traditionally required a step which has utilized [[2-Carbomethoxytropinone|2-CMT]] as an intermediate molecular product.\n\n===Benzoyl branch cleavage substitutions (excluding the exhaustive phenyl group)===\n{| class=\"wikitable\"\n | [[Salicylmethylecgonine]]<ref name=Salicyl>{{cite journal | last1 = Singh | first1 = S | last2 = Basmadjian | first2 = GP | last3 = Avor | first3 = K | last4 = Pouw | first4 = B | last5 = Seale | first5 = TW | year = 1997 | title = A convenient synthesis of 2?- or 4?-hydroxycocaine | url = https://www.scribd.com/doc/39496623/salicylmethylecgonine | journal = Synthetic Communications | volume = 27 | issue = 22| pages = 4003\u20134012 | doi = 10.1080/00397919708005923 }}<br>et. {{cite journal | last1 = el-Moselhy | first1 = TF | last2 = Avor | first2 = KS | last3 = Basmadjian | first3 = GP | date = Sep 2001 | title = 2?-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies | url = | journal = Archiv der Pharmazie (Weinheim) | volume = 334 | issue = 8\u20139| pages = 275\u20138 | pmid = 11688137 | doi = 10.1002/1521-4184(200109)334:8/9<275::aid-ardp275>3.0.co;2-b }}<br> et. {{cite journal | last1 = Seale | first1 = TW | last2 = Avor | first2 = K | last3 = Singh | first3 = S | last4 = Hall | first4 = N | last5 = Chan | first5 = HM | last6 = Basmadjian | first6 = GP | year = 1997 | title = 2?-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding | url = | journal = NeuroReport | volume = 8 | issue = 16| pages = 3571\u20135 | pmid = 9427328 | doi = 10.1097/00001756-199711100-00030 }}</ref>||[[Methylvanillylecgonine]]<ref name=Vanillyl>{{cite journal | year = 1984 | title = Hydroxymethoxybenzoylmethylecgonines: New metabolites of cocaine from human urine | pmid = 6708474 | journal = Journal of Analytical Toxicology | volume = 8 | issue = 1| pages = 29\u201334  | last1 = Smith | first1 = RM | last2 = Poquette | first2 = MA | last3 = Smith | first3 = PJ | doi=10.1093/jat/8.1.29}}</ref>\n |-\n | [[File:Salicylecgonine.png|x220px]] || [[File:Hydroxymethoxycocaine.svg|x150px]]\n |-\n|}\n[[Nota bene|N.B.]] [[Fries rearrangement]] product of aspirin used to make [[salbutamol]]. It is relevant to the precursor here though because the migrated acetyl group can be the subject of a [[haloform reaction]]. A more direct route to [[vanillic acid]] though is just oxidation of the [[vanillin]] to a functionalized [[benzoic acid]].\n\n===[[Aromatic hydrocarbon|Arene benzene-ring]] 2\u2032, 3\u2032, 4\u2032 (5\u2032 & 6\u2032) position ([[aryl]]) substitutions===\n\n====''para''-substituted benzoylmethylecgonines====\n[[File:4-fluorococaine.png|x170px]]\n[[File:P-ISOCOC.svg|x140px]]\n[[File:Cocaine analog 183a.svg|x150px]]<br>\n[[File:Cocaine analog 183b.svg|x150px]]\n[[File:Cocaine analog 183c.svg|x150px]]\n[[File:Cocaine analog 183d.svg|x150px]]\n{| class=\"wikitable sortable\"\n|+Carbon 4\u2032-hydrogen Substitutions ([[benzene]]-4\u2032 \"''para''\" substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30. & Page #973 (49th page of article) Table 28.}}<br><sup>Data-set congruent to, and aggregate with, following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 4\u2032=[[Side chain|R]]\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n| ||(cocaine)||[[hydrogen|H]]||249 \u00b1 37||615 \u00b1 120||2500 \u00b1 70||2.5||10.0\n|-\n|''non-benzoyloxy analogue<br>comparative ligands''<br>{{smallsub|''non-tropane analogue<br>comparative ligands''}}||11b (WIN 35428)<small><br><sub>(nisoxetine)</sub><br><sup>(fluoxetine)</sup></small>||[[fluorine|F]]<small><br><sub>\u2014</sub><br><sup>\u2014</sup></small>||24 \u00b1 4<small><br><sub>775 \u00b1 20</sub><br><sup>5200 \u00b1 1270</sup></small>||690 \u00b1 14<small><br><sub>762 \u00b1 90</sub><br><sup>15 \u00b1 3</sup></small>||258 \u00b1 40<small><br><sub>135 \u00b1 21</sub><br><sup>963 \u00b1 158</sup></small>||28.7<small><br><sub>1.0</sub><br><sup>0.003</sup></small>||10.7<small><br><sub>0.2</sub><br><sup>0.2</sup></small>\n|-\n|rowspan=7|[[File:183a-d.svg|200px|Satendra Singh Rev]]\n|-\n| 183a || [[Iodine|I]] ||2522 \u00b1 4||1052 \u00b1 23||18458 \u00b1 1073||0.4||7.3\n|-\n| 183b || [[Phenyl group|Ph]] ||486 \u00b1 63|| - || - || - || -\n|-\n| 183c || [[Acetoxy group|OAc]] ||144 \u00b1 2|| - || - || - || -\n|-\n| 183d || [[Hydroxyl|OH]] ||158 \u00b1 8||3104 \u00b1 148||601 \u00b1 11||19.6||3.8\n|-\n| ([[4\u2032-Fluorococaine]])<ref name=\"pmid8113802\">{{cite journal |vauthors=Gatley SJ, Yu DW, Fowler JS, MacGregor RR, Schlyer DJ, Dewey SL, Wolf AP, Martin T, Shea CE, Volkow ND |title=Studies with differentially labeled [11C]cocaine, [11C]norcocaine, [11C]benzoylecgonine, and [11C]- and 4\u2032-[18F]fluorococaine to probe the extent to which [11C]cocaine metabolites contribute to PET images of the baboon brain |journal=Journal of Neurochemistry |volume=62 |issue=3 |pages=1154\u201362 |date=March 1994 |pmid=8113802 |doi= 10.1046/j.1471-4159.1994.62031154.x|url=}}</ref> || [[Fluorine|F]] || - || - || - || - || -\n|-\n| ([[(R)-p-Isothiocyanatobenzoylecgonine methyl ester|''para''-Isothiocyanatobenzoylecgonine<br>methyl ester]])<ref>{{cite journal |title= Cocaine Receptor: Biochemical Characterization and Structure-Activity Relationships of Cocaine Analogues at Dopamine Transporter |author1=Carroll, F. I. |author2=Lewin, A. H. |author3=Boja, J. W. |author4=Kuhar, M. J. |journal= Journal of Medicinal Chemistry |volume= 35 |issue= 6 |year= 1992 |pages= 969\u2013981 |doi= 10.1021/jm00084a001 |pmid=1552510}}</ref><br>([[Arene substitution pattern#Ortho, meta, and para substitution|''p'']]-Isococ) || [[Isothiocyanate|NCS]] || - || - || - || - || -\n|}\nThe [[Monoamine transporter|MAT]] [[Active site#Binding site|binding pocket]] analogous to the lipophilic place on cocaine-like compounds, inclusive of the benzene ring, is approximate to 9 [[Angstrom|\u00c5]] in length. Which is only slightly larger than a phenyl ring by itself.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)]}}\n\n====''meta''-substituted benzoylmethylecgonines====\n[[File:Cocaine analog 184a.svg|x150px]]\n[[File:Cocaine analog 184b.svg|x150px]]\n[[File:M-Isococ.svg|x160px]]\n[[File:C3benzyloxycocaine.svg|x170px]]\n\n{| class=\"wikitable sortable\"\n|+Carbon 3\u2032-hydrogen Substitutions (benzene-3\u2032 \"''meta''\" substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 3\u2032=R\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n|rowspan=5|[[File:184a-b.svg|200px|Satendra Singh Rev]]\n|-\n| 184a || I ||325<sup>'''\u0251'''</sup>|| - || - || - || -\n|-\n| 184b || OH ||1183 \u00b1 115||793 \u00b1 33||3760 \u00b1 589||0.7||3.2\n|-\n| 191 || O[[Benzyl|Bn]] || - || - || - || - || -\n|-\n| ([[Arene substitution pattern#Ortho, meta, and para substitution|''m'']]-Isococ) || [[Isothiocyanate|NCS]] || - || - || - || - || -\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> value for displacement of [<sup>3</sup>H]cocaine</small>\n\n====''ortho''-substituted benzoylmethylecgonines====\n[[File:Cocaine analog 185a.svg|x150px]]\n[[File:Cocaine analog 185b.svg|x150px]]\n[[File:Cocaine analog 185c.svg|x190px]]\n[[File:Cocaine analog 185d.svg|x150px]]\n\nThe hydroxylated 2\u2032-OH analogue exhibited a tenfold increase in potency over cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#48 Page #972 (48th page of article)] \u00b62, Line 10.}}\n\n{| class=\"wikitable sortable\"\n|+Carbon 2\u2032-hydrogen Substitutions (benzene-2\u2032 \"''ortho''\" substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 2\u2032=R\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n|rowspan=5|[[File:185a-d.svg|200px|Satendra Singh Rev]]\n|-\n| 185a || I ||350<sup>'''\u0251'''</sup>|| - || - || - || -\n|-\n| 185b || F ||604 \u00b1 67||1770 \u00b1 309||1392 \u00b1 173||2.9||2.3\n|-\n| 185c<br>([[2\u2032-Acetoxycocaine]])<ref>{{cite journal | pmid = 9427328 | year = 1997 | last1 = Seale | first1 = TW | last2 = Avor | first2 = K | last3 = Singh | first3 = S | last4 = Hall | first4 = N | last5 = Chan | first5 = HM | last6 = Basmadjian | first6 = GP | title = 2\u2032-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding | volume = 8 | issue = 16 | pages = 3571\u20135 | journal = NeuroReport | doi=10.1097/00001756-199711100-00030}}</ref> || OAc ||70 \u00b1 1||219 \u00b1 20||72 \u00b1 9||3.1||1.0\n|-\n| 185d<br>([[Salicylmethylecgonine|2\u2032-Hydroxycocaine]])<ref name=Salicyl /> || OH ||25 \u00b1 4||143 \u00b1 21||48 \u00b1 2||5.7||1.9\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> value for displacement of [<sup>3</sup>H]cocaine</small>\n\n====manifold benzoyloxy phenyl-substitutions====\n[[File:Hydroxymethoxycocaine.svg|x150px]]\n[[File:Cocaine analog 186.svg|x150px]]\n\nMulti-substitutions (substitutions of substitutions; e.g. [[Arene substitution pattern#Ortho, meta, and para substitution|''meta''- & ''para''-]]) or manifold (\"many-fold\") substituted analogues are analogues where more than one modification from the parent molecule takes place (having numerous intermediary constituents). These are created with often surprising structure\u2013activity relationship results extrapolated therefrom. It is even a common case where two separate substitutions can each yield a weaker, lower affinity or even wholly non-efficacious compound respectively; but due to findings that oftentimes, when used together, such two mutually inferior changes being added in tandem to one analogue has the potential to make the resultant derivative display much greater efficacy, affinity, selectivity &/or strength than even the parent compound; which otherwise was compromised by either of those two alternations when made alone.\n\n<small>For an exposition & allusion to this mechanism observe that the opioid oxycodone, derived from codeine, is 1.5\u00d7\u20141.7\u00d7 the analgesic potency of morphine (an opioid to which codeine is by comparison only 8%\u201412% as potent relatively, or 0.17th its strength in rats); yet oxycodone's intermediates in its synthesis from codeine are: \u2153 the potency of codeine (''i.e.'' codeinone); 0.13 that of morphine (''i.e.'' 14-hydroxycodeine) in rats and less in mice (to illustrate: the former even being less than the 0.17 of morphine that codeine is); with the final possible stand alone intermediate compound between codeine & oxycodone (''i.e.'' 7,8-dihydrocodeine) being at most 150% to 200% that of codeine.</small><ref>{{cite journal | year = 1964 | title = The analgesic properties of some 14-substituted derivatives of codeine and codeinone | url = | journal = J. Pharm. Pharmacol | volume = 16 | issue = | pages = 174\u2013182 | doi = 10.1111/j.2042-7158.1964.tb07440.x  | last1 = Buckett | first1 = W. R. | last2 = Farquharson | first2 = Muriel E. | last3 = Haining | first3 = C. G.}}</ref>\n\n{| class=\"wikitable sortable\"\n|+Manifold Compositions of Terminating Phenyl Ring Substitutions (Multiple benzene-2\u2032,3\u2032 & 4\u2032 combined substituted benzoyloxytropanes){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set (excepting instanced references inside table) congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''ortho''-2\u2032=''R''\n! ''meta''-3\u2032=''R''\n! ''para''-4\u2032=''R''\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n| [[File:2hydroxy4iodococaine.png|x120px]] || 186 || HO || H || I ||215 \u00b1 19||195 \u00b1 10||1021 \u00b1 75||0.9||4.7\n|-\n| [[File:Hydroxymethoxycocaine.svg|x70px]] || ([[Methylvanillylecgonine|Vanillylmethylecgonine]])<ref name=Vanillyl /> || H || [[Methoxy|OCH<sub>3</sub>]] || OH || - || - || - || - || -\n|}\n\n====benzoyl phenyl-alterations====\n[[File:Cocaine analog 187.svg|x150px]]\n[[File:Cocaine analog 188.svg|x150px]]\n\nThe naphthalene analogs allow for further numeric substitutions, including eight position ''[[Arene substitution pattern#Ipso, meso, and peri substitution|peri]]'' substituted patterns. Many more alterations creating [[Simple aromatic ring|differing aromatic rings]] are possible.\n\n{| class=\"wikitable sortable\"\n|+Terminating Phenyl Carbon Ring Fusions & Alterations{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] Figure 30 & Page #971 (47th page of article) Figure 30 & [https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973] (49th page of article) Table 28}}<br><sup>Data-set congruent to, and aggregate with, preceding table<br>IC<sub>50</sub> values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! C=''R''\n! DAT\n[<sup>3</sup>H]Cocaine (IC<sub>50</sub>)\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n| [[File:Cocaine analog 187 alt.png|x110px]] || 187 || 1-naphthalene ||742 \u00b1 48|| - || - || - || -\n|-\n| [[File:Cocaine analog 188 alt.png|x120px]] || 188 || 2-naphthalene ||327 \u00b1 63|| - || - || - || -\n|}\n\n===Benzoyl branch modifications===\n {{multiple image\n | direction = vertical\n | image1 = Spirocyclic cocaine analog.svg\n | width1 = 220\n | caption1 = Spirocyclic benzoyl branch modification [[List of phenyltropanes#C3 to 1\u2032 + 2\u2032 (ortho) tropane locant dual arene bridged|that fits criteria]] as a cocaine analog and a phenyltropane both (tropane 2nd locant ester rendered in given depiction shows, as has been attested, to only having been successfully alpha configured)<ref>{{cite journal | last1 = Sakamuri | first1 = Sukumar |display-authors=etal  | year = 2000 | title = Synthesis of novel spirocyclic cocaine analogs using the Suzuki coupling | url = | journal = Tetrahedron Letters | volume = 41 | issue = 13| pages = 2055\u20132058 | doi = 10.1016/S0040-4039(00)00113-1 }}</ref>\n | image2 = Spirocyclic_cocaine_analog_12.svg\n | width2 = 220\n }}\n* [[Benzoylthiomethylecgonine]]<ref>{{cite journal | last1 = Isomura | first1 = Shigeki | last2 = Hoffman | first2 = Timothy Z. | last3 = Wirsching | first3 = Peter | last4 = Janda | first4 = Kim D. | year = 2002 | title = Benzoylthio-. cocaine, analogue substitution. Synthesis, Properties, and Reactivity of Cocaine Benzoylthio Ester Possessing the Cocaine Absolute Configuration | url = | journal = J. Am. Chem. Soc. | volume = 124 | issue = 14| pages = 3661\u20133668 | doi = 10.1021/ja012376y | pmid=11929256}}</ref>\n\n[[File:Benzoylthiomethylecgonine.svg|x150px]]<br>\nA sulfur in place of the oxygen at the benzoyl ester single bond results in a lower electronegativity than that of cocaine.\n\n===C1-tropane-ring hydrogen\u2014substitutions===\n[[File:C1-tropane cocaine analogues.png|350px]]<br>\n''cf.'' [[List of cocaine analogues#See also|hydroxytropacocaine]] for a natural alkaloid (lacking however, the 2-position carbmethoxy) that is a C1 substituent with a [[hydroxy group]].\n{| class=\"wikitable sortable\"\n|+C1 substitutions<ref name=\"DavisGaddiraju2012\">{{cite journal|last1=Davis|first1=Franklin A.|last2=Gaddiraju|first2=Narendra V.|last3=Theddu|first3=Naresh|last4=Hummel|first4=Joshua R.|last5=Kondaveeti|first5=Sandeep K.|last6=Zdilla|first6=Michael J.|title=Enantioselective Synthesis of Cocaine C-1 Analogues using Sulfinimines (N-Sulfinyl Imines)|journal=The Journal of Organic Chemistry|volume=77|issue=5|year=2012|pages=2345\u20132359|issn=0022-3263|doi=10.1021/jo202652f|pmid=22300308|url=https://figshare.com/articles/Enantioselective_Synthesis_of_Cocaine_C_1_Analogues_using_Sulfinimines_i_N_i_Sulfinyl_Imines_/2544925}}</ref><br>HEK-293 heterologously expressed human monoamine transporter cells for ''K''<sub>i</sub> values of compounds inhibiting neurotransmitter uptake.<ref name=\"ReithAli2012\">{{cite journal|last1=Reith|first1=M. E. A.|last2=Ali|first2=S.|last3=Hashim|first3=A.|last4=Sheikh|first4=I. S.|last5=Theddu|first5=N.|last6=Gaddiraju|first6=N. V.|last7=Mehrotra|first7=S.|last8=Schmitt|first8=K. C.|last9=Murray|first9=T. F.|last10=Sershen|first10=H.|last11=Unterwald|first11=E. M.|last12=Davis|first12=F. A.|title=Novel C-1 Substituted Cocaine Analogs Unlike Cocaine or Benztropine|journal=Journal of Pharmacology and Experimental Therapeutics|volume=343|issue=2|year=2012|pages=413\u2013425|issn=1521-0103|doi=10.1124/jpet.112.193771|pmid=22895898|pmc=3477221}} [http://jpet.aspetjournals.org/content/343/2/413.full.pdf#page=1&view=FitH Full article]</ref>\n! Structure\n! Trivial name\n! ''R''<br>(C1 moiety)\n! ''K''<sub>i</sub> (''nM'') @ DAT\n! ''K''<sub>i</sub> (''nM'') @ SERT\n! ''K''<sub>i</sub> (''nM'') @ NET\n! \u03c3<sub>1</sub> affinity<br>''K''<sub>i</sub>\n! \u03c3<sub>2</sub> affinity<br>''K''<sub>i</sub>\n! IC<sub>50</sub> (\u03bcM) Na+ inhibition<br>(Vertridine-Stimulated<br>influx of sodium channels<br>in Neocortical neurons)<sup>'''c'''</sup>\n! LogP<br>(XLogP3 algorithm, Cheng et al., 2007)\n|-\n| || (\u2014)-Cocaine || H ||326 \u00b1 106||513 \u00b1 143||358 \u00b1 69||6.7 \u00b1 0.3 \u03bcM'''<sup>d</sup>'''<ref>{{cite journal | pmid = 2840298 | volume=149 | issue=1\u20132 | title=Cocaine binding at sigma receptors | journal=Eur J Pharmacol | pages=171\u20134 | last1 = Sharkey | first1 = J | last2 = Glen | first2 = KA | last3 = Wolfe | first3 = S | last4 = Kuhar | first4 = MJ | doi = 10.1016/0014-2999(88)90058-1 | year=1988 }}</ref>||\"significant\"<ref name=\"NuwayhidWerling2006\">{{cite journal|last1=Nuwayhid|first1=Samer J.|last2=Werling|first2=Linda L.|title=Sigma2 (\u03c32) receptors as a target for cocaine action in the rat striatum|journal=European Journal of Pharmacology|volume=535|issue=1\u20133|year=2006|pages=98\u2013103|issn=0014-2999|doi=10.1016/j.ejphar.2005.12.077|pmid=16480713}}</ref>||6.99 \u00b1 2.43||2.30\n|-\n|[[File:1-methylcocaine.svg|x120px]] || (\u2014)-1-methyl-cocaine|| Me ||163 \u00b1 23||435 \u00b1 77||488 \u00b1 101||\"unappreciable\"||1.13 \u03bcM||16.01 \u00b1 1.90||2.67\n|-\n|[[File:1-ethylcocaine.svg|x120px]] || (\u2014)-1-ethyl-cocaine|| Et ||95.1 \u00b1 17.0<sup>'''\u0251'''</sup>||1,106 \u00b1 112||598 \u00b1 179||\u2014||\u2014||\u2014||3.20\n|-\n|[[File:1-propylcocaine.svg|x150px]] || (\u2014)-1-n-propyl-cocaine||''n''-Pr ||871 \u00b1 205<sup>'''\u0251'''</sup>||2,949 \u00b1 462<sup>'''b'''</sup>||796 \u00b1 195||\u2014||\u2014||\u2014||3.56\n|-\n|[[File:1-pentylcocaine.svg|x160px]] || (\u2014)-1-n-pentyl-cocaine||''n''-C<sub>5</sub>H<sub>11</sub> ||1,272 \u00b1 199<sup>'''b'''</sup>||1,866 \u00b1 400<sup>'''\u0251'''</sup>||1,596 \u00b1 21<sup>'''b'''</sup>||\u2014||\u2014||\u2014||4.64\n|-\n|[[File:1-phenylcocaine.svg|x150px]] || (\u2014)-1-phenyl-cocaine|| Ph ||32.3 \u00b1 5.7<sup>'''b'''</sup>||974 \u00b1 308||1,980 \u00b1 99<sup>'''b'''</sup>||524 ''nM''||198 ''nM''||0.29 \u00b1 0.07||3.77\n|}\n*<small><sup>'''\u0251'''</sup>, ''P'' < 0.05 compared with (\u2014)-cocaine (one-way ANOVA followed by Dunnett's multiple comparisons test)</small>\n*<small><sup>'''b'''</sup>, ''P'' < 0.01 compared with (\u2014)-cocaine (one-way ANOVA followed by Dunnett's multiple comparisons test)</small>\n*<small><sup>'''c'''</sup>Lidocaine was found to have a value of 39.6 \u00b1 2.4, the weakest of all tested.</small>\n*<small><sup>'''d'''</sup>Same reference gives 25.9 \u00b1 2.4 \u03bcM for (+)-cocaine and 13.6 \u00b1 1.3 \u03bcM for norcocaine. Comparably it gives 12.7 \u00b1 1.5 \u03bcM for the sigmaergic affinity of (+)-amphetamine. Another reference gives 1.7-6.7 \u03bcM for (\u2014)-cocaine. All values ''K''<sub>i</sub>.</small><ref>[http://www.nature.com/npp/journal/v26/n4/full/1395834a.html Involvement of the Sigma<sub>1</sub> Receptor in Cocaine-induced Conditioned Place Preference: Possible Dependence on Dopamine Uptake Blockade] Pascal Romieu et al. Neuropsychopharmacology (2002) 26 444-455.10.1038/S0893-133X(01)00391-8</ref>\n*<small>'''Using same data-set as above table, the following compounds were found to compare as:'''</small>\n**<small>CFT @ DAT = 39.2 \u00b1 7.1 (n = 5)</small>\n**<small>fluoxetine @ SERT = 27.3 \u00b1 9.2 (n = 3)</small>\n**<small>desipramine @ NET = 2.74 \u00b1 0.59 (n = 3)</small>\nCocaine analogs substituting the C1-tropane ring position, requiring sulfinimine (''N''-sulfinyl-imine) chemistry (before the innovation of which were untenable) which bind unlike the typical configuration at DAT (open to out) as cocaine (with its terminal D79-Y156 distance of 6.03 \u00c5), or in the atypical (closed to out) conformation of the benztropines (3.29 \u00c5). Though closer to the open to out: (\u2014)-1-methyl-cocaine = 4.40 \u00c5 & (\u2014)-1-phenyl-cocaine = 4.89 \u00c5, and exhibiting preferential interaction with outward facing DAT conformation, they appear to have the lack of behavioral stimulation as-like the closed to out type. Despite having non-stimulant behavior profiles, they still seem to have anti-depressant behavioral profiles.<ref name=\"ReithAli2012\"/>\n\nThe C1 phenyl analog is ten times stronger than cocaine as a dopamine reuptake pump ligand, and twenty four times stronger as a local anesthetic (voltage-dependent Na+ channel blocker), whereas the C1 methyl analog is 2.3 times less potent as a local anesthetic.<ref name=\"ReithAli2012\"/>\n\n===2''\u03b2''-substitutions (including transesterification metabolite substitution cocaethylene)===\n[[File:Cocaine analog (former 196c error).svg|190px|thumb|Extra methylene length to the 196c cocaine analogue, as given in error previously; \"2-methylpropyl\", ''i.e.'' isobutanol.]]\n[[File:Cocaine analog 196a.svg|x165px]]\n[[File:Cocaine analog 196b.svg|x195px]]\n[[File:Cocaine analog 196c.svg|x185px]]\n[[File:Cocaine analog 196d.svg|x225px]]\n[[File:Cocaine analog 197a.svg|x175px]]<br>\nThe consideration that large, bulky C2 substituents would alter the tropane by distorting the piperidine ring part of its skeleton sufficiently enough to impair its functionality, or that in said event such would hamper binding, in particular at the 8-aza end to ease steric strain going toward its place from the 2-position,{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50st page of article)] First (left) column, third \u00b6}} appear to in many cases be unfounded.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #937 (13th page of article)] Second (right) column, first \u00b6. Above/before \u00a72}} (examples shown in table of images below)\n\n{| class=\"wikitable\"\n|+ Compounds with greater SERT affinity than cocaine parent (slightly less @ DAT, significantly less, except for #196g, @ NET)\n |-\n |[[File:Cocaine analog 196e.svg|x220px]] || [[File:Cocaine analog 196f.svg|x220px]] || [[File:Cocaine analog 196g.svg|x210px]] || [[File:Cocaine analog 196h.svg|x210px]]\n|}\n[[File:Cocaine analog 196i.svg|x280px]]\n[[File:Cocaine analog 196j.svg|x260px]]\n[[File:Cocaine analog 196l.svg|x250px]]\n[[File:Cocaine analog 196m.svg|x270px]]\n{| class=\"wikitable\"\n|+ Compounds with greater DAT affinity than cocaine parent (SERT & NET affinity untested; note however their similarity to more potent SERT ligands above) ||(greater)>@ DAT, (lesser)<@ SERT, (much less)<<@ NET\n |-\n |[[File:Cocaine analog 196k.svg|x260px]] || [[File:Cocaine analog 196n.svg|x270px]] || [[File:Cocaine analog 196o.svg|x260px]] || [[File:Cocaine analog 197c.svg|x170px]]\n|}\n[[File:Hydroxypropyl_benzoylecgonine.svg|190px|thumb|hydroxypropylbenzoylecgonine (HPBE), which imparts the topical analgesic effect in the preparation [[Esterom]].<ref>{{cite journal | title = A-854: Comparative Potency for Impulse-Blockade and for Cutaneous Analgesia of Traditional and Novel Local Anesthetics | author = Yoshihiro Hamaya, Hesham Abdelrazek, Gary R. Strichartz | date = 2002 | url = http://w.asaabstracts.com/strands/asaabstracts/abstract.htm?year=2002&index=10&absnum=1331 | quote = ...hydroxypropylbenzoylecgonine (HPBE) is the only effective analgesic compound in [Esterom]. | journal = Abstracts of American Society of Anesthesiologists Annual Meeting }}{{Dead link|date=March 2020 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>]]\n[[File:Cocaine analog 197b.svg|x170px]]\n[[File:Cocaine analog 197d.svg|x170px]]\n[[File:Cocaine analog 197e.svg|x170px]]\n[[File:Cocaine analog 197f.svg|x160px]]\n[[File:Cocaine analog 197g.svg|x160px]]\n\nCompound '''197b''' displayed a 1,131-fold increased selectivity in affinity over the serotonin transporter, with only slight reductions in potency for the dopamine & norepinephrine transporters.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Final \u00b6 (5th), Second line.}} Whereas '''197c''' had a 469\u00d7 increase at [[serotonin transporter|SERT]], with greater affinity for [[dopamine transporter|DAT]] than cocaine & was approximately equipotent to [[norepinephrine transporter|NET]].{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#51 Page #975 (51st page of article)] First \u00b6, first line.}} '''197b''' was 137\u00d7, and '''196c''' 27\u00d7 less potent at binding to the serotonin transporter, but both had a NET / DAT ratio that made for a better [[dopaminergic]] than cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#51 Page #975 (51st page of article)] First \u00b6, 4th line.}}\n[[File:196a-o.svg|thumb|325px]] [[File:197a-d.svg|thumb|325px]] [[File:197f.svg|thumb|325px]]\n{| class=\"wikitable sortable\"\n|+Direct 2''\u03b2'' Substitutions{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#49 Page #973 (49th page of article)] \u00a7C. & Page #974 (50th page of article) Figure 31 & Page #976 (52nd page of article) Table 29.}}<br><sup>(IC<sub>50</sub> nM values)</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! DAT\n[<sup>3</sup>H]WIN 35428\n! 5-HTT\n[<sup>3</sup>H]Paroxetine\n! NET\n[<sup>3</sup>H]Nisoxetine\n! Selectivity\n5-HTT/DAT\n! Selectivity\nNET/DAT\n|-\n|rowspan=17|[[File:Cocaine analog 196a-o.svg|200px|Satendra Singh Rev]]\n|-\n| (Cocaine) || [[Methyl group|Me]] ||89 \u00b1 4.8||1045 \u00b1 89||3298 \u00b1 293||11.7||37.0\n|-\n| 196a<br>([[Cocaethylene]]) || [[Ethyl group|Et]] ||195 \u00b1 45||5801 \u00b1 493||10000 \u00b1 751||29.7||51.3\n|-\n| 196b || ''n''-Pr ||196 \u00b1 46||4517 \u00b1 430||6124 \u00b1 262||23.3||31.2\n|-\n| 196c || ''i''-Pr ||219 \u00b1 48||25224 \u00b1 1498||30384 \u00b1 1685||115||139\n|-\n| 196d || Ph ||112 \u00b1 31||33666 \u00b1 3330||31024 \u00b1 1909||300||277\n|-\n| 196e || Bn||257 \u00b1 14||302 \u00b1 23||20794 \u00b1 950||1.2||80.9\n|-\n| 196f || \u03b2-phenethyl ||181 \u00b1 10||615 \u00b1 52||19944 \u00b1 1026||3.4||110\n|-\n| 196g || \u03b3-phenylpropyl ||147 \u00b1 19||374 \u00b1 15||4893 \u00b1 344||2.5||33.3\n|-\n| 196h || [[cinnamyl]] ||371 \u00b1 15||368 \u00b1 6.3||68931 \u00b1 3476||1.0||186\n|-\n| 196i || ''p''-NO<sub>2</sub>-\u03b2-phenethyl ||601 \u00b1 28|| - || - || - || -\n|-\n| 196j || ''p''-Cl-\u03b2-phenethyl ||271 \u00b1 12|| - || - || - || -\n|-\n| 196k || ''p''-NH<sub>2</sub>-\u03b2-phenethyl ||72 \u00b1 7|| - || - || - || -\n|-\n| 196l || ''p''-[[isothiocyanato|NCS]]-\u03b2-phenethyl||196 \u00b1 14|| - || - || - || -\n|-\n| 196m || ''p''-[[azido]]-\u03b2-phenethyl ||227 \u00b1 19|| - || - || - || -\n|-\n| 196n || (''p''-NHCOCH<sub>2</sub>Br)\u03b2-phenethyl ||61 \u00b1 6|| - || - || - || -\n|-\n| 196o || (''p''-NHCO(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>Et)\u03b2-phenethyl ||86 \u00b1 4|| - || - || - || -\n|-\n|rowspan=5|[[File:Cocaine analog 197a-d.svg|200px|Satendra Singh Rev]]|| 197a || NH<sub>2</sub> ||753 \u00b1 41.3||13725 \u00b1 1256||3981 \u00b1 229||18.2||5.3\n|-\n| 197b || -NMe<sub>2</sub> ||127 \u00b1 6.36||143713 \u00b1 8854||7329 \u00b1 158||1131||57.7\n|-\n| 197c || -N(OMe)Me ||60 \u00b1 6.4||28162 \u00b1 2565||3935 \u00b1 266||469||65.6\n|-\n| 197d || -NHMe ||2424 \u00b1 118||44798 \u00b1 2105||4213 \u00b1 206||18.5||1.7\n|-\n| 197e<br>([[Benzoylecgonine]]) || -OH || 195000 || - || - || - || -\n|-\n|rowspan=2|[[File:Cocaine analog 196-197.svg|200px|Satendra Singh Rev]]|| 197f || HOCH<sub>2</sub>- ||561 \u00b1 149|| - || - || - || -\n|-\n| 197g<br>([[Tropacocaine]]) || H ||5180 \u00b1 1160|| - || - || - || -\n|}\n\n====[[Bioisostere]] 2-position carbmethoxy-ester functional replacements====\n[[File:Cocaine analog 203.svg|thumb|200px|Intermediate compound #'''203''']]\n[[File:Cocaine analog 198a.svg|x180px]]\n[[File:Cocaine analog 198b.svg|x220px]]\n[[File:Cocaine analog 198c.svg|x220px]]\n[[File:Cocaine analog 198d.svg|x220px]]\n[[File:Cocaine analog 198e.svg|x250px]]<br>\nBenzoylecgonine, ''i.e.'' compound '''197e''', (differing from its cocaine parent only by de-methylation of the C2 carbmethoxy to that of a carboxy) has an extreme loss in potency (its approximate affinity being 195,000 nM) as displayed by ''in vitro'' methodologies for determining binding efficacy (wherein [[Blood\u2013brain barrier|BBB]] penetration does not factor-in on the matter in the manner as ''in vivo'' studies) and is posited to be due possibly to [[zwitterion]] [[Ion#Formation|formation]].{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50st page of article)] First (left) column, fourth \u00b6}}\n[[File:198a-e.svg|thumb|400px]]\n{| class=\"wikitable sortable\"\n|+2''\u03b2''-isoxazole and isoxazoline ring containing analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, following tables<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! [<sup>3</sup>H][[Mazindol]]\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n| || (Cocaine) || (H) ||580 \u00b1 70||570 \u00b1 180||1.0\n|-\n|rowspan=7|[[File:Cocaine analog 198.svg|200px|Satendra Singh Rev]]\n|-\n| 198a || H ||520 \u00b1 40||260 \u00b1 70||0.5\n|-\n| 198b || CO<sub>2</sub>Et (5\u2032-carboethoxy-)||120 \u00b1 10||290 \u00b1 40||2.4\n|-\n| 198c || [[tert-Butyloxycarbonyl protecting group|BOC]] ||2230 \u00b1 220||1820 \u00b1 810||0.8\n|-\n| 198d || Ph ||2000 \u00b1 640||2920 \u00b1 1620||1.5\n|-\n| 198e || CH=CHCO<sub>2</sub>Me ||3600 \u00b1 400||3590 \u00b1 1180||1.0\n|}\n[[File:2-((2-methoxy-2-oxoethoxy)methyl)_cocaine_analogue.png|thumb|right|x180px|2-<nowiki>[</nowiki>(2-methoxy-2-oxoethoxy)methyl<nowiki>]</nowiki> cocaine analogue.<ref name=\"Carroll\"/>]]\n[[File:Cocaine analog 199a.svg|x220px]]\n[[File:Cocaine analog 199b.svg|x220px]]\n[[File:D3-methyl cocaine.svg|thumb|<nowiki>[</nowiki>''<sup>2</sup>H<sub>3</sub>-N-methyl''<nowiki>]</nowiki>-cocaine: [[reagent]] analogue used in [[Radioactive tracer|radio-labeling]] ligand binding sites.]]\n{| class=\"wikitable sortable\"\n|+nonplanar 2''\u03b2''-isoxazoline ring containing analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n|rowspan=3|\n|-\n| 199a || \u03b2(or ''R'')CO<sub>2</sub>Et ||710 \u00b1 150||1060 \u00b1 340||1.5\n|-\n| 199b || \u03b1(or ''S'')CO<sub>2</sub>Et ||5830 \u00b1 630||8460 \u00b1 620||1.4\n|}\n[[File:Cocaine analogue C2-EthOSO2CF2.png|thumb|C2-ethyl-OSO<sub>2</sub>CF<sub>2</sub> cocaine analogue.<ref name=\"Carroll\"/>]]\n[[File:Cocaine analog 200.svg|x260px]]\n\n{| class=\"wikitable sortable\"\n|+2''\u03b2''-isoxazoline atomically N/O reversed analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, preceding and following tables<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n| || 200 || ||880 \u00b1 350||400 \u00b1 140||0.4\n|}\n\n====Vinylogous 2''\u03b2''-position carbmethoxy-ester functional replacements====\n[[File:Cocaine analog 201a.svg|x150px]]\n[[File:Cocaine analog 201b.svg|x180px]]\n[[File:Cocaine analog 201c.svg|x220px]]\n[[File:Cocaine analog 201d.svg|x260px]]\n[[File:Cocaine analog 201e.svg|x260px]]\n\n'''201b''' & '''201c''' show significant increased potency over cocaine; whereas '''201a''', '''201d''' & '''201e''' are considerably less so. This infers the hydrogen bond acceptor at the 2''\u03b2'' position to not necessarily be of exclusive import in creation of higher binding analogues of cocaine.\n[[File:D5-phenyl cocaine.svg|thumb|<nowiki>[</nowiki>''<sup>2</sup>H<sub>5</sub>-phenyl''<nowiki>]</nowiki>-cocaine: reagent analogue, as above thumbnail of similar compound: rendered from its cocaine parent by replacing a cluster of several adjacent hydrogens (from among the hydrogens that comprise the entire circumference common to every basic molecular perimeter) with [[deuterium]], in an equivalent but localized spread or cluster.]]\n{| class=\"wikitable sortable\"\n|+vinylogous 2''\u03b2'' analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#50 Page #974 (50th page of article)] Figure 31 & Page #977 (53rd page of article) Table 30.}}<br><sup>Data-set congruent to, and aggregate with, preceding table<br>IC<sub>50</sub> nM values</sup>\n! Structure\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n|rowspan=6|[[File:Cocaine analog 201.svg|220px]]\n|-\n| 201a || H ||1730 \u00b1 550||1120 \u00b1 390||0.6\n|-\n| 201b || Cl ||222 \u00b1 49||368 \u00b1 190||1.6\n|-\n| 201c || CO<sub>2</sub>Et ||50 \u00b1 10||130 \u00b1 10||2.6\n|-\n| 201d || CH=CHCO<sub>2</sub>Et ||1220 \u00b1 100||870 \u00b1 50||0.7\n|-\n| 201e || PO(OEt)<sub>2</sub> ||4850 \u00b1 470||5500 \u00b1 70||1.1\n|}\n\n===''N''-modifications===\n[[File:Cocaine analog 218 (norcocaine).svg|x170px]]\n[[File:Cocaine analog 219a.svg|x170px]]\n[[File:Cocaine analog 219b.svg|x170px]]\n[[File:219a-b.svg|thumb|325px]]\n[[File:Cocaine analog 219c.svg|x160px]]\n[[File:Cocaine analog 219d.svg|x160px]]\n[[File:Cocaine analog 219e.svg|x160px]]\n\n{| class=\"wikitable\"\n|+ Additional ''N''-modified cocaine analogue molecular structures\n|-\n[[File:Norcocaine.png|x180px]]\n[[File:Cocaine analog 220a.svg|x170px]]\n[[File:Cocaine analog 220b.svg|x170px]]\n[[File:Cocaine analog 220c.svg|x170px]]<br>\n[[File:Cocaine analog 220d.svg|x170px]]\n[[File:Cocaine analog 220e.svg|x190px]]\n[[File:Cocaine analog 220f.svg|x170px]]\n|}\n[[File:Cocaine analog 221a.svg|x160px]]\n[[File:Cocaine analog 221b.svg|x160px]]\n[[File:Cocaine analog 221c.svg|x160px]]\n[[File:Cocaine analog 221d.svg|x160px]]\n[[File:8-oxa cocaine.svg|thumb|200px|right|'''''8-oxa'' cocaine''' analogs:<ref>{{Cite journal | doi = 10.1016/S0960-894X(99)00273-5| pmid = 10406650| title = Synthesis of 8-oxa analogues of norcocaine endowed with interesting cocaine-like activity| journal = Bioorganic & Medicinal Chemistry Letters| volume = 9| issue = 13| pages = 1831\u20131836| year = 1999| last1 = Kozikowski | first1 = A. P. | last2 = Simoni | first2 = D. | last3 = Roberti | first3 = M. | last4 = Rondanin | first4 = R. | last5 = Wang | first5 = S. | last6 = Du | first6 = P. | last7 = Johnson | first7 = K. M. }}</ref> (cf Meltzer with [[List of phenyltropanes|PTs]])]]\n {{multiple image\n | direction = vertical\n | footer = Eight position carba ''N''6 & ''N''7 analogues.<ref name=\"Carroll\"/>\n | image1 = (1R,3S,5S)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl_benzoate.svg\n | width1 = 250\n | image2 = (1S,3R,5R)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl_benzoate.svg\n | width2 = 290\n }}\n[[File:(1S,3R,5R)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl 2-phenylbenzoate.svg|thumb|right|x200px|''ortho''-phenyl of the moved nitrogen.<ref name=\"Carroll\"/>]]\n{| class=\"wikitable sortable\"\n|+Nitrogen Substitutions<br>Mazindol comparison table<br>(<sup>'''\u0251'''</sup>''\u03b2''-CFT comparison notation){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#54 Page #978 (54th page of article)] \u00a7D & Page #980 (56th page of article) Figure 33 & Page #981 (57th page of article) Table 32.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''N''8-''R''\n! [<sup>3</sup>H]Mazindol<br>binding\n! [<sup>3</sup>H]DA<br>uptake\n! Selectivity\nUptake/Binding\n|-\n| [[File:Cocaine methiodide.svg|240px]] ||217<br>(Cocaine methiodide)||-||10700 \u00b1 1530<sup>'''\u0251'''</sup>|| - || -\n|-\n|rowspan=17|[[File:Cocaine analog 219.svg|210px|Satendra Singh Rev]]|| (Cocaine) || CH<sub>3</sub> ||280 \u00b1 60<br>102<sup>'''\u0251'''</sup>||320 \u00b1 10||1.1\n|-\n| 218<br>([[Norcocaine]]) || H ||303 \u00b1 59<sup>'''\u0251'''</sup>|| - || -\n|-\n| 219a || [[benzyl|Bn]] ||668 \u00b1 67<sup>'''\u0251'''</sup>|| - || -\n|-\n| 219b || [[acetyl|Ac]] ||3370 \u00b1 1080<sup>'''\u0251'''</sup>|| - || -\n|-\n| 219c || CH<sub>2</sub>CH<sub>2</sub>OH ||700 \u00b1 100||1600 \u00b1 200||2.3\n|-\n| 219d || CH<sub>2</sub>CO<sub>2</sub>CH<sub>3</sub> ||480 \u00b1 40||1600 \u00b1 100||3.3\n|-\n| 219e || CH<sub>2</sub>CO<sub>2</sub>H ||380 \u00b1 20||2100 \u00b1 400||5.5\n|-\n| 220a || SO<sub>2</sub>CH<sub>3</sub> ([[mesyl|Ms]]) ||1290 \u00b1 80||1970 \u00b1 70||1.5\n|-\n| 220b || SO<sub>2</sub>CF<sub>3</sub> ([[Triflyl|Tf]]) ||330 \u00b1 30||760 \u00b1 20||2.3\n|-\n| 220c || SO<sub>2</sub>NCO ||120 \u00b1 10||160 \u00b1 10||1.3\n|-\n| 220d || SO<sub>2</sub>Ph ||20800 \u00b1 3500|| 61000 ||2.9\n|-\n| 220e || SO<sub>2</sub>C<sub>6</sub>H<sub>4</sub>-4-NO<sub>2</sub> ([[nosyl]]) ||5720 \u00b1 1140||18800 \u00b1 90||3.3\n|-\n| 220f || SO<sub>2</sub>C<sub>6</sub>H<sub>4</sub>-4-OCH<sub>3</sub> ||6820 \u00b1 580||16400 \u00b1 1400||2.4\n|-\n| 221a || NO ||99500 \u00b1 12300||231700 \u00b1 39500||2.3\n|-\n| 221b || NO<sub>2</sub> ||7500 \u00b1 900||21200 \u00b1 600||2.8\n|-\n| 221c || NHCOCH<sub>3</sub> || >1000000 || >1000000 || -\n|-\n| 221d || NH<sub>2</sub> || - || - || -\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> (nM) for displacement of [<sup>3</sup>H]WIN 35428</small>\n\n===Bridged (''N''-constrained/tethered) tropane-fused cocaine analogues===\n====8 to 2 position tropane bridge====\n[[File:Bridged Cocaine Analogs.svg|right|thumb|x350px|A selection of \"front bridged\" & \"back bridged\" cocaine analogs.<br>''See'' [[List of phenyltropanes#Bridged N-constrained phenyltropanes (fused/tethered)|''N''-front & back bridged phenyltropanes]].]]\n{| class=\"wikitable sortable\"\n|+Derivations upon fusions of the tropane's nitrogen bridge{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#56 Page #980 (56th page of article)] Scheme 52.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation\n! ''R''\n! [<sup>3</sup>H]Mazindol\n! [<sup>3</sup>H]DA\n! Selectivity\nUptake/Binding\n|-\n| [[File:Cocaine analog 222.svg|200px]] || 222 || ||44900 \u00b1 6200||115000 \u00b1 15700||2.6\n|}\nBack-bridged cocaine analogues are considered more akin to untethered cocaine analogs & phenyltropane derivatives (where the nitrogen [[Orbital hybridisation|lone pair is not fixed or constrained]]) and better mimics their affinities. This is due to when the eighth carbon tropane position is freely rotatable and unbound it preferably occupies the ''axial'' position as defining its least energy & most unhindered state. In front-bridged analogs the nitrogen lone pairings rigid fixity makes it reside in an ''equatorial'' placing for the piperidine ring-part of the tropane nucleus, pointing to the two-carbon & three methylene unit bridgehead; giving the attested front-bridged cocaine analogues preference for SERT over DAT.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#39 Page #963 (39th page of article)] 2nd (right side) column, 2nd paragraph.}}\n\n=== Tricyclic cocaine analogues ===\nTethering the nitrogen 8 tropane position one position further (beyond 2''\u03b2'' and crossed-over it / leaving it open as hydrogen and thus possible of having additional unconstrained substitutions there) and linking all the way across to the 3''\u03b2'' aryl, replacing it; yields an expansive front-bridged structure to create a structurally [[tricyclic]] series of cocaine analogues.\n\n==== 8 to 3 position ====\n[[File:Constrained tropane.png|thumb|right|400px|Constrained thiophene tropane<ref>{{cite journal | doi = 10.1021/jm0001121 | pmid= 10821718 | title= Novel Conformationally Constrained Tropane Analogues by 6- e ndo-trig Radical Cyclization and Stille Coupling \u2212 Switch of Activity toward the Serotonin and/or Norepinephrine Transporter | journal=Journal of Medicinal Chemistry | date=2000 | volume=43 | issue=10 | pages=2064\u20132071 | first=Alexander | last=Hoepping}}</ref><ref>{{cite journal | doi = 10.1016/S0960-894X(02)00103-8 | pmid=11909701 | title=Thiophene derivatives: a new series of potent norepinephrine and serotonin reuptake inhibitors | journal=Bioorganic | date=2002 | volume=12 | issue=7 | pages=993\u2013995 | first=Ao | last=Zhang}}</ref> Note the [[Green\u2013Davies\u2013Mingos rules|''pi'' symmetry]] of the partially hydrogen-unsaturated cyclopentane substitutes the benzene place with the other tricyclic tropanes to the left.]]\n[[File:Tricyclic tropanes.png|thumb|left|800px|Tricyclic tropanes, values in ''K<sub>i</sub>'' (nM)<ref>{{cite journal | doi = 10.1021/jm0105373 | pmid= 11960503 | title= Further Studies on Conformationally Constrained Tricyclic Tropane Analogues and Their Uptake Inhibition at Monoamine Transporter Sites: Synthesis of ( Z )-9-(Substituted arylmethylene)-7-azatricyclo[4.3.1.0 3,7 ]decanes as a Novel Class of Serotonin Transporter Inhibitors | journal=Journal of Medicinal Chemistry | date=2002 | volume=45 | issue=9 | pages=1930\u20131941 | first=Ao | last=Zhang}}</ref><br>1st structure (di-''chloro'' benzene, 2''\u03b2''-CH<sub>2</sub>OCOMe) SERT = 1.6, DAT = 1870, NET = 638<br>2nd structure (''para''-bromo, ''meta''-chloro, 2''\u03b2''-CO<sub>2</sub>Me) SERT = 2.3, DAT = 5420, NET = 459<br>3rd structure (''para''-iodo, ''meta''-chloro, 2''\u03b2''-CH<sub>2</sub>OCOPh) SERT = 0.06, DAT/NET both = >10K]]\n\n{| class=\"wikitable\" colwidth=\"500px\" align=\"center\"\n|Compound||X||Y||R||SERT ''K<sub>i</sub>'' (nM)||DAT ''K<sub>i</sub>'' (nM)||NET ''K<sub>i</sub>'' (nM)\n|-\n|1||Cl||Cl||CH<sub>2</sub>OCOMe||1.6||1870||638\n|-\n|2||Br||Cl||CO<sub>2</sub>Me||2.3||5420||459\n|-\n|3||I||Cl||CH<sub>2</sub>OCOPh||0.06||>10K||>10K\n|}\n{{clear}}\n\n===Azabornane tropane ring contraction===\nAlterations shortening the tropane ring system while including the benzoyloxy length at the C3 have been made, contrasting the [[List of phenyltropanes#Azabornane (outer ring contracted)|azabornane phenyltropanes]];<ref name=\"Carroll\">{{US patent|6479509}}</ref> likely remedying the shallow penetration (for good efficacy) of the latter.<br>\n5-benzoatic (left, below) & 6-benzoatic (right, below)<br>\n[[File:(5S)-2-methyl-2-azabicyclo(2.2.1)heptan-5-yl benzoate.svg|275px]]\n[[File:(6R)-2-methyl-2-azabicyclo(2.2.1)heptan-6-yl benzoate.svg|275px]]<br>\n[[File:NorbornaneBMEanalog.png]]<br>\nComparison of tropane ring versus the norbornane in overlay, with contrast of benzoyl branch in its configuration of how it lays extended out from body of either main ring type (shown twice in different colors, for visibility, above)\n\n===6/7 tropane position methoxycocaine & methoxypseudococaine analogues===\n[[File:Cocaine analog 225a.svg|270px]]\n[[File:Cocaine analog 225b.svg|270px]]\n[[File:Cocaine analog 225c.svg|270px]]\n[[File:Cocaine analog 225d.svg|270px]]\n[[File:Cocaine analog 225e.svg|270px]]\n[[File:Methyl (1R,4R,5S)-4-chloro-8-methyl-3-(phenylsulfanyl)-8-azabicyclo(3.2.1)oct-2-ene-2-carboxylate.svg|thumb|right|Phenylsulfanyl, C2-C3 unsaturated nonisomeric (C2 inclusive) C4 chloro analog.<ref name=\"Carroll\"/>]]\n{| class=\"wikitable sortable\"\n|+Substitutions upon the 6 & 7 positions of the tropane{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)] \u00a7G & Page #983 (59th page of article) Figure 36 & Page #984 (60th page of article) Table 35.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''X''\n! K<sub>i</sub> (nM)<br>[<sup>3</sup>H]Mazindol binding\n! K<sub>i</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! Selectivity\nUptake/Binding\n|-\n| || (Cocaine) || ||280 \u00b1 60||320 \u00b1 10||1.1\n|-\n| || (Pseudococaine) || ||10400 \u00b1 300||13800 \u00b1 1500||1.3\n|-\n|rowspan=6|\n|-\n| 225a || 2\u03b2, 6\u03b2-OCH<sub>3</sub> ||98000 \u00b1 12000||68000 \u00b1 5000||0.7\n|-\n| 225b || 2\u03b1, 6\u03b2-OCH<sub>3</sub> ||190000 \u00b1 11000||510000 \u00b1 110000||2.7\n|-\n| 225c || 2\u03b2, 7\u03b2-OCH<sub>3</sub> ||4200 \u00b1 100||6100 \u00b1 200||1.4\n|-\n| 225d || 2\u03b1, 7\u03b2-OCH<sub>3</sub> ||45000 \u00b1 5000||110000 \u00b1 4000||2.4\n|-\n| 225e || 2\u03b1, 7\u03b1-OCH<sub>3</sub> ||54000 \u00b1 3000||200000 \u00b1 70000||3.7\n|}\n\n===3''\u03b2''-position 2\u2032\u2014(6\u2032) & 2''\u03b2''-substitution combination analogues===\n[[File:Cocaine analog 211a.svg|260px]]\n[[File:Cocaine analog 211b.svg|260px]]\n[[File:Cocaine analog 211c.svg|260px]]\n[[File:Cocaine analog 211d.svg|260px]]\n[[File:Cocaine analog 211e.svg|260px]]<br>\n[[File:Cocaine analog 211f.svg|260px]]\n[[File:Cocaine analog 211g.svg|260px]]\n[[File:Cocaine analog 211h.svg|260px]]\n[[File:Cocaine analog 211i.svg|260px]]\n[[File:Cocaine analog 211j.svg|260px]]\n{| class=\"wikitable sortable\"\n|+4\u2032-Iodococaine-2''\u03b2''-substituted analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#55 Page #979 (55th page of article)] Table 31.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation\n! 2''\u03b2''-''R''\n! C2\u2032-''R''\n! IC<sub>50</sub> (nM)<br>(displacement of [<sup>3</sup>H]WIN 35428)\n|-\n|rowspan=8|[[File:Cocaine_analog_211.svg|220px]]\n|-\n| 211a || CO<sub>2</sub>OH || H ||6214 \u00b1 1269\n|-\n| 211b || CH<sub>2</sub>OCOCH<sub>3</sub> || H ||2995 \u00b1 223\n|-\n| 211c || CONHCH<sub>3</sub> || H || >100000\n|-\n| 211d || CO<sub>2</sub>Et || H ||2031 \u00b1 190\n|-\n| 211e || CO<sub>2</sub>-''i''-Pr || H ||1377 \u00b1 10\n|-\n| 211f || CO<sub>2</sub>Ph || H ||2019 \u00b1 253\n|-\n| 211g || CO<sub>2</sub>CH<sub>2</sub>Ph || H ||4602 \u00b1 325\n|-\n| || 211h || 3-phenyl-1,2,4-oxadiazole || H ||3459 \u00b1 60\n|-\n|rowspan=3|\n|-\n| 211i || CH=CH<sub>2</sub> || H ||2165 \u00b1 253\n|-\n| 211j || CH<sub>2</sub>CH<sub>3</sub> || H ||2692 \u00b1 486\n|-\n| [[File:Cocaine analog 212.svg|200px]] || 212 || CO<sub>2</sub>-''i''-Pr || HO ||663 \u00b1 70<br>4507 \u00b1 13<sup>'''\u0251'''</sup><br>34838 \u00b1 796<sup>'''b'''</sup>\n|}\n*<sup>'''\u0251'''</sup><small>For displacement of [<sup>3</sup>H]paroxetine (5-HTT & NET)</small>\n*<sup>'''b'''</sup><small>For displacement of [<sup>3</sup>H]nisoxetine (5-HTT & NET)</small>\n\n===3''\u03b2''-Carbamoyl analogues===\n[[File:Cocaine analog 223a.svg|x170px]]<br>\n[[File:Cocaine analog 223b.svg|x200px]]\n[[File:Cocaine analog 223c.svg|x170px]]\n[[File:Cocaine analog 223d.svg|x170px]]\n[[File:Cocaine analog 223e.svg|x170px]]<br>\n[[File:Cocaine analog 223f.svg|x170px]]\n[[File:Cocaine analog 223g.svg|x170px]]\n[[File:Cocaine analog 223h.svg|x170px]]\n[[File:Cocaine analog 223i.svg|x170px]]\n{| class=\"wikitable sortable\"\n|+3-position carbamoyl linkage substituting benzoyloxy analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#57 Page #981 (57th page of article)] \u00a7E & Page #982 (58th page of article) Table 33.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''X''\n! IC<sub>50</sub> (nM)<br>inhibition of [<sup>3</sup>H]Cocaine binding<br>(Rat Striatal Tissue)\n! IC<sub>50</sub> (nM)<br>inhibition of [<sup>3</sup>H]DA uptake<br>(Rat Striatal Tissue)\n! Selectivity<br>uptake/binding\n|-\n| || (Cocaine) || (H) ||70 \u00b1 10||210 \u00b1 70||3.0\n|-\n|rowspan=6|[[File:Cocaine analog 223a-e.svg|x120px]]\n|-\n| 223a || H ||5600 \u00b1 700||52600 \u00b1 3000||9.4\n|-\n| 223b || 4-NO<sub>2</sub> ||1090 \u00b1 250||5700 \u00b1 1200||5.2\n|-\n| 223c || 4-NH<sub>2</sub> ||63300 \u00b1 12200|| >100000 || -\n|-\n| 223d || 4-N<sub>3</sub> ||1000 \u00b1 240||1180 \u00b1 360||1.2\n|-\n| 223e || 4-NCS ||260 \u00b1 60||490 \u00b1 80||1.9\n|-\n|rowspan=5|[[File:Cocaine analog 223f-i.svg|x120px]]\n|-\n| 223f || 3-NO<sub>2</sub> ||37 \u00b1 10||178 \u00b1 23||4.8\n|-\n| 223g || 3-NH<sub>2</sub> ||2070 \u00b1 340||23100 \u00b1 900||11.1\n|-\n| 223h || 3-N<sub>3</sub> ||630 \u00b1 150||3900 \u00b1 1590||6.2\n|-\n| 223i || 3-NCS ||960 \u00b1 210||4900 \u00b1 420||5.1\n|}\n\n===Phenyl 3-position linkage substitutions===\n<div style=\"background-color: #CFCFCF; border:10px solid #666666\">\n[[File:Phenyltropane.gif|thumb|A 3-Dimensional ([[Ball-and-stick model|stick-&-ball]]) rendering of [[Troparil]]: A structural analogue of cocaine with omitted -COO- linkage \u2013 a parent compound of many MAT ligands; those of the [[phenyltropane]] class. (Here it is depicted in an unfavourable conformation of the O-Me; The methyl has to be at the other oxygen and ''[[Cis\u2013trans isomerism|trans]]'' to optimize its functional stimulation.)]]\n{{multiple image\n | align = left\n | direction = vertical\n | footer = The top image above is a 2-Dimensional emulation of the orientation for the animated 3D image to the far right, with a methoxy that is distal from the phenyl group and ''cis''. While the alternate image below that to its bottom shown above is one with the carboxyl methyl group proximal to the phenyl, in its optimum conformation, with a likewise optimum ''trans'' configuration.\n | image1 = Troparil w ph distal cis OMe.png\n | width1 = 190\n | image2 = Troparil w ph proximal trans OMe.png\n | width2 = 200\n }}\n\nSee: [[List of phenyltropanes]] (Many phenyltropanes are derived from cocaine metabolites, such as [[methylecgonidine]], as [[Precursor (chemistry)|precursors]]. Whereas fully synthetic methods have been devised from the starting material of vinylcarbenoids & pyrroles.)<ref>{{cite journal | pmid = 8420793 | volume=244 | issue=1 | title=Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum | year=1993 | journal=Eur. J. Pharmacol. | pages=93\u20137 | last1 = Davies | first1 = HM | last2 = Saikali | first2 = E | last3 = Sexton | first3 = T | last4 = Childers | first4 = SR | doi=10.1016/0922-4106(93)90063-f}}</ref>\n\nThe difference in the length of the benzoyloxy and the phenyl linkage contrasted between cocaine and phenyltropanes makes for a shorter distance between the [[centroid]] of the aromatic benzene and the bridge nitrogen of the tropane in the latter PTs. This distance being on a scale of 5.6 [[Angstrom|\u00c5]] for phenyltropanes and 7.7 [[Angstrom|\u00c5]] for cocaine or analogs with the benzoyloxy intact.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#46 Page #970 (46th page of article)] \u00a7B, 10th line}} This may account for PTs increased behavioral stimulation profile over cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#47 Page #971 (47th page of article)] 1st \u00b6, 10th line}} Differences in binding potency have also been explained considering solvation effects; cocaine containing 2''\u03b2'',3''\u03b2''-ester groups being calculated as more solvated than the WIN-type compounds (i.e. troparil). Higher p''K''<sub>\u0251</sub>s of the tropane nitrogen (8.65 for cocaine, 9.55 for troparil & 11.95 for vinyl analogue '''43a'''), decreased aqueous solvation & decreased conformational flexibility added to increased binding affinity.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#25 Page #949 (25th page of article)] 3rd \u00b6, 20th line}}\n\n[[File:WIN 35,065-2.svg|x150px]]\n[[File:WF-31.svg|x170px]]\n[[File:RTI-11W.svg|x150px]]\n[[File:WF-23.svg|x160px]]\n\nDespite the observation of increased stimulation, phenyltropanes lack the local anesthetic sodium channel blocking effect that the benzoyloxy imparts to cocaine. Beside topical affect, this gives cocaine an affinity for binding to sites on the dopamine and serotonin sodium dependent transport areas that are distinct & specific to MAT in contrast to the general sodium channels; creating a separate mechanism of relational affinity to the transporters in addition to its inhibition of the reuptake for those transporters; this is unique to the local anesthetic value in cocaine & analogues with a similar substitute for the benzoyloxy that leaves the sodium channel blockage ability intact. Rendering such compounds as different functionally in their relation to MAT contrasted to phenyltropane analogues which have the local anesthetic bridge removed.<ref>{{cite web|url=http://www.drugbank.ca/drugs/DB00907 |title=Drugbank website \"drug card\", \"(DB00907)\" for Cocaine: Giving ten targets of the molecule in vivo, including dopamine/serotonin sodium channel affinity & K-opioid affinity |publisher=Drugbank.ca |accessdate=9 March 2010}}</ref> (Requiring some of the sodium ions to be pumped from the axon via [[Na+/K+-ATPase]]). In addition, it even has been postulated that a crucial role regarding the electron energy imparted via voltage sensitization (and thus [[action potential]] blockage with a molecule capable of intersecting its specific channel, in the case of cocaine a [[sodium channel]], that potentially serves in [[Elementary charge#Quantization|re-quantifying]] its charge) upon a receptor binding site may attenuate the mediating influence of the inhibitory regulation that autoreceptors play by their slowing neurotransmitter release when an [[efflux (microbiology)|efflux]] is created through an instance of agonism by a compound; allowing said efflux to be continued without the body's attempt to maintain [[homeostasis]] enacting in as readily responsive a manner to its conformational change.<ref>Kristoffer Sahlholm, Johanna Nilsson, Daniel Marcellino, Kjell Fuxe, Peter \u00c5rhem.  2012 \"Voltage sensitivities and deactivation kinetics of histamine H<sub>3</sub> and H<sub>4</sub> receptors\" ''Biochimica et Biophysica Acta (BBA) - Biomembranes'' Volume 1818, Issue 12, Pages 3081\u20133089 {{DOI|10.1016/j.bbamem.2012.07.027}} ''...Agonist potency at some neurotransmitter receptors has been shown to be regulated by voltage, a mechanism which has been suggested to play a crucial role in the regulation of neurotransmitter release by inhibitory autoreceptors...''</ref>\n\n{| class=\"wikitable\"\n|+ Various phenyltropane examples\n|-\n<div style=\"background-color: #FFFFFF; border:10px solid #E9E9E9\">\n[[File:RTI-353 structure.png|x180px]]\n[[File:RTI-150.png|x200px]]\n[[File:RTI-171 structure.png|x195px]]\n[[File:RTI-336.png|x185px]]\n<br>\n[[File:Altropane.svg|x170px]]\n[[File:Ioflupane.png|x190px]]\n[[File:Brasofensine.svg|x200px]]\n[[File:Tesofensine chemical structure.png|x140px]]\n</div>\n|}\n{{clear}}\n</div>\n\n===3''\u03b2''-Alkylphenyltropane & 3''\u03b2''-Alkenyl analogues===\n\nThe compound '''224e''', the 3''\u03b2''-styrene analogue, had the highest potency in its group. While '''224b''' & '''224c''' showed the most selectivity, with '''224b''' having a ten-fold greater potency for the dopamine transporter than cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)] 3rd \u00b6, lines 2, 5 & 6.}}\n\n[[File:Cocaine analog 224a.svg|x190px]]\n[[File:Cocaine analog 224b.svg|x140px]]\n[[File:Cocaine analog 224c.svg|x200px]]<br>\n[[File:Cocaine analog 224d.svg|x190px]]\n[[File:Cocaine analog 224e.svg|x140px]]\n[[File:Cocaine analog 224e alt.svg|thumb|3''\u03b2''-styrene alkylphenyl cocaine analog image showing stereochemistry.<br>(''i.e.'' compound \"'''224e'''\")]]\n{| class=\"wikitable sortable\"\n|+3-position alkylphenyl linkage substituting benzoyloxy analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#58 Page #982 (58th page of article)] \u00a7F, Table 34 & Figure 35.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''n''\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]Cocaine binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! Selectivity<br>uptake/binding\n|-\n| || (Cocaine) || ||101 \u00b1 26||209 \u00b1 20||2.1\n|-\n|rowspan=4|[[File:Cocaine_analog_224.svg|x140px]]\n|-\n| 224a || <sub>1</sub> ||885 \u00b1 18||1020 \u00b1 52||1.1\n|-\n| 224b || <sub>2</sub> ||9.9 \u00b1 0.33||70.5 \u00b1 1.0||7.1\n|-\n| 224c || <sub>3</sub> ||344 \u00b1 12||2680 \u00b1 190||7.8\n|-\n| || 224d ||  ||71.6 \u00b1 0.7||138 \u00b1 9||1.9\n|-\n| || 224e ||  ||2.10 \u00b1 0.04||5.88 \u00b1 0.09||2.8\n|}\n\n===6-Alkyl-3-benzyltropane analogues===\n[[File:Cocaine analog 229a.svg|x200px]]\n[[File:Cocaine analog 230a.svg|x180px]]\n[[File:Cocaine analog 231b.svg|x200px]]\n[[File:Cocaine analog 232b.svg|x180px]]\n\n{| class=\"wikitable\"\n|+ Cocaine 229b\u2014f series analogues\n|-\n[[File:Cocaine analog 229b.svg|x200px]]\n[[File:Cocaine analog 229c.svg|x200px]]\n<br>\n[[File:Cocaine analog 229d.svg|x240px]]\n[[File:Cocaine analog 229e.svg|x250px]]\n[[File:Cocaine analog 229f.svg|x250px]]\n|}\n\n{| class=\"wikitable\"\n|+ Cocaine 230b\u2014f series analogues\n|-\n[[File:Cocaine analog 230b.svg|x180px]]\n[[File:Cocaine analog 230c.svg|x180px]]\n<br>\n[[File:Cocaine analog 230d.svg|x220px]]\n[[File:Cocaine analog 230e.svg|x220px]]\n[[File:Cocaine analog 230f.svg|x220px]]\n|}\n\n{| class=\"wikitable\"\n|+ Cocaine 231c\u2014f series analogues\n|-\n[[File:Cocaine analog 231c.svg|x200px]]\n[[File:Cocaine analog 231d.svg|x200px]]\n<br>\n[[File:Cocaine analog 231e.svg|x200px]]\n[[File:Cocaine analog 231f.svg|x200px]]\n|}\n\n{| class=\"wikitable\"\n|+ Cocaine 232c, d & f series analogues\n|-\n[[File:Cocaine analog 232c.svg|x200px]]\n[[File:Cocaine analog 232d.svg|x200px]]\n[[File:Cocaine analog 232f.svg|x200px]]\n|}\n\n{| class=\"wikitable sortable\"\n|+6-Alkyl-3-benzyl-2[(methoxycarbonyl)methyl]tropane analogues{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#60 Page #984 (60th page of article)] \u00a7H, Figure 37 & Page #985 (61st page of article) Table 36.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name/[[Sterling Drug|WIN]] number)\n! ''R''\n! K<sub>i</sub> (nM)<br>[<sup>3</sup>H]WIN 35428 binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! Selectivity\nuptake/binding\n|-\n| || (Cocaine) || ||32 \u00b1 5<br>338 \u00b1 221||405 \u00b1 91<br>405 \u00b1 91||12.6<br>1.2\n|-\n| || 11a<br>(WIN 35065-2) || ||33 \u00b1 17<br>314 \u00b1 222||373 \u00b1 10||11.3\n|-\n|rowspan=8|\n|-\n| (\u2212)-229a || H ||33 \u00b1 5||161 \u00b1 100||4.9\n|-\n| 229a || H ||91 \u00b1 10||94 \u00b1 26||1.0\n|-\n| 229b || Me ||211 \u00b1 23|| - || -\n|-\n| 229c || Et ||307 \u00b1 28|| - || -\n|-\n| 229d || ''n''-Pr ||4180 \u00b1 418|| - || -\n|-\n| 229e || ''n''-Bu ||8580 \u00b1 249|| - || -\n|-\n| 229f || Bn ||3080 \u00b1 277|| - || -\n|-\n|rowspan=8|\n|-\n| (+)-230a || H ||60 \u00b1 6||208 \u00b1 63||3.5\n|-\n| 230a || H ||108 \u00b1 14||457 \u00b1 104||4.2\n|-\n| 230b || Me ||561 \u00b1 64|| - || -\n|-\n| 230c || Et ||1150 \u00b1 135|| - || -\n|-\n| 230d || ''n''-Pr ||7240 \u00b1 376|| - || -\n|-\n| 230e || ''n''-Bu ||19700 \u00b1 350|| - || -\n|-\n| 230f || Bn ||7590 \u00b1 53|| - || -\n|-\n|rowspan=5|\n|-\n| 231b || Me ||57 \u00b1 5||107 \u00b1 36||1.9\n|-\n| 231c || Et ||3110 \u00b1 187|| - || -\n|-\n| 231d || ''n''-Pr ||5850 \u00b1 702|| - || -\n|-\n| 231f || Bn ||1560 \u00b1 63|| - || -\n|-\n|rowspan=5|\n|-\n| 232b || Me ||294 \u00b1 29||532 \u00b1 136||1.8\n|-\n| 232c || Et ||6210 \u00b1 435|| - || -\n|-\n| 232d || ''n''-Pr ||57300 \u00b1 3440|| - || -\n|-\n| 232f || Bn ||3080 \u00b1 277|| - || -\n|-\n| || 241 || Bn ||4830 \u00b1 434|| - || -\n|}\n\n{| class=\"wikitable sortable\"\n|+Benzylidene derivatives of 6-alkyl-3-benzyltropanes{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#60 Page #984 (60th page of article)] Scheme 56.}}\n! Sub-category<br>(''S. Singh compound #'')\n! a<br>''R''=H\n! b<br>''R''=Me\n! c<br>''R''=Et\n! d<br>''R''=''n''-Pr\n! e<br>''R''=''n''-Bu\n! f<br>''R''=Bn\n|-\n|rowspan=2|6\u03b1-isomers:<br>''237a\u2014f''\n|-\n|[[File:Cocaine analog 237a.svg|x95px]]||[[File:Cocaine analog 237b.svg|x105px]]||[[File:Cocaine analog 237c.svg|x110px]]||[[File:Cocaine analog 237d.svg|x125px]]||[[File:Cocaine analog 237e.svg|x135px]]||[[File:Cocaine analog 237f.svg|x135px]]\n|-\n|rowspan=2|6\u03b2-isomers (exo):<br>''238a\u2014f''\n|-\n|[[File:Cocaine analog 238a.svg|x87px]]||[[File:Cocaine analog 238b.svg|x95px]]||[[File:Cocaine analog 238c.svg|x95px]]||[[File:Cocaine analog 238d.svg|x95px]]||[[File:Cocaine analog 238e.svg|x95px]]||\n[[File:Cocaine analog 238f.svg|x115px]]\n|-\n|rowspan=2|3\u03b2-benzyl derivatives:<br>''239a\u2014f''\n|-\n|[[File:Cocaine analog 239a.svg|x115px]]||[[File:Cocaine analog 239b.svg|x110px]]||[[File:Cocaine analog 239c.svg|x110px]]||[[File:Cocaine analog 239d.svg|x130px]]||[[File:Cocaine analog 239e.svg|x135px]]||[[File:Cocaine analog 239f.svg|x135px]]\n|-\n|rowspan=2|intermediate<br>alkylidene esters:<br>''240a\u2014f''\n|-\n|[[File:Cocaine analog 240a.svg|x115px]]||[[File:Cocaine analog 240b.svg|x115px]]||[[File:Cocaine analog 240c.svg|x115px]]||[[File:Cocaine analog 240d.svg|x130px]]||[[File:Cocaine analog 240e.svg|x135px]]||[[File:Cocaine analog 240f.svg|x135px]]\n|-\n|}\n''[[Nota bene|N.B.]]'' that ''237a'' and ''238a'' are the same compound as both are the parent for either series with a hydrogen saturated in their respective substitution place.\n\n===Direct 2,3-pyrimidino fused===\n {{multiple image\n | direction = vertical\n | image1 = Strobamine.svg\n | width1 = 280\n | caption1 = ''above:'' [[Strobamine]], a DARI functional cocaine analog with structural semblance.<ref>[http://www.arkat-usa.org/get-file/36494/ Enantioselective synthesis of strobamine and its analogues] Xing Zhang et al. Center for Organic and Medicinal Chemistry, Research Triangle Institute. Issue in Honor of Prof. James M.Cook ARKIVOC 2010 (iv)96-103</ref> Compare the phenyltropane length [[List of phenyltropanes#C2 + C3 (side-chain) fused (carboxylate & benzene conjoined)|tropane C2 & C3 functional group fusion]] variant.<ref>[https://books.google.com/books?id=rjtEwOFM5owC&pg=PA17&lpg=PA17&dq=Strobamine&source=bl&ots=OsrGUb9wma&sig=S8zt2WGOrdxlQqJ4g0r_njNrATo&hl=en&sa=X&ved=0ahUKEwjax8mlqNTTAhUD6mMKHcIECJUQ6AEIRzAJ#v=onepage&q&f=false The Alkaloids; Vol. 44, Geoffrey Cordell]</ref><br><br>''below:'' [[Chalcostrobamine]]\n | image2 = Chalcostrobamine.png\n | width2 = 190\n }}\n''cf.'' strobamine (at right) for a more efficacious compound as like the below.\n{| class=\"wikitable sortable\"\n|+2,3-direct fused \"di-hetero-benzene\" rigidified cocaine analogs.<ref name=\"AppellDunn2002\">{{cite journal|last1=Appell|first1=Michael|last2=Dunn|first2=William J.|last3=Reith|first3=Maarten E.A.|last4=Miller|first4=Larry|last5=Flippen-Anderson|first5=Judith L.|title=An Analysis of the Binding of Cocaine Analogues to the Monoamine Transporters Using Tensor Decomposition 3-D QSAR|journal=Bioorganic & Medicinal Chemistry|volume=10|issue=5|year=2002|pages=1197\u20131206|issn=0968-0896|doi=10.1016/S0968-0896(01)00389-3|pmid=11886784}}</ref><br>(Binding values @ biogenic amine transporters (BATs) for rigid and semi-rigid analogs)\n! Structure\n! alphanumeric<br>assignation\n! ''R<sub>1</sub>''\n! ''R<sub>2</sub>''\n! hDAT<br>IC<sub>50</sub> (nM)\n! hSERT<br>IC<sub>50</sub> (nM)\n! hNET<br>IC<sub>50</sub> (nM)\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3a.png|230px]]\n|-\n| (\u2014)-3a || H || C<sub>6</sub>H<sub>5</sub> || 58,300 (20,200) || 6140 (3350) || NA\n|-\n| (+)-3a || H || C<sub>6</sub>H<sub>5</sub>  || 48,700 (20,100) || 6030 (3400) || NA\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3b.png|190px]]\n|-\n| (\u2014)-3b || H || NH<sub>2</sub> || NA || NA || NA\n|-\n| (+)-3b || H || NH<sub>2</sub> || NA || NA || NA\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3c.png|190px]]\n|-\n| (\u2014)-3c || H || CH<sub>3</sub> ||NA||NA||NA\n|-\n| (+)-3c || H || CH<sub>3</sub> ||NA||NA||NA\n|-\n|rowspan=3|[[File:Rigid 2,3-fused pyrimidino cocaine analog 3d.png|150px]]\n|-\n| (\u2014)-3d || H || H ||NA||NA||NA\n|-\n| (+)-3d || H || H ||NA||NA||NA\n|-\n| [[File:Rigid 2,3-fused pyrimidino cocaine analog 3e.png|240px]] ||(+/\u2014)-3e || C<sub>6</sub>H<sub>5</sub> || C<sub>6</sub>H<sub>5</sub> || 30,000 (11,200) || 3650 (1700) || NA\n|}\n*<small>\"'''NA'''\" = \"no affinity\", ''e.g.'' unquantifiable.</small>\n\nDirect di-hetero-benzene (pyrimidino) 2,3-fused and thus rigidified cocaine analogs.<ref name=\"AppellDunn2002\"/>\n\n===Piperidine cocaine-homologues===\n[[File:Methyl (1R,2R,3S,5S)-8-methyl-3-(tricyclo(9.4.0.0\u00b3,\u2078)pentadeca-1(11),3,5,7,12,14-hexaene-2-carbonyloxy)-8-azabicyclo(3.2.1)octane-2-carboxylate.svg|thumb|right|x200px|Tricyclo benzoyloxy dibenzene cocaine analogue. ''cf.'' benztropine compound #'''277''', tropatepine, ''etc''.<ref name=\"Carroll\"/>]]\n''cf.'' [[List of phenyltropanes#Piperidine homologues (inner two-carbon bridge excised)|phenyltropane piperidine-homologues]] for compounds with a more optimized conformation that yield higher affinities when binding to MAT.<br>\n[[File:Cocaine analog 242.svg|x140px]]\n[[File:Cocaine analog 243.svg|x180px]]\n{| class=\"wikitable sortable\"\n|+binding potency of piperidine homologues for displacement of [<sup>3</sup>H]WIN 35428{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#62 Page #986 (62nd page of article)] \u00a7I, Table 37 & Scheme 58}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 2''\u03b2''-R\n! IC<sub>50</sub> (nM)\n|-\n| || (Cocaine) ||CO<sub>2</sub>CH<sub>3</sub><br>(''i.e.'' CO<sub>2</sub>Me)||249 \u00b1 37\n|-\n| || 183a ||CO<sub>2</sub>CH<sub>3</sub>||2522 \u00b1 4\n|-\n|rowspan=3|\n|-\n| 242 || H ||11589 \u00b1 4\n|-\n| 243 || CO<sub>2</sub>CH<sub>3</sub> ||8064 \u00b1 4\n|}\n\n===Cocaine [[hapten]] analogues===\n[[File:Cocaine analog GNC.svg|right|thumb|x200px|\"'''GNC'''\", a cocaine analog designed to minimize the formation of noncocaine-like structures through its chemical coupling to the Ad proteins; all while maintaining the element of its antigenic determinant from the moiety of cocaine.<ref>{{cite journal | pmc = 3048190 | pmid=21206484 | doi=10.1038/mt.2010.280 | volume=19 | issue=3 | title=Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs | journal=Mol Ther | pages=612\u20139 | last1 = Hicks | first1 = MJ | last2 = De | first2 = BP | last3 = Rosenberg | first3 = JB | last4 = Davidson | first4 = JT | last5 = Moreno | first5 = AY | last6 = Janda | first6 = KD | last7 = Wee | first7 = S | last8 = Koob | first8 = GF | last9 = Hackett | first9 = NR | last10 = Kaminsky | first10 = SM | last11 = Worgall | first11 = S | last12 = Toth | first12 = M | last13 = Mezey | first13 = JG | last14 = Crystal | first14 = RG | year=2011}}</ref>]]\n{| class=\"wikitable sortable\"\n|+Cocaine analogs which elicit noncatalytic antibodies{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#90 Page #1,014 (90th page of article)] \u00a7VIII, A. Figure 59.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! 2''\u03b2''-R\n|-\n| [[File:CocaineNoncatalyticHapten394.svg|200px]] ||394<br>(GNC)<sup>'''\u0251'''</sup>||CO<sub>2</sub>(CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|-\n| [[File:CocaineNoncatalyticHapten395.svg|240px]] ||395<br>(Succinyl Norcocaine)<ref>{{cite journal | pmc = 3142961 | pmid=21796226 | doi=10.1358/dof.2010.035.04.1474292 | volume=35 | issue=4 | title=Active immunotherapy for the Treatment of Cocaine Dependence | journal=Drugs of the Future | pages=301\u2013306 | last1 = Kinsey | first1 = BM | last2 = Kosten | first2 = TR | last3 = Orson | first3 = FM | year=2010}}</ref>||CO<sub>2</sub>CH<sub>3</sub>\n|-\n| [[File:Cocaine hapten GNE.svg|210px]] ||GNE<sup>'''b'''</sup><ref>{{cite journal | pmc = 3306868 | pmid=21918504 | doi=10.1038/npp.2011.200 | volume=37 | issue=5 | title=Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects | journal=Neuropsychopharmacology | pages=1083\u201391 | last1 = Wee | first1 = S | last2 = Hicks | first2 = MJ | last3 = De | first3 = BP | last4 = Rosenberg | first4 = JB | last5 = Moreno | first5 = AY | last6 = Kaminsky | first6 = SM | last7 = Janda | first7 = KD | last8 = Crystal | first8 = RG | last9 = Koob | first9 = GF | year=2011}}</ref><br><small>including carrier proteins:<br>GNE-FLiC<br>GNE-KLH<br>GNE-BSA</small>||\n|-\n| [[File:CocaineNoncatalyticHapten396.svg|200px]]||396||CONH(CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|}\n*<sup>'''\u0251'''</sup><small>6-(2R,3S)-3-(benzoyloxy)-8-methyl-8-azabicyclo <nowiki>[3.2.1]</nowiki> octane-2-carbonyloxy-hexanoic acid</small>\n*<sup>'''b'''</sup><small>6-(2R,3S)-3-(benzoyloxy)-8-methyl-8-azabicyclo <nowiki>[3.2.1]</nowiki> octane-2-carboxamido-hexanoic acid</small>\n[[File:Cocaine analog 400 intermediate.svg|right|thumb|x150px|Tetrahedral-intermediate cocaine-hapten compound #'''400''']]\n{| class=\"wikitable sortable\"\n|+Cocaine transition state analogues (TSAs) which generate catalytic antibodies{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#92 Page #1,016 (92nd page of article)] Figure 60.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n|-\n|rowspan=8|[[File:Cocaine analog 401.svg|200px]]\n|-\n| 401a || CH<sub>3</sub>\n|-\n| 401b || (CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|-\n| 401c || CH<sub>2</sub>CO<sub>2</sub>H\n|-\n| 401d || COCH<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H\n|-\n| 401e || H\n|-\n| 401f || CH<sub>2</sub>CH<sub>2</sub>Br\n|-\n| 385g || (CH<sub>2</sub>)<sub>2</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CONH<sub>2</sub>\n|-\n|rowspan=6|[[File:Cocaine analog 402.svg|200px]]\n|-\n| 402a || O(CH<sub>2</sub>)<sub>4</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CO<sub>2</sub>...2,3-dihydro-1H-isoindole-1,3-dione\n|-\n| 402b || OH\n|-\n| 402c || O(CH<sub>2</sub>)<sub>2</sub>...1,4-xylene...NH<sub>2</sub>\n|-\n| 402d || NH(CH<sub>2</sub>)<sub>5</sub>CO<sub>2</sub>H\n|-\n| 402e || O(CH<sub>2</sub>)<sub>4</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CONH<sub>2</sub>\n|-\n|rowspan=5|[[File:Cocaine analog 403.svg|220px]]\n|-\n| 403a || NH<sub>2</sub>\n|-\n| 403b || NHCOCH<sub>2</sub>Br\n|-\n| 403c || NHCO(CH<sub>2</sub>)<sub>3</sub>CO<sub>2</sub>H\n|-\n| 403d || (CH<sub>2</sub>)<sub>3</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>CONH<sub>2</sub>\n|}\nCocaine haptens that create catalytic anti-bodies require transitional states as affected ''in vivo''.<ref>[https://www.google.com/patents/US6566084 Catalytic antibodies against cocaine and methods of using and producing same] Google patents US 6566084 B1</ref><ref name=\"DengBharat2004\">{{cite journal|last1=Deng|first1=Shixian|last2=Bharat|first2=Narine|last3=de Prada|first3=Paloma|last4=Landry|first4=Donald W.|title=Substrate-assisted antibody catalysis|journal=Organic & Biomolecular Chemistry|volume=2|issue=3|year=2004|pages=288\u201390|issn=1477-0520|doi=10.1039/b314264g|pmid=14747854}}</ref>\n{| class=\"wikitable sortable\"\n|+Anti-idiotypic & butyl-cholinesterase mediated immunopharmacotherapy cocaine analogs<ref>{{cite journal | pmc = 3295240 | pmid=12878327 | volume=1638 | issue=3 | title=Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties | journal=Biochim Biophys Acta | pages=257\u201366 | last1 = Ho | first1 = M | last2 = Segre | first2 = M | doi=10.1016/s0925-4439(03)00091-7 | year=2003}}</ref>\n! Compound\n! Name\n|-\n|rowspan=2|[[File:K1-KLH-BSA.svg|x260px]]\n|-\n| K1-KLH/BSA<ref>{{cite journal | pmc = 2326984 | pmid=10809958 | volume=100 | issue=1 | title=Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies | journal=Immunology | pages=48\u201356 | last1 = Schabacker | first1 = DS | last2 = Kirschbaum | first2 = KS | last3 = Segre | first3 = M | doi=10.1046/j.1365-2567.2000.00004.x | year=2000}}</ref>\n|-\n|rowspan=2|[[File:K2-KLH-BSA.svg|x170px]]\n|-\n| K2-KLH/BSA\n|}\n\n==Structural/Functional intermediate analogues==\n\n===Tropane (non-ecgonine) analogues===\nThe first compound of those categorized as an \"intermediate analog\" in the series presented immediately below (''para''-fluoro-benzoyl-tropane), although several modifications distant from its cocaine parent structure, fits every technical criteria of a strict analog type to cocaine. It is given here, however, as the nearest relational structure along the instanced spectrum trajectory of substituent permutations of those following from it (in this first section), and set it as the beginning ingress point for the range of those comparable but sufficiently divergent from those in full homogeneity of structure and function to distinguish a more median class that is not in as much a rigid stereotyped placement to both (and not yet approaching the fringe or outermost terms allowing inclusion)\n {{multiple image\n | direction = vertical\n | footer = [[Tematropium]], an anticholinergic that diverges from the MAT relational criteria for being a functional analog to cocaine.<ref>{{cite journal| doi=10.1016/S0968-0896(00)82119-7 | pmid=8081850 | volume=1 | issue=3 | title=Soft drugs\u2014XIV. Synthesis and anticholinergic activity of soft phenylsuccinic analogs of methatropine | year=1993 | journal=Bioorganic & Medicinal Chemistry | pages=183\u2013187 | last1 = Hammer | first1 = R.H. | last2 = Gunes | first2 = E. | last3 = Kumar | first3 = G.N. | last4 = Wu | first4 = W.M. | last5 = Srinivasan | first5 = V. | last6 = Bodor | first6 = N.S.}}</ref> (''cf.'' [[tropatepine]])\n | image1 = Tematropium.png\n | width1 = 240\n | image2 = Tematropium.svg\n | width2 = 280\n }}\n''p''FBT: [[File:3-(p-Fluorobenzoyloxy)tropane.png|x150px]]\nZatosetron: [[File:Zatosetron.svg|x200px]]\nTropanserin: [[File:Tropanserin.svg|x180px]]\nBemesetronum: [[File:Bemesetron.svg|x170px]]\n\n* [[3-(p-Fluorobenzoyloxy)tropane|3-(''p''-Fluorobenzoyloxy)tropane]] (30% stimulant potency of cocaine & equipotent as an anaesthetic)\n* [[Zatosetron]] (anxiolytic & antinauseant 5HT<sub>3</sub> receptor antagonist)\n* [[Tropanserin]] (migraine medication, potent & selective 5HT<sub>3</sub> antagonist)\n* [[Bemesetron]]um (antiemetic, mechanisms related to oxytocin function, serotonin D-receptors, cholinoreceptors of the muscarinic or nicotinic kind and histamine H<sub>1</sub>-receptors<ref>[http://chem.sis.nlm.nih.gov/chemidplus/rn/40796-97-2 Bemesetron @ U.S. National Library of Medicine's TOXNET: Toxicology Data Network]</ref>)\n:''cf.'' [[Tropisetron]]\nConvolamine: [[File:Convolamine.svg|x200px]]\nPhyllalbine: [[File:Phyllalbine.svg|x200px]]\nMeteloidine: [[File:((6R,7S)-6,7-dihydroxy-8-methyl-8-azabicyclo(3.2.1)octan-3-yl) (E)-2-methylbut-2-enoate.png|x200px]]<br>\nSimilarly, many natural tropane alkaloids found in plants of various families have benzoyl tropane structures. Including; [[catuabine]], [[convolamine]] of the ''convolvulaceae'' & [[phyllalbine]] of ''euphorbiaceae'' (''Phyllanthus disco\u00efdes'') families. The latter is a central and peripheral sympathomimetic drug.<ref>[https://www.researchgate.net/publication/17341322_An_alkaloid_of_Phyllanthus_discoides_%28Euphorbiaceae%29_phyllalbine_a_central_and_peripheral_sympathomimetic An alkaloid of Phyllanthus discoides (Euphorbiaceae) phyllalbine, a central and peripheral sympathomimetic] (Impact Factor: 0.4). 01/1965; 20(4):1033-41</ref> Phyllalbine is also to [[methylvanillylecgonine]] what [[tropacocaine]], as a metabolite, is to cocaine. Likewise [[vanillin]] would be a [[Hydrolysis|hydrolytic]] degradation product of phyllalbine just as [[methyl benzoate]] is for cocaine. The alkaloid Meteloidine, found in Datura & Brugmansia, is tentatively also extant in the Australian Erythroxylum species.\n\n[[Hyoscine butylbromide|Butylscopolamine]]: [[File:Butylscopolamine_skeletal.svg|x210px]]\n[[Methylscopolamine bromide|Methylscopolamine]]: [[File:Methscopolamine.png|x220px]]\n[[Fentonium]]: [[File:Fentonium bromide.svg|x180px]]\n\nOther tropanyl compounds (naturally found or otherwise) begin to fall outside the spectrum of functional analogues to cocaine altogether; having negligible affinity of any kind for the monoamine system. Compare for example [[Ipratropium bromide|ipratropium]], [[mirisetron]], [[technepine]], [[levomepate]] or [[Hyoscine|scopolamine]] & [[atropine]]. Many of the natural varieties being [[deliriant]]s.\n\nNK-1145: [[File:NK1145.png|x200px]]\nEGIS-3886: [[File:Deramciclane.svg|x200px]]\n[[Chemical compound|cpd]] #278{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#66 Page #990 (66th page of article)] Figure 44}} (mono-phenyl benztropine):[[File:Benztropine 278.svg|x160px]]<br>\nThe benzoyloxy can even be replaced with other branch formations (terminating in a benzene ring) and the bridge between will still serve to create a parasympatholytic drug compound that causes behavioral stimulation, as the above: [[NK-1145]] \"tropine-3''\u03b2''-phenyl ether.\"<ref>ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1-1951-Volume(issue)/page/year: 18,517,1968</ref> [[Deramciclane]] (EGIS-3886) is a [[camphor]] derived [[serotonergic]]. Similar to several other kinds of [[aroma compound|aromatics]] in structure and being an [[inverse agonist]] at the [[5-HT2C receptor|5-HT<sub>2C</sub> receptor]] as well as an antagonist at the [[5-HT2A receptor|5-HT<sub>2A</sub>]].\n\nAzaprocin: [[File:Azaprocin.png|x200px]]\nPseudotropinearylether: [[File:US4861889.png|x200px]]\n* [[Azaprocin]] (a fast onset, short duration opioid analgesic with tropane emulating every constituent element shared by cocaine; somewhat similar to how fentanyl overlays methylphenidate, save for in that case there's an additional constituent of a phenylethyl tail).\n* Also of note: arene-fluorinated pseudotropinearylethers with respect to {{US patent|4861889}}\n\n===Piperidine Analogues===\n<div style=\"background-color: #E9E9E9; border:10px solid #CFCFCF\">\n {{multiple image\n | direction = vertical\n | footer = 3-dimensional ([[Space-filling model|space-filling]]) rendering of piperidine structure-based, MAT re-uptake inhibiting functional stimulant: \"methylphenidate\" (MPH)\n | image1 = DextroMPH-overlays-betaCPT.png\n | width1 = 300\n | image2 = Methylphenidate3Dan.gif\n | width2 = 300\n }}\nSee: [[List of methylphenidate analogues]]\n\nMany of the piperidine analogues of cocaine serve as the 'missing link' between the cocaine structure and that of the [[methylphenidate]] class of drugs. For example, [[N,O-Dimethyl-4-(2-naphthyl)piperidine-3-carboxylate|DMNPC]] preserves an orientation similar to the phenyltropanes, but is a structural isomer of [[HDMP-28|methylnaphthidate]].\n\n[[File:HDMP28andCFT-3D-overlay.png|x200px]]\n\nThe above depicts the 3D structure of the above-mentioned methylnaphthidate shown with the same modeling for the cocaine derivative [[WIN 35428]], a simple phenyltropane with a short addition to its ''para'' position. This overlay shows the closeness of where the two hold their respective oxygen and nitrogens in their structure (also their benzene & cycloalkane ring formations) and is meant to convey a sense of their similarity for binding to MAT. Correspondingly most other monoamine reuptake inhibitors bind to the dopamine transporter ''substrate recognition site'' at [[Tm ligands|Tm]] loci 1, 7 & 10\u201412; whereas cocaine & methylphenidate similarly share the 1 & 7 places, but diverge from the usual ligand site of the latter and instead cohabit the 9\u201411 loci.{{efn|<ref>Dopamine reuptake transporter (DAT) ``inverse agonism\u00b4\u00b4 - A novel hypothesis to explain the enigmatic pharmacology of cocaine 2014-12-24 17:08:48  2014-12-25 00:28:27</ref> \u2190Page #31, \u00a73.2. \u00b63, 15th & 16th lines, final sentence.}} Site-directed mutagenesis techniques have elucidated that the hydrophobic putative transmembrane regions at one & seven contain aspartate and serine residues, and that the carboxyl-group interacts with the former aspartic acid residue ''79'' which engages with cocaine & methylphenidate's protonated nitrogen at the transporter.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#3 Page #927 (3rd page of article)] second \u00b6. Lines seven \u2014 fifteen.}} Previous theories of an allosteric site for cocaine and related compounds which do not overlap with the binding site of dopamine itself are less prevalent in light of more recent observations since [[Bacterial Leucine Transporter|LeuT]] became feasible as a modeling template.<ref>{{cite journal | pmc = 2692229 | pmid=18568020 | doi=10.1038/nn.2146 | volume=11 | issue=7 | title=The binding sites for cocaine and dopamine in the dopamine transporter overlap | date=July 2008 | journal=Nat. Neurosci. | pages=780\u20139 | last1 = Beuming | first1 = T | last2 = Kniazeff | first2 = J | last3 = Bergmann | first3 = ML |display-authors=etal }}</ref>\n\nOne rationale to denote the subjective preference for cocaine over methylphenidate in animal habituation & human addiction models has to do with the respective difference in their entropy of binding: cocaine being \u20145.6 kcal/mol & methylphenidate being \u201425.5 kcal/mol ([[Derivative|\u0394]][[Entropy|''s'']]\u00b0, measured using <nowiki>[</nowiki>\u00b3H<nowiki>]</nowiki>GBR 1278 @ 25&nbsp;\u00b0C){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#82 Page #1,006 (82nd page of article)] 2nd row, 1st \u00b6 (orig. ref.: Bonnet, J.-J.; Benmansour, S.; Costenin, J.; Parker, E. M. ;Cubeddu, L. X. ''J. Pharmacol. Exp. Ther.'' '''1990''', ''253'', 1206)}}\n</div>\n* [[JZ-IV-10]] (a \"[[Modafinil]] hybrid\" with nocaine.<ref name=\"ZhouHe2004\">{{cite journal|last1=Zhou|first1=Jia|last2=He|first2=Rong|last3=Johnson|first3=Kenneth M.|last4=Ye|first4=Yanping|last5=Kozikowski|first5=Alan P.|title=Piperidine-Based Nocaine/Modafinil Hybrid Ligands as Highly Potent Monoamine Transporter Inhibitors: Efficient Drug Discovery by Rational Lead Hybridization|journal=Journal of Medicinal Chemistry|volume=47|issue=24|year=2004|pages=5821\u20135824|issn=0022-2623|doi=10.1021/jm040117o|pmid=15537337|pmc=1395211}}</ref> ''cf.'' [[Modafinil#Modafinil analogs|List of modafinil analogues]])\n[[File:16e chemical structure.png|x150px]]\n* [[(+)-CPCA|Nocaine]]\n[[File:(+)-CPCA.svg|x100px]]\n\nA somewhat recent occurrence among tentative modern folklore which has traversed the circling of rumors mostly confined to the likes of universities and popular culture trivia has been that cocaine is one element, or molecule increment of weight or charge etc., away from the molecular structure of sugar.<ref>[http://skeptics.stackexchange.com/questions/20216/is-sugar-one-element-away-from-cocaine-or-any-other-drug Skeptics Stack Exchange: Is sugar one element away from cocaine (or any other drug?)]</ref> Though such a statement is false as a general pretense, there is a dextrose based super-structure that has a vaguely similar overlay with cocaine which is \"benzoyl-''beta''-<small>D</small>-glucoside.\"\n*[[Benzoyl-beta-D-glucoside|'''Benzoyl-''beta''-<small>D</small>-glucoside''']]\n[[File:Benzoyl-beta-D-glucoside.svg|x110px]]\n\n===Benztropine (3\u03b1-Diphenylmethoxy Tropane) Analogs===\n[[File:Benzatropina.gif|right|300px]]\n* [[Benzatropine]] (BZT)<ref name=\"Vel\u00e1zquez-S\u00e1nchezGarc\u00eda-Verdugo2013\">{{cite journal|last1=Vel\u00e1zquez-S\u00e1nchez|first1=Clara|last2=Garc\u00eda-Verdugo|first2=Jos\u00e9 M.|last3=Murga|first3=Juan|last4=Canales|first4=Juan J.|title=The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens|journal=Progress in Neuro-Psychopharmacology and Biological Psychiatry|volume=44|year=2013|pages=73\u201380|issn=0278-5846|doi=10.1016/j.pnpbp.2013.01.016|pmid=23385166}}</ref>\n* [[Difluoropine]] (O-620), More selective as a DARI than cocaine. Also an anticholinergic & antihistamine.\n* [[AHN 1-055]] Same structure as for benztropine but 4\u2032,4\u2032-bisfluorinated.\n* [[GA 103]] N-phenylpropyl bis-4-fluorobenztropine.\n* [[JHW 007]]<ref>{{cite journal | last1 = Tanda | first1 = G | last2 = Newman | first2 = A | last3 = Ebbs | first3 = AL | last4 = Tronci | first4 = V | last5 = Green | first5 = J | last6 = Tallarida | first6 = RJ | last7 = Katz | first7 = JL | year = 2009 | title = Combinations of Cocaine with other Dopamine Uptake Inhibitors: Assessment of Additivity | url = | journal = J Pharmacol Exp Ther | volume = 330| issue = 3| pages = 802\u20139| doi = 10.1124/jpet.109.154302 | pmid = 19483071 | pmc=2729796}}</ref> N-(n-butyl)-3\u03b1-[bis(4\u2032-fluorophenyl)methoxy]-tropane.\n[[File:Benzatropine.svg|x150px]]\n[[File:Difluoropine.png|x200px]]\n[[File:MFZ-R.svg|x180px]]<br>\nUnlike cocaine & phenyltropanes, the benztropines & GBR compounds (and, as an exception to the cocaine pharmacophore itself, ''allotropacocaine'') among others are considered \"atypical\" DAT re-uptake pump ligands because they stabilize the dopamine transporter in an inward-facing or closed-to-out conformation, this contrasts what is considered \"cocaine-like\" affinity to DAT; which would instead keep DAT stable in an open-to-out conformation. This means the binding of many dopamine reuptake inhibitors is atypical of cocaine's method of binding to DAT and significantly diverges from it.<ref>{{cite journal | pmc = 3684841 | pmid=23568856 | doi=10.1124/jpet.111.191056 | volume=346 | issue=1 | title=Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates | year=2013 | journal=J. Pharmacol. Exp. Ther. | pages=2\u201310 | last1 = Schmitt | first1 = KC | last2 = Rothman | first2 = RB | last3 = Reith | first3 = ME}}</ref>\n\n\"Difluoropine\" is not a phenyltropane but actually belongs to the benzatropine family of DRIs. Not to be confused for the [[List of phenyltropanes#Diaryl|\"diaryl\"-phenyltropanes]].\n\nIn certain respects these are important because they share SAR overlap with [[Vanoxerine|GBR 12909]] and related analogs.\n\nSARs have shown that 4\u2032,4\u2032-difluorination is an excellent way to boost DAT activity of benztropine, and gives excellent selectivity over the SERT and the NET.<ref name=Rothman>Rothman RB, Baumann MH, Prisinzano TE, Newman AH. \"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.  Biochem Pharmacol. 2008 Jan 1;75(1):2-16.  {{DOI|10.1016/j.bcp.2007.08.007}} {{PMID|17897630}}</ref><ref name=Runyon>{{cite journal | last1 = Runyon | first1 = SP | last2 = Carroll | first2 = FI | year = 2006 | title = Dopamine transporter ligands: recent developments and therapeutic potential | url = | journal = Curr Top Med Chem | volume = 6 | issue = 17| pages = 1825\u201343 | doi = 10.2174/156802606778249775 | pmid = 17017960 }}</ref>\n\nFurthermore, replacing the N-Me with, e.g. n-phenylpropyl helps to bring [[muscarinic]] activity down to something that is the same as DRI affinity.<ref name=Rothman/>\n\nThis is remarkable considering unmodified (native) benztropine is 60 times more active as an anticholinergic than as a dopaminergic.<ref name=Rothman/>\n\nM1 receptor considerations aside, analogues of this benztropine class still won't substitute for cocaine, and have no propensity to elevate locomotor activity.\n[[File:Benztropine 276.svg|thumb|right|x230px|Compound '''276''']]\n[[File:Etybenzatropine.svg|thumb|x230px|[[Etybenzatropine]]]]\n[[File:3-CPMT.svg|thumb|x210px|3-CPMT]]\n[[File:PG01053.svg|thumb|x230px|PG01053]]\n[[File:MFZ 2-71.svg|thumb|x240px|MFZ 2-71]]\n[[File:MFZ 4-86.svg|thumb|x240px|MFZ 4-86]]\n{| class=\"wikitable sortable\"\n|+3\u03b1-Diphenylmethoxy tropanes<br>(Benztropine analog affinities binding to DAT & DA uptake){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#63 Page #987 (63rd page of article)] \u00a7IV, Figure 39 & Page #988 (64th page of article) Table 38.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R\u2032''\n! ''K<sub>i</sub>'' (nM)<br>[<sup>3</sup>H]WIN 35428 binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA\nuptake\n! Selectivity\nuptake/binding\n|-\n| || (Cocaine) || || ||388 \u00b1 47|| - || -\n|-\n| || (GBR 12909) || || ||11.6 \u00b1 31|| - || -\n|-\n|rowspan=29|[[File:Cocaine analog 249-251.svg|200px]]\n|-\n| (Benztropine) || H || H ||118 \u00b1 9||403 \u00b1 115||3.4\n|-\n| 249a || 4\u2032-F || H ||32.2 \u00b1 10|| 48 ||1.5\n|-\n| 249b<br>(AHN 1-055) || 4\u2032-F || 4\u2032-F ||11.8 \u00b1 1|| 71 ||6.0\n|-\n| 249c || 3\u2032,4\u2032-di-F || H ||27.9 \u00b1 11||181 \u00b1 45.7||6.5\n|-\n| 249d || 4\u2032-Cl || H ||30.0 \u00b1 12|| 115 ||3.8\n|-\n| 249e || 4\u2032-Cl || 4\u2032-Cl ||20.0 \u00b1 14|| 75 ||3.8\n|-\n| 249f || 3\u2032,4\u2032-di-Cl || H ||21.1 \u00b1 19|| 47 ||2.2\n|-\n| 249g || 3\u2032,4\u2032-di-Cl || F ||18.9 \u00b1 14|| 24 ||1.3\n|-\n| 249h || 4\u2032-Br || H ||37.9 \u00b1 7|| 29 ||0.8\n|-\n| 249i || 4\u2032-Br || 4\u2032-Br || 91.6 || 34 ||0.4\n|-\n| 249j || 4\u2032-NO<sub>2</sub> || H ||197 \u00b1 8|| 219 ||1.1\n|-\n| 249k || 4\u2032-CN || H ||196 \u00b1 9|| 222 ||1.1\n|-\n| 249l || 4\u2032-CF<sub>3</sub> || H ||635 \u00b1 10|| 2155 ||3.4\n|-\n| 249m || 4\u2032-OH || H ||297 \u00b1 13|| 677 ||2.3\n|-\n| 249n || 4\u2032-OMe || H ||78.4 \u00b1 8|| 468 ||6.0\n|-\n| 249o || 4\u2032-OMe || 4\u2032-OMe ||2000 \u00b1 7|| 2876 ||1.4\n|-\n| 249p || 4\u2032-Me || H ||187 \u00b1 5|| 512 ||2.7\n|-\n| 249q || 4\u2032-Me || 4\u2032-Me ||420 \u00b1 7|| 2536 ||6.0\n|-\n| 249r || 4\u2032-Et || H ||520 \u00b1 8|| 984 ||1.9\n|-\n| 249s || 4\u2032-''t''-Bu || H || 1918 || 4456 ||2.3\n|-\n| 250a || 3\u2032-F || H ||68.5 \u00b1 12||250 \u00b1 64.7||3.6\n|-\n| 250b || 3\u2032-F || 3\u2032-F ||47.4 \u00b1 1||407 \u00b1 63.9||8.6\n|-\n| 250c || 3\u2032-Cl || H ||21.6 \u00b1 7||228 \u00b1 77.1||10.5\n|-\n| 250d || 3\u2032-CF<sub>3</sub> || H ||187 \u00b1 5||457 \u00b1 72.0||2.4\n|-\n| 251a || 2\u2032-F || H ||50.0 \u00b1 12||140 \u00b1 17.2||2.8\n|-\n| 251b || 2\u2032-Cl || H ||228 \u00b1 9||997 \u00b1 109||4.4\n|-\n| 251c || 2\u2032-Me || H ||309 \u00b1 6||1200 \u00b1 1.64||3.9\n|-\n| 251d || 2\u2032-NH<sub>2</sub> || H ||840 \u00b1 8||373 \u00b1 117||0.4\n|}\n{| class=\"wikitable sortable\"\n|+3\u03b1-Diphenylmethoxy-2\u03b2-carbomethoxybenztropine<br>(Benztropine affinities to DAT & 5-HTT in [[Crab-eating macaque|cynomologous monkey]] [[Striatum|caudate-putamen]]){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#63 Page #987 (63rd page of article)] Figure 40, Page #988 (64th page of article) \u00a7B & Page #989 (65th page of article) Table 39.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R\u2032''\n! IC<sub>50</sub> (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Binding of [<sup>3</sup>H]Citalopram)\n! Selectivity<br>5-HTT/DAT\n|-\n| || (benztropine) || || ||312 \u00b1 1.1 || 24100 \u00b1 14800||77.2\n|-\n| || (WIN 35428) || || ||12.9 \u00b1 1.1||160 \u00b1 20||12.4\n|-\n| || ''R''-256 || || ||2040 \u00b1 283||1460 \u00b1 255||0.7\n|-\n|rowspan=13|[[File:Cocaine analog 257.svg|200px]]\n|-\n| ''S''-257a || H || H ||33.5 \u00b1 4.5||10100 \u00b1 1740||301\n|-\n| ''S''-257b || H || F ||13.2 \u00b1 1.9||4930 \u00b1 1200||373\n|-\n| ''S''-257c<br>(difluoropine) || F || F ||10.9 \u00b1 1.2||3530 \u00b1 1480||324\n|-\n| ''S''-257d || H || Cl ||15.8 \u00b1 0.95||5960 \u00b1 467||377\n|-\n| ''S''-257e || Cl || Cl ||91.4 \u00b1 0.85||3360 \u00b1 1480||36.8\n|-\n| ''S''-257f || H || Br ||24.0 \u00b1 4.6||5770 \u00b1 493||240\n|-\n| ''S''-257g || Br || Br ||72.0 \u00b1 3.65||2430 \u00b1 339||33.7\n|-\n| ''S''-257h || H || I ||55.9 \u00b1 10.3||9280 \u00b1 1640||166\n|-\n| ''S''-257i || Br || I ||389 \u00b1 29.4||4930 \u00b1 82||12.7\n|-\n| ''S''-257j || I || I ||909 \u00b1 79||8550 \u00b1 442||9.4\n|-\n| ''S''-257k || H || Me ||49.5 \u00b1 6.0|| 13200 ||266\n|-\n| ''S''-257l || Me || Me ||240 \u00b1 18.4||9800 \u00b1 2680||40.8\n|}\n[[File:Benztropine 277.svg|thumb|right|Compound '''277''']]\n{| class=\"wikitable sortable\"\n|+''N''-Modified 2-carbomethoxybenztropines<br>(Benztropine affinities to DAT & 5-HTT in cynomologous monkey caudate-putamen){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#63 Page #987 (63rd page of article)] Figure 41, Page #989 (65th page of article) \u00a7C & Page #990 (66th page of article) Table 40.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! n\n! IC<sub>50</sub> (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Binding of [<sup>3</sup>H]Citalopram)\n! Selectivity<br>5-HTT/DAT\n|-\n|rowspan=7|[[File:Cocaine analog 258.svg|300px]]\n|-\n| 258a || || ||20.3 \u00b1 3.5|| - || -\n|-\n| 258b || H || <sub>1</sub> ||223 \u00b1 53||4970 \u00b1 700||22.3\n|-\n| 258c || H || <sub>3</sub> ||22.0 \u00b1 11.9||19.7 \u00b1 3||0.9\n|-\n| 258d || Br || <sub>3</sub> ||80.2 \u00b1 8.8||234 \u00b1 0.5||2.9\n|-\n| 258e || I || <sub>3</sub> ||119 \u00b1 11||2200 \u00b1 1250||18.5\n|-\n| 258f || H || <sub>5</sub> ||99.0 \u00b1 28||550 \u00b1 63||5.5\n|-\n| || 259 ||  ||  ||616 \u00b1 88||55200 \u00b1 20000||89.3\n|}\n\n{| class=\"wikitable sortable\"\n|+''N''-substituted 3\u03b1[bis(4\u2032-fluorophenyl)methoxy]tropanes<br>(Benztropine affinities to DAT & 5-HTT){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#64 Page #988 (64th page of article)] Figure 42, Page #990 (66th page of article) \u00a72 & Page #992 (68th page of article) Table 41.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''K<sub>i</sub>'' (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Uptake of [<sup>3</sup>H]DA)\n! Selectivity<br>uptake/binding\n|-\n|rowspan=23|[[File:Cocaine analog 260-265.svg|200px]]\n|-\n| 260<br>(AHN 2-003) || H ||11.2 \u00b1 11|| 9.7 ||0.9\n|-\n| 261a || 3-phenylpropyl ||41.9 \u00b1 11|| 230 ||5.5\n|-\n| 261b || indole-3-ethyl ||44.6 \u00b1 11|| 1200 ||26.9\n|-\n| 261c || 4-phenylbutyl ||8.51 \u00b1 14|| 39 ||4.6\n|-\n| 261d || 4-(4\u2032-nitrophenyl)butyl ||20.2 \u00b1 11|| 650 ||32.2\n|-\n| 261e || 3-(4\u2032-fluorophenyl)propyl ||60.7 \u00b1 12|| - || -\n|-\n| 262a || ''n''-butyl ||24.6 \u00b1 8|| 370 ||15.0\n|-\n| 262b || cyclopropylmethyl ||32.4 \u00b1 9|| 180 ||5.5\n|-\n| 262c || allyl ||29.9 \u00b1 10|| 14 ||0.5\n|-\n| 262d || benzyl ||82.2 \u00b1 15|| 290 ||3.5\n|-\n| 262e || 4-fluorobenzyl ||95.6 \u00b1 10|| 200 ||2.1\n|-\n| 262f || cinnanyl ||86.4 \u00b1 12|| 180 ||2.1\n|-\n| 262g || [bis(4-fluorophenyl)methoxy]ethyl ||634 \u00b1 23|| - || -\n|-\n| 262h || [(4-nitrophenyl)phenylmethoxy]ethyl ||57.0 \u00b1 17|| - || -\n|-\n| 263 || acetyl || 2340 || 4600 ||2.0\n|-\n| 264 || formyl ||2020 \u00b1 13|| 5400 ||2.7\n|-\n| 265a || Ts || 0%<sup>'''\u0251'''</sup> || - || -\n|-\n| 265b || Ms || 18%<sup>'''\u0251'''</sup> || - || -\n|-\n| (AHN 2-005)<ref name=\"LolandDesai2007\">{{cite journal|last1=Loland|first1=C. J.|last2=Desai|first2=R. I.|last3=Zou|first3=M.-F.|last4=Cao|first4=J.|last5=Grundt|first5=P.|last6=Gerstbrein|first6=K.|last7=Sitte|first7=H. H.|last8=Newman|first8=A. H.|last9=Katz|first9=J. L.|last10=Gether|first10=U.|title=Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors|journal=Molecular Pharmacology|volume=73|issue=3|year=2007|pages=813\u2013823|issn=0026-895X|doi=10.1124/mol.107.039800|pmid=17978168|url=https://semanticscholar.org/paper/217b45ef75e8d9ba8fb73d9a130968daf77a9368}}</ref> || CH<sub>2</sub>CH=CH<sub>2</sub> || - || - || -\n|-\n| (JHW 007)<ref name=\"LolandDesai2007\"/> || CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> || - || - || -\n|-\n| (GA 2-99)<ref name=\"LolandDesai2007\"/> || CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub> || - || - || -\n|-\n| (GA 103)<ref name=\"LolandDesai2007\"/> || CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>Ph || - || - || -\n|-\n| [[File:Cocaine analog 266.svg|200px]] || 266 ||  ||108 \u00b1 12|| 130 ||1.2\n|-\n|}\n<sup>'''\u0251'''</sup><small>Inhibition at 10 \u03bcM</small>\n[[File:JHW 007-d9.png|thumb|350px|Deuterium labeled radio-ligand of benztropine analog [[JHW-007]]; a di-''para''-fluoro benztropine, and hybrid between benzatropine & difluoropine (with fluorine groups in the former to breach the difference or the latter being descarbmethoxy to approach identification with the former).]]\n{| class=\"wikitable sortable\"\n|+8-Oxa-2-carbomethoxy norbenztropines<br>(8-Oxanortropane benztropine analog affinities to DAT & 5-HTT){{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#64 Page #988 (64th page of article)] Figure 43, Page #992 (68th page of article) \u00a73 & Table 42.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n!\n! IC<sub>50</sub> (nM)<br>DAT<br>(Binding of [<sup>3</sup>H]WIN 35428)\n! IC<sub>50</sub> (nM)<br>5-HTT<br>(Binding of [<sup>3</sup>H]Citalopram)\n|-\n| [[File:Cocaine analog 268.svg|200px]] || ''R/S''-268 || 2\u03b2,3\u03b2 || >10000 || >1660\n|-\n| || ''R/S''-269 || 2\u03b1,3\u03b2 || 20300 || >1660\n|-\n| || ''R/S''-270 || 2\u03b1,3\u03b1 || 22300 || >1660\n|-\n| [[File:Cocaine analog 271.svg|200px]] || ''R/S''-271 || 2\u03b2,3\u03b1 || 520 || >1660\n|}\n\n===Tropanyl Isoxazoline Analogues===\n {{multiple image\n | header = Spirocyclic tropanyl-\u0394(2)-isoxazoline compound:\n | direction = vertical\n | footer = ''[[3\u2032-methoxy-8-methyl-spiro(8-azabicyclo(3.2.1)octane-3,5\u2032(4\u2032H)-isoxazole]]'' which allosterically enhances SERT binding of other reuptake ligands. Compound '''7a ''' (likewise compound '''11a''' with regard to DAT), construed as a potentiating allosteric effect (by unveiling occluded configured serotonin uptake-area ligand-site on surface of transporter that allows for binding by exogenous ligand, when SERT is otherwise conformed in a transitional manner where a SERT ligand cannot bind, this effect with compound in question occurs) at concentrations of 10\u03bcM\u201430\u03bcM (wherein it acts by interconverting the conformational state of unexposed SERTs to ones exposing the SSRI binding site via a shift to the equilibrium of the MAT) while exerting an inhibitory orthosteric effect when concentrations reach >30\u03bcM and above.<br><br>This is the only known compound to allosterically modulate SERT in such a way within ''in vitro'' conditions ([[tianeptine]] has been shown to do similar, but has only shown efficacy doing so in living ''in vivo'' tissue samples). Considering its noncompetitive inhibition of 5-HT transporters decreasing ''V''<sub>max</sub> with small change in the ''K''<small>m</small> for serotonin, putatively stabilizing the cytoplasm-facing conformation of SERT: in such respect it is considered to have the opposite effect profile of the anti-addiction drug [[ibogaine]] (save for the function by which its anti-addictive properties are thought to be mediated, ''i.e.'' \u03b1<sub>3</sub>\u03b2<sub>4</sub> nicotinic channel blockage. ''cf.'' [[18-Methoxycornaridine]] for such nicotinergic activity without the likewise SERT affinity).<ref name=\"DallanoceCanovi2012\">{{cite journal|last1=Dallanoce|first1=Clelia|last2=Canovi|first2=Mara|last3=Matera|first3=Carlo|last4=Mennini|first4=Tiziana|last5=De Amici|first5=Marco|last6=Gobbi|first6=Marco|last7=De Micheli|first7=Carlo|title=A novel spirocyclic tropanyl-\u03942-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake|journal=Bioorganic & Medicinal Chemistry|volume=20|issue=21|year=2012|pages=6344\u20136355|issn=0968-0896|doi=10.1016/j.bmc.2012.09.004|pmid=23022052}}</ref><br><br>Similarly, such peripheral DAT considerations (when, as often is, considered conformational rather than otherwise explained as being electrostatic) may constitute the difference in affinity, through allosertic occulsion, between [[List of phenyltropanes#\u03b76-3\u03b2-(transition metal complexed phenyl)tropanes|cyclopentyl-ruthenium]] phenyltropane in its difference from the tricarbonyl-chromium\n | image1 = 3\u2032-methoxy-8-methyl-spiro(8-azabicyclo(3.2.1)octane-3,5\u2032(4\u2032H)-isoxazole.svg\n | width1 = 260\n | image2 = 3\u2032-methoxy-8-methyl-spiro(8-azabicyclo(3.2.1)octane-3,5\u2032(4\u2032H)-isoxazole.png\n | width2 = 260\n }}\n\n{| class=\"wikitable sortable\"\n|+ Tropanyl-\u03942-isoxazoline derivatives<ref>C. Dallanoce et al. - Bioorg. Med. Chem. 20 (2012) 6344-6355</ref>\n|-\n! Compound\n! Name\n|-\n|rowspan=2| -||[[File:Dallanoce 4a.svg|x200px]]||[[File:Dallanoce 4c.svg|x210px]]||[[File:Dallanoce 5a.svg|x190px]]||[[File:Dallanoce 5c.svg|x210px]]\n|-\n| 4a||4c||5a||5c\n|-\n|rowspan=2| -||[[File:Dellancoe 6a.svg|x170px]]||[[File:Dallanoce 6b.svg|x170px]]||[[File:Dallanoce 6c.svg|x170px]]||[[File:Dallanoce 7a.svg|x170px]]\n|-\n| 6a||6b||6c||7a\n|-\n|rowspan=2| -||[[File:Dallanoce 7b.svg|x170px]]||[[File:Dallanoce 7c.svg|x190px]]||[[File:Dallanoce 8a.svg|x190px]]||[[File:Dallanoce 8b.svg|x170px]]\n|-\n| 7b||7c||8a||8b\n|-\n|rowspan=2| -||[[File:Dallanoce 8c.svg|x170px]]||[[File:Dallanoce 9a.svg|x170px]]||[[File:Dallanoce 9b.svg|x170px]]||[[File:Dallanoce 9c.svg|x190px]]\n|-\n| 8c||9a||9b||9c\n|-\n|rowspan=2| -||[[File:Dallanoce 10a.svg|x170px]]||[[File:Dallanoce 10b.svg|x170px]]||[[File:Dallanoce 10c.svg|x190px]]\n|-\n| 9c||10a||10b||10c\n|-\n|rowspan=2| -||[[File:Dallanoce 11a.svg|x180px]]||[[File:Dallanoce 11b.svg|x180px]]||[[File:Dallanoce 12a.svg|x180px]]||[[File:Dallanoce 12b.svg|x180px]]\n|-\n| 11a||11b||12a||12b\n|} <!-- End of the table -->\n\n===8-Aminopentacyclo (\u03c3 receptor ligand) [[Trishomocubane]] Analogs===\n<small>''cf.'' other trishomocubanes such as [[basketane]].</small>\n\nSigma receptor agonists with nanomolar affinity such as [[CM156]] have been shown to counteract the deleterious effects of cocaine when co-administered with it. Indicative that ''e.g.'' the local anesthetic effect at the sigma site mediating the toxicity or otherwise a cross over or tie in of cocaine's separate functionalities lowering threshold to its safety profile.<ref name=\"XuKaushal2010\">{{cite journal|last1=Xu|first1=Y. T.|last2=Kaushal|first2=N.|last3=Shaikh|first3=J.|last4=Wilson|first4=L. L.|last5=Mesangeau|first5=C.|last6=McCurdy|first6=C. R.|last7=Matsumoto|first7=R. R.|title=A Novel Substituted Piperazine, CM156, Attenuates the Stimulant and Toxic Effects of Cocaine in Mice|journal=Journal of Pharmacology and Experimental Therapeutics|volume=333|issue=2|year=2010|pages=491\u2013500|issn=0022-3565|doi=10.1124/jpet.109.161398|pmid=20100904|pmc=2872963}}</ref><br>\n[[File:Banister sigmaergic cocaine analog 1 & 2.png]][[File:Banister sigmaergic cocaine analog 3.png]][[File:Banister sigmaergic cocaine analog 4.png]][[File:Banister sigmaergic cocaine analog 5.png]][[File:Banister sigmaergic cocaine analog 6.png]]<br>Polycyclic cage molecules: ''N''-substituted 8-aminopentacyclo[5.4.0.0<sup>2,6</sup>.0<sup>3,10</sup>.0<sup>5,9</sup>]undecanes (AHDs) & related.<br>The 3-FPh, '''14b''', has  1.2 \u00b1 0.1 ''K<sub>i</sub>'' (nM \u00b1 SEM) @ DAT.<ref name=\"BanisterManoli2013\">{{cite journal|last1=Banister|first1=Samuel D.|last2=Manoli|first2=Miral|last3=Barron|first3=Melissa L.|last4=Werry|first4=Eryn L.|last5=Kassiou|first5=Michael|title=N-substituted 8-aminopentacyclo[5.4.0.02,6.03,10.05,9]undecanes as \u03c3 receptor ligands with potential neuroprotective effects|journal=Bioorganic & Medicinal Chemistry|volume=21|issue=19|year=2013|pages=6038\u20136052|issn=0968-0896|doi=10.1016/j.bmc.2013.07.045|pmid=23981939}}</ref><br>\n[[File:(1R,2S,3S,5S,6S,7R,8R,9S,10S)-N-((3-fluorophenyl)methyl)-N-methylpentacyclo(5.4.0.0<sup>2,6</sup>.0<sup>3,10</sup>.0<sup>5,9</sup>)undecan-8-amine.png]]\n\n===Bicyclic Amine Analogues===\n* [[EXP-561]]\n[[File:EXPfivesixone.png|x150px]]\n\n===Quinuclidine Analogues===\n* [[Butyltolylquinuclidine]]\n[[File:Butyltolylquinuclidine.png|x150px]]\n\n==Miscellaneous [[Functional analog (chemistry)|loosely analogous]] stimulants==\n{| class=\"wikitable\"  style=\"margin:auto 1em auto 1em; float:right;\"\n|-\n|<center>'''Chromen-2-one<br>(SNDRI compound)'''<br>[[File:Chromen-2-one (SNDRI).png|center|300px]]</center>\n{| class=\"wikitable\" style=\"text-align:center\"\n|+ {{Patent|US|2011136854}}\n|-\n!IUPAC name\n! 5-HT-uptake IC<sub>50</sub>(\u03bcM)\n! DA-uptake IC<sub>50</sub>(\u03bcM)\n! NE-uptake IC<sub>50</sub>(\u03bcM)\n|-\n|<small>7-(((1R,3r,5S)-9-Azabicyclo[3.3.1]nonan-3-yl)oxy)-2H-chromen-2-one</small>||0.0013||0.24||0.076\n|-\n|<small>7-(((1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-yl)oxy)-2H-chromen-2-one</small>||0.0029||0.15||0.27\n|}\n|}\n\n===Benzoates (Structures with both [[stimulant]] & [[local anesthetic]] effects)===\n* [[Dimethocaine|Dimethocaine/Larocaine (DMC)]] (An aniline)\n* [[Nitracaine]]\n[[File:Dimethocaine-structure.svg|x220px]]\n[[File:Nitracaine structure.png|x150px]]\n\nSee some of [http://pubs.acs.org/action/doSearch?text1=Robert+Clarke&field1=Contrib Robert Clarke's contributions]\n\n===Organochlorides===\n[[File:ORG 6582.png|thumb|[[Org 6582]]<br>A potent and long-lasting monoamine re-uptake inhibitor used in drug research.]]\n* [[Diclofensine]]\n* [[LR-5182]]\n[[File:Diclofensine.svg|x130px]]\n[[File:LR-5182.png|x100px]]\n\n====Quinolizidines====\n*[[List of methylphenidate analogues#Restricted rotational analogs of methylphenidate (quinolizidines)|Quinolizidine analogues of piperidine methylphenidate structure]]\n[[File:MPH RRA 11.png|80px]][[File:MPH RRA 12a\u2014c.png|95px]][[File:MPH RRA 16.png|100px]][[File:MPH RRA 18\u201419.png|100px]][[File:MPH RRA 23a 24ab 31ab.png|100px]][[File:MPH RRA 25ab.png|100px]][[File:MPH RRA 26ab 27a 33ab.png|90px]][[File:MPH RRA 29ab.png|110px]][[File:MPH RRA 30.png|120px]][[File:MPH RRA 36a\u201436e.png|100px]]\n\n===2,3-Benzodiazepines===\n* [[GYKI-52895]]\n[[File:GYKI 52895.svg|x175px]]\n\n===Phenethylamines===\n[[Methylenedioxypyrovalerone]]: [[File:MDPV.svg|x150px]] [[Prolintane]]: [[File:Prolintane.svg|x150px]] [[alpha-Pyrrolidinopropiophenone|\u03b1-Pyrrolidinopropiophenone]]: [[File:A-PPP.svg|x110px]]\n\nMany phenethylamines are dopamine releasers, however, certain drugs of the family inhibit dopamine reuptake & transport which may be loosely classed as cocaine analogs. Dependent upon their specific configurations. Like has been shown with cocaine, methylenedioxypyrovalerone (MDPV) has been shown to similarly be neuroprotective against the neural damage caused by amphetamine type drugs (''i.e.'' releasers)<ref>{{cite journal | pmc = 4759647 | pmid=25626880 | doi=10.1111/jnc.13048 | volume=133 | issue=2 | title=3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: \u03b2-ketoamphetamine modulation of neurotoxicity by the dopamine transporter | journal=J Neurochem | pages=211\u201322 | last1 = Anneken | first1 = JH | last2 = Angoa-P\u00e9rez | first2 = M | last3 = Kuhn | first3 = DM | year=2015}}</ref>\n\n===Adamantanes===\n* [[A-77636]]\n[[File:A-77636.svg|x150px]]\n* [[Bromantane]]\n[[File:Bromantan.svg|x100px]]\n\n===Pyridines===\n* [[Altinicline]]\n[[File:Altinicline_structure.png|x150px]]\n\nNicotinic agonist which stimulates the release of dopamine.\n\n===Naphthyridines===\n[[File:Desmethoxyyangonin.svg|thumb|right|x175px|[[Desmethoxyyangonin]] (''5,6-dehydrokawain''), reversible [[Monoamine oxidase B|MAO-B]] [[monoamine oxidase inhibitor|inhibitor]] believed to contribute to mediating dopamine release in [[nucleus accumbens]].]]\n* [[Amfonelic acid]]\n[[File:Amfonelic acid.png|x150px]]<br>\nBeing a carboxylic acid, amfonelic acid could potentially be used as a carboxylate for the protonation to the free base of another compound; even conceivably creating a 'cocaine amfonelate' or 'cocaine AFA' as opposed to cocaine [[Hydrogen chloride|HCl]], cocaine [[citrate]] or cocaine [[Hydrobromic acid|HBr]] ''et cetera'' wherein such a case it's conjugate used to form it as a salt would additionally be dopaminergic.\n\n===Quinazolinamines (Allosteric functional DAT reuptake inhibitors)===\n* [[SoRI-20041]]\n* [[SoRI-9804]]\n[[File:SoRI-20041.png|x200px]]\n[[File:SoRI-9804.svg|x200px]]\n''cf.'' the benztropine phenyltropanes:\n[[File:Benztropine phenyltropane.png|x200px]]\n\nSoRI-20041 is a functional, but not structural, cocaine analog which violates traditional structure analog categorization in its case that it has an entirely other binding site. It is however an analog to cocaine in the sense that it functions as a partial DARI on DAT, although doing so when said DAT is compromised by amphetamine-type mediated release of DA. Something unaugmented cocaine cannot do. It nevertheless performs the role of an analogous adjunct to cocaine's function for phosphorylated DAT. It is however worth noting that as for its structure, it displays a certain degree of shared conformation with the benztropine phenyltropanes.\n\n===Piperazines (Aryl-1,4-dialkyl piperazines)===\n[[File:Methylphenidate overlaid 1-(2-Phenylethyl)piperazine.png|thumb|Methylphenidate rendered in 3D (in blue) overlaid with 1-(2-Phenylethyl) piperazine skeleton (turquoise) showing the basic 3- point pharmacophore shared between them and other dopamine reuptake inhibitors such as [[1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine|3C-PEP]] (that itself is only a 3-chlorophenyl more than 1-(2-Phenylethyl) piperazine).]]\nGBR-13098: [[File:GBR 13098.svg|370px]]\n281 (decanoate 5): [[File:GBR compound 281 decanoate 5.svg|370px]]\n* [[GBR-13098]]\n* [[DBL-583]]\n\nGBR compounds were derived from the benztropines by replacing their tropane nucleus with a piperazine ring (and therefore constitute being [[Congener (chemistry)|congener]]s with cocaine).{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#69 Page #993 (69th page of article)] \u00a7V. \u00b62. Fourth line. First sentence.}} The name \"GBR\" is derived from its maker [[DSM (company)|'''G'''ist-'''Br'''ocades]] (now DSM), Netherlands.\n\n[[File:Vanoxerine.png|x170px]]\n[[File:GBR-12783.svg|x170px]]\n\n[[File:3C-PEP_structure.png|thumb|right|x150px|''cf.'' to the GBRs the non-diphenyl and still quite highly specific dopaminergic (selective) stimulant [[1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine|3C-PEP]]; shown to be roughly 10,000\u00d7 more potent than cocaine as a DAT reuptake inhibitor. There are other related stimulants structurally.<ref name=\"SchmittZhen2008\">{{cite journal|last1=Schmitt|first1=Kyle C.|last2=Zhen|first2=Juan|last3=Kharkar|first3=Prashant|last4=Mishra|first4=Manoj|last5=Chen|first5=Nianhang|last6=Dutta|first6=Aloke K.|last7=Reith|first7=Maarten E. A.|title=Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties|journal=Journal of Neurochemistry|year=2008|issn=0022-3042|doi=10.1111/j.1471-4159.2008.05667.x|pmid=18786172|pmc=2728472|volume=107|issue=4|pages=928\u201340}}</ref>]]\n[[File:UMB38.svg|thumb|right|x150px|UMB38]]\n[[File:UMB38 analogs.svg|thumb|right|x150px|UMB38 analogs:<ref name=\"MotelHealy2013\">{{cite journal|last1=Motel|first1=William C.|last2=Healy|first2=Jason R.|last3=Viard|first3=Eddy|last4=Pouw|first4=Buddy|last5=Martin|first5=Kelly E.|last6=Matsumoto|first6=Rae R.|last7=Coop|first7=Andrew|title=Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands|journal=Bioorganic & Medicinal Chemistry Letters|volume=23|issue=24|year=2013|pages=6920\u20136922|issn=0960-894X|doi=10.1016/j.bmcl.2013.09.038|pmid=24211020|pmc=3919026}}</ref><br>''R'' = 2-Cl, ''n'' = 1<br>''R'' = 3-Cl, ''n'' = 1<br>''R'' = 4-Cl, ''n'' = 1<br>''R'' = 2-Cl, ''n'' = 2<br>''R'' = 3-Cl, ''n'' = 2<br>''R'' = 4-Cl, ''n'' = 2]]\nGBR compounds are sometimes broadly classed as being, and referred to by the term, \"[[rimcazole]] analogs\"<ref name=\"KatzLibby2003\">{{cite journal|last1=Katz|first1=Jonathan L.|last2=Libby|first2=Therissa A.|last3=Kopajtic|first3=Theresa|last4=Husbands|first4=Stephen M.|last5=Newman|first5=Amy Hauck|title=Behavioral effects of rimcazole analogues alone and in combination with cocaine|journal=European Journal of Pharmacology|volume=468|issue=2|year=2003|pages=109\u2013119|issn=0014-2999|doi=10.1016/S0014-2999(03)01638-8|pmid=12742518}}</ref> - for example the compounds: [[JJC 2-006]], [[JJC 2-010]], and [[JJC 1-059]].<ref name=\"LolandDesai2007\"/>\n[[File:JJC 2-006.svg|x170px]]\n[[File:JJC 2-010.svg|x170px]]\n[[File:JJC 1-059.svg|x170px]]\n{| class=\"wikitable sortable\"\n|+GBR 12783 analogues inhibition of DAT binding & DA uptake{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#69 Page #993 (69th page of article)] \u00a7V, Figure 46 & Table 43.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''K<sub>i</sub>'' (nM)<br>[<sup>3</sup>H]WIN 35425\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA\n! Selectivity<br>DA/DAT<br>uptake/binding\n|-\n| || (Cocaine) || ||224 \u00b1 3.4||208 \u00b1 7.4||0.93\n|-\n| || (WIN 35428) || ||24 \u00b1 3.1||14 \u00b1 1.8||0.58\n|-\n| [[File:Dopamine2.svg|170px]] || (DA) || ||10000 \u00b1 2400||44 \u00b1 5.3||0.004\n|-\n| [[File:GBR 12909.svg|300px]] || 279<br>([[Vanoxerine|GBR 12909]]/Vanoxerine) ||  ||27 \u00b1 4.1<br>0.06 \u00b1 0.02<sup>'''b'''</sup><br>52.8 \u00b1 4.4<sup>'''c'''</sup><br> >20,000<sup>'''d'''</sup>||0.21 \u00b1 0.06||0.007<br>880<sup>'''e'''</sup><br> >333,333.3<sup>'''f'''</sup>\n|-\n| [[File:GBR 12783.svg|300px]] || 282<br>([[GBR-12783|GBR 12783]]) || H ||12 \u00b1 1.2<sup>'''\u0251'''</sup>|| - || -\n|-\n|rowspan=7|[[File:GBR compound 284.svg|300px]]\n|-\n| 284a || 3-NH<sub>2</sub> ||12 \u00b1 1.0||7 \u00b1 3.5||0.58\n|-\n| 284b || 3-NCS ||160 \u00b1 17||106 \u00b1 37||0.67\n|-\n| 284c || 4-NH<sub>2</sub> ||11 \u00b1 0.7||1.6 \u00b1 0.2||0.14\n|-\n| 284d || 4-NO<sub>2</sub> ||26 \u00b1 9.3||2.7 \u00b1 0.1||0.10\n|-\n| 284e || 4-NCS ||159 \u00b1 12||26 \u00b1 1.8||0.16\n|-\n| 284f || 4-[[maleimide]] ||2327 \u00b1 1000||476 \u00b1 61||0.20\n|}\n*<sup>'''\u0251'''</sup><small>IC<sub>50</sub> for inhibiting [<sup>3</sup>H]methylphenidate</small>\n*<sup>'''b'''</sup><small>''K<sub>i</sub>'' (nM) for inhibiting [<sup>3</sup>H]GBR 12935</small>\n*<sup>'''c'''</sup><small>''K<sub>i</sub>'' (nM) for inhibiting [<sup>3</sup>H]Paroxetine @ 5-HTT</small>\n*<sup>'''d'''</sup><small>''K<sub>i</sub>'' (nM) for inhibiting [<sup>3</sup>H]Nisoxetine @ NET</small>\n*<sup>'''e'''</sup><small>Selectivity between 5-HTT/DAT</small>\n*<sup>'''f'''</sup><small>Selectivity between NET/DAT</small>\n{| class=\"wikitable sortable\"\n|+GBR analogue compounds with piperazine ring-alterations. Binding affinities and inhibition of uptake for DA & 5-HT.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#71 Page #995 (71st page of article)] Figure 47 & Page #997 (73rd page of article) Table 44.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''X-Y'' (289-290)<br> ''R<sub>1</sub>'' (298)\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]GBR 12935 binding\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]DA uptake\n! IC<sub>50</sub> (nM)<br>[<sup>3</sup>H]5-HT uptake\n! Selectivity<br>[<sup>3</sup>H]DA uptake/DAT binding\n! Selectivity<br>[<sup>3</sup>H]5-HT/[<sup>3</sup>H]DA uptake\n|-\n| || (Cocaine) ||  ||  ||660 \u00b1 30<br>(''K<sub>i</sub>'' value)||478 \u00b1 25||304 \u00b1 10|| 0.72 ||0.64\n|-\n| [[File:GBR 12935.svg|300px]] || ([[GBR-12935|GBR 12935]]) ||  ||  ||4.1 \u00b1 0.6||3.7 \u00b1 0.4||289 \u00b1 29|| 0.90 ||78.1\n|-\n| || 279<br>(GBR 12909) ||  ||  ||5.5 \u00b1 0.4||4.3 \u00b1 0.3||73 \u00b1 1.5|| 0.78 ||17.0\n|-\n|rowspan=7|[[File:GBR compound 289.svg|300px]]\n|-\n| 289a || H || C-C ||21 \u00b1 1.0||9.6 \u00b1 1.5||1720 \u00b1 70|| 0.46 ||179\n|-\n| 289b || F || C-C ||40 \u00b1 1||15 \u00b1 2||459 \u00b1 26|| 0.37 ||30.6\n|-\n| (-)289b (2''S'',5''R'') || F || C-C ||3.6 \u00b1 0.14||8.1 \u00b1 0.3|| - || 2.25 || -\n|-\n| (+)289b (2''R'',5''S'') || F || C-C ||125 \u00b1 7.0||87 \u00b1 4.1|| - || 0.70 || -\n|-\n| 289c || H || C=C ||103 \u00b1 13||20 \u00b1 4||2680 \u00b1 122|| 0.19 ||134\n|-\n| 289d || F || C=C ||23 \u00b1 3||28 \u00b1 5||1180 \u00b1 404|| 1.22 ||42.1\n|-\n|rowspan=5|[[File:GBR compound 290.svg|300px]]\n|-\n| 290a<br>(LR1111) || H || C-C ||7.9 \u00b1 1.7||7.2 \u00b1 0.5||34100 \u00b1 359|| 0.91 ||4736\n|-\n| 290b || F || C-C ||4.4 \u00b1 0.4||3.4 \u00b1 0.4||112 \u00b1 24|| 0.77 ||32.9\n|-\n| 290c || H || C=C ||8.6 \u00b1 1.1||0.6 \u00b1 0.1||503 \u00b1 103|| 0.07 ||838\n|-\n| 290d || F || C=C ||2.6 \u00b1 0.4||3.4 \u00b1 0.4||234 \u00b1 10|| 1.31 ||68.8\n|-\n| [[File:GBR compound 291.svg|300px]] || 291 ||  || ||286 \u00b1 8||87 \u00b1 5||3150 \u00b1 491|| 0.30 ||36.2\n|-\n| [[File:GBR compound 292.svg|300px]] || 292 ||  || ||864 \u00b1 91||93 \u00b1 6||1590 \u00b1 60|| 0.11 ||17.1\n|-\n| [[File:GBR compound 293.svg|310px]] || 293 ||  || ||27 \u00b1 4||18 \u00b1 1||2450 \u00b1 57|| 0.67 ||136\n|-\n| [[File:GBR compound 294.svg|330px]] || 294 ||  || ||169 \u00b1 5||83 \u00b1 7||1890 \u00b1 268|| 0.49 ||22.8\n|-\n| [[File:GBR compound 295.svg|330px]] || 295 ||  || ||80 \u00b1 6||35 \u00b1 2||376 \u00b1 19|| 0.44 ||10.7\n|-\n| [[File:GBR compound 296.svg|210px]] || 296 ||  || ||74 \u00b1 5||57 \u00b1 10||2860 \u00b1 45|| 0.77 ||50.2\n|-\n| [[File:GBR compound 297.svg|180px]] || 297 ||  || ||20 \u00b1 0.7||9.3 \u00b1 1.8||1480 \u00b1 69|| 0.46 ||159\n|-\n|rowspan=5|[[File:GBR compound 298.svg|350px]]\n|-\n| (-)298a || H || H ||5.1 \u00b1 0.4||0.7 \u00b1 0.05||986 \u00b1 34|| 0.14 ||1409\n|-\n| (+)298a || H || H ||747 \u00b1 163||127 \u00b1 10||3210 \u00b1 450|| 0.17 ||25.3\n|-\n| (-)298b || F || H ||104 \u00b1 8||29 \u00b1 2||20100 \u00b1 2400|| 0.28 ||693\n|-\n| (-)298c || H || OH ||222 \u00b1 13||31 \u00b1 0.1||857 \u00b1 17|| 0.14 ||27.6\n|}\n\n{| class=\"wikitable sortable\"\n|+Heteroaromatic and fused ring GBR analogue affinities reuptake inhibition for DA & 5-HT and [<sup>125</sup>I]RTI-55 labeled DAT & 5-HTT binding affinities.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#73 Page #997 (73rd page of article)] \u00a7C, Page #998 (74th page of article) Figure 48 & Page #1,000 Table 45.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R<sub>1</sub>''\n! IC<sub>50</sub> (nM)<br>[<sup>125</sup>I]RTI-55 binding<br>DAT\n! IC<sub>50</sub> (nM)<br>[<sup>125</sup>I]RTI-55 binding<br>5-HTT\n! IC<sub>50</sub> (nM)<br>reuptake<br>[<sup>3</sup>H]DA\n! IC<sub>50</sub> (nM)<br>reuptake<br>[<sup>3</sup>H]5-HT\n! Selectivity<br>binding<br>5-HTT/DAT\n! Selectivity<br>uptake<br>[<sup>3</sup>H]5-HT/[<sup>3</sup>H]DA\n|-\n| || (GBR 12935) || C<sub>6</sub>H<sub>5</sub> ||  ||3.7 \u00b1 0.3||623 \u00b1 13||3.7 \u00b1 0.4||298 \u00b1 29|| 168 ||80.5\n|-\n|rowspan=4|[[File:GBR compound 304.svg|300px]]\n|-\n| 304a || 2-thienyl ||  ||5.2 \u00b1 0.3||842 \u00b1 30||9.7 \u00b1 0.2||1990 \u00b1 58|| 162 ||205\n|-\n| 304b || 2-furyl ||  ||6.5 \u00b1 0.2||1520 \u00b1 47||8.5 \u00b1 0.5||2550 \u00b1 87|| 34 ||300\n|-\n| 304c || 2-pyridyl ||  ||78 \u00b1 4||2420 \u00b1 65||70 \u00b1 6||3700 \u00b1 148|| 31.0 ||52.8\n|-\n| [[File:GBR compounds 279-281.svg|300px]] || 279 (GBR 12909) || C<sub>6</sub>H<sub>5</sub> ||  ||3.7 \u00b1 0.4||126 \u00b1 5||7.3 \u00b1 0.2||73 \u00b1 2|| 34.0 ||10.0\n|-\n|rowspan=4|[[File:GBR compound 305.svg|300px]]\n|-\n| 305a || 2-thienyl ||  ||3.3 \u00b1 0.1||105 \u00b1 2||6.1 \u00b1 0.7||335 \u00b1 17|| 31.8 ||54.9\n|-\n| 305b || 2-furyl ||  ||5.9 \u00b1 0.3||204 \u00b1 7||7.9 \u00b1 0.5||412 \u00b1 9|| 34.6 ||52.1\n|-\n| 305c || 2-pyridyl ||  ||16 \u00b1 0.2||2800 \u00b1 139||20 \u00b1 0.8||6520 \u00b1 293|| 175 ||326\n|-\n| || 282 (GBR 12783) || C<sub>6</sub>H<sub>5</sub> ||  || - || - || - || - || - || -\n|-\n|rowspan=4|[[File:GBR compound 306.svg|300px]]\n|-\n| 306a || 2-thienyl ||  ||6.4 \u00b1 0.3||1170 \u00b1 31||10 \u00b1 0.7||2020 \u00b1 141|| 183 ||202\n|-\n| 306b || 2-furyl ||  ||5.0 \u00b1 0.3||1840 \u00b1 59||9.6 \u00b1 0.3||2700 \u00b1 136|| 368 ||281\n|-\n| 306c || 2-pyridyl ||  ||44 \u00b1 3||2670 \u00b1 66||64 \u00b1 2||3620 \u00b1 179|| 60.7 ||56.6\n|-\n| [[File:GBR 13069.svg|300px]] || 283 ([[GBR-13069|GBR 13069]]) || C<sub>6</sub>H<sub>5</sub> ||  ||0.9 \u00b1 0.1||135 \u00b1 7||11 \u00b1 0.6||576 \u00b1 32|| 150 ||52.4\n|-\n|rowspan=4|[[File:GBR compound 307.svg|300px]]\n|-\n| 307a || 2-thienyl ||  ||2.2 \u00b1 0.1||88 \u00b1 2||13 \u00b1 1.4||374 \u00b1 17|| 40.0 ||28.8\n|-\n| 307b || 2-furyl ||  ||1.8 \u00b1 0.3||109 \u00b1 4||7.2 \u00b1 0.4||442 \u00b1 23|| 60.5 ||61.4\n|-\n| 307c || 2-pyridyl ||  ||13.6 \u00b1 0.2||334 \u00b1 12||14.5 \u00b1 1.9||666 \u00b1 21|| 24.5 ||45.9\n|-\n|rowspan=3|[[File:GBR compound 308.svg|300px]]\n|-\n| 308a || H || (benzothiophen-2-yl)methyl ||18.1 \u00b1 1||2420 \u00b1 109||19 \u00b1 1||3520 \u00b1 289|| 134 ||185\n|-\n| 308b || F || (benzothiophen-2-yl)methyl ||4.1 \u00b1 1.1||495 \u00b1 18||34 \u00b1 2||1230 \u00b1 40|| 121 ||36.2\n|-\n|rowspan=3|[[File:GBR compound 309.svg|300px]]\n|-\n| 309a || H || (benzofuran-2-yl)methyl ||17 \u00b1 0.5||1890 \u00b1 48||22 \u00b1 0.7||3040 \u00b1 213|| 111 ||138\n|-\n| 309b || F || (benzofuran-2-yl)methyl ||6.4 \u00b1 0.2||286 \u00b1 10||18.6 \u00b1 0.6||767 \u00b1 27|| 44.7 ||41.2\n|-\n|rowspan=3|[[File:GBR compound 310.svg|300px]]\n|-\n| 310a || H || (indol-2-yl)methyl ||1.1 \u00b1 0.1||668 \u00b1 39||8.8 \u00b1 0.7||2120 \u00b1 166|| 607 ||241\n|-\n| 310b || F || (indol-2-yl)methyl ||0.7 \u00b1 0.1||119 \u00b1 5||13 \u00b1 0.2||506 \u00b1 23|| 170 ||38.9\n|-\n|rowspan=3|[[File:GBR compound 311.svg|300px]]\n|-\n| 311a || H || (benzimidazol-2-yl)methyl ||46 \u00b1 1||1884 \u00b1 72||37 \u00b1 2||4076 \u00b1 221|| 41.0 ||110\n|-\n| 311b || F || (benzimidazol-2-yl)methyl ||15 \u00b1 0.2||256 \u00b1 7||20 \u00b1 0.8||797 \u00b1 43|| 17.1 ||39.8\n|-\n|rowspan=3|[[File:GBR compound 312.svg|300px]]\n|-\n| 312a || H || (quinolin-2-yl)methyl ||199 \u00b1 5||1990 \u00b1 5||192 \u00b1 8||4120 \u00b1 212|| 10.0 ||21.5\n|-\n| 312b || F || (quinolin-2-yl)methyl ||56 \u00b1 1||51 \u00b1 16||106 \u00b1 12||339 \u00b1 31|| 0.9 ||3.2\n|-\n|rowspan=3|[[File:GBR compound 313.svg|300px]]\n|-\n| 313a || H || (quinolin-3-yl)methyl ||72 \u00b1 2||1160 \u00b1 27||111 \u00b1 3||3040 \u00b1 252|| 16.1 ||27.4\n|-\n| 313b || F || (quinolin-3-yl)methyl ||16 \u00b1 3||485 \u00b1 16||74 \u00b1 3||851 \u00b1 36|| 30.3 ||11.5\n|-\n|rowspan=3|[[File:GBR compound 314.svg|300px]]\n|-\n| 314a || H || (quinolin-6-yl)methyl ||190 \u00b1 6||845 \u00b1 15||140 \u00b1 4||1640 \u00b1 58|| 4.4 ||11.7\n|-\n| 314b || F || (quinolin-6-yl)methyl ||62 \u00b1 2||551 \u00b1 21||73 \u00b1 3||1040 \u00b1 46|| 8.9 ||14.2\n|-\n|rowspan=3|[[File:GBR compound 315.svg|300px]]\n|-\n| 315a || H || 3-(benzimidazol-2-yl)propyl ||23 \u00b1 0.5||309 \u00b1 9||17 \u00b1 0.7||627 \u00b1 12|| 13.4 ||36.9\n|-\n| 315b || F || 3-(benzimidazol-2-yl)propyl  ||2.5 \u00b1 0.1||28 \u00b1 2||8.1 \u00b1 0.3||74 \u00b1 4|| 11.2 ||9.1\n|-\n|rowspan=3|[[File:GBR compound 316.svg|300px]]\n|-\n| 316a || H || (naphthalen-2-yl)methyl ||43 \u00b1 2||903 \u00b1 47||32 \u00b1 0.6||926 \u00b1 33|| 21.0 ||28.9\n|-\n| 316b || F || (naphthalen-2-yl)methyl ||8.0 \u00b1 0.3||312 \u00b1 15||30 \u00b1 1||588 \u00b1 39|| 39.0 ||19.6\n|-\n|rowspan=3|[[File:GBR compound 317.svg|300px]]\n|-\n| 317a || H || (naphthalen-1-yl)methyl ||114 \u00b1 5||336 \u00b1 22||406 \u00b1 11||83 \u00b1 5|| 2.9 ||0.2\n|-\n| 317b || F || (naphthalen-1-yl)methyl ||31 \u00b1 1||243 \u00b1 6||312 \u00b1 19||257 \u00b1 12|| 7.8 ||0.8\n|-\n|rowspan=3|[[File:GBR compound 318.svg|300px]]\n|-\n| 318a || H || 2-(naphthalen-1-yl)ethyl ||92 \u00b1 13||462 \u00b1 17||42 \u00b1 0.9||578 \u00b1 17|| 5.0 ||13.8\n|-\n| 318b || F || 2-(naphthalen-1-yl)ethyl ||7.8 \u00b1 0.2||46 \u00b1 1||25 \u00b1 0.8||119 \u00b1 4|| 5.9 ||4.8\n|-\n|}\n\n{| class=\"wikitable sortable\"\n|+Piperidine analogues of piperazine GBR compounds & their affinity to bind at DAT & 5-HTT{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#76 Page #1,000 (76th page of article)] \u00a7D, Page #1,001 (77th page of article) Figure 49 & Page #1,005 (81st page of article) Table 46.}}\n! Compound\n! S. Singh's<br>alphanumeric<br>assignation<br>(name)\n! ''R''\n! ''R\u2032''\n! ''R\u2033''\n! IC<sub>50</sub> (nM)<br>DAT<br>[<sup>3</sup>H]WIN 35428\n! IC<sub>50</sub> (nM)<br>5-HTT<br>[<sup>3</sup>H]citalopram\n! Selectivity<br>5-HTT/DAT\n|-\n| || 279 (GBR 12909) ||  || || ||14.0 \u00b1 0.6||82 \u00b1 4||5.8\n|-\n| [[File:GBR compound 320.svg|300px]] || 320 (O-549) ||  || || ||595 \u00b1 148||38 \u00b1 127||0.6\n|-\n|rowspan=6|[[File:GBR compound 321-322.svg|300px]]\n|-\n| 321 (O-526) || F || || ||24.9 \u00b1 3.23||248 \u00b1 72||9.9\n|-\n| 322a || H || || ||12.0 \u00b1 0.4||232 \u00b1 28||19.3\n|-\n| 322b || Cl || || ||65.0 \u00b1 12||224 \u00b1 10||3.4\n|-\n| 322c || Br || || ||159 \u00b1 56||835 \u00b1 142||5.2\n|-\n| 322d || OCH<sub>3</sub> || || ||255 \u00b1 32||340 \u00b1 24||1.3\n|-\n|rowspan=6|[[File:GBR compound 323.svg|300px]]\n|-\n| 323a || H || || ||10.6 \u00b1 0.85||102 \u00b1 5||9.6\n|-\n| 323b || F || || ||19.9 \u00b1 9.5||31.9 \u00b1 7.1||1.6\n|-\n| 323c || Cl || || ||115 \u00b1 22||414 \u00b1 32||3.6\n|-\n| 323d || Br || || ||382 \u00b1 167||638 \u00b1 71||1.7\n|-\n| 323e || CH<sub>3</sub> || || ||311 \u00b1 71||888 \u00b1 58||2.8\n|-\n|rowspan=3|[[File:GBR compound 324.svg|300px]]\n|-\n| 324a || H || || ||15.2 \u00b1 2.8||743 \u00b1 6||48.9\n|-\n| 324b || F || || ||9.7 \u00b1 0.4||198 \u00b1 7||20.4\n|-\n|rowspan=3|[[File:GBR compound 325.svg|300px]]\n|-\n| 325a || H || || ||14.5 \u00b1 1.9||58 \u00b1 7||3.7\n|-\n| 325b || F || || ||13.0 \u00b1 2.5||112 \u00b1 4||8.6\n|-\n|rowspan=3|[[File:GBR compound 326.svg|300px]]\n|-\n| 326a || H || || ||108 \u00b1 14||456 \u00b1 90||4.2\n|-\n| 326b || F || || ||13.5 \u00b1 2.6||237 \u00b1 53||17.5\n|-\n|rowspan=3|[[File:GBR compound 327.svg|300px]]\n|-\n| 327a || H || || ||702 \u00b1 34||544 \u00b1 91||0.8\n|-\n| 327b || F || || ||126 \u00b1 13||761 \u00b1 101||6.0\n|-\n|rowspan=12|[[File:GBR compound 328.svg|300px]]\n|-\n| 328a || H || H || F ||17.2 \u00b1 4.7||1920 \u00b1 233||111.6\n|-\n| 328b || H || H || Cl ||24.7 \u00b1 5.5||1610 \u00b1 119||65.2\n|-\n| 328c || H || H || Br ||31.1 \u00b1 2.9||1490 \u00b1 319||47.9\n|-\n| 328d || H || Cl || Cl ||85.7 \u00b1 4.7||2880 \u00b1 281||33.6\n|-\n| 328e || H || H || OCH<sub>3</sub> ||27.8 \u00b1 6.8||1240 \u00b1 342||44.6\n|-\n| 328f || Cl || H || F ||52.4 \u00b1 7.8||1810 \u00b1 107||34.5\n|-\n| 328g || F || H || F ||14.0 \u00b1 3.3||1260 \u00b1 72||90.0\n|-\n| 328h || H || H || CH<sub>3</sub> ||23.0 \u00b1 3.7||1390 \u00b1 240||60.4\n|-\n| 328i || H || Cl || F ||28.2 \u00b1 3.1||2530 \u00b1 50||89.7\n|-\n| 328j || H || H || NO<sub>2</sub> ||16.4 \u00b1 3.0||1770 \u00b1 305||107.9\n|-\n| 328k || H || H || NH<sub>2</sub> ||101 \u00b1 13||1570 \u00b1 201||15.5\n|-\n|rowspan=7|[[File:GBR compound 329.svg|240px]]\n|-\n| 329a || Ph || 3-pyridyl || ||48.6 \u00b1 8.4||680 \u00b1 12.0||14.0\n|-\n| 329b || Ph || 2-benzo[''b'']thiophenyl || ||172 \u00b1 16.4||1540 \u00b1 251||8.9\n|-\n| 329c || Ph || 2-thienyl || ||59.3 \u00b1 5.8||1250 \u00b1 87||21.1\n|-\n| 329d || 2-thienyl || Ph || ||27.2 \u00b1 0.1||741 \u00b1 108||27.2\n|-\n| 329e || 2-thienyl || 4-F-Ph || ||13.8 \u00b1 3.4||1390 \u00b1 243||101\n|-\n| 329f || 2-thienyl || 3-pyridyl || ||58.3 \u00b1 5.7||927 \u00b1 34||15.9\n|-\n|rowspan=6|[[File:GBR compound 330.svg|300px]]\n|-\n| 330a || F || 4-F-Ph || ||15.1 \u00b1 2.0||75.8 \u00b1 22.1||5.0\n|-\n| 330b || F || Ph || ||41.4 \u00b1 8.0||271 \u00b1 18.4||6.5\n|-\n| 330c || H || Ph || ||10.1 \u00b1 1.6||231 \u00b1 4.5||22.9\n|-\n| 330d || H || 4-F-Ph || ||10.8 \u00b1 3.2||205 \u00b1 13.3||19.0\n|-\n| 330e || H || 2-thienyl || ||9.8 \u00b1 2.4||290 \u00b1 63||29.6\n|-\n|rowspan=5|[[File:GBR compound 331.svg|300px]]\n|-\n| 331a || Ph || H || 4-F-Ph ||6.6 \u00b1 1.4||223 \u00b1 32.3||33.8\n|-\n| 331b || Ph || H || 3-pyridyl ||29.9 \u00b1 0.3||194 \u00b1 20.1||6.5\n|-\n| 331c || 2-thienyl || H || Ph ||6.0 \u00b1 0.5||180 \u00b1 21.6||30.0\n|-\n| 331d || 2-thienyl || F || Ph ||11.7 \u00b1 1.0||85.7 \u00b1 2.6||7.3\n|-\n|rowspan=3|[[File:GBR compound 332.svg|300px]]\n|-\n| 332a || H || F || ||9.4 \u00b1 2.6||585 \u00b1 101||62.2\n|-\n| 332b || F || H || || - || - || -\n|}\n\n===Dihydroimidazoles===\n[[File:Mazindol analogs 2.svg|thumb|right|200px|Possible substitutions of the [[Mazindol]] molecular structure.]]\nSee: [[Mazindol#Analogs|List of Mazindol analogues]]\n\nMazindol is usually considered a non-habituating (in humans, and some other mammals, but is habituating for ''e.g.'' [[Beagle]]s{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#87 Page #1,011 (87th page of article)] \u00a7VII (7) 1st \u00b6.}}) [[Tetracyclic antidepressant|tetracyclic]] dopamine reuptake inhibitor (of somewhat spurious classification in the former).\n\nIt is a loosely functional analog used in cocaine research; due in large part to [[N-Ethylmaleimide|''N''-Ethylmaleimide]] being able to inhibit approximately 95% of the specific binding of [<sup>3</sup>H]Mazindol to the residues of the MAT binding site(s), however said effect of 10 [[Molar concentration#millimolar|mM]] ''N''-Ethylmaleimide was prevented in its entirety by just 10 ''\u03bc''M cocaine. Whereas neither 300 ''\u03bc''M dopamine or <small>D</small>-amphetamine afforded sufficient protection to contrast the efficacy of cocaine.{{efn|<ref name=\"Singh2\"/> \u2190[https://www.erowid.org/archive/rhodium/pdf/cocaineanalogs.pdf#45 Page #969 (45th page of article)] 2nd (right-side) column 2nd [[Paragraph|\u00b6]].}}<br>\n[[File:Mazindol synthesis.svg|1000px]][[File:Mazindol3Dan.gif]]\n<br>The above steps in its synthesis show the similitude of its precursors to the MAT reuptake inhibitor [[pipradrol]] & related compounds.\n{{Clear}}\n\n==Local anesthetics (not usually CNS stimulants)==\n {{multiple image\n | direction = vertical\n | image1 = Amylocaine.png\n | width1 = 220\n | caption1 = [[Amylocaine]], or Stovaine (above), the first synthetically constructed local anesthetic. Compare structure to [[dimethylaminopivalophenone]] (below), an analgesic (opioid). Cocaine's classification as a narcotic under [[United States|U.S.]] legal code, as has been stretched to be medicinally rationalized such when defining terms very broadly (due to its topical numbing affect, hindering pain signals from CNS recognition via local anesthesia) usually considered an exaggeration of traditional medicine naming convention, in this instance between the first synthetic sodium channel blocker and one of the very simplest opioids there remains a measure of apparent structural similarity between the former anesthetic and latter analgesic \"narcotic\"; despite the highly differing methods of action for the respective 'pain-killing' properties of either.<ref>{{cite journal | last1 = Ruetsch | first1 = YA | last2 = B\u00f6ni | first2 = T | last3 = Borgeat | first3 = A | date = Aug 2001 | title = From cocaine to ropivacaine: the history of local anesthetic drugs | url = | journal = Curr Top Med Chem | volume = 1 | issue = 3| pages = 175\u201382 | pmid = 11895133 | doi=10.2174/1568026013395335}}</ref>\n | image2 = 3-(dimethylamino)-2,2-dimethyl-1-phenylpropan-1-one.png\n | width2 = 220\n }}\n[[File:Beta-Eucaine.png|thumb|right|\u03b2-Eucaine (Betacain)]]\nIn animal studies, certain of the local anesthetics have displayed residual [[dopamine reuptake inhibitor]] properties,<ref name=Wilcox>{{cite journal|last1=Wilcox |first1=K.M. |last2=Kimmel |first2=H.L. |last3=Lindsey |first3=K.P. |last4=Votaw |first4=J.R. |last5=Goodman |first5=M.M. |last6=Howell |first6=L.L. |year=2005 |title=In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys |url=http://research.yerkes.emory.edu/Howell/Synapse58.pdf |journal=Synapse |volume=58 |issue= 4|pages=220\u2013228 |doi=10.1002/syn.20199 |pmid=16206183 |url-status=dead |archiveurl=https://web.archive.org/web/20100611201857/http://research.yerkes.emory.edu/Howell/Synapse58.pdf |archivedate=2010-06-11 |citeseerx=10.1.1.327.1264 }}</ref> although not normally ones that are easily available. These are expected to be more cardiotoxic than phenyltropanes. For example, dimethocaine has behavioral stimulant effects (and therefore not here listed below) if a dose of it is taken that is 10 times the amount of cocaine. Dimethocaine is equipotent to cocaine in terms of its anesthetic equivalency.<ref name=Wilcox/> [[Local anesthetic#Treatment of overdose: \"Lipid rescue\"|Intralipid \"rescue\"]] has been shown to reverse the cardiotoxic effects of sodium channel blockers and presumably those effects when from cocaine administered intravenously as well.\n\n{| class=\"wikitable\"\n|+ [[List of local anesthetics]]\n|-\n! scope=\"col\" | Name\n! scope=\"col\" | Other common names\n|-\n| [[Amylocaine]] || Stovaine\n|-\n| [[Articaine]] || Astracaine, Septanest, Septocaine, Ultracaine, Zorcaine\n|-\n| [[Benzocaine]] ||\n|-\n| [[Bupivacaine]] || Marcaine, Sensorcaine, Vivacaine\n|-\n| [[Butacaine]] ||\n|-\n| [[Carticaine]] ||\n|-\n| [[Chloroprocaine]] || Nesacaine\n|-\n| [[Cinchocaine|Cinchocaine/Dibucaine]] || Cincain, Cinchocaine, Nupercainal, Nupercaine, Sovcaine\n|-\n| [[Cyclomethycaine]] || Surfacaine, Topocaine\n|-\n| [[Etidocaine]] ||\n|-\n| [[Eucaine]] || \u03b1-eucaine, \u03b2-eucaine\n|-\n| [[Fomocaine]]<ref name=\"SchoenbergerDamijonaitis2014\">{{cite journal|last1=Schoenberger|first1=Matthias|last2=Damijonaitis|first2=Arunas|last3=Zhang|first3=Zinan|last4=Nagel|first4=Daniel|last5=Trauner|first5=Dirk| authorlink5 = Dirk Trauner | title=Development of a New Photochromic Ion Channel Blocker via Azologization of Fomocaine|journal=ACS Chemical Neuroscience|volume=5|issue=7|year=2014|pages=514\u2013518|issn=1948-7193|doi=10.1021/cn500070w|pmid=24856540|pmc=4102962}} [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102962/ nih.gov article]</ref>||\n|-\n| [[Fotocaine]]<ref name=\"SchoenbergerDamijonaitis2014\"/>||\n|-\n| [[Hexylcaine]] || Cyclaine, Osmocaine\n|-\n| [[Levobupivacaine]] || Chirocaine\n|-\n| [[Lidocaine|Lidocaine/Lignocaine]] || Xylocaine, Betacain'''e'''\n|-\n| [[Mepivacaine]] || Carbocaine, Polocaine\n|-\n| [[Meprylcaine|Meprylcaine/Oracaine]] || Epirocain\n|-\n| [[Metabutoxycaine]] || Primacaine\n|-\n| [[Phenacaine|Phenacaine/Holocaine]] ||\n|-\n| [[Piperocaine]] || Metycaine\n|-\n| [[Pramocaine|Pramocaine/Pramoxine]] ||\n|-\n| [[Prilocaine]] || Citanest\n|-\n| [[Propoxycaine|Propoxycaine/Ravocaine]] ||\n|-\n| [[Procaine|Procaine/Novocaine]] || Borocaine (Procaine Borate), Ethocaine\n|-\n| [[Proparacaine|Proparacaine/Alcaine]] ||\n|-\n| [[Quinisocaine]] || Dimethisoquin\n|-\n| [[Risocaine]] ||\n|-\n| [[Ropivacaine]] || Naropin\n|-\n| [[Tetracaine|Tetracaine/Amethocaine]] || Pontocaine, Dicaine\n|-\n| [[Trimecaine]] || Mesdicain, Mesocain, Mesokain\n|}\n\n==Analogues for other purposes==\n\n===Tropanes (Non-ecgonine)===\n[[File:Homatropine.svg|x150px]]\n* [[Homatropine]]\n* [[Methylhomatropine]]\n[[File:Homatropine.svg|x150px]]\n[[File:Methylhomatropine bromide.svg|x150px]]\n\n===Benzamides===\n[[File:Mefexamide.svg|x150px|thumb|right|[[Mefexamide]] is not a benzamide, but it has structure that is related and is described as a central stimulant, and therefore more correctly a \"functional analog\". ''cf.'' the benzoate stimulants]]\n* [[Procainamide]] (also an aniline, like dimethocaine)\n[[File:Procainamide.svg|x180px]]\n\n===Toxins===\n[[File:Cocaine to Anatoxin-a.svg|thumb|right|700px|Cocaine to [[Anatoxin-a]]:<ref>{{cite journal|doi=10.1016/S0957-4166(00)00059-8|title=A new and efficient synthetic route to enantiopure (+)-anatoxin-a from (\u2212)-cocaine hydrochloride|journal=Tetrahedron: Asymmetry|volume=11|issue=6|pages=1405\u20131410|year=2000|last1=Wegge|first1=Thomas|last2=Schwarz|first2=Simone|last3=Seitz|first3=Gunther}}</ref>]]\n* [[Anatoxin-a]], also known as \"Very Fast Death Factor\" (VFDF), is an acutely toxic cyanotoxin with a method of action as an agonist of acetylcholine via those nicotinic class of receptors. Cocaine can be used as a precursor in its synthesis.\n{| class=\"wikitable\"\n|-\n| [[File:Anatoxin-a.png|x200px]]<br>VFDF<br><small>Note its eight, instead of seven, sides<br>(not counting the nitrogen-bridge inside ring)</small>||[[File:methylecgonidine.png|thumb|left|200px|''[[cf.]]'' [[methylecgonidine]], a [[pyrolysis]] product of cocaine freebase.]] ||[[File:Ferruginine.svg|200px|thumb|left|''[[cf.]]'' also: [[ferruginine]], a compound even more analogous to the former.<ref>[http://biol-chem.uwb.edu.pl/new/pdf/ferrugine_tet_aam_2012%20.pdf Approaches to the enantioselective synthesis of ferrugine and its analogues] Institute of Chemistry, University of Bialystok, ul. Hurtowa 1, 15-339 Bialystok, Poland</ref>]]\n|}\n[[File:UB-165_structure.png|thumb|right|[[UB-165]], a [[Nicotinic acetylcholine receptor|nAChR]] agonist of a subtype with a function leading to release of dopamine and noradrenaline in the brain.\n\n<small>(''n.b.'' UB-165 is similarly manufactured (in depicted \"''Cocaine-to-Anatonix\u2014a''\" schematic @ top current \u00a7) from numbered precursor intermediate '''7''', ''i.e.'' ''9-azabicyclo[4.2.1]nonan-2-one'')</small>]]\n[[File:Epibatidine structure.png|300px]]\n* [[Epibatidine]] <small>(''cf.'' [[nicotine]])</small>\n[[File:Pinnamine.png|250px]]\n* [[Pinnamine]] <small>(''vide supra''; locants shown)</small>\n[[File:3-quinuclidinyl_benzilate.svg]]\n* [[3-Quinuclidinyl benzilate]]<ref>{{cite journal | pmid = 7823767 | volume=56 | issue=3 | title=Antagonism of nicotine's action by cocaine analogs | journal=Life Sci | pages=PL67\u201370 | last1 = Lerner-Marmarosh | first1 = N | last2 = Carroll | first2 = FI | last3 = Abood | first3 = LG | doi=10.1016/0024-3205(94)00900-7 | year=1995}}</ref> <small>(synthetic deliriant used as [[incapacitating agent]])</small>\n[[File:EBOB.svg|160px]]\n* [[EBOB|1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo[2.2.2]octane]]<ref>{{cite journal|title=[3H]Ethynylbicycloorthobenzoate ([3H]EBOB) Binding in Recombinant GABAA Receptors|journal=Neurotoxicology|volume=24|issue=6|pages=817\u201324|doi=10.1016/s0161-813x(03)00051-2|pmid=14637376|year=2003|last1=Yagle|first1=M. A|last2=Martin|first2=M. W|last3=De Fiebre|first3=C. M|last4=De Fiebre|first4=N. C|last5=Drewe|first5=J. A|last6=Dillon|first6=G. H}}</ref><small> (GABA receptor antagonist neurotoxin)</small>\n{{Clear}}\n\n==See also==\n[[Cocaine-N-oxide|Cocaine-''N''-oxide]]: [[File:Cocaine N-oxide.svg|x180px]]\n[[Hydroxytropacocaine]]: [[File:Hydroxytropacocaine.svg|x150px]]\n[[m-Hydroxybenzoylecgonine|''m''-Hydroxybenzoylecgonine]]: [[File:M-Hydroxybenzoylecgonine.svg|x150px]]\n[[File:Cinnamoylcocaine.svg|thumb|[[Methylecgonine cinnamate]], an alkaloid widely considered inactive in its own right, but postulated to be active under pyrolysis. (''cf.'' alkylphenyltropane analogue \"[[List of cocaine analogues#3\u03b2-Alkylphenyltropane & 3\u03b2-Alkenyl analogues|224e]]\") It is, however, found in patents of active cocaine analogue structures.<ref>{{US patent|6479509}} Patent inventor Frank Ivy Carroll, Assignee: Research Triangle Institute</ref><ref>[https://patentimages.storage.googleapis.com/US6479509B1/US06479509-20021112-C00016.png U.S. patent US6479509 B1 structures given for submission, 5th compound down in image.]</ref>|right|x150px]]\n[[File:Methyl benzoate.svg|thumb|Cocaine HCl hydrolyzes in moist air and enucleates from on its tropane-skeleton arrangement to become the above compound; [[methyl benzoate]]|right|x150px]]\n* [[Coca alkaloid]]s, the ones relating to [[Biosynthesis of cocaine|cocaine biosynthesis]] include: benzoylecgonine, ecgonidine, ecgonine, hydroxytropacocaine, methylecgonine cinnamate, tropacocaine & truxilline\n* [[Cocaine#Pharmacology|Cocaine metabolites (Human)]], which include: benzoylecgonine (BE), ecgonine methyl ester (EME), ecgonine, norcocaine, ''p''-hydroxycocaine, ''m''-hydroxycocaine, ''p''-hydroxybenzoylecgonine (''p''OHBE) & ''m''-hydroxybenzoylecgonine\n* [[Dopaminergic]]s\n* [[Federal Analog Act]]\n* [[Pharmacophore]]\n* [[Pharmacopoeia]]\n* [[Pharmacokinetics]]\n* [[Pharmacodynamics]]\n\n'''Common analogues to prototypical [[Dopamine|D]]-[[Monoamine releasing agent|RAs]]:'''\n:*[[Substituted amphetamine]]s\n:*[[Substituted cathinone]]s\n:*[[Substituted phenethylamine]]s\n:*[[Substituted phenylmorpholine]]s\n:*[[Substituted methylenedioxyphenethylamine]]s\n\n==Notes (inclu. specific locations of citations from within references used)==\n{{Notelist|20em}}\n\n==References==\n{{Reflist}}\n\n==External links==\n{{commons category|Cocaine analogs}}\n* [http://www.wipo.int/pctdb/en/wo.jsp?wo=2003099783&IA=WO2003099783&DISPLAY=DESC U. S. Provisional Patent Application listing examples of compounds which are tropanes for prospective use in research]\n* [http://www.emory.edu/ACAD_EXCHANGE/2001/octnov/kuharqa.html Article on cocaine analogue research]\n* [http://chemicalland21.com/info/TROPANYL%20COMPOUNDS.htm List of tropanyl type molecules] and their [[CAS Registry Number]]s\n\n{{Phenyltropanes}}\n{{Stimulants}}\n{{Serotonergics}}\n{{Sigmaergics}}\n{{Anorectics}}\n{{Antidepressants}}\n{{Receptor agonists and antagonists}}\n\n{{DEFAULTSORT:Cocaine Analogues}}\n[[Category:Cocaine]]\n[[Category:Local anesthetics]]\n[[Category:Euphoriants]]\n[[Category:Carboxylate esters]]\n[[Category:Methyl esters]]\n[[Category:Tropanes]]\n[[Category:Chemical classes of psychoactive drugs]]\n", "name_user": "Rjwilmsi", "label": "safe", "comment": "Journal cites:,", "url_page": "//en.wikipedia.org/wiki/List_of_cocaine_analogues"}
{"title_page": "The Clipper", "text_new": "{{Distinguish|text=the ''[[New York Clipper]]''}}\n{{Use dmy dates|date=June 2019}}\n{{Infobox newspaper\n |image              = Clipper1.jpg\n |image_size         = 200\n |image_border       = yes\n |caption            = Edition of 23 September 1893\n |type               = [[Periodical]]\n |editor             = {{ubl|James Paton (1893)|[[Walter Woods (politician)|Walter Woods]] (1903)}}\n |launched           = {{start date|1893|04|08|df=y}}\n |political          = [[Socialism in Australia]]\n |ceased publication = {{end date|1909|12|25|df=y}}\n |publishing_city    = [[Hobart, Tasmania]]\n |ISSN               = 1839-714X\n}}\n'''''The Clipper''''' was a weekly labor-orientated newspaper published in [[Hobart, Tasmania]], from 8 April 1893 until 25 December 1909,<ref>{{cite web|title = The Clipper (Hobart, Tasmania: 1893\u20131909)|url = http://nla.gov.au/nla.news-title271|work = Trove|publisher = National Library of Australia|accessdate = 2013-11-29|df = dmy-all}}</ref> before its merger with the ''Daily Post'' in 1910.<ref>{{cite web|title = The Clipper (Newspaper, Serial, Microfilm)|url = http://catalogue.statelibrary.tas.gov.au/item/?q=clipper+newspaper&i=1&id=501075|publisher = LINC Tasmania|accessdate = 2013-11-29|df = dmy-all}}</ref><ref>{{cite web|title = Companion to Tasmanian History|url = http://www.utas.edu.au/library/companion_to_tasmanian_history/L/Labor%20Newspapers.htm|publisher = University of Tasmania|accessdate = 2013-11-29|df = dmy-all}}</ref>\n\n== History ==\nIts first editor was James Paton, a Christian socialist. [[Walter Alan Woods]] became editor and part owner in 1903, until the newspaper merged with the ''Daily Post'' in 1910.<ref>{{cite web|title = Woods, Walter Alan (1861\u20131939)|url = http://adb.anu.edu.au/biography/woods-walter-alan-9180|publisher = Australian Dictionary of Biography|accessdate = 2013-11-29|df = dmy-all}}</ref>\n\nThe paper has been digitised as part of the [[Australian Newspapers Digitisation Project]] by the [[National Library of Australia]].\n\n== See also ==\n* [[List of newspapers in Australia]]\n\n== Footnotes ==\n{{reflist}}\n\n== External links ==\n* {{trove newspaper|271|3=Hobart, Tasmania: 1893\u20131909}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Clipper}}\n[[Category:1893 establishments in Australia]]\n[[Category:1909 disestablishments in Australia]]\n[[Category:Australian labour movement]]\n[[Category:Defunct newspapers of Tasmania]]\n[[Category:Newspapers on Trove]]\n[[Category:Publications disestablished in 1909]]\n[[Category:Publications established in 1893]]\n[[Category:Socialist newspapers]]\n[[Category:Newspapers in Hobart, Tasmania]]\n", "text_old": "{{Distinguish|text=the ''[[New York Clipper]]''}}\n{{Use dmy dates|date=June 2019}}\n{{Infobox newspaper\n |image              = Clipper1.jpg\n |image_size         = 200\n |image_border       = yes\n |caption            = Edition of 23 September 1893\n |type               = [[Periodical]]\n |editor             = {{ubl|James Paton (1893)|[[Walter Woods (politician)|Walter Woods]] (1903)}}\n |launched           = {{start date|1893|04|08|df=y}}\n |political          = [[Socialism in Australia]]\n |ceased publication = {{end date|1909|12|25|df=y}}\n |publishing_city    = [[Hobart, Tasmania]]\n |ISSN               = 1839-714X\n}}\n'''''The Clipper''''' was a weekly labor-orientated newspaper published in [[Hobart, Tasmania]], from 8 April 1893 until 25 December 1909,<ref>{{cite web|title = The Clipper (Hobart, Tasmania: 1893\u20131909)|url = http://nla.gov.au/nla.news-title271|work = Trove|publisher = National Library of Australia|accessdate = 2013-11-29|df = dmy-all}}</ref> before its merger with the ''Daily Post'' in 1910.<ref>{{cite web|title = The Clipper (Newspaper, Serial, Microfilm)|url = http://catalogue.statelibrary.tas.gov.au/item/?q=clipper+newspaper&i=1&id=501075|publisher = LINC Tasmania|accessdate = 2013-11-29|df = dmy-all}}</ref><ref>{{cite web|title = Companion to Tasmanian History|url = http://www.utas.edu.au/library/companion_to_tasmanian_history/L/Labor%20Newspapers.htm|publisher = University of Tasmania|accessdate = 2013-11-29|df = dmy-all}}</ref>\n\n== History ==\nIts first editor was James Paton, a Christian socialist. [[Walter Alan Woods]] became editor and part owner in 1903, until the newspaper merged with the ''Daily Post'' in 1910.<ref>{{cite web|title = Woods, Walter Alan (1861\u20131939)|url = http://adb.anu.edu.au/biography/woods-walter-alan-9180|publisher = Australian Dictionary of Biography|accessdate = 2013-11-29|df = dmy-all}}</ref>\n\nThe paper has been digitised as part of the [[Australian Newspapers Digitisation Project]] project by the [[National Library of Australia]].\n\n== See also ==\n* [[List of newspapers in Australia]]\n\n== Footnotes ==\n{{reflist}}\n\n== External links ==\n* {{trove newspaper|271|3=Hobart, Tasmania: 1893\u20131909}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Clipper}}\n[[Category:1893 establishments in Australia]]\n[[Category:1909 disestablishments in Australia]]\n[[Category:Australian labour movement]]\n[[Category:Defunct newspapers of Tasmania]]\n[[Category:Newspapers on Trove]]\n[[Category:Publications disestablished in 1909]]\n[[Category:Publications established in 1893]]\n[[Category:Socialist newspapers]]\n[[Category:Newspapers in Hobart, Tasmania]]\n", "name_user": "John of Reading", "label": "safe", "comment": "\u2192\u200eHistory:Typo fixing, replaced:Australian Newspapers Digitisation Projectproject \u2192Australian Newspapers Digitisation Project", "url_page": "//en.wikipedia.org/wiki/The_Clipper"}
{"title_page": "The Beta Band (album)", "text_new": "{{Infobox album\n| name       = The Beta Band\n| type       = studio\n| artist     = [[The Beta Band]]\n| cover      = Betaband eponymous.jpg\n| alt        =\n| released   = 21 June 1999\n| recorded   = 1999\n| venue      =\n| studio     =\n| genre      = [[Psychedelic music|Psychedelia]], [[experimental music|experimental]], [[alternative pop]]\n| length     = 62:02\n| label      = {{hlist|[[Regal Zonophone Records|Regal]]|[[Astralwerks]]}}\n| producer   = {{hlist|The Beta Band|[[Chris Allison]]}}\n| prev_title = [[The Three E.P.'s]]\n| prev_year  = 1998\n| next_title = [[Hot Shots II]]\n| next_year  = 2001\n}}\n\n'''''The Beta Band''''' is the official studio debut album of [[The Beta Band]], released in June 1999 by [[Regal Records (1914)|Regal Records]]. The album followed the critically acclaimed compilation of their first three [[Extended play|EPs]] titled ''[[The Three E.P.'s]]'' (1998). With high anticipation for ''The Beta Band'', the band originally planned to record the album in four separate continents, but financial constraints slimmed the recording locations down; however, the album was still recorded in a variety of locations. The band approached creating the songs in a variety of ways, sometimes forming songs from single melodies, sometimes bringing together other strands of music, among other forms.\n\nThe album builds upon the experimental nature of their EPs, and is often seen as a particularly intricate, experimental and layered album, with a variety of different influences, sound effects, instrumentation and song structures. Based more-so around beat and rhythm than prior releases, the numerous different styles and influences incorporated into ''The Beta Band'' include [[psychedelia]], [[hip hop music|hip hop]] and [[blues music|blues]]. Vocalist [[Steve Mason (musician)|Steve Mason]] described his lyrics as fitting but without narrative interests. The band also recorded an [[ambient music|ambient]] bonus disc of two long compositions, but decided not to include the disc in the final release.\n\nUpon its release, the band made their dissatisfaction with the album public, infamously calling it \"fucking awful,\"<ref name=\"on-second\">{{cite web |url=http://www.stylusmagazine.com/articles/on_second_thought/the-beta-band-the-beta-band.htm |title=The Beta Band \u2013 The Beta Band \u2013 On Second Thought |work=[[Stylus Magazine]] |date=22 November 2005 |accessdate=8 November 2010 |last=Miller |first=Derek |archiveurl=https://web.archive.org/web/20170206104210/http://www.stylusmagazine.com/articles/on_second_thought/the-beta-band-the-beta-band.htm |archivedate=6 February 2017 |url-status=live }}</ref> largely blaming time constraints. Upon its release, it reached number 18 on the [[UK Albums Chart]]. Critics were favourable towards the album, although many found the album particularly messy and disappointing after the EPs. In later years however, several critics have found the album to be underrated and have praised its ambitions.\n\n==Background==\nIn 1997 and 1998, Scottish-based The Beta Band recorded their first releases, three EPs, ''[[Champion Versions]]'', ''[[The Patty Patty Sound]]'' and ''[[Los Amigos del Beta Bandidos]]'', which were met with high critical acclaim.<ref>{{cite web |last=Strong |first=Martin C. |authorlink=Martin C. Strong |title=The Beta Band Biography |url=http://thegreatrockbible.com/portfolio-item/beta-band-biography/ |website=The Great Rock Bible |accessdate=7 February 2017}}</ref> After signing to [[Regal Records (1914)|Regal Records]], a subsidiary of [[EMI]]'s label [[Parlophone]], the three EPs were released together as the album ''[[The Three E.P.'s]]'' in September 1998, which similarly was met with positive reviews.<ref>{{Cite web |url=http://www.netcomuk.co.uk/~tewing/ned/n43.html |title=The Beta Band \u2013 The Three EPs |work=[[Freaky Trigger]] |last=Raggett |first=Ned |date=November 1999 |archive-url=https://web.archive.org/web/20000518114629/http://www.netcomuk.co.uk/~tewing/ned/n43.html |archive-date=18 May 2000}}</ref><ref>{{cite web|last1=Warshaw|first1=Aaron|title=The Three E.P.'s \u2013 The Beta Band|url=http://www.allmusic.com/album/the-three-eps-mw0000048753|publisher=[[AllMusic]]|accessdate=7 February 2017}}</ref><ref>{{cite web|title=The Beta Band: The Three E.P.'s|url=http://www.popmatters.com/review/betaband-3eps/|website=[[PopMatters]]|accessdate=7 February 2017|archiveurl=https://web.archive.org/web/20170208035513/http://www.popmatters.com/review/betaband-3eps/|archivedate=8 February 2017|url-status=live}}</ref> In 1999, they signed to [[Astralwerks]] in the United States and the label subsequently released ''The Three E.P.'s'' in the country.<ref name=\"booklet2\">{{cite AV media notes| title = The Three E.P.'s| others= The Beta Band| year = 1999| type = liner| publisher = [[Astralwerks]]}}</ref> According to writer Ted Hedrickson, the band \u2013 consisting of multi-instrumentalists [[Steve Mason (musician)|Steve Mason]], [[Robin Jones (musician)|Robin Jones]], [[Richard Greentree]] and John MacLean \u2013 fused musical elements like [[ambient music|ambient]] [[drone (music)|drone]]s, [[trip hop]] beats and [[Pink Floyd]]-style introspective balladry to create their unique sound throughout their EPs, and that these releases \"served as a fabulous taster for the band's self-titled debut.\"<ref name=\"Hendrickson\" />\n\nBy the time of ''The Beta Band'', the group had undergone a successful, quick American tour while having become known in Britain for their live performances.<ref name=\"Hendrickson\" /> Their gigs typically featured films, a [[DJ set]] that they would perform before the show, and quirky on-stage sampling from Mclean.<ref name=\"Vanderloo\" /> Although anticipation for the band's official debut album was high,<ref name=\"on-second\" /> McLean later admitted they were \"sure a bit worried about doing an album.\"<ref name=\"Hendrickson\" /> They would later tour in the United States in promotion of ''The Beta Band''.<ref name=\"Hendrickson\" />\n\n==Writing and recording==\nEach song on the album was approached differently; some songs the band developed from a single idea or melody, while the chords and melodies of others were developed beforehand. Robin Jones stated \"We never really had a master plan ... after we did a song, we turned around and tried to do exactly the opposite. The most exciting songs were the ones where we were making something out of nothing.\"<ref name=\"great-scots\">{{cite web|last1=Perry|first1=Jonathan|title=Great Scots, It's the Beta Band!|url=https://www.rollingstone.com/music/news/great-scots-its-the-beta-band-19990613|website=[[Rolling Stone]]|date=13 June 1999|accessdate=6 February 2017}}</ref> Describing his lyrics for the record, vocalist Steve Mason explained he typically just followed \"the rhythms of the songs, more like a percussionist,\" and mentioned that the songs \"don't really tell a story. It's just words that go in there. They mean something, but they don't mean\u2026anything.\"<ref name=\"Vanderloo\" /> Despite some critics believing some of the tracks to be pastiches, the band explained to writer Lydia Vanderloo that they were not \"really into pastiche or irony or anything,\" with Maclean commenting, \"Everything's very serious and honest, hopefully. We're not so scared that we hide behind the irony that a lot of folks seem to hide behind these days.\"<ref name=\"Vanderloo\" /> Mason later explained to Hedrickson about the creation of the songs:\n{{quote|\"Each song starts differently, really. Some times it's a sample or a drum beat. Sometimes it's lyrics or a melody or something like that. It's different every time. [...] 'The Hard One' is a good example because we did something in a way we've never tried before. We don't really have songs where its verse and chorus, but the song has two verses and two choruses. Just to make it a bit more interesting we split everything up. We treated each section like a separate song. So the first verse was like one song. The second verse wasn't a copy at all and we tried to treat the choruses that way as well. Then we combined the songs together to make one song.\"<ref name=\"Hendrickson\" />}}\n\n[[File:Chris Allison.jpg|thumb|right|150px|[[Chris Allison]] co-produced ''The Beta Band''.]]\nAccording to [[Steve Taylor (author)|Steve Taylor]] in ''The A to X of Alternative Music'', none of the songs were prepared before the band entered the studio, which is where they were \"determined to keep their manual looping techniques.\"<ref name=\"The A to X of Alternative Music\">{{cite book|last1=Taylor|first1=Steve|title=The A to X of Alternative Music|date=27 September 2006|publisher=A&C Black|location=London|isbn=0826482171|page=32|url=https://books.google.com/books?id=KPOsu8JOHO8C&pg=PA32&dq=the+beta+band+1999&hl=en&sa=X&ved=0ahUKEwiCi5O3yvvRAhUFLcAKHUgQDFMQ6AEIMDAE#v=onepage&q=the%20beta%20band%201999&f=false}}</ref> The band's original intention for ''The Beta Band'' was for it to be a [[double album]] with each side of the LP recorded in a different continent, \"one in [[Tokyo]], one in [[Mexico]] and so on.\"<ref name=\"could-beta\"/> The band tried to plan this with their manager and Regal owner Miles Leonard, but ultimately Leonard dismissed the idea as impossible, \"it would have cost three-quarters of a million pounds or something and they would have lost the plot.\"<ref name=\"could-beta\"/>\n\nInstead, according to ''[[Spin (magazine)|Spin]]'', the album was at least partly recorded in a small hut belonging to Maclean's grandfather in a remote northwest part of Scotland, where the group found themselves with no room to sleep as they filled the hut with an excessive amount of musical equipment and homemade instruments.<ref name=\"space-jam\">{{cite journal|last1=McLean|first1=Craig|title=Space Jammers|journal=[[Spin (magazine)|Spin]]|date=June 1999|volume=15|issue=6|pages=114|url=https://books.google.com/books?id=xY9xO99TYMYC&pg=PA114&dq=spin+the+beta+band&hl=en&sa=X&ved=0ahUKEwjZsp3qu_vRAhXEVhQKHW6hBPEQ6AEIHjAB#v=onepage&q=spin%20the%20beta%20band&f=false|accessdate=6 February 2017}}</ref> [[Sawmills Studio]], [[Rockfield Studios]] and Jacobs Studio were also recording locations for the album.<ref name=\"MojoCollection\" /> In a 1999 interview, Mclean clarified that separate sections of the albums were recorded in different places: \"Four songs here, four songs somewhere else. You know, break it up a bit?\"<ref name=\"Hendrickson\">{{cite journal|last1=Hendrickson|first1=Tad|title=The Last Word|journal=[[CMJ New Music Monthly]]|date=12 July 1999|volume=59|issue=626|page=53|url=https://books.google.com/books?id=bzN6AY_LLbwC&pg=PA53&lpg=PA53&dq=cmj+beta+band+hard+one&source=bl&ots=lhetCEJyav&sig=k7CD3HJKcRAfQx-tcJfuEfthJKU&hl=en&sa=X&ved=0ahUKEwis4MXuvf7RAhXJPxQKHadBCfMQ6AEIIzAC#v=onepage&q=cmj%20beta%20band%20hard%20one&f=false|accessdate=7 February 2017}}</ref> As with the band's prior releases, The Beta Band co-produced the album with [[Chris Allison]], who also engineered it, although the band's manager later admitted he felt the collaboration was not as successful this time.<ref name=\"could-beta\">{{cite web|title=Could Do Beta?|url=http://www.nme.com/news/music/beta-band-47-1386956|website=[[NME]]|accessdate=6 February 2017|date=15 May 1999}}</ref>\n\n===Ambient bonus disc===\nIn one of their attempts to \"make something out of nothing,\"<ref name=\"great-scots\"/> the band had originally intended the album to contain a bonus disc of two long form [[ambient music|ambient]] pieces, \"Happiness and Colour\" and \"The Hut\", both of which lasted over 20 minutes and represented the band's desire to \"make a record of sound as a description for something like happiness, where a distinct first part gives way to a distinct second part\".<ref name=\"great-scots\"/> The band's idea to record ''The Beta Band'' in Maclean's grandfather's hut was so they could record the sounds of the ocean for these pieces, and during which they discussed the possibility of a quadruple album.<ref name=\"space-jam\"/> After the band returned to London, they had with them several hours of audio that they had recorded, which were then edited down into the two tracks.<ref name=\"space-jam\"/>\n\nAccording to Craig McLean of ''[[Spin (magazine)|Spin]]'', \"both sounded a little random, like a radio scanning across the ether.\"<ref name=\"space-jam\"/> However, the band ultimately decided to remove these tracks from the album. Jones recalled: \"We liked some of what we recorded, but it's not really what we wanted it to be from start to finish. We felt the second part was lacking in direction.\"<ref name=\"great-scots\"/> Nonetheless, this decision came several weeks after the band's record label had already included the ambient disc with promotional copies of the album distributed to various people in the music industry.<ref name=\"great-scots\"/> Drummer Robin Jones felt the reason they dropped the disc was because they were rushed into constructing it in only four days, saying they intended it to be \"an ambient\u2026 sound-piece. It\u2019s really indulgent on our part, but I wanted to make it a musical story. In the same way ''[[Chill Out (KLF album)|Chill Out]]'' by [[The KLF]] is a story. So it sort of succeeds. It just needed more\u2026 conclusions. Rushed again.\"<ref name=\"could-beta\"/> The bonus disc was eventually released officially alongside special editions of the album's 2018 remaster.<ref name=\"Rough Trade\">{{cite web |title=Beta Band The Beta Band (Deluxe Edition) |url=https://www.roughtrade.com/gb/music/beta-band-the-beta-band-deluxe-edition |website=Rough Trade |accessdate=14 May 2019}}</ref>\n\n==Composition==\n===Musical style===\n{{quote box|quote=\"''The Beta Band'' swerves crazily from [[Wagnerian]] drama ('It's Not So Beautiful') to futurist [[country-rock]] ('Broken Up Like a Ding-Dong'), with detours into [[prog-rock]], proto-[[Hip hop music|hip-hop]] and [[ambient dub]].\"|source=\u2014Craig Mclean of ''[[Spin (magazine)|Spin]]''.<ref name=\"space-jam\" />|width=20%|align=right|style=padding:8px;|border=2px}}\n\n''The Beta Band'' is an [[experimental music|experimental]],<ref name=\"on-second\" /> sonically complex,<ref name=\"allmusic-review\" /> dense and detailed album.<ref name=\"allmusic-review\" /> Unlike the band's previous EPs, which presented their varied genre influences in a less coarse way, the album is more abstract<ref name=\"Hendrickson\" /> and beat-minded,<ref name=\"Hart\" /> fusing genres more abrasively,<ref name=\"regal-years\">{{cite web|last1=Berman|first1=Stuart|title=The Beta Band: The Regal Years: 1997\u20132004|url=http://pitchfork.com/reviews/albums/18603-the-beta-band-the-regal-years-1997-2004/|website=[[Pitchfork (website)|Pitchfork]]|accessdate=6 February 2017|date=4 November 2013}}</ref> whilst being less influenced by [[folk music]].<ref name=\"Hendrickson\" /> Described by [[AllMusic]]'s Jason Ankeny as \"a brashly schizophrenic freak-out which weaves its way throughout the history of rock & roll,\"<ref name=\"allmusic-review\" /> the album crosses a wide variety of musical ground which, in the words of ''[[CMJ New Music Monthly]]'', makes it \"hard to locate exactly where the foursome are coming from.\"<ref name=\"Vanderloo\" /> Ankeny, describing the styles, said: \"[[Pop music|Pop]], [[blues]], [[folk music|folk]], [[psychedelia]], [[hip-hop]] -- they're all here, sometimes even colliding within the same song; the disc somehow sounds almost completely different with each successive listen, consistently revealing new layers and possibilities.\u201d<ref name=\"allmusic-review\" />\n\nThe ten songs on the album rely on a snippet of melody, often sung and played on acoustic guitar by Steve Mason, but surrounding his voice are not only guitars or drums but many other, more unusual instruments and techniques, including [[sampling (music)|samples]], [[xylophones]], [[sleigh bell]]s, [[hand claps]], [[spoon]]s, and a diversity of [[bird song|bird whistle]]s, including a [[cuckoo]],<ref name=\"Vanderloo\" /> with its songs integrating numerous [[tape loop]]s and offbeat [[breakbeat]]s into what writer Ron Hart called the album's \"[[ambient music|ambient]] [[classic rock]] jams and textured pop melodies.\"<ref name=\"Hart\" /> The music is said to disregard melody and other examples of [[musical theory]] such as verses and choruses in favour a chaotic approach.<ref name=\"allmusic-review\" /> Jonathan Perry of ''[[Rolling Stone]]'', describing the tracks, said:\n{{quote|\"Each track unfolds into panoramic vistas of texture and sound that suggest other ethereal worlds even as the band's approach remains rooted in organic instrumentation like acoustic guitar and percussion and lyrics that often amount to little more than earth-bound mantra-like chants. It's that sense of improvisational freedom within the framework of a specific song that gives the band's material its expansive flair\"<ref name=\"great-scots\" />}}\n\nAs with prior albums, the band's early [[Pink Floyd]] influence is prominent throughout ''The Beta Band'',<ref name=\"Hart\" /> although hip hop is said to be a more prominent influence on this record,<ref name=\"great-scots\" /> with rapping, splicing and samples appearing prominently.<ref name=\"Vanderloo\" /> Mason hoped, regardless of the \"really obvious\" criss-cross of styles on \"The Beta Band Rap\", the band's various influences throughout the rest of ''The Beta Band'' would sound \"a bit more subtly involved.\"<ref name=\"Vanderloo\" /> He also felt the record was both a conscious and natural effort, adding \"it's just something we all really wanted to do,\"<ref name=\"Hendrickson\" /> while Greentree himself described the album as \"like a bird without all the fleshy bits and feathers.\"<ref name=\"Vanderloo\" /> ''[[Stylus Magazine]]''{{'}}s Derek Miller called the album a \"testimony to balls-out astral tribalism\" which features \"some of the more singular '[[alternative pop|alt-pop]] music' of the last decade,\" while doing so \"in a veiled manner that never shows its hand until you\u2019re four songs deep and still stuck in thought about the first.\u201d<ref name=\"on-second\" />\n\n===Songs===\n\"The Beta Band Rap\" opens the album and consists of three distinctive parts, opening with a spirited [[marching band]] introduction that segues into a rap section whose lyrics recount the band's history to date in detail,<ref name=\"regal-years\"/> describing the band's formation, signing to [[Parlophone]] subsidiary label [[Regal Records (1914)|Regal Records]] and \"drinking champagne at [[EMI]].\"<ref name=\"great-scots\" /> It was described by writer Stuart Berman as \"actually equal parts [[barbershop quartet|barbershop-quartet]] serenade, proto-'[[Lazy Sunday (The Lonely Island song)|Lazy Sunday]]' faux [[b-boy]] braggadocio, and [[Elvis Presley|Elvis]] pelvis thrusts.\"<ref name=\"regal-years\"/> \"It's Not Too Beautiful\" follows, starting with pulsating guitars that push \"a wished whirlpool sound\" and followed by Mason's [[multitrack recording|multitracked]] vocals.<ref name=\"on-second\" /> According to one review, \"the song seems to take flight on the whirl of a helicopter, with blades blunted and made soft by the dander in the air.\"<ref name=\"on-second\" /> \"Simple Boy\" is a quieter song, backed by atmospheric changes.<ref name=\"on-second\" />\n\n{{quote box|quote=\"The Beta Band were always headstrong, and here you see them chasing their own tails in wild-eyed delight, summoning all the fires of the forest and the scattered stars in the sky to cast light on their studio jams.\"|source=\u2014Derek Miller of ''[[Stylus Magazine|Stylus]]''<ref name=\"on-second\" />|width=20%|align=left|style=padding:8px;|border=2px}}\nDescribed as a [[country rock]] ramble,<ref name=\"regal-years\"/> \"Round the Bend\" is among the more focused songs.<ref name=\"Bowe\" /> Mason's very specific lyrics are displayed as internal monologue as he recalls a disappointing night.<ref name=\"Bowe\" /> He blends simple thoughts about drinking and dinner with travel fantasies about pyramids, opinions on [[the Beach Boys]]' ''[[Wild Honey (album)|Wild Honey]]'' and \"moments of deep awkwardness\".<ref name=\"Bowe\" /> A jam of both organic and electronic elements, \"Dance O\u2019er the Border\" is heavy on repetition and percussion and lacks a melody for the first four minutes, while featuring lyrics that forgo verses, choruses and rhyming in favour of Mason spoken, [[stream-of-consciousness]] comments.<ref name=\"Bowe\" /> Miles Bowe named it the album's best song and the band's fifth best overall, saying that although not \"very representative of the Beta Band's sound,\" it \"does a pretty great job\" of anticipating [[LCD Soundsystem]].<ref name=\"Bowe\" />\n\n\"Brokenupadingdong\" and \"Smiling\" were compared to [[Julian Cope]] by writer Tom Ewing, who described them as \"ramshackle campfire clapalong jams with a powerful communal momentum\" that partly recall [[Amon Duul I]], [[Can (band)|Can]] and late 1980s British [[house music]].<ref name=\"Ewing\" /> Between them is \"Number 15\", a frustrated song with an emphasis on dance music and unusual choral refrains,<ref name=\"on-second\" /> alongside [[gamelan]] elements played with [[kitchen utensil]]s.<ref name=\"Ewing\" /> \"The Hard One\" was partly inspired by [[Bonnie Tyler]]'s 1983 hit \"[[Total Eclipse of the Heart]]\". The band sampled the piano motif from the song, and \"although [they] put it through stuff,\" they declared it \"their cover version\"; \"We switched the lyrics to the chorus around\", Mason told ''[[CMJ New Music Monthly|CMJ]]'', \"I thought that it was a great song, so we ended up writing a tune around it.\"<ref name=\"Hendrickson\" /> [[Jim Steinman]], who wrote and produced \"Total Eclipse of the Heart\", threatened the band with legal action over using its lyrics, \"Once upon a time I was falling in love, now I'm only falling apart,\"<ref name=\"CMJJune1999\" /> which the band changed slightly so that they became \"Once upon a time I was falling apart, now I'm only falling in love,\"<ref name=\"Day\">{{cite journal |last1=Day |first1=Adrienne |title=Reviews |journal=Vibe |date=August 1999 |volume=6 |issue=10 |page=181 |url=https://books.google.co.uk/books?id=YygEAAAAMBAJ&pg=PA181&dq=beta+band+hard+one+falling+in+love&hl=en&sa=X&ved=0ahUKEwjn_e_x1JviAhUHRBUIHY9DBUcQ6AEILDAB#v=onepage&q=beta%20band%20hard%20one%20falling%20in%20love&f=false |accessdate=14 May 2019}}</ref> but changed his mind after he heard the song.<ref name=\"CMJJune1999\">{{cite journal|title=Steinman Backs Off The Beta Band|journal=CMJ New Music Monthly|date=28 June 1999|volume=59|issue=624|page=11|url=https://books.google.com/books?id=zDJToDVsTA4C&pg=PA11&lpg=PA11&dq=cmj+beta+band+hard+one&source=bl&ots=Y8n44wN_IV&sig=N0LpxbU4lxzJu6o8aoUWlSjSjj8&hl=en&sa=X&ved=0ahUKEwis4MXuvf7RAhXJPxQKHadBCfMQ6AEIITAB#v=onepage&q=cmj%20beta%20band%20hard%20one&f=false|accessdate=7 February 2017}}</ref> \"The Cow's Wrong\" closes the record in a muted fashion.<ref>{{cite web |last1=Costa |first1=Maddy |title=The Beta Band Astoria, London |url=https://www.theguardian.com/culture/2000/jan/27/artsfeatures5 |website=The Guardian |accessdate=14 May 2019 |date=27 January 2000}}</ref><ref name=\"Schreiber\" />\n\n==Release and promotion==\n\n''The Beta Band'' was highly anticipated,<ref name=\"on-second\" /><ref name=\"space-jam\" /><ref name=\"great-scots\"/> with  ''Spin'' calling it \"one of the most anticipated releases in Britain since [[Oasis (band)|Oasis]]' ''[[Definitely Maybe]]''.\"<ref name=\"space-jam\"/> Prior to release, ''The Beta Band'' was played before an invite-only industry audience in a studio/bar in [[Shoreditch]], [[London]], which included [[Noel Gallagher]] and [[The Verve|Verve]] guitarist [[Nick McCabe]]. The band were in attendance, \"looking slightly embarrassed, like gate crashes at a party in their own home,\" according to Craig McLean.<ref name=\"space-jam\"/> Gallagher praised the album when talking to an ''NME'' journalist.<ref name=\"space-jam\"/> As the band told Lydia Vanderloo of ''[[CMJ New Music Monthly]]'', the band did not enjoy promoting the album.<ref name=\"Vanderloo\">{{cite journal|last1=Vanderloo|first1=Lydia|title=Motley Stew|journal=CMJ New Music Monthly|date=July 1999|issue=71|pages=32\u201334|url=https://books.google.com/books?id=sikEAAAAMBAJ&pg=PA32&lpg=PA32&dq=THE+BETA+BAND+CMJ&source=bl&ots=hLXvOyV3Db&sig=Kct4_l_1y9AutMyVcTkSIclZh_w&hl=en&sa=X&ved=0ahUKEwii_tOx4v3RAhUJrxoKHT_9C7sQ6AEIIDAC#v=onepage&q=THE%20BETA%20BAND%20CMJ&f=false|accessdate=7 February 2017}}</ref> ''The Beta Band'' was released by [[Regal Records (1914)|Regal Records]] in the United Kingdom on 21 June 1999,<ref name=\"MojoCollection\">{{cite book|title=The Mojo Collection: The Ultimate Music Companion|date=2007|publisher=Canongate Books|location=Edinburgh|isbn=1841959731|page=664|url=https://books.google.co.uk/books?id=AVQbF9lTBwgC&pg=PA664&lpg=PA664&dq=the+beta+band+21+june+1999+regal&source=bl&ots=NbImmzFrgV&sig=ACfU3U0601H3r4e56WYU6NKZr1WcWs4PnQ&hl=en&sa=X&ved=2ahUKEwiNyOjv25viAhWO2hQKHUhuCrkQ6AEwBHoECAgQAQ#v=onepage&q=the%20beta%20band%2021%20june%201999%20regal&f=false|accessdate=14 May 2019}}</ref> and by [[Astralwerks]] in the United States on 29 June 1999.<ref name=\"Hart\" /> Astralwerks also released \"Round the Bend\" and \"The Cow's Song\" as a promotional cassette single in the US.<ref name=\"booklet1\">{{cite AV media notes| title = Round the Bend/The Cow's Song| others= The Beta Band| year = 1999| type = liner| publisher = Astralwerks}}</ref> Upon its release, ''The Beta Band'' debuted and peaked at number 18 on the [[UK Albums Chart]] and stayed on the chart for two weeks.<ref>{{cite web|title=Beta Band|url=http://www.officialcharts.com/artist/3413/beta-band/|publisher=[[Official Charts Company]]|accessdate=7 February 2017}}</ref>\n\n===Band denouncement===\n[[File:SteveMason.jpg|thumb|140px|Band leader [[Steve Mason (musician)|Steve Mason]] (''pictured in 2010'') infamously denounced the album.]]\nA week prior to the album's release, Steve Mason infamously denounced the album as \"fucking awful\", adding that \"it\u2019s definitely the worst record we\u2019ve ever made and it\u2019s probably one of the worst records that\u2019ll come out this year.\"<ref name=\"could-beta\" /><ref name=\"Bowe\" >{{cite web|last1=Bowe|first1=Miles|title=The 10 Best Beta Band Songs|url=http://www.stereogum.com/1655001/the-10-best-beta-band-songs/franchises/10-best-songs/|website=[[Stereogum]]|accessdate=7 February 2017|date=6 February 2014}}</ref><ref name=\"allmusic-review\"/> Speaking to the ''[[NME]]'', he said the album contained \"some terrible songs,\" opining that none of the album's tracks were fully written or developed, dismissing them as \"[h]alf-written songs with jams in the middle.\u201d<ref name=\"could-beta\"/> Greentree felt the production should have been less muddy, while McLean noted that their apparent shortcomings were the band's fault; however, the band also blamed Regal for their dissatisfaction with the final album, including the abandoning of the ambient disc, which they saw as having been incomplete, and for not providing them with enough time or money to work on the album satisfyingly.<ref name=\"could-beta\"/>\n\nThe statements immediately caused tension between the band and their label; ''[[The Guardian]]'' quoted \"an enraged EMI chairman\" as demanding to know \"what the fuck is going on with the Beta Band?\"<ref>{{cite web|last1=Simpson|first1=Dave|title=Steve Mason: Out of the blackness|url=https://www.theguardian.com/music/2010/apr/06/steve-mason-beta-band-interview|website=[[The Guardian]]|accessdate=6 February 2017|date=6 April 2010}}</ref> The newspaper said the band \"began a public slagging match with their record company.\"<ref name=\"Petridis\">{{cite web|last1=Petridis|first1=Alexis|authorlink=Alexis Petridis|title=Effing but blinding|url=https://www.theguardian.com/lifeandstyle/2001/nov/30/shopping.artsfeatures|website=The Guardian|accessdate=6 February 2017|date=30 November 2001}}</ref> Miles Leonard, boss of Regal and the band's manager, dismissed their complaints, calling them \"lame excuses\" as \"they had as much time as they wanted to have to make it, they were not forced to do anything they didn't want to.\"<ref name=\"could-beta\"/> However, he did admit that some of the financial constraints lead him to prevent the band's continental recording idea, but felt the album was \"nowhere near as bad as they say,\" despite feeling it could have better.<ref name=\"could-beta\"/> By the time of follow-up album ''[[Hot Shots II]]'' (2001), the band's opinion on ''The Beta Band'' had not changed and spoke out against it being mentioned to them in interviews, with Greentree adding: \"We just never felt the album was properly finished.\"<ref name=\"Petridis\" />\n\n==Critical reception==\n{{Album ratings\n| rev1       = [[AllMusic]]\n| rev1Score  = {{Rating|4|5}}<ref name=\"allmusic-review\">{{cite web |url=http://www.allmusic.com/album/the-beta-band-mw0000667113 |title=The Beta Band \u2013 The Beta Band |last=Ankeny |first=Jason |publisher=AllMusic |accessdate=6 February 2017}}</ref>\n| rev2       = ''[[Entertainment Weekly]]''\n| rev2Score  = A\u2212<ref>{{cite web |url=http://ew.com/article/1999/07/16/beta-band-2/ |title=The Beta Band |last=Hermes |first=Will |authorlink=Will Hermes |work=[[Entertainment Weekly]] |date=16 July 1999 |accessdate=24 April 2017}}</ref>\n| rev3       = ''[[The Guardian]]''\n| rev3Score  = {{Rating|4|5}}<ref>{{cite news |title=Beta by far |last=Sullivan |first=Caroline |work=The Guardian |date=18 June 1999}}</ref>\n| rev4       = ''[[The Independent]]''\n| rev4Score  = {{Rating|3|5}}<ref>{{cite news |url=https://www.independent.co.uk/arts-entertainment/pop-album-reviews-1101119.html |title=Pop: Album Reviews |last=Perry |first=Tim |work=[[The Independent]] |date=19 June 1999 |accessdate=30 March 2020}}</ref>\n| rev5       = ''[[The List (magazine)|The List]]''\n| rev5Score  = {{Rating|5|5}}<ref>{{cite journal |url=https://archive.list.co.uk/the-list/1999-06-10/47/ |title=The Beta Band: The Beta Band (Regal) |last=Mabbott |first=Alastair |work=[[The List (magazine)|The List]] |issue=361 |date=10 June 1999 |accessdate=20 July 2017 |page=45}}</ref>\n| rev6       = ''[[NME]]''\n| rev6Score  = 6/10<ref>{{cite web |url=http://www.nme.com:80/reviews/reviews/19990516151016reviews.html |title=The Beta Band \u2013 The Beta Band |last=Mulvey |first=John |work=NME |date=16 June 1999 |accessdate=24 April 2017 |archiveurl=https://web.archive.org/web/20000817222055/http://www.nme.com/reviews/reviews/19990516151016reviews.html |archivedate=17 August 2000 |url-status=dead}}</ref>\n| rev7       = ''[[Pitchfork (website)|Pitchfork]]''\n| rev7Score  = 8.6/10<ref name=\"Pitchfork review\">{{cite web |url=http://www.pitchforkmedia.com/article/record_review/15407/Beta_Band_The_Beta_Band |title=Beta Band: The Beta Band |last=DiCrescenzo |first=Brent |work=Pitchfork |date=1 July 1999 |accessdate=7 February 2017 |archiveurl=https://web.archive.org/web/20080509203205/http://www.pitchforkmedia.com/article/record_review/15407-the-beta-band |archivedate=9 May 2008 |url-status=dead}}</ref>\n| rev8       = ''[[Q (magazine)|Q]]''\n| rev8Score  = {{Rating|4|5}}<ref>{{cite journal |title=The Beta Band: The Beta Band |work=[[Q (magazine)|Q]] |issue=155 |date=August 1999 |page=102}}</ref>\n| rev9       = ''[[Rolling Stone]]''\n| rev9Score  = {{Rating|3|5}}<ref name=\"RS review\">{{cite web |url=https://www.rollingstone.com/artists/thebetaband/albums/album/116673/review/5941751/the_beta_band |title=The Beta Band: The Beta Band |last=Sheffield |first=Rob |authorlink=Rob Sheffield |work=Rolling Stone |date=8 July 1999 |accessdate=7 February 2017 |archiveurl=https://web.archive.org/web/20100111050221/http://www.rollingstone.com/artists/thebetaband/albums/album/116673/review/5941751/the_beta_band |archivedate=11 January 2010 |url-status=dead}}</ref>\n| rev10       = ''[[Select (magazine)|Select]]''\n| rev10Score  = 3/5<ref>{{cite journal |title=The Beta Band: The Beta Band |last=Harris |first=John |authorlink=John Harris (critic) |work=[[Select (magazine)|Select]] |issue=109 |date=July 1999 |page=89}}</ref>\n}}\n\n''The Beta Band'' was less well received by music critics than the Beta Band's previous releases.<ref name=\"on-second\" /> According to ''[[Pitchfork (website)|Pitchfork]]''{{'}}s Stuart Berman, the album \"deflated the ballooning expectations surrounding the group in the wake of ''The Three EPs'' with all the elegance and subtlety of a whoopee cushion.\"<ref name=\"regal-years\"/> While many critics praised the band's ambitions, the album was also concurrently criticised as overstuffed and messy.<ref name=\"allmusic-review\" /><ref name=\"The A to X of Alternative Music\"/> In a retrospective piece, Derek Miller of ''[[Stylus Magazine]]'' disagreed that it was messy, saying it was \"brave and cohesive,\" and noted how \"they manage to somehow form a whole out of shattered, uneven pieces. It\u2019s awkward, [[Salvador Dal\u00ed|Dalian]], almost completely disinterested in closing the circle, and that\u2019s the beauty in its madness.\"<ref name=\"on-second\" />\n\nAmong original reviews, Brent DiCrescenzo of ''[[Pitchfork (website)|Pitchfork]]'' hailed ''The Beta Band'' as a unique sounding album that was \"so psychedelic, yet not excessively experimental.\"<ref name=\"Pitchfork review\"/> Ron Hart, writing for ''[[CMJ New Music Monthly]]'', was favourable, praising the album and its \"experimental dabblings\" a \"fully realised concept.\"<ref name=\"Hart\">{{cite journal|last1=Hart|first1=Ron|title=Must Hear|date=21 June 1999|work=CMJ New Music Monthly|volume=59|issue=623|page=3|url=https://books.google.com/books?id=n-JzBKPWncQC&pg=PA3&lpg=PA3&dq=THE+BETA+BAND+CMJ&source=bl&ots=k0egKUSIwh&sig=7EnVlpa7HRKrMY1Kwn8qMylJgCo&hl=en&sa=X&ved=0ahUKEwjbqYPo6P3RAhUFnBoKHf1yDs0Q6AEIMTAF#v=onepage&q=THE%20BETA%20BAND%20CMJ&f=false|accessdate=7 February 2017}}</ref> [[Rob Sheffield]] of ''[[Rolling Stone]]'' said the band \"layer warped voices, pastoral guitars and random sound effects over slow-motion loops to evoke a chance meeting between [[King Crimson]] circa 1969 and [[Happy Mondays]] circa 1989,\" highlighting \"The Cow's Wrong.\"<ref name=\"RS review\"/> [[Robert Christgau]] of ''[[The Village Voice]]'' gave the album a three-star honourable mention rating, signifying \"an enjoyable effort consumers attuned to its overriding aesthetic or individual vision may well treasure.\"<ref>{{cite book |chapter-url=http://www.robertchristgau.com/xg/bk-cg90/grades-90s.php |chapter=Key to Icons |accessdate=7 February 2017 |title=[[Christgau's Consumer Guide: Albums of the '90s]] |last=Christgau |first=Robert |authorlink=Robert Christgau |publisher=[[St. Martin's Press]] |year=2000 |isbn=0-312-24560-2}}</ref> He stated that the band is \"still lost in sound, but oriented enough here to make tunes out of it.\"<ref name=\"Christgau\">{{cite book |chapter-url=https://www.robertchristgau.com/get_album.php?id=3495 |chapter=The Beta Band: The Beta Band |accessdate=6 February 2017 |title=Christgau's Consumer Guide: Albums of the '90s |last=Christgau |first=Robert |publisher=St. Martin's Press |year=2000 |isbn=0-312-24560-2 |url-access=registration |url=https://archive.org/details/christgausconsum00chri_0 }}</ref>\n\nWriting several months after the release of ''The Beta Band'', Tom Ewing of ''[[Freaky Trigger]]'' called it \"the most troublesome album of 1999,\" highlighting how \"its makers disown it, its few disciples adore it, a whole lot of people hate it, and a whole lot more like me just don't know what to make of it, but keep playing it anyway. While there are certainly good bits and bad bits on ''The Beta Band'', it\u2019s not always possible to work out which is which, let alone pull them apart. And the funny thing is that after a few months you stop caring and just take the whole damn lot as it comes.\"<ref name=\"Ewing\">{{cite web|last1=Ewing|first1=Tom|title=Messthetics: The Beta Band \u2013 The Beta Band|url=http://freakytrigger.co.uk/ft/1999/10/beta/|website=Freaky Trigger|accessdate=27 May 2017|date=17 October 1999}}</ref>\n\nAt the end of 1999, ''The Beta Band'' was ranked in several publications' lists of the year's best albums; ''Intro'' named it 9th,<ref name=\"acclaimed\">{{cite web|title=The Beta Band|url=http://www.acclaimedmusic.net/Current/A3767.htm|publisher=[[Acclaimed Music]]|accessdate=7 February 2017}}</ref> ''[[Mojo (magazine)|Mojo]]'' named it the 10th,<ref name=\"acclaimed\" /> ''[[Rockdelux]]'' named it the 26th,<ref name=\"acclaimed\" /> ''[[Muzik]]'' named it the 27th,<ref name=\"acclaimed\" /> and ''[[NME]]'' named it the 36th.<ref>{{Cite web |url=http://www.nme.com/bestalbumsandtracksoftheyear/1999-2-1045360 |title=Albums And Tracks of the Year: 1999 |work=NME |access-date=9 February 2017}}</ref> In a retrospective review, [[AllMusic]] critic Jason Ankeny thought that the album \"constantly runs the risk of collapsing into complete self-indulgence.\" Nevertheless, Ankeny further stated: \" In its way the Beta Band's genius is their wanton disregard for niceties like verses, choruses, and melodies; rejecting musical theory in favor of the chaos theory, the album's neither a masterpiece nor a mess, but both.\"<ref name=\"allmusic-review\"/> Miles Bowe of ''[[Stereogum]]'' have conceded no less that \"everyone knew that the record was rushed, and that maybe the band didn\u2019t have enough time to fully develop the songs or lyrics as much,\" while also noting that \"people tend to forget that ''The Beta Band'' is not 'fucking awful' \u2014 it\u2019s actually pretty fucking great.\"<ref name=\"Bowe\" />\n\n==Legacy==\n{{quote box|quote=\"''The Beta Band'' stands as a time capsule of possibly the last instance when a group this strange could not just get signed to a major label, but use the company dime to make themselves sound even stranger.\"|source=\u2014Stuart Berman of ''[[Pitchfork (website)|Pitchfork]]'', 2013<ref name=\"regal-years\"/>|width=25%|align=right|style=padding:8px;|border=2px}}\nIn retrospect, ''The Beta Band'' has been re-assessed by some critics and considered underrated.<ref name=\"The Best of the Beta Band\">{{cite web|last1=Harvell|first1=Jess|title=The Beta Band: The Best of the Beta Band|url=http://pitchfork.com/reviews/albums/672-the-best-of-the-beta-band/|website=Pitchfork|accessdate=6 February 2017|date=3 October 2005}}</ref><ref name=\"regal-years\"/>\nWriting in 2005, Jess Harvell of ''[[Pitchfork (website)|Pitchfork]]'' felt the band were neglected by critics and said \"there's not a single band in the past year with the balls\u2013 or lack of sense, your call\u2013 to release a debut album as overgrown with ideas (not always good ones, mind you) as ''The Beta Band''.\"<ref name=\"The Best of the Beta Band\"/> Stuart Berman, also of ''Pitchfork'', described ''The Beta Band'' as the group's most notorious release and felt it was the last known example of a \"group this strange\" signing to a major label and then using their new label to make even stranger music, especially when considering the abandoned ambient bonus disc. \"If the record violently vascillates between fascinating and frustrating on a song-by-song basis,\" he said, \"its over-arching oddness retains its own peculiar allure.\"<ref name=\"regal-years\"/>\n\nDerek Miller of ''[[Stylus Magazine]]'' said that by the time the band split up in 2004, ''The Beta Band'' was widely considered to be \"unnecessarily difficult, a short side-step in the career of a remarkably talented band,\" but he felt the album had been long underrated and was due for re-evaluation, praising its unique sound and adding that it \"remains the broken-toothed step-child with a little bit of dander on the lip and a tangle of hair on its back, but Christ those eyes, so keen and full of mischief, forgive the ugly parts.\"<ref name=\"on-second\"/> ''Pitchfork'' founder Ryan Schreiber called ''The Beta Band'' \"the greatest acid-burnt full-length of the late 90's\", saying that although it \"took some getting used to, since half of its songs were, to put it gently, cracked,\" the \"densely layered electronic psychedelia\" songs proved the band as \"one of the few modern electronic-based bands capable of successfully splicing hundreds of self-created sources into huge, pastoral symphonies, grounded in both pop music and [[Salvador Dali|Dali]] [[surrealism]].\"<ref name=\"Schreiber\">{{cite web|last1=Schreiber|first1=Ryan|title=The Beta Band|url=http://pitchfork.com/features/interview/5825-the-beta-band/|website=Pitchfork|accessdate=6 February 2017|date=1 August 2001}}</ref> The album is featured in ''[[Mojo (magazine)|Mojo]]'' magazine's book ''The Mojo Collection'', which lists what its authors consider to be the 1,000 greatest albums of all time.<ref name=\"acclaimed\"/><ref name=\"MojoCollection\" />\n\n==Track listing==\nAll tracks written by The Beta Band.\n\n#\"The Beta Band Rap\" \u2013 4:41\n#\"It's Not Too Beautiful\" \u2013 8:29\n#\"Simple Boy\" \u2013 2:18\n#\"Round the Bend\" \u2013 4:56\n#\"Dance O'er the Border\" \u2013 5:33\n#\"Brokenupadingdong\" \u2013 4:46\n#\"Number 15\" \u2013 6:49\n#\"Smiling\" \u2013 8:35\n#\"The Hard One\" \u2013 10:06\n#\"The Cow's Wrong\" \u2013 5:49\n\n==Personnel==\n*Steve Mason - vocals\n*Richard Greentree \u2013 bass\n*Robin Jones \u2013 drums\n*Chris Allison \u2013 producer, recorder\n*John Maclean \u2013 sampler, turntables\n*Fergus Percell \u2013 human beatbox (track 5)\n*Kingsley \u2013 vocals (track 1)\n*Neil Richardson \u2013 trumpet (track 9)\n*Gordon Anderson \u2013 lyrics (track 10)\n*Stephen Mason \u2013 lyrics (track 10)\n\n==References==\n{{reflist|30em}}\n\n==External links==\n*{{MusicBrainz release group|name=The Beta Band|id=4e78704a-2ab1-3352-b7e0-3a3b355ca6b7}}\n\n{{The Beta Band}}\n\n{{DEFAULTSORT:Beta Band, The}}\n[[Category:The Beta Band albums]]\n[[Category:1999 debut albums]]\n[[Category:Astralwerks albums]]\n[[Category:Experimental music albums by Scottish artists]]\n[[Category:Psychedelic music albums by Scottish artists]]\n", "text_old": "{{Infobox album\n| name       = The Beta Band\n| type       = studio\n| artist     = [[The Beta Band]]\n| cover      = Betaband eponymous.jpg\n| alt        =\n| released   = 21 June 1999\n| recorded   = 1999\n| venue      =\n| studio     =\n| genre      = [[Psychedelic music|Psychedelia]], [[experimental music|experimental]], [[alternative pop]]\n| length     = 62:02\n| label      = {{hlist|[[Regal Zonophone Records|Regal]]|[[Astralwerks]]}}\n| producer   = {{hlist|The Beta Band|[[Chris Allison]]}}\n| prev_title = [[The Three E.P.'s]]\n| prev_year  = 1998\n| next_title = [[Hot Shots II]]\n| next_year  = 2001\n}}\n\n'''''The Beta Band''''' is the official studio debut album of [[The Beta Band]], released in June 1999 by [[Regal Records (1914)|Regal Records]]. The album followed the critically acclaimed compilation of their first three [[Extended play|EPs]] titled ''[[The Three E.P.'s]]'' (1998). With high anticipation for ''The Beta Band'', the band originally planned to record the album in four separate continents, but financial constraints slimmed the recording locations down; however, the album was still recorded in a variety of locations. The band approached creating the songs in a variety of ways, sometimes forming songs from single melodies, sometimes bringing together other strands of music, among other forms.\n\nThe album builds upon the experimental nature of their EPs, and is often seen as a particularly intricate, experimental and layered album, with a variety of different influences, sound effects, instrumentation and song structures. Based more-so around beat and rhythm than prior releases, the numerous different styles and influences incorporated into ''The Beta Band'' include [[psychedelia]], [[hip hop music|hip hop]] and [[blues music|blues]]. Vocalist [[Steve Mason (musician)|Steve Mason]] described his lyrics as fitting but without narrative interests. The band also recorded an [[ambient music|ambient]] bonus disc of two long compositions, but decided not to include the disc in the final release.\n\nUpon its release, the band made their dissatisfaction with the album public, infamously calling it \"fucking awful,\"<ref name=\"on-second\">{{cite web |url=http://www.stylusmagazine.com/articles/on_second_thought/the-beta-band-the-beta-band.htm |title=The Beta Band \u2013 The Beta Band \u2013 On Second Thought |work=[[Stylus Magazine]] |date=22 November 2005 |accessdate=8 November 2010 |last=Miller |first=Derek |archiveurl=https://web.archive.org/web/20170206104210/http://www.stylusmagazine.com/articles/on_second_thought/the-beta-band-the-beta-band.htm |archivedate=6 February 2017 |url-status=live }}</ref> largely blaming time constraints. Upon its release, it reached number 18 on the [[UK Albums Chart]]. Critics were favourable towards the album, although many found the album particularly messy and disappointing after the EPs. In later years however, several critics have found the album to be underrated and have praised its ambitions.\n\n==Background==\nIn 1997 and 1998, Scottish-based The Beta Band recorded their first releases, three EPs, ''[[Champion Versions]]'', ''[[The Patty Patty Sound]]'' and ''[[Los Amigos del Beta Bandidos]]'', which were met with high critical acclaim.<ref>{{cite web |last=Strong |first=Martin C. |authorlink=Martin C. Strong |title=The Beta Band Biography |url=http://thegreatrockbible.com/portfolio-item/beta-band-biography/ |website=The Great Rock Bible |accessdate=7 February 2017}}</ref> After signing to [[Regal Records (1914)|Regal Records]], a subsidiary of [[EMI]]'s label [[Parlophone]], the three EPs were released together as the album ''[[The Three E.P.'s]]'' in September 1998, which similarly was met with positive reviews.<ref>{{Cite web |url=http://www.netcomuk.co.uk/~tewing/ned/n43.html |title=The Beta Band \u2013 The Three EPs |work=[[Freaky Trigger]] |last=Raggett |first=Ned |date=November 1999 |archive-url=https://web.archive.org/web/20000518114629/http://www.netcomuk.co.uk/~tewing/ned/n43.html |archive-date=18 May 2000}}</ref><ref>{{cite web|last1=Warshaw|first1=Aaron|title=The Three E.P.'s \u2013 The Beta Band|url=http://www.allmusic.com/album/the-three-eps-mw0000048753|publisher=[[AllMusic]]|accessdate=7 February 2017}}</ref><ref>{{cite web|title=The Beta Band: The Three E.P.'s|url=http://www.popmatters.com/review/betaband-3eps/|website=[[PopMatters]]|accessdate=7 February 2017|archiveurl=https://web.archive.org/web/20170208035513/http://www.popmatters.com/review/betaband-3eps/|archivedate=8 February 2017|url-status=live}}</ref> In 1999, they signed to [[Astralwerks]] in the United States and the label subsequently released ''The Three E.P.'s'' in the country.<ref name=\"booklet2\">{{cite AV media notes| title = The Three E.P.'s| others= The Beta Band| year = 1999| type = liner| publisher = [[Astralwerks]]}}</ref> According to writer Ted Hedrickson, the band \u2013 consisting of multi-instrumentalists [[Steve Mason (musician)|Steve Mason]], [[Robin Jones (musician)|Robin Jones]], [[Richard Greentree]] and John MacLean \u2013 fused musical elements like [[ambient music|ambient]] [[drone (music)|drone]]s, [[trip hop]] beats and [[Pink Floyd]]-style introspective balladry to create their unique sound throughout their EPs, and that these releases \"served as a fabulous taster for the band's self-titled debut.\"<ref name=\"Hendrickson\" />\n\nBy the time of ''The Beta Band'', the group had undergone a successful, quick American tour while having become known in Britain for their live performances.<ref name=\"Hendrickson\" /> Their gigs typically featured films, a [[DJ set]] that they would perform before the show, and quirky on-stage sampling from Mclean.<ref name=\"Vanderloo\" /> Although anticipation for the band's official debut album was high,<ref name=\"on-second\" /> McLean later admitted they were \"sure a bit worried about doing an album.\"<ref name=\"Hendrickson\" /> They would later tour in the United States in promotion of ''The Beta Band''.<ref name=\"Hendrickson\" />\n\n==Writing and recording==\nEach song on the album was approached differently; some songs the band developed from a single idea or melody, while the chords and melodies of others were developed beforehand. Robin Jones stated \"We never really had a master plan ... after we did a song, we turned around and tried to do exactly the opposite. The most exciting songs were the ones where we were making something out of nothing.\"<ref name=\"great-scots\">{{cite web|last1=Perry|first1=Jonathan|title=Great Scots, It's the Beta Band!|url=https://www.rollingstone.com/music/news/great-scots-its-the-beta-band-19990613|website=[[Rolling Stone]]|date=13 June 1999|accessdate=6 February 2017}}</ref> Describing his lyrics for the record, vocalist Steve Mason explained he typically just followed \"the rhythms of the songs, more like a percussionist,\" and mentioned that the songs \"don't really tell a story. It's just words that go in there. They mean something, but they don't mean\u2026anything.\"<ref name=\"Vanderloo\" /> Despite some critics believing some of the tracks to be pastiches, the band explained to writer Lydia Vanderloo that they were not \"really into pastiche or irony or anything,\" with Maclean commenting, \"Everything's very serious and honest, hopefully. We're not so scared that we hide behind the irony that a lot of folks seem to hide behind these days.\"<ref name=\"Vanderloo\" /> Mason later explained to Hedrickson about the creation of the songs:\n{{quote|\"Each song starts differently, really. Some times it's a sample or a drum beat. Sometimes it's lyrics or a melody or something like that. It's different every time. [...] 'The Hard One' is a good example because we did something in a way we've never tried before. We don't really have songs where its verse and chorus, but the song has two verses and two choruses. Just to make it a bit more interesting we split everything up. We treated each section like a separate song. So the first verse was like one song. The second verse wasn't a copy at all and we tried to treat the choruses that way as well. Then we combined the songs together to make one song.\"<ref name=\"Hendrickson\" />}}\n\n[[File:Chris Allison.jpg|thumb|right|150px|[[Chris Allison]] co-produced ''The Beta Band''.]]\nAccording to [[Steve Taylor (author)|Steve Taylor]] in ''The A to X of Alternative Music'', none of the songs were prepared before the band entered the studio, which is where they were \"determined to keep their manual looping techniques.\"<ref name=\"The A to X of Alternative Music\">{{cite book|last1=Taylor|first1=Steve|title=The A to X of Alternative Music|date=27 September 2006|publisher=A&C Black|location=London|isbn=0826482171|page=32|url=https://books.google.com/books?id=KPOsu8JOHO8C&pg=PA32&dq=the+beta+band+1999&hl=en&sa=X&ved=0ahUKEwiCi5O3yvvRAhUFLcAKHUgQDFMQ6AEIMDAE#v=onepage&q=the%20beta%20band%201999&f=false}}</ref> The band's original intention for ''The Beta Band'' was for it to be a [[double album]] with each side of the LP recorded in a different continent, \"one in [[Tokyo]], one in [[Mexico]] and so on.\"<ref name=\"could-beta\"/> The band tried to plan this with their manager and Regal owner Miles Leonard, but ultimately Leonard dismissed the idea as impossible, \"it would have cost three-quarters of a million pounds or something and they would have lost the plot.\"<ref name=\"could-beta\"/>\n\nInstead, according to ''[[Spin (magazine)|Spin]]'', the album was at least partly recorded in a small hut belonging to Maclean's grandfather in a remote northwest part of Scotland, where the group found themselves with no room to sleep as they filled the hut with an excessive amount of musical equipment and homemade instruments.<ref name=\"space-jam\">{{cite journal|last1=McLean|first1=Craig|title=Space Jammers|journal=[[Spin (magazine)|Spin]]|date=June 1999|volume=15|issue=6|pages=114|url=https://books.google.com/books?id=xY9xO99TYMYC&pg=PA114&dq=spin+the+beta+band&hl=en&sa=X&ved=0ahUKEwjZsp3qu_vRAhXEVhQKHW6hBPEQ6AEIHjAB#v=onepage&q=spin%20the%20beta%20band&f=false|accessdate=6 February 2017}}</ref> [[Sawmills Studio]], [[Rockfield Studios]] and Jacobs Studio were also recording locations for the album.<ref name=\"MojoCollection\" /> In a 1999 interview, Mclean clarified that separate sections of the albums were recorded in different places places: \"Four songs here, four songs somewhere else. You know, break it up a bit?\"<ref name=\"Hendrickson\">{{cite journal|last1=Hendrickson|first1=Tad|title=The Last Word|journal=[[CMJ New Music Monthly]]|date=12 July 1999|volume=59|issue=626|page=53|url=https://books.google.com/books?id=bzN6AY_LLbwC&pg=PA53&lpg=PA53&dq=cmj+beta+band+hard+one&source=bl&ots=lhetCEJyav&sig=k7CD3HJKcRAfQx-tcJfuEfthJKU&hl=en&sa=X&ved=0ahUKEwis4MXuvf7RAhXJPxQKHadBCfMQ6AEIIzAC#v=onepage&q=cmj%20beta%20band%20hard%20one&f=false|accessdate=7 February 2017}}</ref> As with the band's prior releases, The Beta Band co-produced the album with [[Chris Allison]], who also engineered it, although the band's manager later admitted he felt the collaboration was not as successful this time.<ref name=\"could-beta\">{{cite web|title=Could Do Beta?|url=http://www.nme.com/news/music/beta-band-47-1386956|website=[[NME]]|accessdate=6 February 2017|date=15 May 1999}}</ref>\n\n===Ambient bonus disc===\nIn one of their attempts to \"make something out of nothing,\"<ref name=\"great-scots\"/> the band had originally intended the album to contain a bonus disc of two long form [[ambient music|ambient]] pieces, \"Happiness and Colour\" and \"The Hut\", both of which lasted over 20 minutes and represented the band's desire to \"make a record of sound as a description for something like happiness, where a distinct first part gives way to a distinct second part\".<ref name=\"great-scots\"/> The band's idea to record ''The Beta Band'' in Maclean's grandfather's hut was so they could record the sounds of the ocean for these pieces, and during which they discussed the possibility of a quadruple album.<ref name=\"space-jam\"/> After the band returned to London, they had with them several hours of audio that they had recorded, which were then edited down into the two tracks.<ref name=\"space-jam\"/>\n\nAccording to Craig McLean of ''[[Spin (magazine)|Spin]]'', \"both sounded a little random, like a radio scanning across the ether.\"<ref name=\"space-jam\"/> However, the band ultimately decided to remove these tracks from the album. Jones recalled: \"We liked some of what we recorded, but it's not really what we wanted it to be from start to finish. We felt the second part was lacking in direction.\"<ref name=\"great-scots\"/> Nonetheless, this decision came several weeks after the band's record label had already included the ambient disc with promotional copies of the album distributed to various people in the music industry.<ref name=\"great-scots\"/> Drummer Robin Jones felt the reason they dropped the disc was because they were rushed into constructing it in only four days, saying they intended it to be \"an ambient\u2026 sound-piece. It\u2019s really indulgent on our part, but I wanted to make it a musical story. In the same way ''[[Chill Out (KLF album)|Chill Out]]'' by [[The KLF]] is a story. So it sort of succeeds. It just needed more\u2026 conclusions. Rushed again.\"<ref name=\"could-beta\"/> The bonus disc was eventually released officially alongside special editions of the album's 2018 remaster.<ref name=\"Rough Trade\">{{cite web |title=Beta Band The Beta Band (Deluxe Edition) |url=https://www.roughtrade.com/gb/music/beta-band-the-beta-band-deluxe-edition |website=Rough Trade |accessdate=14 May 2019}}</ref>\n\n==Composition==\n===Musical style===\n{{quote box|quote=\"''The Beta Band'' swerves crazily from [[Wagnerian]] drama ('It's Not So Beautiful') to futurist [[country-rock]] ('Broken Up Like a Ding-Dong'), with detours into [[prog-rock]], proto-[[Hip hop music|hip-hop]] and [[ambient dub]].\"|source=\u2014Craig Mclean of ''[[Spin (magazine)|Spin]]''.<ref name=\"space-jam\" />|width=20%|align=right|style=padding:8px;|border=2px}}\n\n''The Beta Band'' is an [[experimental music|experimental]],<ref name=\"on-second\" /> sonically complex,<ref name=\"allmusic-review\" /> dense and detailed album.<ref name=\"allmusic-review\" /> Unlike the band's previous EPs, which presented their varied genre influences in a less coarse way, the album is more abstract<ref name=\"Hendrickson\" /> and beat-minded,<ref name=\"Hart\" /> fusing genres more abrasively,<ref name=\"regal-years\">{{cite web|last1=Berman|first1=Stuart|title=The Beta Band: The Regal Years: 1997\u20132004|url=http://pitchfork.com/reviews/albums/18603-the-beta-band-the-regal-years-1997-2004/|website=[[Pitchfork (website)|Pitchfork]]|accessdate=6 February 2017|date=4 November 2013}}</ref> whilst being less influenced by [[folk music]].<ref name=\"Hendrickson\" /> Described by [[AllMusic]]'s Jason Ankeny as \"a brashly schizophrenic freak-out which weaves its way throughout the history of rock & roll,\"<ref name=\"allmusic-review\" /> the album crosses a wide variety of musical ground which, in the words of ''[[CMJ New Music Monthly]]'', makes it \"hard to locate exactly where the foursome are coming from.\"<ref name=\"Vanderloo\" /> Ankeny, describing the styles, said: \"[[Pop music|Pop]], [[blues]], [[folk music|folk]], [[psychedelia]], [[hip-hop]] -- they're all here, sometimes even colliding within the same song; the disc somehow sounds almost completely different with each successive listen, consistently revealing new layers and possibilities.\u201d<ref name=\"allmusic-review\" />\n\nThe ten songs on the album rely on a snippet of melody, often sung and played on acoustic guitar by Steve Mason, but surrounding his voice are not only guitars or drums but many other, more unusual instruments and techniques, including [[sampling (music)|samples]], [[xylophones]], [[sleigh bell]]s, [[hand claps]], [[spoon]]s, and a diversity of [[bird song|bird whistle]]s, including a [[cuckoo]],<ref name=\"Vanderloo\" /> with its songs integrating numerous [[tape loop]]s and offbeat [[breakbeat]]s into what writer Ron Hart called the album's \"[[ambient music|ambient]] [[classic rock]] jams and textured pop melodies.\"<ref name=\"Hart\" /> The music is said to disregard melody and other examples of [[musical theory]] such as verses and choruses in favour a chaotic approach.<ref name=\"allmusic-review\" /> Jonathan Perry of ''[[Rolling Stone]]'', describing the tracks, said:\n{{quote|\"Each track unfolds into panoramic vistas of texture and sound that suggest other ethereal worlds even as the band's approach remains rooted in organic instrumentation like acoustic guitar and percussion and lyrics that often amount to little more than earth-bound mantra-like chants. It's that sense of improvisational freedom within the framework of a specific song that gives the band's material its expansive flair\"<ref name=\"great-scots\" />}}\n\nAs with prior albums, the band's early [[Pink Floyd]] influence is prominent throughout ''The Beta Band'',<ref name=\"Hart\" /> although hip hop is said to be a more prominent influence on this record,<ref name=\"great-scots\" /> with rapping, splicing and samples appearing prominently.<ref name=\"Vanderloo\" /> Mason hoped, regardless of the \"really obvious\" criss-cross of styles on \"The Beta Band Rap\", the band's various influences throughout the rest of ''The Beta Band'' would sound \"a bit more subtly involved.\"<ref name=\"Vanderloo\" /> He also felt the record was both a conscious and natural effort, adding \"it's just something we all really wanted to do,\"<ref name=\"Hendrickson\" /> while Greentree himself described the album as \"like a bird without all the fleshy bits and feathers.\"<ref name=\"Vanderloo\" /> ''[[Stylus Magazine]]''{{'}}s Derek Miller called the album a \"testimony to balls-out astral tribalism\" which features \"some of the more singular '[[alternative pop|alt-pop]] music' of the last decade,\" while doing so \"in a veiled manner that never shows its hand until you\u2019re four songs deep and still stuck in thought about the first.\u201d<ref name=\"on-second\" />\n\n===Songs===\n\"The Beta Band Rap\" opens the album and consists of three distinctive parts, opening with a spirited [[marching band]] introduction that segues into a rap section whose lyrics recount the band's history to date in detail,<ref name=\"regal-years\"/> describing the band's formation, signing to [[Parlophone]] subsidiary label [[Regal Records (1914)|Regal Records]] and \"drinking champagne at [[EMI]].\"<ref name=\"great-scots\" /> It was described by writer Stuart Berman as \"actually equal parts [[barbershop quartet|barbershop-quartet]] serenade, proto-'[[Lazy Sunday (The Lonely Island song)|Lazy Sunday]]' faux [[b-boy]] braggadocio, and [[Elvis Presley|Elvis]] pelvis thrusts.\"<ref name=\"regal-years\"/> \"It's Not Too Beautiful\" follows, starting with pulsating guitars that push \"a wished whirlpool sound\" and followed by Mason's [[multitrack recording|multitracked]] vocals.<ref name=\"on-second\" /> According to one review, \"the song seems to take flight on the whirl of a helicopter, with blades blunted and made soft by the dander in the air.\"<ref name=\"on-second\" /> \"Simple Boy\" is a quieter song, backed by atmospheric changes.<ref name=\"on-second\" />\n\n{{quote box|quote=\"The Beta Band were always headstrong, and here you see them chasing their own tails in wild-eyed delight, summoning all the fires of the forest and the scattered stars in the sky to cast light on their studio jams.\"|source=\u2014Derek Miller of ''[[Stylus Magazine|Stylus]]''<ref name=\"on-second\" />|width=20%|align=left|style=padding:8px;|border=2px}}\nDescribed as a [[country rock]] ramble,<ref name=\"regal-years\"/> \"Round the Bend\" is among the more focused songs.<ref name=\"Bowe\" /> Mason's very specific lyrics are displayed as internal monologue as he recalls a disappointing night.<ref name=\"Bowe\" /> He blends simple thoughts about drinking and dinner with travel fantasies about pyramids, opinions on [[the Beach Boys]]' ''[[Wild Honey (album)|Wild Honey]]'' and \"moments of deep awkwardness\".<ref name=\"Bowe\" /> A jam of both organic and electronic elements, \"Dance O\u2019er the Border\" is heavy on repetition and percussion and lacks a melody for the first four minutes, while featuring lyrics that forgo verses, choruses and rhyming in favour of Mason spoken, [[stream-of-consciousness]] comments.<ref name=\"Bowe\" /> Miles Bowe named it the album's best song and the band's fifth best overall, saying that although not \"very representative of the Beta Band's sound,\" it \"does a pretty great job\" of anticipating [[LCD Soundsystem]].<ref name=\"Bowe\" />\n\n\"Brokenupadingdong\" and \"Smiling\" were compared to [[Julian Cope]] by writer Tom Ewing, who described them as \"ramshackle campfire clapalong jams with a powerful communal momentum\" that partly recall [[Amon Duul I]], [[Can (band)|Can]] and late 1980s British [[house music]].<ref name=\"Ewing\" /> Between them is \"Number 15\", a frustrated song with an emphasis on dance music and unusual choral refrains,<ref name=\"on-second\" /> alongside [[gamelan]] elements played with [[kitchen utensil]]s.<ref name=\"Ewing\" /> \"The Hard One\" was partly inspired by [[Bonnie Tyler]]'s 1983 hit \"[[Total Eclipse of the Heart]]\". The band sampled the piano motif from the song, and \"although [they] put it through stuff,\" they declared it \"their cover version\"; \"We switched the lyrics to the chorus around\", Mason told ''[[CMJ New Music Monthly|CMJ]]'', \"I thought that it was a great song, so we ended up writing a tune around it.\"<ref name=\"Hendrickson\" /> [[Jim Steinman]], who wrote and produced \"Total Eclipse of the Heart\", threatened the band with legal action over using its lyrics, \"Once upon a time I was falling in love, now I'm only falling apart,\"<ref name=\"CMJJune1999\" /> which the band changed slightly so that they became \"Once upon a time I was falling apart, now I'm only falling in love,\"<ref name=\"Day\">{{cite journal |last1=Day |first1=Adrienne |title=Reviews |journal=Vibe |date=August 1999 |volume=6 |issue=10 |page=181 |url=https://books.google.co.uk/books?id=YygEAAAAMBAJ&pg=PA181&dq=beta+band+hard+one+falling+in+love&hl=en&sa=X&ved=0ahUKEwjn_e_x1JviAhUHRBUIHY9DBUcQ6AEILDAB#v=onepage&q=beta%20band%20hard%20one%20falling%20in%20love&f=false |accessdate=14 May 2019}}</ref> but changed his mind after he heard the song.<ref name=\"CMJJune1999\">{{cite journal|title=Steinman Backs Off The Beta Band|journal=CMJ New Music Monthly|date=28 June 1999|volume=59|issue=624|page=11|url=https://books.google.com/books?id=zDJToDVsTA4C&pg=PA11&lpg=PA11&dq=cmj+beta+band+hard+one&source=bl&ots=Y8n44wN_IV&sig=N0LpxbU4lxzJu6o8aoUWlSjSjj8&hl=en&sa=X&ved=0ahUKEwis4MXuvf7RAhXJPxQKHadBCfMQ6AEIITAB#v=onepage&q=cmj%20beta%20band%20hard%20one&f=false|accessdate=7 February 2017}}</ref> \"The Cow's Wrong\" closes the record in a muted fashion.<ref>{{cite web |last1=Costa |first1=Maddy |title=The Beta Band Astoria, London |url=https://www.theguardian.com/culture/2000/jan/27/artsfeatures5 |website=The Guardian |accessdate=14 May 2019 |date=27 January 2000}}</ref><ref name=\"Schreiber\" />\n\n==Release and promotion==\n\n''The Beta Band'' was highly anticipated,<ref name=\"on-second\" /><ref name=\"space-jam\" /><ref name=\"great-scots\"/> with  ''Spin'' calling it \"one of the most anticipated releases in Britain since [[Oasis (band)|Oasis]]' ''[[Definitely Maybe]]''.\"<ref name=\"space-jam\"/> Prior to release, ''The Beta Band'' was played before an invite-only industry audience in a studio/bar in [[Shoreditch]], [[London]], which included [[Noel Gallagher]] and [[The Verve|Verve]] guitarist [[Nick McCabe]]. The band were in attendance, \"looking slightly embarrassed, like gate crashes at a party in their own home,\" according to Craig McLean.<ref name=\"space-jam\"/> Gallagher praised the album when talking to an ''NME'' journalist.<ref name=\"space-jam\"/> As the band told Lydia Vanderloo of ''[[CMJ New Music Monthly]]'', the band did not enjoy promoting the album.<ref name=\"Vanderloo\">{{cite journal|last1=Vanderloo|first1=Lydia|title=Motley Stew|journal=CMJ New Music Monthly|date=July 1999|issue=71|pages=32\u201334|url=https://books.google.com/books?id=sikEAAAAMBAJ&pg=PA32&lpg=PA32&dq=THE+BETA+BAND+CMJ&source=bl&ots=hLXvOyV3Db&sig=Kct4_l_1y9AutMyVcTkSIclZh_w&hl=en&sa=X&ved=0ahUKEwii_tOx4v3RAhUJrxoKHT_9C7sQ6AEIIDAC#v=onepage&q=THE%20BETA%20BAND%20CMJ&f=false|accessdate=7 February 2017}}</ref> ''The Beta Band'' was released by [[Regal Records (1914)|Regal Records]] in the United Kingdom on 21 June 1999,<ref name=\"MojoCollection\">{{cite book|title=The Mojo Collection: The Ultimate Music Companion|date=2007|publisher=Canongate Books|location=Edinburgh|isbn=1841959731|page=664|url=https://books.google.co.uk/books?id=AVQbF9lTBwgC&pg=PA664&lpg=PA664&dq=the+beta+band+21+june+1999+regal&source=bl&ots=NbImmzFrgV&sig=ACfU3U0601H3r4e56WYU6NKZr1WcWs4PnQ&hl=en&sa=X&ved=2ahUKEwiNyOjv25viAhWO2hQKHUhuCrkQ6AEwBHoECAgQAQ#v=onepage&q=the%20beta%20band%2021%20june%201999%20regal&f=false|accessdate=14 May 2019}}</ref> and by [[Astralwerks]] in the United States on 29 June 1999.<ref name=\"Hart\" /> Astralwerks also released \"Round the Bend\" and \"The Cow's Song\" as a promotional cassette single in the US.<ref name=\"booklet1\">{{cite AV media notes| title = Round the Bend/The Cow's Song| others= The Beta Band| year = 1999| type = liner| publisher = Astralwerks}}</ref> Upon its release, ''The Beta Band'' debuted and peaked at number 18 on the [[UK Albums Chart]] and stayed on the chart for two weeks.<ref>{{cite web|title=Beta Band|url=http://www.officialcharts.com/artist/3413/beta-band/|publisher=[[Official Charts Company]]|accessdate=7 February 2017}}</ref>\n\n===Band denouncement===\n[[File:SteveMason.jpg|thumb|140px|Band leader [[Steve Mason (musician)|Steve Mason]] (''pictured in 2010'') infamously denounced the album.]]\nA week prior to the album's release, Steve Mason infamously denounced the album as \"fucking awful\", adding that \"it\u2019s definitely the worst record we\u2019ve ever made and it\u2019s probably one of the worst records that\u2019ll come out this year.\"<ref name=\"could-beta\" /><ref name=\"Bowe\" >{{cite web|last1=Bowe|first1=Miles|title=The 10 Best Beta Band Songs|url=http://www.stereogum.com/1655001/the-10-best-beta-band-songs/franchises/10-best-songs/|website=[[Stereogum]]|accessdate=7 February 2017|date=6 February 2014}}</ref><ref name=\"allmusic-review\"/> Speaking to the ''[[NME]]'', he said the album contained \"some terrible songs,\" opining that none of the album's tracks were fully written or developed, dismissing them as \"[h]alf-written songs with jams in the middle.\u201d<ref name=\"could-beta\"/> Greentree felt the production should have been less muddy, while McLean noted that their apparent shortcomings were the band's fault; however, the band also blamed Regal for their dissatisfaction with the final album, including the abandoning of the ambient disc, which they saw as having been incomplete, and for not providing them with enough time or money to work on the album satisfyingly.<ref name=\"could-beta\"/>\n\nThe statements immediately caused tension between the band and their label; ''[[The Guardian]]'' quoted \"an enraged EMI chairman\" as demanding to know \"what the fuck is going on with the Beta Band?\"<ref>{{cite web|last1=Simpson|first1=Dave|title=Steve Mason: Out of the blackness|url=https://www.theguardian.com/music/2010/apr/06/steve-mason-beta-band-interview|website=[[The Guardian]]|accessdate=6 February 2017|date=6 April 2010}}</ref> The newspaper said the band \"began a public slagging match with their record company.\"<ref name=\"Petridis\">{{cite web|last1=Petridis|first1=Alexis|authorlink=Alexis Petridis|title=Effing but blinding|url=https://www.theguardian.com/lifeandstyle/2001/nov/30/shopping.artsfeatures|website=The Guardian|accessdate=6 February 2017|date=30 November 2001}}</ref> Miles Leonard, boss of Regal and the band's manager, dismissed their complaints, calling them \"lame excuses\" as \"they had as much time as they wanted to have to make it, they were not forced to do anything they didn't want to.\"<ref name=\"could-beta\"/> However, he did admit that some of the financial constraints lead him to prevent the band's continental recording idea, but felt the album was \"nowhere near as bad as they say,\" despite feeling it could have better.<ref name=\"could-beta\"/> By the time of follow-up album ''[[Hot Shots II]]'' (2001), the band's opinion on ''The Beta Band'' had not changed and spoke out against it being mentioned to them in interviews, with Greentree adding: \"We just never felt the album was properly finished.\"<ref name=\"Petridis\" />\n\n==Critical reception==\n{{Album ratings\n| rev1       = [[AllMusic]]\n| rev1Score  = {{Rating|4|5}}<ref name=\"allmusic-review\">{{cite web |url=http://www.allmusic.com/album/the-beta-band-mw0000667113 |title=The Beta Band \u2013 The Beta Band |last=Ankeny |first=Jason |publisher=AllMusic |accessdate=6 February 2017}}</ref>\n| rev2       = ''[[Entertainment Weekly]]''\n| rev2Score  = A\u2212<ref>{{cite web |url=http://ew.com/article/1999/07/16/beta-band-2/ |title=The Beta Band |last=Hermes |first=Will |authorlink=Will Hermes |work=[[Entertainment Weekly]] |date=16 July 1999 |accessdate=24 April 2017}}</ref>\n| rev3       = ''[[The Guardian]]''\n| rev3Score  = {{Rating|4|5}}<ref>{{cite news |title=Beta by far |last=Sullivan |first=Caroline |work=The Guardian |date=18 June 1999}}</ref>\n| rev4       = ''[[The Independent]]''\n| rev4Score  = {{Rating|3|5}}<ref>{{cite news |url=https://www.independent.co.uk/arts-entertainment/pop-album-reviews-1101119.html |title=Pop: Album Reviews |last=Perry |first=Tim |work=[[The Independent]] |date=19 June 1999 |accessdate=30 March 2020}}</ref>\n| rev5       = ''[[The List (magazine)|The List]]''\n| rev5Score  = {{Rating|5|5}}<ref>{{cite journal |url=https://archive.list.co.uk/the-list/1999-06-10/47/ |title=The Beta Band: The Beta Band (Regal) |last=Mabbott |first=Alastair |work=[[The List (magazine)|The List]] |issue=361 |date=10 June 1999 |accessdate=20 July 2017 |page=45}}</ref>\n| rev6       = ''[[NME]]''\n| rev6Score  = 6/10<ref>{{cite web |url=http://www.nme.com:80/reviews/reviews/19990516151016reviews.html |title=The Beta Band \u2013 The Beta Band |last=Mulvey |first=John |work=NME |date=16 June 1999 |accessdate=24 April 2017 |archiveurl=https://web.archive.org/web/20000817222055/http://www.nme.com/reviews/reviews/19990516151016reviews.html |archivedate=17 August 2000 |url-status=dead}}</ref>\n| rev7       = ''[[Pitchfork (website)|Pitchfork]]''\n| rev7Score  = 8.6/10<ref name=\"Pitchfork review\">{{cite web |url=http://www.pitchforkmedia.com/article/record_review/15407/Beta_Band_The_Beta_Band |title=Beta Band: The Beta Band |last=DiCrescenzo |first=Brent |work=Pitchfork |date=1 July 1999 |accessdate=7 February 2017 |archiveurl=https://web.archive.org/web/20080509203205/http://www.pitchforkmedia.com/article/record_review/15407-the-beta-band |archivedate=9 May 2008 |url-status=dead}}</ref>\n| rev8       = ''[[Q (magazine)|Q]]''\n| rev8Score  = {{Rating|4|5}}<ref>{{cite journal |title=The Beta Band: The Beta Band |work=[[Q (magazine)|Q]] |issue=155 |date=August 1999 |page=102}}</ref>\n| rev9       = ''[[Rolling Stone]]''\n| rev9Score  = {{Rating|3|5}}<ref name=\"RS review\">{{cite web |url=https://www.rollingstone.com/artists/thebetaband/albums/album/116673/review/5941751/the_beta_band |title=The Beta Band: The Beta Band |last=Sheffield |first=Rob |authorlink=Rob Sheffield |work=Rolling Stone |date=8 July 1999 |accessdate=7 February 2017 |archiveurl=https://web.archive.org/web/20100111050221/http://www.rollingstone.com/artists/thebetaband/albums/album/116673/review/5941751/the_beta_band |archivedate=11 January 2010 |url-status=dead}}</ref>\n| rev10       = ''[[Select (magazine)|Select]]''\n| rev10Score  = 3/5<ref>{{cite journal |title=The Beta Band: The Beta Band |last=Harris |first=John |authorlink=John Harris (critic) |work=[[Select (magazine)|Select]] |issue=109 |date=July 1999 |page=89}}</ref>\n}}\n\n''The Beta Band'' was less well received by music critics than the Beta Band's previous releases.<ref name=\"on-second\" /> According to ''[[Pitchfork (website)|Pitchfork]]''{{'}}s Stuart Berman, the album \"deflated the ballooning expectations surrounding the group in the wake of ''The Three EPs'' with all the elegance and subtlety of a whoopee cushion.\"<ref name=\"regal-years\"/> While many critics praised the band's ambitions, the album was also concurrently criticised as overstuffed and messy.<ref name=\"allmusic-review\" /><ref name=\"The A to X of Alternative Music\"/> In a retrospective piece, Derek Miller of ''[[Stylus Magazine]]'' disagreed that it was messy, saying it was \"brave and cohesive,\" and noted how \"they manage to somehow form a whole out of shattered, uneven pieces. It\u2019s awkward, [[Salvador Dal\u00ed|Dalian]], almost completely disinterested in closing the circle, and that\u2019s the beauty in its madness.\"<ref name=\"on-second\" />\n\nAmong original reviews, Brent DiCrescenzo of ''[[Pitchfork (website)|Pitchfork]]'' hailed ''The Beta Band'' as a unique sounding album that was \"so psychedelic, yet not excessively experimental.\"<ref name=\"Pitchfork review\"/> Ron Hart, writing for ''[[CMJ New Music Monthly]]'', was favourable, praising the album and its \"experimental dabblings\" a \"fully realised concept.\"<ref name=\"Hart\">{{cite journal|last1=Hart|first1=Ron|title=Must Hear|date=21 June 1999|work=CMJ New Music Monthly|volume=59|issue=623|page=3|url=https://books.google.com/books?id=n-JzBKPWncQC&pg=PA3&lpg=PA3&dq=THE+BETA+BAND+CMJ&source=bl&ots=k0egKUSIwh&sig=7EnVlpa7HRKrMY1Kwn8qMylJgCo&hl=en&sa=X&ved=0ahUKEwjbqYPo6P3RAhUFnBoKHf1yDs0Q6AEIMTAF#v=onepage&q=THE%20BETA%20BAND%20CMJ&f=false|accessdate=7 February 2017}}</ref> [[Rob Sheffield]] of ''[[Rolling Stone]]'' said the band \"layer warped voices, pastoral guitars and random sound effects over slow-motion loops to evoke a chance meeting between [[King Crimson]] circa 1969 and [[Happy Mondays]] circa 1989,\" highlighting \"The Cow's Wrong.\"<ref name=\"RS review\"/> [[Robert Christgau]] of ''[[The Village Voice]]'' gave the album a three-star honourable mention rating, signifying \"an enjoyable effort consumers attuned to its overriding aesthetic or individual vision may well treasure.\"<ref>{{cite book |chapter-url=http://www.robertchristgau.com/xg/bk-cg90/grades-90s.php |chapter=Key to Icons |accessdate=7 February 2017 |title=[[Christgau's Consumer Guide: Albums of the '90s]] |last=Christgau |first=Robert |authorlink=Robert Christgau |publisher=[[St. Martin's Press]] |year=2000 |isbn=0-312-24560-2}}</ref> He stated that the band is \"still lost in sound, but oriented enough here to make tunes out of it.\"<ref name=\"Christgau\">{{cite book |chapter-url=https://www.robertchristgau.com/get_album.php?id=3495 |chapter=The Beta Band: The Beta Band |accessdate=6 February 2017 |title=Christgau's Consumer Guide: Albums of the '90s |last=Christgau |first=Robert |publisher=St. Martin's Press |year=2000 |isbn=0-312-24560-2 |url-access=registration |url=https://archive.org/details/christgausconsum00chri_0 }}</ref>\n\nWriting several months after the release of ''The Beta Band'', Tom Ewing of ''[[Freaky Trigger]]'' called it \"the most troublesome album of 1999,\" highlighting how \"its makers disown it, its few disciples adore it, a whole lot of people hate it, and a whole lot more like me just don't know what to make of it, but keep playing it anyway. While there are certainly good bits and bad bits on ''The Beta Band'', it\u2019s not always possible to work out which is which, let alone pull them apart. And the funny thing is that after a few months you stop caring and just take the whole damn lot as it comes.\"<ref name=\"Ewing\">{{cite web|last1=Ewing|first1=Tom|title=Messthetics: The Beta Band \u2013 The Beta Band|url=http://freakytrigger.co.uk/ft/1999/10/beta/|website=Freaky Trigger|accessdate=27 May 2017|date=17 October 1999}}</ref>\n\nAt the end of 1999, ''The Beta Band'' was ranked in several publications' lists of the year's best albums; ''Intro'' named it 9th,<ref name=\"acclaimed\">{{cite web|title=The Beta Band|url=http://www.acclaimedmusic.net/Current/A3767.htm|publisher=[[Acclaimed Music]]|accessdate=7 February 2017}}</ref> ''[[Mojo (magazine)|Mojo]]'' named it the 10th,<ref name=\"acclaimed\" /> ''[[Rockdelux]]'' named it the 26th,<ref name=\"acclaimed\" /> ''[[Muzik]]'' named it the 27th,<ref name=\"acclaimed\" /> and ''[[NME]]'' named it the 36th.<ref>{{Cite web |url=http://www.nme.com/bestalbumsandtracksoftheyear/1999-2-1045360 |title=Albums And Tracks of the Year: 1999 |work=NME |access-date=9 February 2017}}</ref> In a retrospective review, [[AllMusic]] critic Jason Ankeny thought that the album \"constantly runs the risk of collapsing into complete self-indulgence.\" Nevertheless, Ankeny further stated: \" In its way the Beta Band's genius is their wanton disregard for niceties like verses, choruses, and melodies; rejecting musical theory in favor of the chaos theory, the album's neither a masterpiece nor a mess, but both.\"<ref name=\"allmusic-review\"/> Miles Bowe of ''[[Stereogum]]'' have conceded no less that \"everyone knew that the record was rushed, and that maybe the band didn\u2019t have enough time to fully develop the songs or lyrics as much,\" while also noting that \"people tend to forget that ''The Beta Band'' is not 'fucking awful' \u2014 it\u2019s actually pretty fucking great.\"<ref name=\"Bowe\" />\n\n==Legacy==\n{{quote box|quote=\"''The Beta Band'' stands as a time capsule of possibly the last instance when a group this strange could not just get signed to a major label, but use the company dime to make themselves sound even stranger.\"|source=\u2014Stuart Berman of ''[[Pitchfork (website)|Pitchfork]]'', 2013<ref name=\"regal-years\"/>|width=25%|align=right|style=padding:8px;|border=2px}}\nIn retrospect, ''The Beta Band'' has been re-assessed by some critics and considered underrated.<ref name=\"The Best of the Beta Band\">{{cite web|last1=Harvell|first1=Jess|title=The Beta Band: The Best of the Beta Band|url=http://pitchfork.com/reviews/albums/672-the-best-of-the-beta-band/|website=Pitchfork|accessdate=6 February 2017|date=3 October 2005}}</ref><ref name=\"regal-years\"/>\nWriting in 2005, Jess Harvell of ''[[Pitchfork (website)|Pitchfork]]'' felt the band were neglected by critics and said \"there's not a single band in the past year with the balls\u2013 or lack of sense, your call\u2013 to release a debut album as overgrown with ideas (not always good ones, mind you) as ''The Beta Band''.\"<ref name=\"The Best of the Beta Band\"/> Stuart Berman, also of ''Pitchfork'', described ''The Beta Band'' as the group's most notorious release and felt it was the last known example of a \"group this strange\" signing to a major label and then using their new label to make even stranger music, especially when considering the abandoned ambient bonus disc. \"If the record violently vascillates between fascinating and frustrating on a song-by-song basis,\" he said, \"its over-arching oddness retains its own peculiar allure.\"<ref name=\"regal-years\"/>\n\nDerek Miller of ''[[Stylus Magazine]]'' said that by the time the band split up in 2004, ''The Beta Band'' was widely considered to be \"unnecessarily difficult, a short side-step in the career of a remarkably talented band,\" but he felt the album had been long underrated and was due for re-evaluation, praising its unique sound and adding that it \"remains the broken-toothed step-child with a little bit of dander on the lip and a tangle of hair on its back, but Christ those eyes, so keen and full of mischief, forgive the ugly parts.\"<ref name=\"on-second\"/> ''Pitchfork'' founder Ryan Schreiber called ''The Beta Band'' \"the greatest acid-burnt full-length of the late 90's\", saying that although it \"took some getting used to, since half of its songs were, to put it gently, cracked,\" the \"densely layered electronic psychedelia\" songs proved the band as \"one of the few modern electronic-based bands capable of successfully splicing hundreds of self-created sources into huge, pastoral symphonies, grounded in both pop music and [[Salvador Dali|Dali]] [[surrealism]].\"<ref name=\"Schreiber\">{{cite web|last1=Schreiber|first1=Ryan|title=The Beta Band|url=http://pitchfork.com/features/interview/5825-the-beta-band/|website=Pitchfork|accessdate=6 February 2017|date=1 August 2001}}</ref> The album is featured in ''[[Mojo (magazine)|Mojo]]'' magazine's book ''The Mojo Collection'', which lists what its authors consider to be the 1,000 greatest albums of all time.<ref name=\"acclaimed\"/><ref name=\"MojoCollection\" />\n\n==Track listing==\nAll tracks written by The Beta Band.\n\n#\"The Beta Band Rap\" \u2013 4:41\n#\"It's Not Too Beautiful\" \u2013 8:29\n#\"Simple Boy\" \u2013 2:18\n#\"Round the Bend\" \u2013 4:56\n#\"Dance O'er the Border\" \u2013 5:33\n#\"Brokenupadingdong\" \u2013 4:46\n#\"Number 15\" \u2013 6:49\n#\"Smiling\" \u2013 8:35\n#\"The Hard One\" \u2013 10:06\n#\"The Cow's Wrong\" \u2013 5:49\n\n==Personnel==\n*Steve Mason - vocals\n*Richard Greentree \u2013 bass\n*Robin Jones \u2013 drums\n*Chris Allison \u2013 producer, recorder\n*John Maclean \u2013 sampler, turntables\n*Fergus Percell \u2013 human beatbox (track 5)\n*Kingsley \u2013 vocals (track 1)\n*Neil Richardson \u2013 trumpet (track 9)\n*Gordon Anderson \u2013 lyrics (track 10)\n*Stephen Mason \u2013 lyrics (track 10)\n\n==References==\n{{reflist|30em}}\n\n==External links==\n*{{MusicBrainz release group|name=The Beta Band|id=4e78704a-2ab1-3352-b7e0-3a3b355ca6b7}}\n\n{{The Beta Band}}\n\n{{DEFAULTSORT:Beta Band, The}}\n[[Category:The Beta Band albums]]\n[[Category:1999 debut albums]]\n[[Category:Astralwerks albums]]\n[[Category:Experimental music albums by Scottish artists]]\n[[Category:Psychedelic music albums by Scottish artists]]\n", "name_user": "John of Reading", "label": "safe", "comment": "\u2192\u200eWriting and recording:Typo fixing, replaced: places places \u2192 places", "url_page": "//en.wikipedia.org/wiki/The_Beta_Band_(album)"}
